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Abstract 
Pharmaceuticals intended for human use are frequently detected in the aquatic 
environment. This is predominantly from their excretion following ingestion and subsequent 
discharge in domestic sewage. Wastewater treatment provides an opportunity to control 
their release to surface waters however, their removal is often incomplete. This thesis 
addresses this pharmaceutical pathway and the potential impact on the aquatic 
environment. 
The progress of bezafibrate, carbamazepine, ciprofloxacin and clarithromycin were 
monitored through the treatment stages (screened sewage, settled sewage and final 
effluent) of a large urban wastewater treatment plant (WWTP) and in surface waters up-
stream and down-stream of the effluent discharge point. All except clarithromycin were 
detected in the screened sewage (369 – 2696 ng/L). Reductions in the pharmaceutical 
concentrations throughout the WWTP (22.5 – 94.3 %) indicate the removal of these 
compounds is variable.  Bezafibrate and carbamazepine were observed at higher 
concentrations (67.5 - 305.5 ng/L) in surface water down-stream of the effluent discharge 
point compared to up-stream (31.0 – 116.7 ng/L).  
The presence of antibiotics in the environment may contribute to the dissemination of 
antibiotic resistance. The second part of this thesis monitors the prevalence of resistant 
faecal bacteria through WWTPs and in surface waters. Determination of antibiotic minimum 
inhibitory concentration (MIC) values for E.coli and E.faecium indicated that the WWTP did 
not influence the proportions of the resistant bacterial species. Elevated levels of E.coli with 
acquired ciprofloxacin resistance increased from not detectable in surface waters up-stream 
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to 9.3% down-stream of the WWTP discharge point. The need for standardisation of the 
interpretation of MIC data is addressed. 
The potential of ciprofloxacin within surface water to select for ciprofloxacin resistant E.coli 
were investigated through microcosm studies in the third part of this study. A significant 
increase (p < 0.05) in the level of resistant E.coli was observed in microcosms exposed to ≥ 5 
µg/L ciprofloxacin. At the ciprofloxacin levels typically detected in surface waters receiving 
treated effluent (<300 ng/L), the levels of resistance amongst E.coli were maintained. 
iii 
 
Contents 
Abstract ................................................................................................................................................ i 
Contents ......................................................................................................................................... iii 
List of figures ................................................................................................................................... x 
Abbreviations .............................................................................................................................. xviii 
Acknowledgments ........................................................................................................................ xix 
1 Introduction .............................................................................................................. 1 
1.1 Thesis objectives .......................................................................................................... 5 
1.1.1 Rationale ......................................................................................................................................... 5 
1.1.2 Aims ................................................................................................................................................ 6 
1.2 Organisation of thesis .................................................................................................. 7 
2 The Occurrence of Pharmaceuticals in Environmental Waters .................................. 10 
2.1 Pharmaceuticals ........................................................................................................ 10 
2.1.1 Pharmaceutical consumption ....................................................................................................... 10 
2.2 Sources of pharmaceuticals into the aquatic environment ........................................... 11 
2.2.1 Pharmaceuticals and the wastewater treatment process ............................................................ 12 
2.3 Occurrence of pharmaceuticals in wastewater and surface water ............................... 18 
2.4 Analytical methods to detect pharmaceuticals in environmental waters ...................... 20 
iv 
 
2.4.1 Sample preparation and analysis .................................................................................................. 20 
2.4.2 Liquid chromatography-mass spectrometry (LC-MSn) .................................................................. 21 
2.5 Legislation relating to the occurrence of pharmaceuticals in environmental waters ..... 23 
2.5.1 The Water Framework Directive ................................................................................................... 24 
2.5.2 Urban Wastewater Treatment Directive (UWWTD) ..................................................................... 24 
2.5.3 Registration, evaluation, authorisation and restriction of chemicals (REACH) ............................. 25 
2.5.4 European Medicines Agency (EMA) .............................................................................................. 25 
3 Water quality indicator bacteria and antibiotic resistance ....................................... 28 
3.1 Microbial indicators of water quality .......................................................................... 28 
3.1.1 Coliform bacteria and Escherichia coli .......................................................................................... 29 
3.1.2 Enterococci .................................................................................................................................... 30 
3.1.3 Staphylococci ................................................................................................................................ 31 
3.1.4 Pseudomonas aeruginosa ............................................................................................................. 32 
3.2 Detection, enumeration and identification of indicator bacteria .................................. 32 
3.2.1 Enumeration methods .................................................................................................................. 33 
3.2.2 Identification of bacteria .............................................................................................................. 36 
3.3 Antibiotic resistance in bacteria indicative of faecal contamination ............................. 40 
3.3.1 Antibiotics and antibiotic action on bacteria ................................................................................ 40 
v 
 
3.3.2 Mechanisms of antibiotic resistance ............................................................................................. 43 
3.3.3 Dissemination of antibiotic resistance .......................................................................................... 44 
3.3.4 Antibiotic resistance in environmental waters.............................................................................. 47 
3.3.5 Antibiotic resistance in E.coli ........................................................................................................ 48 
3.3.6 Antibiotic resistance in enterococci .............................................................................................. 50 
3.4 Antibiotic susceptibility testing ................................................................................... 53 
3.4.1 Definition of resistance to antibiotics ........................................................................................... 55 
4 Detection of Pharmaceuticals in the Urban Water Environment ............................... 58 
4.1 Introduction ............................................................................................................... 58 
4.1.1 Selection of pharmaceuticals ........................................................................................................ 59 
4.2 Materials and methods for the analysis of pharmaceuticals in environmental waters .. 70 
4.2.1 Chemicals and reagents ................................................................................................................ 70 
4.2.2 Description of study area .............................................................................................................. 70 
4.2.3 Sample collection .......................................................................................................................... 72 
4.2.4 Water quality parameter analysis ................................................................................................ 75 
4.2.5 Analytical method to determine target pharmaceutical concentrations...................................... 76 
4.2.6 Validation of the analytical method to determine target pharmaceuticals in environmental 
waters 78 
4.2.7 Prediction of pharmaceutical consumption .................................................................................. 79 
vi 
 
4.3 Wastewater and surface water analysis ..................................................................... 80 
4.3.1 Water quality parameters ............................................................................................................ 80 
4.3.2 Detection of pharmaceuticals in environmental waters with LC-MSn .......................................... 81 
4.3.3 Occurrence of pharmaceuticals in wastewaters and surface waters ........................................... 93 
4.3.4 Reduction of pharmaceuticals through wastewater treatment processes. .................................. 96 
4.3.5 Comparison of predicted and measured influent concentrations ............................................... 100 
4.3.6 Comparison of pharmaceutical levels in surface waters up- and down-stream of the WWTP 
treated effluent discharge point ............................................................................................................... 103 
4.4 Discussion ................................................................................................................ 105 
4.5 Summary ................................................................................................................. 119 
5 Antibiotic resistance patterns of Escherichia coli and enterococci in an urban 
environment ................................................................................................................. 121 
5.1 Introduction ............................................................................................................. 121 
5.1.1 Selection of bacteria ................................................................................................................... 123 
5.1.2 Selection of antibiotics for susceptibility testing ......................................................................... 124 
5.2 Materials and methods for bacterial analysis............................................................ 127 
5.2.1 Method overview ........................................................................................................................ 127 
5.2.2 Study area ................................................................................................................................... 128 
5.2.3 Sample collection ........................................................................................................................ 128 
vii 
 
5.2.4 Media and reagents .................................................................................................................... 129 
5.2.5 Detection and enumeration methods ......................................................................................... 130 
5.2.6 Identification methods ................................................................................................................ 134 
5.2.7 Antibiotic susceptibility testing method ...................................................................................... 139 
5.2.8 Reference control strains ............................................................................................................ 142 
5.2.9 Repeated sub-culture of resistant isolates .................................................................................. 144 
5.2.10 One and two proportions statistical analysis ......................................................................... 144 
5.3 Wastewater and surface water bacterial analysis ..................................................... 145 
5.3.1 Enumeration of indicator bacteria in wastewater and surface waters ...................................... 145 
5.3.2 Evaluation of detection and enumeration growth media to detect indicator bacteria in 
wastewater and surface water ................................................................................................................. 147 
5.3.3 Antibiotic resistance in Escherichia coli from environmental waters .......................................... 159 
5.3.4 Antibiotic resistance in E.faecium from environmental waters .................................................. 168 
5.4 Discussion ................................................................................................................ 177 
5.4.1 Indicator bacteria in wastewater and surface water .................................................................. 177 
5.4.2 Interpretive criteria for assessing antibiotic susceptibility in environmental bacteria ............... 180 
5.4.3 The antibiotic susceptibility of E.faecium and E.coli in environmental waters ........................... 182 
5.5 Summary ................................................................................................................. 189 
viii 
 
6 The prevalence of E.coli with resistance to ciprofloxacin within constructed 
microcosms. ................................................................................................................. 192 
6.1 Introduction ............................................................................................................. 192 
6.2 Material and methods .............................................................................................. 196 
6.2.1 Method overview ........................................................................................................................ 196 
6.2.2 Media and reagents .................................................................................................................... 200 
6.2.3 Microcosm preparation .............................................................................................................. 202 
6.2.4 Enumeration of total culturable E.coli ........................................................................................ 203 
6.2.5 Enumeration of E.coli resistant to 32, 64, 125 and 2000 µg/L ciprofloxacin .............................. 203 
6.2.6 Evaluation of TBX supplemented with ciprofloxacin to determine ciprofloxacin MIC values. .... 205 
6.2.7 Application of TBX supplemented with ciprofloxacin to detect E.coli within surface waters ..... 206 
6.2.8 Evaluation of protozoa inhibitor compounds on the survival of E.coli in microcosms ................ 207 
6.2.9 Microcosm experiment to assess the proliferation of ciprofloxacin resistant E.coli ................... 208 
6.3 Microcosm bacteriological analysis .......................................................................... 211 
6.3.1 The effect of protozoa inhibitors on the survival of E.coli in surface water microcosms ............ 211 
6.3.2 Evaluation of TBX supplemented with ciprofloxacin to determine ciprofloxacin minimum 
inhibitory concentration values of E.coli. .................................................................................................. 212 
6.3.3 Application of TBX supplemented with ciprofloxacin to detect E.coli resistant to different 
concentrations of ciprofloxacin. ................................................................................................................ 213 
ix 
 
6.3.4 Microcosm experiments to assess the proliferation of ciprofloxacin resistant E.coli .................. 215 
6.4 Discussion ................................................................................................................ 228 
6.4.1 Microcosm studies ...................................................................................................................... 228 
6.4.2 Total culturable E.coli ................................................................................................................. 228 
6.4.3 Ciprofloxacin MIC determination ................................................................................................ 230 
6.4.4 Proportion of total E.coli with acquired ciprofloxacin resistance................................................ 231 
6.5 Summary ................................................................................................................. 236 
7 Conclusion ............................................................................................................ 238 
7.1 Occurrence of pharmaceuticals in environmental waters .......................................... 238 
7.2 Antibiotic resistance profiles of faecal indicators in environmental waters ................ 239 
7.3 Ciprofloxacin resistant profiles of E.coli in surface water microcosms ........................ 241 
7.4 Thesis recommendations and future work ................................................................ 242 
8 References ............................................................................................................ 245 
Appendix 1 ....................................................................................................................................... 269 
Appendix 2 ....................................................................................................................................... 270 
Appendix 3 ....................................................................................................................................... 271 
Appendix 4 ....................................................................................................................................... 272 
Appendix 5 ....................................................................................................................................... 273 
x 
 
List of figures 
Figure 2-1: Flow chart showing the major pathways of PPCPs within the environment. ....... 12 
Figure 2-2: Schematic showing ion trajectories through a quadrupole m/z selector ............. 22 
Figure 3-1: Histogram showing the distribution of ciprofloxacin minimum inhibitory 
concentration (MIC) values measured for Escherichia coli strains (n = 16702) submitted to 
the European Committee of Antimicrobial Susceptibility Testing (EUCAST). ......................... 57 
Figure 4-1: Arial view of the WWTP from which samples were collected. Arrows identify the 
locations for grit removal, the primary settling tanks, the activated sludge basins (AS) and 
the final settlement tanks. ....................................................................................................... 71 
Figure 4-2: Schematic of the WWTP sampled in this study. Red arrows indicate the positions 
of sampling points. ................................................................................................................... 73 
Figure 4-3: Map of the lower Lee catchment showing the locations of the surface water 
sampling points relative to the WWTP. ................................................................................... 74 
Figure 4-4: Map showing in more detail the location of the sampling point located down-
stream of the WWTP effluent discharge. ................................................................................ 75 
Figure 4-5: Chromatogram showing target pharmaceuticals in settled sewage. ................... 92 
Figure 4-6: Mean concentrations of target pharmaceuticals detected in different samples . 96 
Figure 4-7: The percentage reduction of bezafibrate, carbamazepine and ciprofloxacin 
calculated for each sampling occasion; following primary sedimentation (n = 3), activated 
sludge treatment (n = 6) and the overall reduction (n = 3).. ................................................. 100 
Figure 4-8: Interval plot presenting the individual concentrations of target pharmaceuticals 
in the surface waters both up- and down-stream of the treated effluent discharge point of 
the WWTP investigated in this study.. ................................................................................... 105 
xi 
 
Figure 5-1: API 20 Strep strips used for the identification of presumed enterococci isolates
................................................................................................................................................ 136 
Figure 5-2: Example of the comparison of MALDI-TOF-MS analysis acquired spectrum of an 
unknown bacterial sample to a reference spectrum in manufacturer’s bacteria database for 
the calculation of identification scores. ................................................................................. 139 
Figure 5-3: The measurement of amoxicillin and ciprofloxacin MIC values using antibiotic 
gradient strips.. ...................................................................................................................... 141 
Figure 5-4: The distribution (%) of enterococci species in settled sewage (Settled), final 
treated effluent (Final), surface water up-stream (Up) and down-stream (Down) of the 
wastewater treatment plant discharge point.. ...................................................................... 159 
Figure 5-5: Distributions of the amoxicillin MIC values measured for E.coli isolated from 
settled sewage, final effluent and surface waters up- and down-stream of the effluent 
discharge point. ..................................................................................................................... 163 
Figure 5-6: Distributions of ciprofloxacin MIC values measured for E.coli isolated from 
settled sewage, final effluent and surface waters up- and down-stream of the effluent 
discharge point. ..................................................................................................................... 164 
Figure 5-7: Distributions of cefpodoxime MIC values measured for E.coli isolated from 
settled sewage, final effluent and surface waters up- and down-stream of the effluent 
discharge point. ..................................................................................................................... 165 
Figure 5-8: Distribution of amoxicillin MIC values measured for E.faecium isolated from 
settled sewage, final effluent and surface waters up- and down-stream of the effluent 
discharge point.. .................................................................................................................... 172 
xii 
 
Figure 5-9: Distribution of ciprofloxacin MIC values measured for E.faecium isolated from 
settled sewage, final effluent and surface waters up- and down-stream of the effluent 
discharge point. ..................................................................................................................... 173 
Figure 5-10: Distribution of clarithromycin MIC values measured for E.faecium isolated from 
settled sewage, final effluent and surface waters up- and down-stream of the effluent 
discharge point.. .................................................................................................................... 174 
Figure 5-11: Distribution of vancomycin MIC values measured for E.faecium isolated from 
settled sewage, final effluent and surface waters up- and down-stream of the effluent 
discharge point.. .................................................................................................................... 175 
Figure 6-1: Changes in the total culturable E.coli concentrations within microcosms exposed 
to different protozoa inhibitor treatments ........................................................................... 213 
Figure 6-2: The enumeration of total culturable E.coli (average ± standard deviation) within 
the constructed microcosms exposed to different levels of additional ciprofloxacin on five 
sampling dates in November 2012 (A) and six sampling dates in July 2013 (B).................... 220 
Figure 6-3: The proportion (%) of E.coli with acquired ciprofloxacin resistance within 
microcosms exposed to different levels of ciprofloxacin over time. .................................... 229 
 
  
xiii 
 
List of tables 
Table 2-1: Pharmaceutical compounds detected in wastewater influents, effluents and 
surface waters .......................................................................................................................... 19 
Table 2-2: Physico-chemical, fate and effect studies recommended for the environmental 
risk assessment of new medicinal products with predicted surface water concentrations 
exceeding 10 ng/L. ................................................................................................................... 27 
Table 3-1: Specific culture media used to detect and enumerate bacteria indicators in 
environmental waters .............................................................................................................. 34 
Table 3-2: Biochemical confirmation tests for indicator bacteria ........................................... 37 
Table 3-3: Antibiotic classes and their modes of action (from Black, 1996) ........................... 42 
Table 3-4: Mechanisms of bacterial resistance to antibiotics (Black, 1996) ........................... 45 
Table 4-1: Structure and properties of the pharmaceuticals selected for this study ............. 60 
Table 4-2: Reported concentrations of selected pharmaceuticals in wastewaters. ............... 63 
Table 4-3: Reported concentrations of selected pharmaceuticals in surface waters. ............ 65 
Table 4-4: Water quality parameters (mean ± standard deviation) measured for each 
sampling point for each sampling occasion. ............................................................................ 80 
Table 4-5: Physicochemical properties of target pharmaceuticals and instrumental detection 
limits (IDL). ............................................................................................................................... 81 
Table 4-6: SPE recoveries and extraction precision (% RSD) determined for target 
pharmaceuticals in the different environmental water matrices investigated in this study. . 86 
Table 4-7: Examples of the target pharmaceutical concentrations in environmental waters 
quantified by standard addition and the standard deviation of the extrapolated value (±) .. 90 
Table 4-8: Retention times and parent ion [M-H]+ for the target pharmaceuticals. .............. 92 
xiv 
 
Table 4-9: Linearity of calibration method and method limit of detection (MLOD) 
determined for the selected pharmaceuticals in different environmental water matrices. .. 93 
Table 4-10: Pharmaceuticals detected in wastewater sampled at different points throughout 
the treatment process and receiving waters between February 2011 and February 2012. .. 94 
Table 4-11: Mean (n = 6) percentage reductions (mean ± standard deviation) of 
pharmaceuticals at different treatment stages of the WWTP. ............................................... 98 
Table 4-12: Prescription quantities (England, 2011) for selected pharmaceuticals and 
predicted wastewater influent concentrations ..................................................................... 100 
Table 4-13: Predicted influent concentrations (using typical excretion data) compared to 
those measured in screened sewage. ................................................................................... 103 
Table 5-1: Culture media used for the specific detection of target indicator bacteria ......... 130 
Table 5-2: Confirmation tests used for presumptive bacteria .............................................. 132 
Table 5-3: E.coli CBP and ECOff values for selected antibiotics ............................................ 141 
Table 5-4: E.faecium CBP and ECOff values for selected antibiotics ..................................... 142 
Table 5-5: Reference bacteria control strains used in the methods for detection, 
identification of bacteria and for antibiotic susceptibility testing. ....................................... 143 
Table 5-6: a Enumeration of bacteria in wastewater effluents and surface waters. ............. 146 
Table 5-7: Reduction of indicator bacteria during activated sludge treatment .................... 147 
Table 5-8: a Phenotypic identification (Biochemical kits) to species level of presumptive E.coli 
and coliform bacteria isolated from wastewaters and surface waters grown on 
E.coli/coliform chromogenic agar. ......................................................................................... 148 
Table 5-9: Identification of presumptive Staphylococci species isolated from environmental 
waters using API Staph®. ....................................................................................................... 152 
xv 
 
Table 5-10: Identification of presumptive Pseudomonas isolated from environmental waters 
using API 20 NE® .................................................................................................................... 153 
Table 5-11: Identification of presumptive Enterococci isolates using API 20 Strep biochemical 
system and MALDI-TOF-MS analysis ..................................................................................... 155 
Table 5-12: Assessment of a chromogenic media to differentiate Enterococcus faecium from 
other Enterococci species. ..................................................................................................... 157 
Table 5-13: The proportion (%) of the most prevalent of Enterococci species identified in the 
environmental waters sampled for this study. ...................................................................... 159 
Table 5-14: Amoxicillin, cefpodoxime and ciprofloxacin minimum inhibitory concentration 
values (mg/L) for E.coli isolated from wastewaters and surface waters ............................... 160 
Table 5-15: The proportion (%) of E.coli isolates from four different water samples resistant 
(according to ECOffs and CBP values) to amoxicillin, ciprofloxacin and cefpodoxime. ........ 166 
Table 5-16: Proportion of resistant E.coli isolates (according to ECOff values and CBP values) 
maintaining resistance, following repeated sub-culture. ...................................................... 167 
Table 5-17: Amoxicillin, ciprofloxacin, clarithromycin and vancomycin minimum inhibitory 
concentrations (mg/L) for E.faecium isolated from wastewaters and surface waters ......... 169 
Table 5-18: The proportion (%) of E.faecium isolates resistant (according to ECOFF and CBP 
values) to amoxicillin, ciprofloxacin, clarithromycin and vancomycin. ................................. 175 
Table 5-19: Proportion (%) of resistant E.faecium isolates maintaining resistance, following 
repeated sub-culture ............................................................................................................. 177 
Table 6-1: Preparation of ciprofloxacin solutions used to prepare TBX supplemented with 16, 
32, 64, 125 and 2000 µg/L ciprofloxacin. ............................................................................... 201 
xvi 
 
Table 6-2: Protozoa inhibitors used to increase the survival of E.coli in surface water 
microcosms. ........................................................................................................................... 208 
Table 6-3: Administration of ciprofloxacin to constructed microcosms. .............................. 209 
Table 6-4: Comparison of the ciprofloxacin MIC values determined for fifty E.coli isolates by 
TBX supplemented with ciprofloxacin and the ETEST®. ........................................................ 213 
Table 6-5: The proportion (%) of isolates taken from surface water using TBX, verified as 
E.coli and the proportion of isolates that produced ciprofloxacin MIC values exceeding the 
TBX supplemented concentration. ........................................................................................ 214 
Table 6-6: Water quality parameters measured within microcosms exposed to different 
additional concentrations of ciprofloxacin (0, 5, 10, 50 and 100 μg/L), in the experiments 
carried out in November 2012 and July 2013 ........................................................................ 216 
Table 6-7: Reduction of E.coli (%) in constructed microcosms after 1 day following exposure 
to either, 0, 5, 10, 50 or 100 µg/L additional ciprofloxacin. .................................................. 219 
Table 6-8: Ciprofloxacin minimum inhibitory concentration (MIC) values for the E.coli 
population within microcosms before (day 0) and after (days 1, 7, 10 and 14) exposure to 
different levels of additional ciprofloxacin during the experiment commenced November 
2012. ...................................................................................................................................... 221 
Table 6-9: Ciprofloxacin minimum inhibitory concentration (MIC) values for the E.coli 
population within microcosms before (day 0) and after (days 1, 3, 7, 10 and 14) exposure to 
different levels of additional ciprofloxacin during the experiment commenced in July 2013.
................................................................................................................................................ 222 
xvii 
 
Table 6-10: The proportion (%) of total E.coli with acquired ciprofloxacin resistance within 
microcosms exposed to different additional levels of ciprofloxacin over the course of the 
experiment in November 2012. ............................................................................................. 224 
Table 6-11: The proportion (%) of total E.coli with acquired ciprofloxacin resistance within 
microcosms exposed to different additional levels of ciprofloxacin over the course of the 
experiment in July 2013. ........................................................................................................ 225 
 
  
xviii 
 
Abbreviations 
CBP  clinical breakpoint 
ECOff   epidemiological cut off value 
LC-MS  liquid chromatography mass spectrometry 
LOD  limit of detection 
MIC   minimum inhibitory concentration 
PPCP   pharmaceuticals and personal care products 
TBX   tryptone bile x glucuronide 
TSS  total suspended solids 
SIM  selective ion monitoring 
WWTP  wastewater treatment plant  
 
xix 
 
Acknowledgments 
I would especially like to thank my Supervisors Professor Mike Revitt, Professor Hemda 
Garelick and Dr Huw Jones for giving me this opportunity. I greatly appreciate your support 
and advice throughout.  
I am very grateful to Hanroun, Renata and Tom at the molecular identification services unit 
(MISU), Public Health England for letting me use their laboratory facilities. 
I would also like to thank my colleagues and friends at Middlesex University for all their 
support and good humour. I miss working with you – Tamas, Darshna and Manika. 
My indebted thanks to Andy who always believed in me, I love you very much.
1 
 
1 Introduction 
Water is essential to life and therefore it is imperative to protect and maintain water 
quality. However, the quality of natural waters is under threat from the chemical substances 
discharged in industrial and domestic waste. Consequently, water quality is enforced under 
legislation such as, the Water Framework Directive (Defra, 2009) in Europe and the Clean 
Water Act (EPA, 2010) in the USA. Currently, legislation is focused on reducing ‘priority 
pollutants’ that include persistent organic compounds (e.g. polyaromatic hydrocarbons and 
dioxins) and heavy metals. However, a new class of emerging pollutants which is gaining 
increasing attention includes pharmaceutical compounds and the active ingredients used in 
personal care products (collectively termed PPCPs). With improving analytical techniques, 
these active compounds, although at trace concentrations (ng/L to µg/L) have been 
detected in wastewaters (Gracia-Lor et al., 2010;  Gros et al., 2010;  Golet et al., 2001) and 
natural waters (Kasprzyk-Hordern et al., 2008a;  Kasprzyk-Hordern et al., 2007;  Cha et al., 
2006;  Roberts et al., 2006;  Farré et al., 2001) although their environmental fate and the 
possible risks that they pose to aquatic ecosystems still require further elucidation (Boxall, 
2004).  
Depending on their pharmokinetic properties, PPCPs will be excreted after ingestion, either 
as the parent compound or as metabolites and discharged into domestic wastewaters 
(Garcia-Ac et al., 2009). Due to incomplete elimination during wastewater treatment or as a 
result of their presence in agricultural run off after the application of manure to fields as a 
fertilizer, PPCPs are released into receiving waters (Carballa et al., 2004;  Boxall et al., 2002). 
The removal rate of PPCPs from wastewaters varies according to the physico-chemical and 
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biological properties of the active compound, and is affected by several factors, such as the 
treatment process employed, activated sludge (type and age), environmental temperature, 
and light exposure (Farré et al., 2007). PPCPs may be released from wastewater treatment 
processes in a modified form, as either hydroxylated or conjugated transformation products 
(Quintana et al., 2005). In the aquatic environment, PPCPs are subjected to multiple 
environmental factors, either biotic (e.g. bacterial or fungal) or abiotic (e.g. sorption, 
photolysis, oxidation, hydrolysis and reduction) processes (Kümmerer, 2009). In contrast to 
persistent organic pollutants such as organochlorine compounds (e.g. 
dichlorodiphenyltrichloroethane), that were used as insecticides and pesticides, PPCPs are 
more vulnerable to degradation. The continual release of PPCPs into the environment leads 
to their classification as pseudo persistent pollutants (Stackelberg et al., 2004;  Ternes, 
1998).  
Antibiotics are a successful family of pharmaceuticals used in medicine to prevent and treat 
infections caused by micro-organisms such as bacteria and fungi. Their importance in 
medicine in the fight against infectious diseases accounts for their large-scale usage which in 
turn is associated with the emergence of micro-organisms resistant to the antibiotics used 
against them (Henriques et al., 2006). Bacterial resistance to antibiotics increases the 
difficulty in treating both hospital and community acquired infections and this is therefore 
of great concern to public health. Consequently, there has been extensive research in the 
clinical domain into the development of antibiotic resistance. In recent years, there has 
been an increasing interest in the occurrence and fate of antibiotics in the aquatic 
environment because it is still unclear if their presence in natural waters (even at sub 
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therapeutic levels) has contributed to the enhancement of antibiotic resistance amongst 
aquatic micro-organisms (Martinez, 2009;  Baquero et al., 2008).  
Several antibiotics are produced by environmental bacteria (e.g. streptomycin) and bacteria 
with intrinsic resistance to natural antibiotics are found in environmental waters (e.g. 
sewage, treated effluent and surface waters). However, bacteria with resistance and even 
multi-resistance to chemically modified and synthetic antibiotics have been found in 
environmental waters (Watkinson et al., 2007;  Ash et al.,2002;  Pathak et al., 1993;  Jones 
et al., 1986). Antibiotic resistance is a naturally occurring trait of micro-organisms, however 
bacteria have developed different mechanisms to render ineffective the antibiotics used 
against them in order to survive and evolve (Kummerer, 2004). The genes encoding for 
these different resistance mechanisms are located on bacterial chromosomes and are 
passed on to the next generation during cell division. In addition, genes encoding for 
resistance are located on mobile extra chromosomal elements (e.g. plasmids). These extra 
chromosomal elements, through conjugation, can facilitate the transfer of resistant genes 
between bacterial species (Wellington et al., 2013) 
Wastewater treatment plants (WWTPs) not only receive antibiotic residues following 
excretion but also faecal bacteria which may harbour resistance genes (Baquero et al., 
2008). With the high densities of bacteria in aerobic and anaerobic tanks and the abundance 
of nutrients in wastewater, WWTPs are probable hotspots for the horizontal gene transfer 
and therefore the dissemination of antibiotic resistance. This results in a potential  impact 
on the environment when discharged wastewater effluents enter receiving waters or 
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sewage sludge is used in agriculture (Reinthaler et al., 2009;  Zhang et al., 2009;  
Guardabassi et al., 2002).   
Ultimately, the spread of antibiotic pollution due to human perturbations could alter the 
microbial populations in environmental waters (Martinez, 2009). This could result in  
resistant bacteria finding their way into  drinking waters, giving rise to another potential risk 
for human health (Watkinson et al., 2007), as the prevalence of antibiotic resistant 
pathogens increasingly threatens effective management of infectious diseases (Ohlsen et 
al., 2003).  
According to Directive 2001/83/EC on the community code relating to medicinal products 
for human use (European Commission, 2001), an environmental risk assessment (ERA) must 
be performed for new pharmaceutical products. Guidelines for the ERA of pharmaceutical 
products have been created (European Medicines Agency, 2006) and include fate and effect 
experimental studies (The Organisation for Economic Co-operation and Development, 
2013). These studies give valuable information on biodegradability, sorption, 
bioaccumulation and toxicity. However, they do not provide information on the chronic 
exposure to environmentally relevant concentrations, such as has been observed with 
oestrogenic compounds on wild fish (Jobling et al., 1998), or evaluate more specific effects 
such as the development of antibiotic-resistant bacteria. Few studies have investigated the 
prevalence of antibiotic resistant bacteria in environmental waters (Faria et al., 2009;  
Servais et al., 2009;  Watkinson et al., 2007) although  some have investigated the impact of 
antibiotic exposure on the resistance rates of aquatic bacteria through the use of laboratory 
scale experiments (Engemann et al., 2006;  Helt et al., 2011). Most of these studies have 
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defined antibiotic resistance in terms of clinical break points which are used in medicine to 
assess the likelihood of antibiotic therapy success (Kahlmeter et al., 2003). These 
breakpoints may not be adequate to detect emerging resistance in environmental bacteria 
and therefore the development of antibiotic resistance in environmental waters may be 
misinterpreted or underestimated. 
1.1 Thesis objectives 
1.1.1 Rationale 
More research is necessary to understand the occurrence, removal and fate of 
pharmaceuticals in wastewater treatment plants and the impact these substances have on 
surface water receiving treated effluent discharges. The results from this study will provide 
information of the occurrence and removal of selected pharmaceuticals throughout a large 
urban wastewater treatment plant in the UK. This information is important for evaluating 
wastewater treatment processes with regard to their efficiency in removing 
pharmaceuticals and the potential environmental risk. 
There are now recognised experimental studies to assess the fate and effects of 
pharmaceuticals in the environment. However, they are only required by legislation for new 
medicinal products and they are not suitable to assess specific effects such as those of 
antibiotics (Kümmerer, 2009). More research is necessary to observe the occurrence of 
antibiotic resistance among faecal bacteria within wastewater treatment systems and in 
surface waters receiving treated effluent. In addition, a more sensitive interpretation of 
antibiotic susceptibility data is required to detect subtle changes of resistance. The data 
from this study will provide information that can be used to assess the removal capability of 
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antibiotic resistant bacteria by a wastewater treatment process and the impact of the 
process on the expression of antibiotic resistance.  
Currently, there are few studies that demonstrate a link between the presence of low 
concentrations of antibiotics and the prevalence of antibiotic resistant faecal bacteria in 
surface waters.  Further work is required to assess the impact of antibiotic exposure on the 
prevalence of antibiotic resistant bacteria in surface waters. The results from this study will 
provide more information on the impact of antibiotic exposure on the resistance rates in 
E.coli in surface waters receiving treated effluent. 
1.1.2 Aims 
The aims of this study are: to investigate the pathways of selected pharmaceutical 
compounds (including selected antibiotics) from urban wastewater into receiving surface 
water, to then investigate and compare the levels of faecal bacteria (more specifically 
Escherichia coli and Enterococcus faecium) and their respective resistant proportions in 
wastewater and receiving surface water and, to assess the changes in the proportion of 
antibiotic resistant faecal bacteria in surface water exposed to antibiotics within treated 
effluent discharges. 
The specific objectives are: 
1. To quantify selected pharmaceuticals in screened sewage, settled sewage, final 
treated effluent and receiving surface water both up- and down-stream from the 
treated effluent discharge point using solid phase extraction and liquid 
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chromatography-mass spectrometry. To assess the presence and removal of these 
selected compounds during wastewater treatment processes. 
2. To confirm and monitor the presence of Escherichia coli and Enterococcus faecium in 
settled sewage, final treated effluent and receiving surface water both up- and 
down-stream of the wastewater treatment plant treated effluent discharge point. 
3. To determine antibiotic resistance profiles of Escherichia coli and Enterococcus 
faecium isolated from the four sampling points using phenotypic antibiotic 
susceptibility analysis. To assess the impact of the discharged treated effluent on the 
proportion of Escherichia coli and Enterococcus faecium resistant to antibiotics in 
receiving surface water 
4. To better understand the impact of antibiotic exposure on the level of antibiotic 
resistance among Escherichia coli in surface waters receiving treated effluent 
through the use of microcosm studies. 
1.2 Organisation of thesis 
This thesis has been divided into 7 chapters. Three chapters incorporate the results and 
their discussion (Chapters 4-6) and are preceded by three introduction chapters (Chapters 1-
3). Following a general introduction and an outline of the aims and objectives (Chapter 1) 
the first literature review chapter identifies the sources and occurrence of pharmaceuticals 
in environmental waters (Chapter 2). Also included are the current analytical techniques 
used to detect PPCPs in environmental waters and the current legislation pertaining to 
these compounds in the environment. Chapter 3 reviews the literature relating to the use of 
faecal bacteria as indicators of water quality and the prevalence of antibiotic resistance 
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among faecal bacteria. Additionally, a review of the techniques available to detect and 
enumerate faecal bacteria is covered and the methods used for determining antibiotic 
resistance. Chapter 7 presents the thesis conclusions and recommendations for future 
research. 
Chapter 4 presents the optimisation and development of an analytical method to quantify 
trace concentrations of selected pharmaceuticals in water samples collected from a large 
urban wastewater treatment plant and receiving surface waters. The removals of PPCPs are 
evaluated by determining the concentrations at different stages of their treatment process 
and the impacts of the discharged effluent on receiving surface waters are assessed by 
comparing pharmaceutical concentrations in surface waters up- and down-stream of the 
treated effluent discharge point. Prescription data are used as a tool to predict the influent 
wastewater treatment plant concentrations which are compared to the measured levels.  
Chapter 5 presents the distribution of antibiotic resistant Escherichia coli (E.coli) and 
Enterococcus faecium (E.faecium) at different stages of the wastewater treatment process 
and within the receiving surface water. The faecal bacteria were isolated and enumerated 
and tested for antibiotic susceptibility using culturable techniques. Identification of bacteria 
was performed using phenotypic and mass spectrometry techniques. The definition of 
resistance in environmental bacteria is discussed and antibiotic susceptibility data are 
compared to epidemiological cut off values which are a more sensitive measure of detecting 
emerging resistance.  
Chapter 6 presents the changes in the prevalence of ciprofloxacin resistant E.coli in surface 
waters following exposure to an antibiotic within wastewater treated effluent discharges. 
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This is achieved using laboratory microcosm studies over a 14 day period. Different levels of 
antibiotic exposure are investigated. A chromogenic medium specific to the detection of 
E.coli is supplemented with the antibiotic as a tool to determine the prevalence of antibiotic 
resistant E.coli within the constructed microcosms.  
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2 The Occurrence of Pharmaceuticals in Environmental Waters 
2.1 Pharmaceuticals 
Pharmaceutical products are designed to cure and treat disease, improve health, and 
increase life span (Cunningham et al., 2009). However, they cannot be categorised as a 
homogenous group of compounds, since they vary widely in properties such as molecular 
weight, chemical structure and functionality (Cunningham, 2008). Pharmaceuticals are 
typically large, chemically complex structures, containing multiple ionisation sites spread 
throughout the molecule and display a variety of physico-chemical characteristics including 
acid dissociation constants (pKa), water solubility and octanol water coefficients (log Kow) 
(Cunningham, 2008). Pharmaceuticals can be classified according to their purpose and 
biological activity (e.g. antibiotics, analgesics, lipid regulators, antiepileptic substances, anti-
inflammatories, antihistamines and X-ray contrast media etc.) (Kümmerer, 2009b). 
2.1.1 Pharmaceutical consumption 
Over 3000 different pharmaceuticals are commonly used in Europe and new 
pharmaceutically active substances are continually being developed and introduced into the 
market place. The NHS Information Centre - Prescribing and Primary Care Services (2012) 
reported a 4.8 % increase in the £12.9 billion NHS expenditure on medicines between 2009 
and 2010 and Intercontinental Marketing Services (IMS) - Health Market Prognosis (2011) 
have forecast that global pharmaceutical sales will reach US$1.1 trillion by 2014. The use of 
these compounds will continue to increase with increasing population size and associated 
demand.  
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Consumption patterns vary between different countries and over time, depending on 
medicinal product regulations and approvals, prescribing practices, population sizes and 
health care systems (Ternes et al., 2008). It is difficult to obtain a reliable estimate of the 
quantities of pharmaceuticals used each year and currently in England, a central or regional 
record of pharmaceutical use in hospitals or in over-the- counter medicines is not readily 
accessible and therefore it is challenging to investigate consumption patterns. In England, 
consumption data for prescribed medicinal products can be obtained through the 
manipulation of prescription cost analysis (PCA) data collated by The Health and Social Care 
Information Centre - Prescribing and Primary Care Services (2012).  
2.2 Sources of pharmaceuticals into the aquatic environment 
The major sources of pharmaceuticals in the environment together with their water 
transport routes are shown in Figure 2-1. Wastewater treatment plants (WWTPs) are major 
contributors of pharmaceuticals to the environment, mainly through excreta or disposal of 
unused or expired drugs (Gros et al., 2006). WWTPs are not designed to remove or reduce 
such compounds and therefore some pharmaceuticals are incompletely removed and are 
discharged in treated effluents, mainly to our rivers. In addition, direct input into rivers is 
also possible from storm water overflows and leaks in sewer systems. Pharmaceuticals can 
also accumulate in sewage sludges and ultimately can be released to the environment 
through the application of the sludge as an agricultural fertilizer. Furthermore, irrigation of 
treated effluent on arable land can potentially lead to contamination of groundwater if the 
pharmaceutical compounds are not easily removed through sorption or degradation 
processes in soil.  
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Figure 2-1: Flow chart showing the major pathways of pharmaceuticals within the environment. 
In the farming industry, veterinary medicines are widely used to treat disease and protect 
the health of animals. Release of the parent veterinary pharmaceutical and associated 
metabolites from animals to the environment can occur directly through excretion on to 
pasture or application of manure to land. Through leaching or agricultural runoff, these 
veterinary residues can enter our natural waters (Boxall et al., 2002). 
2.2.1 Pharmaceuticals and the wastewater treatment process 
2.2.1.1 Wastewater 
Wastewater is collected from residential, commercial and industrial establishments. It 
includes household liquid waste from toilets, baths, showers, kitchens and sinks that is 
disposed of via sewers. Proper collection, treatment and discharge of waste water, and 
correct disposal or re-use of the resulting sludge help to protect and improve water quality 
in the UK. Urban waste water, commonly referred to as sewage, is generally a mixture of 
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domestic waste water from baths, sinks, washing machines and toilets, waste water from 
industry and rainwater run-off from roads and other surfaced areas (Maier et al., 2009). 
2.2.1.2 The wastewater treatment process 
Wastewater treatment can be differentiated into primary, secondary and tertiary stages. In 
primary treatment, physical operations are used to facilitate the removal of solids. Following 
the removal of gross solids and a brief residence in a grit chamber to allow sand and grit to 
settle out, the effluent is transferred into primary settling tanks. Approximately half the 
suspended solids in wastewater will settle to the bottom of this tank, resulting in the 
production of a primary sludge. Pathogenic bacteria are not removed effectively during this 
treatment step, although some sedimentation of these species does occur (Defra, 2002).  
 In secondary treatment, biological and chemical operations are used to reduce organic 
matter. The settled sewage undergoes biological treatment in which the remaining organic 
suspended solids together with soluble organics are biodegraded by aerobic organisms. This 
treatment step has a large (biochemical) biological oxygen demand and therefore a 
continuous air supply needs to be maintained. Secondary biological treatment is achieved 
using either trickling filter beds or (conventional) activated sludge tanks.  
Trickling filter bed treatment involves spraying the settled sewage over a substrate 
composed of plastic units (in older plants, the filter is a bed of stones) coated with a micro-
organism biofilm. The spraying process oxygenates the settled sewage and facilitates the 
aerobes to decompose the organics. In the activated sludge process, settled sewage is 
transferred to an aeration tank, agitated, aerated and mixed with a bacteria rich sludge 
remaining from earlier treatment (activated sludge) to encourage decomposition of the 
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remaining organic material. From the aeration tank, the effluent moves to a sedimentation 
tank to allow microbial flocs to settle. Important parameters that need to be controlled 
during the activated sludge process to ensure effective treatment include the hydraulic 
retention time (typically four to eight hours), the food to micro-organism ratio (organic load 
to micro-organisms expressed as BOD/kg) and the oxygen supply rate. Both the aeration 
process and secondary sedimentation contribute to the inactivation or removal of 
pathogenic bacteria by microbial antagonism or by floc formation in which the pathogens 
may be trapped and settle out.  
Sometimes further treatment (tertiary) is required to protect sensitive water environments 
(Defra, 2012). Tertiary treatment is practised to further reduce nutrients such as nitrogen 
and phosphorus, metals and organics (Guardabassi et al., 2002) to provide additional 
protection of the environment after effluent discharge into rivers or lakes. It is also 
performed when effluent is to be used for irrigation (e.g. food crops) or as a drinking water 
source. Tertiary treatment is expensive and is usually reserved for the discharge of treated 
effluents into sensitive areas (e.g. eutrophic waters) and bathing waters to ensure 
compliance with legislation (e.g. Urban Wastewater Treatment Directive). Tertiary 
treatments include filtration, sorption to activated carbon, disinfection, ozonation and UV 
oxidation.  
2.2.1.3 Removal of pharmaceutical active compounds in wastewater treatment 
processes. 
The main aims of the wastewater treatment process are to: 
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 reduce the organic content of wastewater including toxic or recalcitrant trace 
organic compounds 
 reduce suspended solids 
 reduce or inactivate pathogenic bacteria  
 reduce the nutrient loads discharged to receiving surface waters 
It has been reported that wastewater treatment plants are inefficient at eliminating 
pharmaceutical compounds resulting in the discharge of these compounds to receiving 
surface waters (Radjenovic et al., 2009). In addition, the removal efficiencies of these 
compounds from wastewater vary considerably between different treatment plants  (Farré 
et al., 2007;  Quintana et al., 2005;  Miao et al., 2004;  Petrovic et al., 2003;  Golet et al., 
2001). Longer solid retention times and hydraulic retention times contribute to higher 
removal efficiencies (Ternes et al., 2008;  Ternes et al., 2004;  Kummerer, 2003) and 
significantly higher removal rates were observed for antibiotics (Göbel et al., 2005) and 
pharmaceuticals (Clara et al., 2005) with increases in sludge age. 
The primary pharmaceutical removal mechanisms associated with biological wastewater 
treatment processes are sorption and biological transformation (Jelic et al., 2011). Other 
removal mechanisms include stripping due to aeration or photodegradation but these are 
considered to be non-existent or have a negligible effect (Ternes et al., 2008).  
Pharmaceuticals can sorb to particulate matter which facilitates their removal by settling or 
flotation. Sorption depends on two main mechanisms: 
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1. Absorption through hydrophobic interactions between aliphatic or aromatic 
functional groups of the pharmaceutical compound with the lipid fractions of 
suspended solids  
2. Adsorption through electrostatic interactions of positively charged functional groups 
of the pharmaceutical compound with negatively charged surfaces of 
microoganisms. 
Several approaches have been used to determine the affinity of a given substance to solids. 
The tendency of a chemical to sorb and accumulate in solids can be assessed by the octanol-
water partition coefficient (Kow) or the organic carbon-based coefficient (Koc) (Carballa et al. 
(2008). However, they are both more useful for investigating the sorption of uncharged 
molecules where the interactions are mainly hydrophobic in nature. The determination of 
the sorption coefficient (Kd) is more useful for predicting the potential of a pharmaceutical 
compound to sorb to wastewater solids (Carballa et al. (2008). The sorption coefficient Kd is 
used to describe the solid liquid partitioning characteristics of a compound and this value is 
the ratio of the sorbed phase concentration to the solution phase concentration at 
equilibrium as shown in Equation 2-1 (Ternes et al., 2008). The removal of active 
compounds through sorption mechanisms is considered negligible (< 10 %) for compounds 
with Kd values ≤ 300 L/kg (Ternes et al., 2008).  
Equation 2-1: 
𝐾𝑑  =  
𝑋𝑝𝑎𝑟𝑡
𝑆
 =
𝑋
𝑋𝑠𝑠 × 𝑆
 
Where: 
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X concentration sorbed onto sludge per unit reactor volume (µg/L) 
Xpart concentration sorbed, per amount of sludge dry matter (µg/g) 
Kd solid-water distribution coefficient (L/g) 
Xss suspended solids concentration in raw water or production of suspended solids in 
primary and or secondary treatment per L of wastewater (g/L) 
S dissolved concentration (µg/L) 
The biological transformations of pharmaceutical active compounds during the wastewater 
treatment process include; mineralisation, transformation to more hydrophobic compounds 
which adsorb to solid particles, and transformation to more hydrophilic compounds which 
remain in the liquid phase. The degree of biodegradation will depend on the characteristics 
of the active compound and on the wastewater treatment plant operating conditions 
including  the biodiversity of the microbial biomass, the floc size of the sludge, the fraction 
of the active biomass within the total suspended solids and temperature (Ternes et al., 
2008;  Clara et al., 2005). There are now increasing reports of biodegradation studies, 
however some only report the degradation of the original active compound but do not 
investigate the appearance of metabolites or transformation products which may also have 
an ecotoxicological effect (Alexy et al., 2004;  Kümmerer et al., 2000;  Al-Ahmad et al., 
1999).  
Tertiary wastewater treatment processes (e.g. sand filtration and disinfection) and 
advanced UV and ozonation processes have been assessed for the elimination of 
pharmaceuticals from wastewaters (Quintana et al., 2009;  Sharma, 2008;  Hua et al., 2006;  
Andreozzi et al., 2003a). High removal rates have been achieved with advanced processes, 
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however the formation of by products and their respective ecotoxicity are not always 
known (Senta et al., 2011;  Sharma, 2008). 
2.3 Occurrence of pharmaceuticals in wastewater and surface water 
There are numerous reports describing the presence of pharmaceuticals in wastewater 
influents, effluent and surface waters. Table 2-1 lists the occurrence of some 
pharmaceuticals from different classes (e.g. antibiotics, anti-inflammatories, beta-blockers, 
anticonvulsants and lipid regulators) in environmental waters.  The environmental fate of 
pharmaceutical actives in aquatic environments will depend on the different physico-
chemical properties of these substances, environmental conditions, the wastewater 
treatment employed and consumption levels within the catchment area (Cunningham, 
2008). These factors represent a challenge when estimating the loads of these substances in 
aquatic environments and justify the variety in pharmaceutical concentrations which have 
been reported in environmental waters.  
The presence of pharmaceuticals in wastewater effluents and rivers confirms that municipal 
wastewater treatment plants do not completely remove these compounds. Some 
pharmaceuticals, such as carbamazepine, have been frequently reported in environmental 
waters leading to its proposal  as an anthropogenic marker for the aquatic environment 
(Clara et al., 2004). Conversely, vancomycin is rarely reported and possibly this could be 
attributed to inadequate analytical methods or to low consumption patterns. In a study 
reported by Sim et al. (2011), carbamazepine was detected in 100 % of the sampled 
municipal wastewater influents and effluents , whilst vancomycin was not detected at all. 
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Table 2-1: Pharmaceutical compounds detected in wastewater influents, effluents and surface waters  
Compound Sample matrix Concentration (ng/L) Location Reference 
Sulfasalazine 
Amoxicillin 
Ibuprofen 
Diclofenac 
Carbamazepine 
Bezafibrate 
Wastewater influent 65 
ND 
3742 
70 
2593 
971 
UK Kasprzyk-Hordern et al. 
(2008) 
Diclofenac 
Bezafibrate 
Carbamazepine 
Clarithromycin 
Wastewater influent 
 
400-1500 
400-1400 
400-1400 
400-1000 
Spain Jelic et al. (2011) 
Carbamazepine, 
Clarithromycin, 
Chlortetracycline 
Ciprofloxacin, 
Diclofenac, 
Sulfonamides 
Tetracycline 
Wastewater influent 24.8-50.9 
ND-724.2 
ND- 15.9 
11.4-300.7 
ND–9.5 
ND-261 
ND-38.9 
US Spongberg et al. (2008) 
Carbamazepine 
Ciprofloxacin 
Vancomycin 
Diclofenac 
Penicillin G 
Wastewater influent  95-21600 
124-246 
ND 
94-523 
ND 
Korea Sim et al. (2011) 
Clofibric acid 
Ketoprofen 
Ibuprofen 
Diclofenac 
Carbamazepine 
Wastewater effluent ND-90 
330-700 
ND-34 
ND-30 
290-960 
Taiwan Chen et al. (2008) 
Bezafibrate 
Ibuprofen 
Diclofenac 
Carbamazepine 
Ciprofloxacin 
Wastewater effluents ND-1007 
50-7110 
680-5450 
870-1200 
60-70 
France, 
Greece, 
Italy, 
Sweden 
Andreozzi et al. (2003b) 
Acebutolol 
Metoprolol 
Carbamazepine 
Ciprofloxacin 
Wastewater effluent 390-510 
980-1350 
290-400 
200-650 
Finland Vieno et al. (2006) 
Amoxicillin 
Chloramphenicol 
River water ND 
266 
Hong Kong Xu et al. (2007) 
Carbamazepine 
Ibuprofen 
Codeine 
River water 65.4-75.1 
61.3-115.2 
26.6-53.6 
Romania Moldovan (2006) 
Bezafibrate 
Carbamazepine 
Clarithromycin 
Ibuprofen 
River water <50-130 
<30-140 
<30-40 
<20-70 
Germany Wiegel et al. (2004) 
ND = not detected 
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2.4 Analytical methods to detect pharmaceuticals in environmental waters 
2.4.1 Sample preparation and analysis 
Environmental waters are complex matrices and pharmaceuticals are typically present at 
only trace levels (ng/L). Therefore, analytical methods require efficient sample extraction 
and pre-concentration procedures to achieve the desired level of analytical sensitivity and 
selectivity. Sample extraction and pre-concentration are usually achieved by using solid 
phase extraction (SPE) methods (Gros et al., 2006;  Miao et al., 2002). SPE involves passing 
the water sample through a cartridge containing a sorbent known to retain the compounds 
of interest but to release other compounds that can interfere with or suppress the detection 
signal. The retained compounds are subsequently desorbed and eluted from the sorbent 
with appropriately selected organic solvents. The volume of eluate is reduced under 
nitrogen and reconstituted with a small volume of a solvent suitable for the chosen 
analytical technique. A range of SPE sorbents is available employing different retention 
mechanisms based on hydrophobic interactions, dipole/dipole interactions, and/or ion 
exchange. Many methods utilise copolymer or polymeric sorbents (Tong et al., 2009;  Gros 
et al., 2008) which provide more than one retention mechanism and are useful for the 
extraction and pre-concentration of polar and moderately polar analytes. Other extraction 
methods that have been used to clean up and pre-concentrate pharmaceuticals from 
environmental waters include hollow fibre-based liquid phase microextraction (HF-LPME) 
(Payán et al., 2010) and solid-phase microextraction (SPME) (Sanchez-Prado et al., 2006) but 
these are less common. 
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Different analytical techniques have been employed for the detection of pharmaceuticals in 
environmental samples including capillary electrophoresis (Nozal et al., 2004), high 
performance liquid chromatography with ultra-violet detection (HPLC-UV) (Sturini et al., 
2009;  Benito-Peña et al., 2006), high performance liquid chromatography with fluorescence 
detection (HPLC-Fl) (Golet et al., 2001) and gas chromatography-mass spectrometry (GC-
MS) (Hao et al., 2007). The most common analytical method used in this field is liquid 
chromatography-mass spectrometry (LC-MSn) (Hernández et al., 2007). LC-MSn is a 
sophisticated technique that is suitable for the separation and analysis of non-volatile 
compounds with medium to high polarity, such as pharmaceuticals. In comparison to 
techniques such as GC-MS (suitable for volatile compounds) it does not require 
derivatization steps prior to analysis and has advantages over HPLC-UV in that it provides 
compound confirmation. Liquid chromatography coupled with tandem mass spectrometry 
(LC-MS2) permits improved sensitivity compared to single quadruple mass spectrometry 
(Pérez et al., 2007). 
2.4.2 Liquid chromatography-mass spectrometry (LC-MSn) 
LC-MSn couples high performance liquid chromatography (HPLC) or ultra-performance liquid 
chromatography (UPLC) with mass spectrometry detection typically using either an 
electrospray ionisation (ESI) or atmospheric pressure chemical ionisation (APCI) interface. 
HPLC is used to separate sample components by using their difference in partitioning 
behaviour between the stationary phase (HPLC column) and mobile liquid phase (solvent). 
The separated components are then ionised before transmission to the mass analyser. 
Ionisation occurs within the interface. With electrospray ionisation, samples are ionised by 
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applying a high voltage to the HPLC eluant after conversion to a heated spray using a 
nebulising gas (usually nitrogen). The resulting gas phase ions are focused through the mass 
analyser to achieve separation according to their mass to charge ratio (m/z). Electrospray 
ionisation is a soft ionisation technique which results in very little fragmentation and 
therefore produces molecular ions (deprotonated or protonated) leading to molecular 
weight information (Seifrtová et al., 2009).  
The quadrupole analyser is the most common mass analyser used in LC-MSn systems and 
uses the stability of ion trajectories in oscillating electric fields to separate the ions 
according to their m/z value. Quadrupole analysers consist of four parallel metal rods where 
adjacent rods have opposite voltage polarity applied to them. The electric force on the ions 
causes them to oscillate/orbit in the area between the four rods and therefore affects the 
trajectories of the ions focussed into the analyser (Figure 2-2).  
 
Figure 2-2: Schematic showing ion trajectories through a quadrupole m/z selector 
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23 
 
To ensure the uninhibited movement of the gas-phase ions within the instrument, a vacuum 
is generated using rotary and turbo-molecular vacuum pumps. Before entering the 
quadrupole, the ions travel through a potential of a certain voltage, generated by a ring 
electrode, in order to give the ions a constant velocity so they can transverse along the 
centre of the quadrupole. The ion moves in a very complex motion that is directly 
proportional to the mass of the ion, voltage on the quadrupole, and the radio frequency. 
Only stable ions pass in between the rods to the detector and are then counted by striking 
the ion detector, generating an amplified signal which is sent to the computer for data 
processing. 
2.5 Legislation relating to the occurrence of pharmaceuticals in 
environmental waters 
There are a number of European directives and regulations including the Water Framework 
Directive (WFD), the Urban Waste Water Treatment Directive (UWWTD) and the 
Registration, Evaluation, Authorisation and restriction of Chemicals regulation (REACH) 
which are designed to protect our natural waters from the adverse effects of chemical 
pollutants and wastewater discharges. Currently, there is no requirement for the monitoring 
of pharmaceutical active compounds in natural waters, despite the concerns from the 
scientific community. However, it is now mandatory to carry out an environmental risk 
assessment of new medicinal products according to Directive 2001/83/EC on the community 
code relating to medicinal products for human use (European Commission, 2001).  
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2.5.1 The Water Framework Directive 
The Water Framework Directive (WFD, 2000) was implemented to regulate how water 
bodies (surface waters including, rivers, lakes, and coastal waters) are managed throughout 
Europe to prevent further deterioration of aquatic ecosystems and to reduce pollution 
especially by harmful substances listed in the daughter directive - Environmental Quality 
Standards Directive (European Commission, 2008). There are 41 substances currently listed 
in this Directive although they do not include pharmaceutical compounds, despite 4 yearly 
reviews and proposals to include pharmaceuticals such as diclofenac. 
2.5.2 Urban Wastewater Treatment Directive (UWWTD) 
The Urban Wastewater Treatment Directive (UWWTD, 1991) regulates how wastewater is 
collected and treated from domestic and industrial sources. It is designed to protect our 
environment from the adverse effects that untreated sewage can have and is imperative for 
protecting public health. The Directive identifies the conditions that should be met before 
treated effluents are discharged to receiving waters. These include the specified limits prior 
to discharge of (biochemical) biological oxygen demand, chemical oxygen demand, 
suspended solids and total phosphorus and nitrogen which all should be reduced to 
specified limits before discharge. Reduction of emerging pollutants such as pharmaceuticals 
are not included in the Directive and therefore monitoring of these compounds in the 
effluents is not enforced.  
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2.5.3 Registration, evaluation, authorisation and restriction of chemicals (REACH) 
REACH is a European Union regulation designed to protect human health and the 
environment from the use of chemicals (European Commission, 2006). The regulation 
requires that manufacturers and importers of chemicals are responsible for the 
understanding and management of the risks associated with those chemicals. However, 
human and veterinary pharmaceuticals are not covered by REACH as they are covered by EU 
pharmaceutical legislation (European Commission, 2001). 
2.5.4 European Medicines Agency (EMA) 
Directive 2001/83/EC on the community code relating to medicinal products for human use 
(European Commission, 2001) states that an evaluation of the potential environmental risks 
must be undertaken for new drugs coming to market. A guidance document (European 
Medicines Agency, 2006) details a two phase approach for conducting an environmental risk 
assessment (ERA). In phase I (the exposure assessment), the maximum predicted 
concentration expected in surface waters (PECsurfacewater) from the discharges of wastewater 
treatment plants is estimated. If the concentration is estimated to be less than the action 
limit (10 ng/L), the ERA may be terminated at this step. In cases where the predicted 
environmental concentrations exceed the action limit, the second step (Phase II) is 
recommended. 
In Phase II, experimental studies are required to assess the fate and effects of the 
pharmaceutical compound under test to determine hazard quotients (Ginebreda et al., 
2010). Physico-chemical characteristics of the test compound including the octanol water 
coefficient (Kow), which is used as an indicator for bioaccumulation, and the soil organic 
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carbon-water partitioning coefficient (Koc), which is recommended to describe the sorption 
behaviour of the pharmaceutical compound in sewage sludges are also evaluated. An 
octanol water coefficient value > 1000 indicates the pharmaceutical can bioaccumulate in 
aquatic organisms. A soil organic carbon-water partition coefficient value > 10,000 L/kg 
indicates the pharmaceutical can be retained in the sewage sludge and therefore possibly 
eventually transported to the terrestrial environment through land spreading (European 
Medicines Agency (2006). The experimental studies recommended to assess the physico-
chemical properties, fate and effects of pharmaceuticals are given in Table 2-2 and are 
reported by The Organisation for Economic Co-operation and Development (2013). 
The effect studies use a set of organisms representing the aquatic ecosystem and food chain 
web to test for acute and chronic toxicity. From this data and with the use of an assessment 
factor (AF), the predicted no-effect concentration (PNECsurfacewater) is determined which is 
used for estimating hazard quotients and therefore risk characterisation. The assessment 
factor is used to account for the degree of uncertainty involved in extrapolating laboratory 
study data to the real environment, inter species variations and differences in sensitivity and 
intra species variability (Ternes et al., 2008). The hazard quotients are defined as the ratio 
between the pharmaceutical predicted surface water concentrations (PECsurfacewater) and the 
predicted no-effect concentrations (PNECsurfacewater). Under this environmental risk 
assessment (ERA) structure, an unacceptable environmental risk is indicated if the hazard 
quotients are > 1.   
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Table 2-2: Physico-chemical, fate and effect studies recommended for the environmental risk assessment of 
new medicinal products with predicted surface water concentrations exceeding 10 ng/L.  
Experimental study Recommended test protocol 
Adsorption-desorption batch equilibrium 
method 
OECD 106/OECD121 
Ready biodegradability OECD 301 
Aerobic and anaerobic transformation in 
aquatic sediment systems 
OECD 308 
Algae, growth inhibition test OECD 201 
Daphnia sp. Reproduction test OECD 211 
Fish early life stage toxicity test OECD 210 
Activated sludge respiration inhibition test OECD 209 
Taken from European Medicines Agency (2006). OECD – the organisation for economic Co-operation and 
development. 
This approach to ERA provides valuable information. However, the outcome does not 
constitute a reason to prevent a new drug being authorised for sale as the human medical 
benefits have precedence over any environmental risk (European Medicines Agency, 2006). 
However, if an environmental risk is identified, there are recommendations for restricted 
use (e.g. hospital only) and product labelling to ensure correct disposal. Currently there is no 
legislation relating to drugs already available on the market, unless an application for 
authorisation to change dose or application is submitted. For veterinary medicines, the 
outcome of the environmental risk assessment may serve as a basis for minimising the 
quantity of the medicine released into the environment.  
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3 Water quality indicator bacteria and antibiotic resistance 
Natural waters polluted by faecal contamination from humans and animals transport a 
variety of human pathogenic microorganisms (viruses, protozoa and bacteria). The 
detection of waterborne pathogens is difficult and therefore various indicators of faecal 
contamination are used to detect faecal pollution (Servais et al., 2009). Human commensal 
and pathogenic bacteria are constantly released with wastewater to natural waters. A 
proportion of these organisms will be resistant to antibiotics. It is believed that the 
continuous release of low levels of antibiotics and resistant bacteria with wastewater has 
the potential to enhance the dissemination of antibiotic resistance in environmental 
bacteria (Castiglioni et al., 2008).  
3.1 Microbial indicators of water quality 
The use of indicator organisms as a means of assessing the potential presence of water-
borne pathogens through the use of simple microbiological tests has been paramount to 
protecting public health. Indicator organisms are selected bacteria that when present in 
water are indicative of either faecal contamination or deterioration of water quality 
(Environment Agency, 2002).  
The criteria for an ideal indicator organism include the following: 
 The organism should be a member of the intestinal microflora of warm blooded 
animals 
 The organism should be present when pathogens are present  
29 
 
 The organism should be present in greater concentrations than the pathogen 
 The organism should survive longer than the hardiest of pathogens 
 The organism should not grow and multiply in water 
 The organism should be easily detectable by inexpensive methods 
 The concentration of the organism should relate to the degree of faecal pollution 
There is no one indicator organism that fulfils all of the criteria and therefore various groups 
of microorganisms have been suggested and used as indicators for example coliforms, 
Escherichia coli, enterococci, pseudomonas aeruginosa and Staphylococcus aureus.   
3.1.1 Coliform bacteria and Escherichia coli 
The coliform group belong to the family Enterobacteriaceae. Typical genera encountered in 
water supplies are Citrobacter, Enterobacter, Escherichia, Hafnia, Klebsiella, Serratia and 
Yersinia (Environment Agency, 2002). Coliform bacteria are used as an indicator of faecal 
pollution because some species originate from faecal sources, survive longer than some 
pathogenic bacteria and are easy to detect and enumerate. However, coliform bacteria can 
grow in natural waters in appropriate conditions (depending on the amount of organic 
matter and temperature) and can therefore give a false indication of faecal pollution (Maier 
et al., 2009;  Bitton, 1994). In addition, coliform bacteria are less resistant to disinfectants 
than protozoans and viruses. Therefore their usefulness as an indicator is limited (Maier et 
al., 2009;  Bitton, 1994). Coliforms are aerobic, facultative anaerobic, gram-negative, non-
spore forming, rod shaped bacteria that produce gas due to lactose fermentation in culture 
media within 48 hrs at 35 °C. They  do not produce cytochrome C oxidase and are therefore 
oxidase negative (Environment Agency, 2009). Coliforms include all coliforms that can 
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ferment lactose at 44 °C. Not all coliform bacteria are exclusively of faecal origin except for 
E.coli. In human excreta, the average density of faecal coliforms per gram is 107 and for 
animals, the average density of faecal coliforms per gram of faeces can be in the range of 
101 to 107 depending on the animal taxonomy (Maier et al., 2009). Whilst coliform bacteria 
are used to indicate the presence of other pathogens, they can themselves be responsible 
for causing infection and illness. Coliform species include Enterobacter species (E. cloacae 
and E. aerogenes) and are commonly identified as the cause of urinary and respiratory tract 
infections. In addition, some Klebsiella species are also opportunistic pathogens. K. 
pneumoniae is the most frequently isolated Klebsiella species from wound, bloodstream and 
urinary tract infections (Health Protection Agency, 2008). However, E.coli is the most 
frequent cause of urinary tract and kidney infections and is the most important food 
poisoning pathogen worldwide. Some strains of E.coli such as E.coli O157:H7 cause disease 
by producing a toxin called Shiga toxin. In addition, E.coli are opportunistic pathogens that 
can cause disease and are increasingly responsible for bloodstream infections (bacteriamas) 
in the UK (Health Protection Agency, 2007). 
3.1.2 Enterococci 
Enterococci are gram-positive aerobic, facultative anaerobic, non-spore forming cocci and 
can be distinguished from closely related bacteria by their ability to grow in 6.5 % NaCl, at a 
pH of 9.6 and a temperature of 45 °C (Environment Agency, 2002). The species of 
enterococci that occur in faeces and, therefore, are more likely to be found in polluted 
waters include Enterococcus faecalis, Enterococcus faecium and Enterococcus hirae. 
Enterococci are used as indicator organisms because they survive environmental stress 
longer than coliforms and therefore many pathogenic bacteria, rarely multiply in 
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environmental waters but persist for long times. However, they are not exclusively from the 
faeces of humans (Junco et al., 2001). In human faeces the average density of enterococci 
per gram of faeces is in the region of 106 whereas, in animals the average concentration of 
enterococci varies according to animal type (domestic, wild or farm animal) and can be in 
the range of 104 to 106 with considerable variation between species (Maier et al., 2009;  
Anderson et al., 1997). Enterococci can cause infections in humans including urinary tract 
infections, bacteraemia (blood stream infections) and wound infections. However, 95% of 
enterococci  infections are caused by two enterococci species, Enterococcus faecium and 
Enterococcus faecalis (Helt et al., 2012). Enterococci are resistant to many antibiotics, so 
infections are most commonly seen in patients hospitalised for long periods of time and 
receiving broad spectrum antibiotics.  
3.1.3 Staphylococci 
Staphylococci are gram-positive non-spore forming, non-motile, aerobic, facultative 
anaerobic cocci bacteria that produce catalase (from hydrogen peroxide) and have the 
ability to grow in 6.5 % NaCl. Staphylococci are ubiquitous in the environment yet are not 
always of faecal origin. However, they have been advocated as indicator organisms of water 
quality in recreational waters and where appropriate, provide a measure of effective water 
treatment and disinfection (Environment Agency, 2000).  Staphylococci are mainly 
associated with the skin, respiratory tract and gastrointestinal tract of humans and warm-
blooded animals and readily gain access to water when a body is immersed. Staphylococcus 
aureus is a pathogenic organism causing wound, skin infections and urinary tract infections 
and can be differentiated from other staphylococci species based on its ability to produce 
coagulase whilst typically other species cannot. The density of coagulase positive 
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staphylococci in raw sewage has been estimated at approximately 103 CFU/100 mL (Maier 
et al., 2009). 
3.1.4 Pseudomonas aeruginosa 
Pseudomonas aeruginosa are Gram-negative, oxidase-positive bacteria which usually 
produce pyocyanin and fluorescein pigments (Environment Agency, 2010). Pseudomonas 
aeruginosa are frequently present, in small numbers, in the normal intestinal flora of 
humans and animals and can be present in raw sewage at concentrations of 105 CFU/100 mL 
(Maier et al., 2009). However these organisms should not be used as an indicator of faecal 
pollution as they are commonly found in soil and on plants and are able to grow in 
oligotrophic waters (Maier et al., 2009). Pseudomonas aeruginosa are opportunistic 
pathogens and large numbers growing in bathing waters, swimming pool waters or spa pool 
waters can result in ear infections for those immersed in the polluted waters. Therefore this 
species is often used as an indicator for recreational water quality (Environment Agency, 
2004). 
3.2 Detection, enumeration and identification of indicator bacteria 
Coliforms (including E.coli), enterococci, staphylococci (including staphylococcus aureus) and 
pseudomonas aeruginosa can be detected and enumerated in environmental waters by 
simple bacteriological methods such as the membrane filtration (MF) or the most probable 
number test (MPN). The significance of the membrane filtration and most probable number 
tests and the interpretation of results are well authenticated and have been used as a basis 
for standards of bacteriological quality for environmental waters (Environment Agency, 
2000). Some methods are routinely used such as those identified by the Environment 
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Agency (Environment Agency, 2010;  Environment Agency, 2007) or as detailed in Standard 
Methods for the Examination of Water and Wastewater (Standard Methods Committee 
(SMC), 2006). Methods employ culture media containing components that encourage the 
growth of target bacteria whilst inhibiting non target bacteria. In other studies, chromogenic 
agars have been employed for the selective and differential detection of Escherichia coli and 
coliform bacteria in environmental waters (Wohlsen, 2011;  Watkinson et al., 2007;  Alonso 
et al., 1996). Chromogenic agars contain chromogenic enzyme substrates that detect 
specific enzyme activity characteristic of certain bacterial groups or species. Examples of 
culture media for the detection and enumeration of Coliforms, enterococci, staphylococci 
and pseudomonas aeruginosa are presented in Table 3-1.   
The detection of target bacteria using culture methods are considered presumptive until 
further confirmation tests have been performed. In addition, the culture media typically 
used are not always species specific and therefore to identify to species level further 
identification tests are required using either, biochemical analysis, genomic analysis or even 
mass spectrometric techniques.  
3.2.1 Enumeration methods 
The most probable number test (MPN) is useful for the determination of the organisms 
under test from water samples with high turbidity which may interfere with accurate colony 
counts (Environment Agency, 2000). In the multiple-tube method, a series of tubes 
containing a suitable selective broth culture medium is inoculated with different dilutions of 
a water sample.  
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Table 3-1: Specific culture media used to detect and enumerate bacteria indicators in environmental waters 
Target bacteria Culture media Selective/indicating components Reference 
E.coli/coliform 
 
E.coli/coliform 
selective chromogenic 
agar 
 
 Rose-Gal chromogenic agent:  to detect ß-galactosidase enzymatic activity 
characteristic of E.coli but not other coliform bacteria 
 X-Glu chromogenic agent: to detect ß-glucuronidase activity (fermentation 
of lactose) characteristic of coliform bacteria. 
 sodium lauryl sulphate: to inhibit non-target organisms 
Wohlsen (2011) 
E.coli Typtone bile x 
glucuronide agar 
 5-bromo-4-chloro-3-indoyl-β-G-glucuronide to detect ß-glucuronidase 
activity 
Geissler et al. (2000) 
Enterococci Slanetz and Bartley 
agar 
 sodium azide: to inhibit Gram negative bacteria 
 triphenyltetrazolium chloride: reduced by enterococci to produce maroon 
colonies 
Environment Agency 
(2010a) 
Staphylococci (including 
Staphylococcus aureus) 
Mannitol salt agar 
with 0.005 % sodium 
azide 
 Sodium azide and 7.5 % sodium chloride: to supress non-target bacteria 
 Mannitol: to differentiate between Staphylococcus aureus and other 
staphylococci species 
 Phenol red: to indicate mannitol has been fermented by turning the red 
medium yellow 
Health Protection 
Agency (2004) 
Pseudomonas aeruginosa Pseudomonas 
selective agar 
 Magnesium chloride and potassium sulphate: To enhance the pigment 
production characteristic of Pseudomonas aeruginosa 
 Antibiotics cetrimide and nalidixic acid: to inhibit non-target bacteria  
Environment Agency 
(2010b) 
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Following incubation, an estimation of the number of bacteria under investigation per unit 
volume of the original sample can be made from the tubes that give a positive result and by 
using a standardised MPN table which is based on statistical probabilities (Environment 
Agency, 2009). The principle of the MPN method is to dilute the sample, so that there will 
be tubes with and without viable organisms. The MPN test is based on the assumption that 
all inoculated tubes containing at least viable organisms will produce detectable growth or 
change (US Food and Drug Administration, 2010). 
The membrane filtration method involves passing a known amount of sample (usually 100 
mL) through a membrane filter (pore size 0.45 µm) to trap bacteria on the surface. This 
membrane is then placed on a specific medium that permits the growth of the bacteria of 
interest and inhibits or differentiates bacteria which are not of interest (Black, 1996). The 
counts on membrane filters are subject to statistical variation, and replicate tests on 
subsamples from the same bulk sample are unlikely to give exactly the same number of 
colonies (Environment Agency, 2000). It has been recommended to report colony counts 
from filters with approximately between 10 and 100 colonies to minimise statistical errors 
(Environment Agency, 2007a). An advantage of the membrane filtration technique is that 
there is considerable saving in labour and in the amount of media and glassware required 
when compared to traditional most probable number (MPN) techniques (Environment 
Agency, 2000).   
3.2.1.1 Confirmation tests 
Enumeration methods use growth media to facilitate the growth of the bacteria of interest. 
However, some non-target bacteria can cause false positive results and therefore all results 
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are considered presumptive.  Presumptive bacteria can be confirmed through a number of 
biochemical tests used to detect characteristics specific to the target bacterial group of 
interest (e.g. coliforms). An example of the biochemical confirmation tests used to confirm 
presumptive coliforms (including E.coli), enterococci, staphylococci and Pseudomonas 
aeruginosa bacteria are presented in Table 3-2.  
3.2.2 Identification of bacteria 
A range of physiological, serological, biochemical and genomic methods such as 16S rRNA 
gene sequence analysis, real-time polymerase chain reaction (PCR) assays, and peptide 
nucleic acid-fluorescent in situ hybridization (PNA-FISH) are typically applied for the 
identification of bacteria. More recently, matrix-assisted laser desorption ionization–time-
of-flight mass spectrometry (MALDI-TOF) has emerged as a new technology for species 
identification (Bizzini et al., 2011).  
Traditional methods of bacterial identification rely on phenotypic identification using gram 
staining, culture and biochemical tests that identify specific metabolic activity (Maier et al., 
2009). If the identification to species level is necessary a multitude of tests may be required 
and therefore phenotypic identification can be very labour intensive. However, there are 
commercial kits available standardising the biochemical identification process.  
Phenotypic methods of bacterial identification suffer from two major drawbacks. First, they 
can be used only for organisms that can be cultivated in vitro. Second, some strains exhibit 
unique biochemical characteristics that do not fit into patterns that have been used as a 
characteristic of any known genus and species (Winston et al., 2004). To overcome these 
drawbacks, genotypic identification methods have become widely used.  
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Table 3-2: Biochemical confirmation tests for indicator bacteria 
Confirmation 
test 
Nature of test Inference reference 
Oxidase 
To detect cytochrome oxidase activity using detection strips 
impregnated with NNN’N’ tetramethyl -p- phenylene-diamine 
dihydrochloride 
Cytochrome oxidase activity is characteristic of 
pseudomonas aeruginosa 
Environment Agency 
(2000) 
Catalase 
To detect the presence of catalase enzymes using hydrogen 
peroxide. The reaction is detected by the release of oxygen gas 
bubbles from the decomposition of hydrogen peroxide 
staphylococci possess the catalase enzyme 
Health Protection 
Agency (2004) 
Indole 
production 
To detect the presence of enzymes that produce indole from 
the hydrolysis the amino acid tryptophan 
Conversion of tryptophan to indole is characteristic 
of E.coli and not other bacteria in the coliform 
group 
Environment Agency 
(2009) 
Gram staining 
To distinguish between the cell wall structure of Gram positive 
and Gram negative bacteria using crystal violet stain. 
Gram positive bacteria (e.g. enterococci and 
staphylococci) can retain the crystal violet stain 
whilst Gram negative (e.g. E.coli) cannot. 
Maier et al. (2009) 
Aesculin 
hydrolysis 
To detect bacteria that can hydrolyse aesculin Enterococci can hydrolyse aesculin 
Environment Agency 
(2010a) 
Growth in 6.5 
% sodium 
chloride 
To distinguish between bacteria tolerant to elevated salt levels. 
Enterococci can tolerate 6.5 % sodium chloride 
growth conditions whilst other bacteria closely 
related to enterococci cannot (e.g. streptococci) 
Environment Agency 
(2010a) 
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Currently, sequencing of the 16S rRNA gene is accepted as the reference method for 
bacterial species identification. Although, not perfect, genotypic identification of 
microorganisms by 16S rRNA gene sequencing has emerged as a more accurate and reliable 
method for bacterial identification compared to phenotypic techniques, with the added 
capability of defining taxonomical relationships among bacteria. The difficulties 
encountered with  this technique include the recognition of novel taxa, too few sequences 
deposited in nucleotide databases, species sharing similar and or identical 16S rRNA 
sequences (Janda et al., 2007). In addition, it has been reported that this technique is timely 
and costly, requiring intricate instrumentation and skilled personnel (Bizzini et al., 2011). 
Recently, bacteriologists have focused their attention on the use matrix assisted laser 
desorption ionization time of flight mass spectrometry (MALDI-TOF-MS) and this recent 
technique is being increasingly used for more routine purposes (Carbonnelle et al., 2011;  
Jamal et al. , 2011;  Dingle et al., 2009;  Eigner et al., 2009). The method analyses bacterial 
proteins from bacterial cell extracts and provides a unique mass spectral fingerprint of the 
microorganisms that can be compared to those in a reference database. This new proteomic 
approach allows rapid and cost effective accurate identification of bacteria. 
3.2.2.1 Matrix assisted laser desorption ionization time of flight mass spectrometry 
(MALDI-TOF-MS) 
Bacteria identification using MALDI-TOF-MS begins by applying a sample of a fresh purified 
culture (either in a solid or liquid form) onto a defined indentation (well) on a solid target 
support plate which is then overlaid with a chemical matrix. The prepared target plate is 
placed into an ionization chamber where each bacterial sample is irradiated with pulses of 
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energy from a laser (typically an ultra violet nitrogen laser at a wavelength of 337 nm). 
Although the mechanism of ionisation remains uncertain, it is believed that this process 
desorbs individual sample and matrix molecules from the target plate into the gas phase, 
with the majority of energy being absorbed by the matrix, which becomes ionized with a 
single positive charge. This positive charge is subsequently transferred from the matrix to 
the sample compounds through their random collision in the gas phase (Kafka et al., 2011). 
Matrix assisted laser desorption is a soft ionisation technique suitable for the ionisation of 
large non-volatile compounds such as proteins (Vargha et al., 2006). The matrix is essential 
for the soft ionization process. It is chosen for its ability to effectively absorb the majority of 
the ionizing energy thereby protecting the sample molecules from fragmenting.  Common 
matrices for the ionisation of proteins are α-cyano-4-hydroxy-cinnamic acid (HCCA), 2,5-
dihydroxybenzoic acid (DHB) and 3,5-dimethoxy-4-hydroxycinnamic acid (sinapic) (Vargha et 
al., 2006). 
The time of flight (TOF) analyser measures the time it takes for the ionised compounds to 
travel a fixed distance. A cloud of ionized compounds (e.g. proteins) from each pulse during 
the ionisation phase are accelerated through a positively charged, electrostatic field into the 
time of flight (TOF) tube. The TOF tube is a pressurised tube that allows ions to travel down 
a field-free region toward the ion detector. The velocity at which individual ions travel 
through the TOF tube is dependent on their mass-to-charge ratio (m/z) and therefore ions 
are separated based on their difference in mass (Kafka et al., 2011). Heavier ions will travel 
through the mass analyser at a slower velocity, compared to lighter ions. As the ions emerge 
from the TOF mass analyser, they collide with the ion detector, which measures their charge 
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and time to impact. Based on standards of known mass, the time to impact for each 
unknown analyte is converted into a m/z value. 
For bacteria, the generated mass spectrum can be thought of as a unique protein profile. 
MALDI-TOF-MS will detect the most abundant proteins over a predefined mass range 
(typically 2 to 20 kDa). These are mostly intracellular, hydrophilic proteins and are primarily 
ribosomal proteins (Cherkaoui et al., 2010). Identification of the unknown bacteria is 
achieved by computerized comparison of the acquired spectra to a database of reference 
spectra composed of previously well-characterized bacterial isolates (Eigner et al., 2009). 
3.3 Antibiotic resistance in bacteria indicative of faecal contamination 
3.3.1 Antibiotics and antibiotic action on bacteria 
Antibiotics are a family of pharmaceuticals used in the treatment of infectious diseases 
caused by microorganisms (Marti et al., 2014b). There are naturally produced antibiotics by 
microorganism (e.g. penicillin from the soil borne fungus Penicillium), antibiotics that are 
chemically synthesized and hybrid substances in which a naturally produced antibiotic is 
modified (semi-synthetic). 
When a host is infected, bacteria can grow and multiply damaging the host. Antibiotics act 
on an important microbial structure or function of the bacterial cell interfering with an 
important cell process essential for growth and division to inhibit or destroy the bacterial 
population (Hooper, 2001). They can be divided into two classes based on their mechanism 
of action: bactericidal and bacteriostatic. Bactericidal antibiotics kill bacteria whilst 
bacteriostatic antibiotics slow their growth or reproduction. Antibiotics are usually classified 
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based on their structure or function. Table 3-3 summarises the antibiotic classes and their 
respective modes of action. 
3.3.1.1 Inhibition of the bacterial cell wall synthesis 
Antibiotics that interfere with the synthesis of the cell wall weaken the peptidoglycan 
scaffold within the bacterial wall so that the structural integrity eventually fails. Bacterial 
cells have a high osmotic internal pressure and without the structural cell wall will burst 
when subjected to hypotonic environments. The basic cell wall structure is a chain of 
disaccharide residues cross linked with peptide bridges creating a rigid mesh structure for 
the bacteria.  The enzymes involved in the building of the cell wall chains are a target for 
antibiotics (e.g. cefpodoxime, amoxicillin and vancomycin).  The binding of the antibiotic to 
the enzymatic target inhibits the assembly of the peptidoglycan chains. These enzymes are 
sometimes referred to as penicillin binding proteins as they are a target for β lactam 
antibiotics (Bugg et al., 2011). Vancomycin interacts with the D-alanine terminal of 
pentapeptide chains sterically interfering with the formation of the cross linking bridges 
(Watanakunakorn, 1984). Vancomycin is too large a molecule to pass through the outer 
membrane pores in Gram negative bacteria to reach the target peptidoglycan site. 
Disruption of the bacterial cell membrane function 
The bacterial cytoplasmic cell membrane separates the cell from its environment and 
consists of phospholipids and proteins that regulate the movement of ions, nutrients and 
water in and out of the cell. Polypeptide antibiotics can distort the cell membrane by 
binding to the phospholipids in the membrane making them more permeable. This disrupts 
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the osmotic balance causing the leakage of cellular molecules, inhibits respiration and 
increases the uptake of water leading to cell death (Black, 1996). 
Table 3-3: Antibiotic classes and their modes of action (from Black, 1996) 
Class Group Example Mode of action Bacteriostatic
/bactericidal 
β Lactams Penicillins Amoxicillin Inhibition of cell 
wall synthesis 
bactericidal 
 Carbapenhams Doripenem 
 Cephalosporins Cefpodoxime 
Macrolides  Clarithromycin Inhibit protein 
synthesis 
bacteriostatic 
Tetracyclines  Oxytetracycline Inhibit protein 
synthesis 
bacteriostatic 
Quinolones  Ciprofloxacin Inhibits nucleic 
acid synthesis 
bactericidal 
Glycopeptides  Vancomycin Interferes with 
cell wall synthesis 
bacteriostatic 
Aminoglycosides  Gentamycin Inhibit protein 
synthesis 
bacteriostatic 
Sulfonamides  Sulfamethoxazole Inhibit metabolic 
pathways. 
bacteriostatic 
 
3.3.1.2 Inhibition of nucleic acid synthesis 
A nucleic acid inhibitor is a type of antibiotic that acts by inhibiting the production of nucleic 
acids and there are two major classes: DNA inhibitors and RNA inhibitors. Rifamycins inhibit 
RNA transcription. Quinolones (e.g. ciprofloxacin) are a key group of antibiotics that 
interfere with DNA synthesis by inhibiting the enzymes topoisomerase II (DNA gyrase) and 
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topoisomerase IV required for DNA replication, transcription, repair, and recombination 
(Marti et al., 2014a;  Robicsek et al., 2006). Quinolones enter the cell through porins in the 
outer membrane and complex selectively and reversibly with DNA gyrase and 
topoisomerase IV resulting in the inhibition of supercoiling DNA.  The DNA gyrase subunit is 
the primary quinolone target in gram negative bacteria, whereas topoisomerase IV is the 
primary target in Gram positive bacteria (Hooper, 2001).  
3.3.1.3 Inhibition of protein synthesis 
Macrolide antibiotics (e.g. clarithromycin) target the 23S ribosomal RNA (rRNA) of the 50S 
ribosomal sub-unit, which inhibits the formation of polypeptides. During translation, these 
antibiotics block the elongation step or peptide release step of protein synthesis. In Gram-
negative bacteria there is limited entry into the cell because macrolides are lipophilic 
molecules and they are too large to pass through the aqueous porins of the cell membrane 
and therefore most Gram negative bacteria are resistant to macrolides (Retsema et al., 
2001). 
3.3.1.4 Inhibition of essential metabolites 
Antibiotics in this group interfere with metabolic processes within the bacterial cell by 
mimicking or imitating the usual molecule required for the specific metabolic processes. 
Examples include sulfonilamide and trimethroprim (Black, 1996). 
3.3.2 Mechanisms of antibiotic resistance 
Antibiotic resistance describes the ability of bacteria to resist the action of antibiotic drugs. 
Some bacteria are naturally resistant to particular antibiotic agents; however, it is of great 
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concern to public health when bacteria that are normally susceptible to a particular agent 
become resistant. Bacteria have developed different mechanisms to resist antibiotics and 
the typical mechanisms that have been employed are summarised in Table 3-4. 
3.3.3 Dissemination of antibiotic resistance 
Bacteria generally become resistant to antibiotics due to changes in the bacterial genes 
either through mutations in the chromosomes, which are then inherited by their progeny 
(vertical transfer), or by the acquisition of extra-chromosomal DNA (e.g. plasmids) by 
horizontal gene transfer (Schwartz et al., 2003). Resistance due to changes in the 
chromosomes usually results in resistance to a single antibiotic group. However, bacteria 
can become resistant to a number of separate antibiotics by the horizontal gene transfer of 
extra-chromosomal DNA (Zhang et al., 2009). 
Horizontal gene transfer generally can occur via three routes:  
 transformation: the mechanism by which the cell can take up isolated DNA molecules 
from the medium surrounding it; this only happens at a certain stage of the growth 
cycle of the cell and is facilitated by competence factors (proteins). Not all bacteria 
can take up DNA molecules in this way (Droge et al., 1999). 
 transduction: this mechanism involves the transfer of isolated DNA molecules by 
bacteria viruses (phages) and requires that both donor and recipient cells have 
surface receptors for phage binding and is therefore usually limited to closely related 
bacteria (Droge et al., 1999). 
 conjugation: this mechanism involves the direct transfer of DNA through cell to cell 
contact and in most cases involves the transfer of plasmid DNA (Droge et al., 1999). 
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Table 3-4: Mechanisms of bacterial resistance to antibiotics (Black, 1996) 
Mechanism Description Example 
antibiotics 
Target alteration Mutations in the DNA alter the antibiotic 
target site. Without binding, no inhibition is 
exerted 
Macrolides 
Glycopeptides 
Membrane 
permeability alteration 
Membrane proteins that allow antibiotics 
into the cell change to prevent them entering 
the cell 
Tetracyclines 
Quinolones 
Aminoglycosides 
Enzymes DNA encoding for enzymes that destroy or 
break down antibiotic active 
β lactams 
Metabolic pathway 
alteration 
Genetic changes to bypass a metabolic 
pathway that the antibiotic exerts its effect 
on 
Sulfonamides 
 
Resistant genes can be transferred on extra chromosomal elements such as plasmids, 
transposons or integrons, all of which are thought to have played a major role in the spread 
of antibiotic resistance (Koczura et al., 2012;  Henriques et al., 2006). Examples of the 
different types of mobile genetic elements associated with antibiotic resistance are given in 
Table 3-5. Plasmids are circular extra chromosomal double stranded DNA elements that can 
supplement the chromosomal DNA. They add an important extra dimension to the flexibility 
of the microorganism response to changes in its surrounding environment regardless of 
whether these changes are hostile (e.g. the presence of antibiotics or toxic materials) or 
favourable (e.g. the availability of a new substrate). Plasmid transfer can occur between 
bacteria of the same species or different species and even between closely related genera of 
bacteria (Schwartz et al., 2003). Replication of a plasmid within a bacterial cell depends on 
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the plasmid. Some plasmids can replicate independently of bacterial chromosome 
replication and other plasmids will only replicate when initiation of chromosomal replication 
occurs. Genes encoding for antibiotic resistance can move from one plasmid to another or 
become inserted into the bacterium chromosome on transposable elements. The 
transposition can occur irrespective of taxonomic class.  
Table 3-5: Examples of mobile genetic elements found in bacteria for the transmission of antibiotic resistance. 
Taken from E. Marti et al. (2014) 
Mobile genetic element Characteristic Examples 
Plasmid Self transmissible or mobilisable 
pP2G1 contains ARGs 
 
Insertion sequence (IS) Encodes transposition 
IS18 mediates overexpression 
of β-lactam ARG 
 
Transposon (Tn) 
Can be flanked by an IS and can 
encode for transposition and a 
functional gene e.g. ARG 
Tn1 and Tn3 confer resistance 
to β-lactams 
 
Integron 
For the capture and expression of 
gene cassettes. Carries genes for 
integration and transcription 
 
Class 1 contains gene cassettes 
conferring multidrug resistance 
 
Genomic island 
Mobile regions of DNA for encoding 
of complex functions 
SGI1 confers resistance to 
streptomycin, β-lactams and 
sulphonamides 
 
Integrating conjugative 
elements (ICE) 
Transmissible mobile genetic 
elements that contain genes for 
conjugation and excision. Integrate 
and replicate in chromosome 
ICEVchHai1 confers resistance 
to different antibiotics 
ARG – antibiotic resistance gene  
Transposable elements or transposons typically consist of genes required for transposition 
of one or more resistance genes and they can only replicate once inserted into the plasmid 
or chromosome. Transposons often contain mobile genetic elements that can capture genes 
situated in mobile gene cassettes called integrons (Koczura et al., 2012). Integrons consist of 
a promoter gene, integrase coding gene, recombination sites and resistance genes 
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(Henriques et al., 2006). They are genetic platforms that are responsible for the integration 
and rearrangement of gene cassettes and therefore resistance genes and consequently are 
considered a large contributor to the spread of multi resistance (Koczura et al., 2012). The 
acquisition of mobile genetic elements may cause a metabolic burden to the bacterial cell.  
However, studies conducted by Enne et al. (2005) and McDermott et al. (1993) have shown 
the acquisition of transposons conferring kanamycin resistance and ampicillin resistance can 
be a fitness advantage to Escherichia coli.  
3.3.4 Antibiotic resistance in environmental waters 
Antibiotic resistant bacteria have been detected in the aquatic environment (Birosova et al., 
2014;  Marti et al., 2014;  Figueira et al., 2011;  Zhang et al., 2009;  Watkinson et al., 2007;  
Ash et al., 2002). The presence of resistant bacteria in surface waters can be attributed to a 
combination of the following factors: discharges of antibiotic residues and resistant bacteria 
with treated wastewater effluent, survival of resistant bacteria in surface waters and 
resistance transfer processes such as horizontal gene transfer. The presence of resistance 
elements in environmental waters and the presence of transferable elements within 
environmental bacteria support these conclusions (Amos et al., 2014;  Marti et al., 2014;  
Kaplan et al., 2013;  Schluter et al., 2007;  Szczepanowski et al., 2007;  Henriques et al., 
2006;  Pei et al., 2006;  Tennstedt et al., 2005;  Goni-Urriza et al., 2000). 
A greater prevalence of resistant bacteria have been observed in wastewater treated 
effluents compared to influent wastewater, indicating wastewater treatment processes may 
contribute to the dissemination of antibiotic resistant bacteria (Silva et al., 2007;  Silva et al., 
2006). In addition, a correlation between resistant bacteria within river waters and urban 
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wastewater input has been reported (Leclercq et al., 2007), indicating that resistant bacteria 
can survive at sub inhibitory antibiotic concentrations. Furthermore, it has been reported 
that bacteria can transfer genetic elements (e.g. plasmids) whilst surviving in a wide range 
of environmental conditions such as low nutrients (Fernandez-Astorga et al., 1992). 
3.3.5 Antibiotic resistance in E.coli  
Escherichia coli and enterococci species (particularly E.faecium and E.faecalis) are frequently 
isolated from human infections (Health Protection Agency, 2007) and therefore it is 
important to monitor their resistance to the antibiotics used against them. 
3.3.5.1 Resistance to β Lactams 
Resistance to penicillins (e.g. amoxicillin) by E.coli is widespread and according to antibiotic 
resistance surveillance co-ordinated by the European Centre for Disease Prevention and 
Control - Antimicrobial resistance interactive database (EARS-net) (2013), E.coli penicillin 
resistance in humans increased from 50.8% to 62.7% in the UK between 2000 to 2012. Over 
the same period, E.coli Resistance to 3rd generation cephalosporins (e.g. cefpodoxime) also 
increased (from 1.2 – 13.1 %). 
In E.coli, resistance to penicillins usually occurs by the acquisition of plasmids carrying genes 
coding for β lactamases (Nafsika, 2007). β lactamases are enzymes that hydrolyse the β 
lactam ring of β lactam antibiotics rendering them inactive and more than 200 different β 
lactamases have been described. They can be classified by their amino acid sequence 
(Nafsika, 2007) and some are specific to penicillins, cephalosporins or carbapenems, 
whereas others have a broad range of activity. The nomenclature of β lactamases varies and 
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may refer to the patient they were first discovered in, the substrate, biochemical property, 
strain of bacteria or even location of the gene on the chromosome (Paterson et al., 2005). 
TEM  type derivatives of β lactamases (named after the patient, Temoneria, this enzyme 
was first isolated from) are the most common type found in E.coli and  account for up to 
60% of penicillin E.coli resistance (European Antimicrobial Resistance Surveillance Network, 
2011). Mutations in the basic amino acid structure of TEM or SHV β lactamases (named after 
the sulfhydryl substrate binding point in which the activity of the inhibition is considered 
variable) extend their spectrum of activity and enhance their hydrolysing ability conferring 
resistance to penicillins and cephalsporins (extended–spectrum β lactamases) (Paterson et 
al., 2005). Most extended spectrum β lactamases (ESBLs) can be inhibited by β lactamase 
inhibitors such as clavulanic acid.  
3.3.5.2 Resistance to fluoroquinolones 
When fluoroquinolones were first introduced for clinical use in the 1980s, the emergence of 
clinical resistance was considered negligible.  However, fluoroquinolone resistance quickly 
emerged globally (Robicsek et al., 2006). Resistance to fluoroquinolones can arise through 
chromosomal mutations arising from stepwise mutations in the gene (gyrA, parC, and parE) 
coding for the sub-units of DNA gyrase and DNA topoisomerase IV (Nafsika, 2007). An 
accumulation of mutations results in an increase of minimum inhibitory concentration 
(Marians et al., 1997). Low level resistance to fluoroquinolones can occur through changes 
in outer membrane porins or by active efflux pumps (Nafsika, 2007). Since the late 1990s, 
plasmid mediated resistance has been identified (Kaplan et al., 2013) and can occur through 
the acquisition of Qnr proteins which inhibit the binding of fluoroquinolones (e.g. 
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ciprofloxacin) with DNA gyrase. There are several variations of these proteins that have 
been identified (QnrA, QnrB, QnrC, QnrD and QnrS) and acquisition of these genes can 
increase fluoroquinolone minimum inhibitory concentrations between 8 and 64 fold in E.coli 
(Martinez, 2009). Additionally, Qnr proteins have been identified in waterborne bacteria 
(Picao et al., 2008). 
Resistance to fluoroquinolones is not widespread in human E.coli isolates. However, the  
European Centre for Disease Prevention and Control - Antimicrobial resistance interactive 
database (EARS-net) (2013) reports an increase in fluoroquinolone resistant E.coli (6.2 % to 
16.6 %) between 2000 and 2012.  
3.3.6 Antibiotic resistance in enterococci 
To assess the susceptibility of a species of enterococci, it is important to first identify the 
causative agent because resistance to some antibiotics can be intrinsic or more widespread 
in some species than others. Enterococci species are intrinsically resistant to a broad range 
of antibiotics including penicillins, cephalosporins (e.g. cefpodoxime), sulphonamides and 
aminoglycosides (European Antimicrobial Resistance Surveillance Network, 2011). 
3.3.6.1 Resistance to β lactams 
Intrinsically, enterococci have low level resistance to β lactamase antibiotics due to the low 
affinity penicillin binding proteins (e.g. PBP5) found on the cell wall. Loss of this non-
essential protein renders strains highly susceptible with ampicillin minimum inhibitory 
concentration values (MICs) < 0.06 mg/L. Whereas, over expression of PBP5 has been 
correlated to ampicillin MIC values up to 64 mg/L (Eliopoulos, 2007). Target modifications in 
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the peptidoglycan cell wall chains have also been associated with ampicillin resistance in 
E.faecium (Mainardi et al., 2000). Contrary to Escherichia coli, the production of β 
lactamases is rare in enterococci. Resistance to penicillins is more widespread in E.faecium 
than in E.faecalis. 
UK surveillance of penicillin resistance in E.faecium has indicated that resistant rates of 
human E.faecium isolates have increased from 77.6 % to 93.1 % during 2005 -2012 
(European Centre for Disease Prevention and Control - Antimicrobial resistance interactive 
database (EARS-net), 2014). 
3.3.6.2 Resistance to vancomycin 
The surveillance of vancomycin resistance in enterococci species is mandatory in clinical 
settings due to the importance of vancomycin therapy for enterococci infections. 
Vancomycin resistance occurs by the synthesis of modified cell wall precursors that express 
a decreased affinity for vancomycin and other glycopeptides. Low level resistance to 
vancomycin with susceptibility for teicoplanin, results from the presence of vanC type 
resistance determinants which are intrinsic to some species of enterococci (E.gallinarum, 
E.casseliflavus and E.flavescens) (Eliopoulos, 2007). These species of enterococci with 
intrinsic vanC resistance can acquire other van resistance genes (e.g. vanA, vanB, vanC and 
vanD) thereby increasing their resistance level. The vanA and vanB determinants confer high 
levels of vancomycin resistance which may be transferred by plasmids (European 
Antimicrobial Resistance Surveillance Network, 2011). Bacteria which are physiologically 
similar to enterococci, including Leuconostoc and Pediococcus species are also intrinsically 
resistant to high levels of vancomycin due to thickening of the cell wall and a decreased 
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affinity for vancomycin to cell wall precursors (Handwerger et al., 1994). Resistance to 
vancomycin in E.faecalis has remained less than 4% in the UK (2005 – 2010). In E.faecium 
resistance to vancomycin has decreased from 33.0 % to 13.3% from 2005 to 2010 in the UK 
(European Centre for Disease Prevention and Control - Antimicrobial resistance interactive 
database (EARS-net), 2014b). 
3.3.6.3 Resistance to macrolides 
Macrolide antibiotics constitute an important alternative therapy for the treatment of 
insidious enterococci infections (Portillo et al., 2000) although, surveillance of macrolide 
(including clarithromycin) resistance in clinical isolates of E.faecium is not mandatory in 
England. Resistance to the macrolide antibiotics is common in enterococci bacteria, despite 
it not being intrinsic to the species (Eliopoulos, 2007). Gram negative bacteria are 
intrinsically resistant to macrolides due to the impermeability of the outer cell membrane. 
However, Gram positive bacteria can acquire resistance to macrolides by altering the 
ribosomal binding site through methylation (mediated by erm genes) or by efflux pumps 
(e.g. mef genes) that prevent the accumulation inside the cell (Pechere, 2001).  
3.3.6.4 Resistance to fluoroquinolones 
There is no mandatory surveillance of fluoroquinolone resistance in human E.faecium 
isolates in the UK, yet there are studies that report resistance to fluoroquinolones is 
widespread in the enterococci genus (Eliopoulos, 2007).   
Resistance to fluoroquinolones can occur through mutations in the enzymes 
(topoisomerase) important for DNA replication and transcription or by efflux pumps 
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preventing the accumulation of the antibiotic inside the cell. Similarly to E.coli, the 
mutations are chromosomal arising from stepwise mutations in the genes (gyrA and parC) 
coding for the sub-units of DNA gyrase and DNA topoisomerase IV. An accumulation of 
mutations results in an increase of minimum inhibitory concentration.  
3.4 Antibiotic susceptibility testing 
Antibiotic susceptibility tests (AST) are carried out to determine which antibiotic will be 
successful in the treatment of a bacterial infection. There are generally two different AST 
methods that are used in clinical environments; the disc diffusion method and the agar 
dilution method (Huang et al., 2012). The disc diffusion method involves swabbing a uniform 
culture of the organism of interest on an agar plate and applying filter paper discs 
impregnated with a specific concentration of the antibiotic to be tested. The plates are then 
incubated and the antibiotic diffuses out from the filter paper, the concentration of the 
antibiotic being highest closer to the filter paper. Following incubation, any clear zones 
around the filter paper discs represent zones of the antibiotic inhibiting the growth of the 
organism (Black, 1996). Different antibiotics will diffuse at different rates and therefore 
interpretation of zones should only be compared to standard measurements such as those 
previously established for the antibiotic by the British Society for Antimicrobial 
Chemotherapy (BSAC, 2011). The disc diffusion test is a qualitative test that correlates 
inhibition zones to clinical break points to determine if the organism under test is resistant 
(R), sensitive (S) or of intermediate sensitivity (I) to the antibiotic (BSAC, 2011).  
Minimum inhibitory concentrations values (MICs) are defined as the lowest concentrations 
of an antibiotic that will inhibit visible growth of a microorganism after overnight incubation 
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(Andrews, 2011). MIC values can be determined by agar or broth dilution techniques 
according to the standards established by various authorities such as the Clinical and 
Laboratory Standards Institute (CLSI, 2012) and the British Society for Antimicrobial 
Chemotherapy (BSAC, 2011). MIC values can also be evaluated using antibiotic gradient 
strips. The use of antibiotic gradient strips is technically straightforward as tests are set up in 
the same way as the disc diffusion method. Their versatility and ease of use make this 
method an attractive alternative to conventional dilution tests (Brown et al., 1991). 
However, antibiotic gradient strips are a quantitative technique for the determination of 
MIC values. They are plastic strips that are impregnated with 15 pre-defined antibiotic 
concentrations along the length of one side of the strip. On application to an inoculated agar 
surface, the antibiotic is released to the agar from the strip, forming a defined concentration 
gradient around the strip. After incubation an ellipse shaped zone of no growth will form 
where the ellipse meets the strip, and the MIC can be read from the concentration markings 
on the strip (Turndge, 2005). It has been reported that results from antibiotic gradient strips 
are as reliable as those obtained by the standard antimicrobial susceptibility testing 
methods (Mushtag et al., 2010;  Hope et al., 2007;  Hong et al., 1996). 
There are different growth mediums available for antibiotic susceptibility testing including 
Mueller Hinton and Iso-Sensitest. Antibiotic Susceptibility protocols recommended by The 
European Committee on Antimicrobial Susceptibility Testing - EUCAST (2014) employ 
Mueller Hinton. The choice of the growth medium for antibiotic susceptibility testing is 
important as supplements or medium constituents may affect the growth of the organism 
and potentially the accuracy and reproducibility of the test Rennie et al. (2012) 
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Advances in molecular biological techniques can be used to detect antibiotic resistance and 
genotypic methods can also be used. DNA based assays have been developed for the 
detection of bacterial resistance genes. Genotypic methods do not provide information on 
antibiotic phenotypes but can identify resistance genes in bacteria that cannot be cultivated 
(Volkmann et al., 2004). The availability of molecular methods are not necessarily an 
improvement over phenotypic methods because the genetic mechanism responsible for the 
resistance needs to be known. If the mechanism is not known, no appropriate molecular 
assay can be developed. In addition, there may be more than one mechanism responsible 
which could lead to very complex assays. Finally if a resistance gene is detected it does not 
necessarily mean that it confers a resistance phenotype (Fluit, 2007). 
3.4.1 Definition of resistance to antibiotics 
Clinical breakpoint values are used in the clinical laboratory to advise on patient therapy. 
Breakpoints for phenotypic antimicrobial susceptibility testing have been determined by 
breakpoint committees (e.g. the British Society for Antimicrobial Chemotherapy, the 
European Committee on Antimicrobial Susceptibility testing and the Clinical and Laboratory 
Standards Institute) and as part of regulatory processes for the approval of new drugs. To 
determine breakpoint antibiotic doses, pharmakinetics, pharmacodynamics, resistance 
mechanisms, MIC value distributions and epidemiological cut-off values (ECOffs) are 
considered EUCAST (2010).  
The European Committee on Antimicrobial Susceptibility Testing (EUCAST) has developed 
the concept of epidemiological cut-off values to aid the identification of the emergence of 
acquired resistance mechanisms (Kahlmeter et al., 2003). Epidemiological cut-off values 
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(ECOffs) are achieved by collecting MIC values from a population of bacteria from the same 
taxonomic group (genus or species). The MIC data is then pooled in a histogram and the 
ECOff values are then visually estimated or statistically calculated (Turnidge et al., 2006). An 
example of ciprofloxacin MIC values collected by the European Committee for Antimicrobial 
Susceptibility Testing (EUCAST) for E.coli and the corresponding ECOff value is shown in 
Figure 3-1. ECOff values are used to distinguish between bacteria with acquired resistance 
mechanisms (non-wild type) and bacteria without acquired resistance mechanisms (wild 
type) (Kahlmeter et al., 2003). 
The EUCAST breakpoint definitions (EUCAST, 2012a) are as follows: 
 clinically Susceptible (S) - The microorganism is defined as susceptible if the 
antibiotic will have therapeutic success at a particular concentration.  
 clinically Resistant (R) – If an applied antibiotic concentration has a high likelihood of 
therapeutic failure then the microorganism is considered resistant.  
 Wild type (WT) - a microorganism is defined as WT by the absence of acquired and 
mutational resistance mechanisms to an antibiotic. A microorganism is categorized 
as WT for a species by applying the appropriate cut-off value in a defined phenotypic 
test system. Wild type microorganisms may or may not respond clinically to 
antimicrobial treatment. 
 Non Wild type (NWT) - a microorganism is defined as non-wild type by the presence 
of an acquired or mutational resistance mechanism to an antibiotic. A 
microorganism is categorized NWT for a species by applying the appropriate cut-off 
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value in a defined phenotypic test system. NWT microorganisms may or may not 
respond clinically to antimicrobial treatment. 
 
Figure 3-1: Histogram showing the distribution of ciprofloxacin minimum inhibitory concentration (MIC) values 
measured for Escherichia coli isolates submitted to the European Committee of Antimicrobial Susceptibility 
Testing (EUCAST). 
 
Image source: the European Committee of Antimicrobial Susceptibility Testing. 
Blue and white bars represent wild and non-wild type respectively (EUCAST, 2014) 
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4 Detection of Pharmaceuticals in the Urban Water Environment 
4.1 Introduction 
Due to advancing analytical techniques, there are increasing numbers of publications 
reporting the detection of trace levels of pharmaceuticals  in wastewater treatment plant 
influents (Zorita et al., 2009;  Karthikeyan et al., 2006), effluents (Stülten et al., 2008;  Brown 
et al., 2006;  Clara et al., 2005) and in river waters  (Gros et al., 2007;  Gros et al., 2006;  
Moldovan, 2006;  Vieno et al., 2006). Collectively, researchers have demonstrated that few 
pharmaceuticals are completely removed during wastewater treatment and can therefore 
be discharged to receiving waters. However, the concentrations reported vary due to 
differences in the types of wastewater treatment employed, population size and critically, 
the prescription quantities. 
In this chapter, an analytical method to detect a selection of pharmaceuticals in 
environmental waters is described and used to investigate the passage of the selected 
pharmaceuticals through a large urban wastewater treatment plant (WWTP) employing 
activated sludge. The concentrations of target pharmaceuticals in wastewater samples 
collected from different stages of the wastewater treatment process are compared and the 
reductions of these compounds estimated. The impact of the treated effluent on the 
receiving surface water is assessed by comparing the pollutant concentrations up-stream 
and down-stream of the discharged effluent.  
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4.1.1 Selection of pharmaceuticals 
The pharmaceuticals originally selected for monitoring throughout the wastewater 
treatment process were amoxicillin, bezafibrate, carbamazepine, ciprofloxacin, and 
clarithromycin. These compounds were selected as they have different physicochemical 
properties (presented in Section 4.3.2) and therefore provide the opportunity to investigate 
the pathways of chemically different compounds through the wastewater treatment 
process. Selection was also based on prescription quantities estimated for the WWTP 
catchment (given in Section 4.3.5) and the detection in environmental waters reported by 
other studies. Finally, the success of the analytical method to determine these compounds 
in environmental waters was important in the compound selection (Section 4.3.2).  
Additional antibiotics, vancomycin and cefpodoxime, were selected for the work described 
in Chapter 5 due to their importance in the treatment of nosocomial infections and because 
they are considered critically important to human medicine (see Chapter 5, Section 5.1.2). 
However, the analytical methodology described in this chapter did not include these 
compounds due to the very low prescription levels (0.025 and 0.002 Tonnes a-1 for 
vancomycin and cefpodoxime respectively) for the community in England leading to very 
low environmental concentrations (see Table 4-2 and Table 4-3). All the compounds 
selected for the studies described in Chapters 4-6 are only available on prescription in 
England and their structures and International Union of Pure and Applied Chemistry (IUPAC) 
names are given in Table 4-1. 
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Table 4-1: Structure and properties of the pharmaceuticals selected for this study 
a. Pharmaceutical  
b. Class 
c. CAS number 
d. Formula 
e. MW (g/mol) 
 
Structure and IUPAC name 
i. pKa 
ii. Sol (mg/L) 
iii. Log KOW 
iv. KOC 
a. Bezafibrate 
b. Lipid regulator 
c. 41859-67-0  
d. C19H20ClNO4 
e. 361.8 
 
 
2-(4-{2-[(4-chlorobenzoyl)amino]ethyl}phenoxy)-2-methylpropanoic acid 
i. 3.6a 
ii. 1.5c 
iii. 4.25a 
iv. 2.5a 
a. Carbamazepine 
b. Anticonvulsant 
c. 298-46-4 
d. C15H12N2O 
e. 236.3 
 
 
5H-dibenzo [b,f]azepine-5-carboxamide 
i. 13.9a 
ii. 18.0b 
iii. 2.45a 
iv. 510b 
a. Ciprofloxacin 
b. Quinolone 
antibiotic 
c. 85721-33-1 
d. C17H18FN3O3  
e. 331.3 
 
 
1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-quinoline-3-carboxylic 
acid 
i. 6.1, 8.7b 
ii. 30,000b 
iii. -0.4a 
iv. 61,000b 
a. Clarithromycin 
b. Macrolide  
antibiotic 
c. 81103-11-9 
d. C38H69NO13  
e. 747.9 
 
3R,4S,5S,6R,7R,9R,11S,12R,13S,14S)-6-{[(2S,3R,4S,6R) -4-
(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy} -14-ethyl-12,13-
dihydroxy-4-{[(2R,4S,5S,6S)-5-hydroxy -4-methoxy-4,6-dimethyloxan-2-
yl]oxy}-7 -methoxy-3,5,7,9,11,13-hexamethyl -1-oxacyclotetradecane-
2,10-dione 
i. 8.99a 
ii. 0.3c 
iii. 3.16a 
iv. 150b 
a. Amoxicillin 
b. Β Lactam 
antibiotic 
c. 26787-78-0 
d. C16H19N3O5S·3H2O 
e. 365. 4 
 
 
 
 
 
 
 
(2S,5R,6R)- 6-{[(2R)-2-amino- 2-(4-hydroxyphenyl)- acetyl]amino}- 3,3-
dimethyl- 7-oxo- 4-thia- 1-azabicyclo[3.2.0]heptane- 2-carboxylic acid 
i. 2.4,7.4,9.6a 
ii. 3740c 
iii. 0.87a 
iv. N/A 
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Table 4-1 (continued) 
Pharmaceutical 
CAS number 
Formula 
MW (g/mol) 
Structure 
i. pKa 
ii Sol (mg/L) 
iii Log KOW 
iv KOC 
a. Vancomycin 
b. Glycopeptide 
antibiotic 
c. 1404-90-6 
d. C66H75Cl2N9O24 
e. 1449.3 
 
 
 
(1S,2R,18R,19R,22S,25R,28R,40S)-48-{[(2S,3R,4S,5S,6R)-3-{[(2S,4S,5S,6S)-4-
amino-5-hydroxy-4,6-dimethyloxan-2-yl]oxy}-4,5-dihydroxy-6-
(hydroxymethyl)oxan-2-yl]oxy}-22- 
 (carbamoylmethyl)-5,47-dichloro-2,18,32,35,37-pentahydroxy-19-[(2R)-4-
methyl-2-(methylamino)pentanamido]-20,23,26,42,44-pentaoxo-7,13-
dioxa-21,24,27,41,43-
pentaazaoctacyclo[26.14.2.2^{3,6}.2^{14,17}.1^{8,12}.1^{29,33}.0^{10,25}.
0^{34,39}]pentaconta-3,5,8,10,12(48),14,16,29(45),30,32,34,36,38,46,49-
pentadecaene-40-carboxylic acid 
i. 2.6,7.2,8.6c 
ii. 225c 
iii. 1.11c 
iv. N/A 
a. Cefpodoxime 
b. Cephalosporin 
antibiotic 
c. 82619-04-3 
d. C15H17N5O6S2 
e. 427.5 
 
 
 
(6R,7R)-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-3-
(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic 
acid 
i. 3.22c 
ii. 185c 
iii. 0.05c 
iv. N/A 
MW - Molecular weight, IUPAC - The International Union of Pure and Applied Chemistry, pKa = acid 
dissociation constant, Sol =solubility, KOC = Soil organic partition coefficient, KOW = octanol water coefficient, 
N/A  = data not available, a Ternes et al. (2008), b Wexler Philip (2001), c Wishart et al. (2008).  
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Bezafibrate is an amphipathic carboxylic acid compound belonging to a group of fibrate drugs that are used to 
regulate lipid levels in the blood. Approximately 50 % of the drug remains un-metabolised and is excreted as 
the parent compound (Garcia-Ac et al., 2009). Bezafibrate has been detected in environmental waters 
including wastewaters and surface waters at the levels reported in Table 4-2 and Table 4-3. However, results of 
toxicology tests (Isidori et al., 2007) indicate that there are no toxic adverse effects in non-target organisms at 
the fibrate concentrations (including bezafibrate) typically found in the environment.  
Carbamazepine is an anticonvulsant used to treat epilepsy and is also used as an 
antidepressant. It is a neutral compound, moderately soluble in water and contains both a 
hydrophobic moiety (two phenyl functional groups) and a hydrophilic urea moiety. 
Carbamazepine is heavily metabolized in the human body. More than 30 metabolites have 
been identified in humans  including 10, 11 –dihydro- 10, 11 epoxycarbamazepine and 10, 
11 –dihydro- 10, 11 dihydroxycarbamazepine (Bahlmann et al., 2014) which are excreted via 
urine and faeces. Although, only a low percentage (approximately 10 %) is excreted as the 
unchanged compound, carbamazepine has been frequently detected in environmental 
waters (see Tables 4-2 and 4-3). No adverse acute toxicity effects of carbamazepine to 
juvenile rainbow trout were observed at environmental relevant concentrations (1.0 µg/L) 
by Li et al. (2011). In addition, Zhang et al. (2012) found carbamazepine did not exhibit an 
acute toxicity effect on algae. However, more chronic toxicity tests should be performed to 
gain more information of the effects of this compound and other pharmaceuticals in the 
environment. 
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Table 4-2: Reported concentrations of selected pharmaceuticals in wastewaters. 
Compound Sample  Concentration  
(ng/L) 
Location Treatment employed  Reference 
Bezafibrate Influent 
Effluent 
209 -1391 
< 85 – 665 
Wales 2TBF (111,000) Kasprzyk-Horden et el 
(2009a) 
 Influent 
Effluent 
1960-7600 
nd-4800 
Austria Various 2B Clara et al. (2005) 
 Effluent 100 -510 Spain 2CAS (140,000) Pedrouzo et al. (2011) 
 Influent 
Effluent 
200-460 
20-390 
Spain Various 2CAS  
(18,000-265,000) 
Gracia-Lor et al. (2012) 
 Influent 
Effluent 
135 – 1285 
<94-393 
Wales 2CAS (30,000) Kasprzyk-Horden et el 
(2009b) 
 Influent 5.7 – 945.9 Greece Various 2CAS  
(20,000-100,000) 
Kosma et al. (2014) 
 Influent 
Effluent 
971a 
418a 
Wales 2TBF (111,000) Kasprzyk-Hordern et al. 
(2008b) 
 Influent 420 ± 300 Finland Various 3B  
(3000-740,000) 
Lindqvist et al. (2005) 
 Influent 121 ±108 Spain 3B (20,000) Collado et al. (2014) 
 PST 1900-2980 Spain Various 2B  (277, 000) Radjenovic et al. (2009) 
Carbamazepine Influent 
Effluent 
2 - 405 
8 - 170 
Spain 2CAS (140,000) Pedrouzo et al. (2011) 
Influent 
Effluent 
290-400 
380-470 
Finland Various 3B Vieno et al. (2006) 
Influent 
Effluent 
570 ± 390 
370 ± 69 
Italy 2CAS (120,000) Verlicchi et al. (2014) 
Effluent 240a Italy 2CAS (138000) Al Aukidy et al. (2012) 
Influent 
Effluent 
325 – 1850 
465 - 1594 
Austria 2CAS (7000) Clara et al. (2005) 
Influent 28.0 - 416.8 Greece Various 2CAS  Kosma et al. (2014) 
Influent 
Effluent 
709 -2930 
104 - 3110 
Wales 2TBF (111,000) Kasprzyk-Horden et el 
(2009a) 
Influent 27 ± 24 Spain 3B (20,000) Collado et al. (2014) 
Influent 
Effluent 
644 - 4596 
152 - 2324 
Wales 2CAS (30,000) Kasprzyk-Horden et el 
(2009b) 
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Table 4.2 (continued) 
Compound Sample  Concentration  
(ng/L) 
Location Treatment employed  Reference 
Ciprofloxacin PST 
Effluent 
84-721 
42-392 
Canada NA Lee et al. (2007) 
Influent 
Effluent 
200-650 
<29-40 
Finland Various 3B Vieno et al. (2006) 
Influent 
Effluent 
1100a 
ND 
Australia Various Watkinson et al. (2009) 
Influent 
Effluent 
200-650 
<29-40 
Finland Various 2CAS 
 (12,400-40,000) 
Vieno et al. (2007) 
Influent 
Effluent 
2200 ± 1800 
630 ± 349 
Italy 2CAS (120,000) Verlicchi et al. (2014) 
Influent 
Effluent 
313-568 
62-106 
Switzerland NA Golet et al. (2002) 
Influent 
Effluent 
513 
147 
Italy 2CAS (229,000) Zuccato et al. (2010) 
Influent 392 ± 218 Spain 3B (20,000) Collado et al. (2014) 
PST 
Effluent 
6900a 
720a 
Australia 2CAS (700,000) Watkinson et al. ( 2007) 
Influent 
Effluent 
143-1304 
46-427 
Croatia Various Senta et al. (2008) 
Clarithromycin Influent 
Effluent 
112 
ND 
USA 3B Loganathan et al. 
(2009) 
Influent 
Effluent 
200 ± 320 
280 ± 24 
Italy 2CAS (120,000) Verlicchi et al. (2014) 
Influent 
Effluent 
138-1396 
103-996 
Croatia Various Senta et al. (2008) 
Influent  
Effluent 
<LOQ-724.2 
<LOQ-610.0 
USA NA Spongberg et al. (2008) 
Amoxicillin Influent 
PST 
280a 
270a 
Australia 2CAS (700,000) Watkinson et al. (2007) 
Influent 
Effluent 
18 
ND 
Italy 2CAS (229,000) Zuccato et al. (2010) 
Vancomycin Influent 
Effluent 
41 
40 
Italy 2CAS (229,000) Zuccato et al. (2010) 
a Maximum detected.  Population equivalent given in parenthesis if available, NA = Data not available, LOQ = 
limit of quantification, 3B =biological with tertiary treatment, 2CAS = secondary conventional activated sludge 
treatment, TBF = trickling bed filter, 2B = secondary biological treatment. PST = effluent from primary 
sedimentation tank. ND = not detected. 
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Table 4-3: Reported concentrations of selected pharmaceuticals in surface waters.  
Compound Sample matrix Concentration 
(ng/L) 
Location Reference 
Bezafibrate Down-stream  < 50–130 Germany Wiegel et al. (2004) 
 Down-stream  
Up-stream 
58 
41 
Wales Kasprzyk-Hordern et al. (2008a) 
 Down-stream  
Up-stream 
4.5a 
4.0a 
Sweden Lindqvist et al. (2005) 
 Down-stream 25.5a Spain Silva et al. (2011) 
 Down-stream 76a Wales Kasprzyk-Hordern et al. (2008b) 
 Various 1.6 Serbia Petrovic et al. (2014) 
 Down-stream 200a Canada Metcalfe et al. (2003) 
 Various surface water 3.4b France Vulliet et al. (2011) 
 Various surface water 0.3-46 Spain Fernan¡ndez et al. (2010) 
 Down-stream 63 Spain Garcia-Ac et al. (2009a) 
 Down-stream 
Up-stream 
90a 
66a 
Wales 
 
Kasprzyk-Hordern et el (2009b) 
Carbamazepine 
 
Down-stream  
Up-stream  
13.5a 
ND 
US Spongberg et al. (2008) 
 Down-stream 684a Wales Kasprzyk-Hordern et al. (2008b) 
 Various 35.6 Serbia Petrovic et al. (2014) 
 Down-stream 
Up-stream 
4.0a 
5.6a 
US Conley et al. (2008) 
 Various surface water 2.9-23.1 US Conley et al. (2008b) 
 Various surface water 6720a France Feitosa-Felizzola et al. (2009) 
 Various surface water 30 -250 Switzerland Öllers et al. (2001) 
 Down-stream 650a Canada Metcalfe et al. 2003 
 Down-stream 6-11 Canada Garcia-Ac et al. (2009b) 
 Various surface water 13.9b France Vulliet et al. (2011) 
 Various surface water 0.3 -104 Spain Fernan¡ndez et al. (2010) 
 Down-stream 53.8a Spain Silva et al. (2011) 
 Down-stream 
Up-stream 
495a 
647a 
Wales 
 
Kasprzyk-Hordern et el (2009b) 
 Down-stream 112-67715 Spain Valcarcel et al. (2011) 
 Down-stream  < 30 – 140 Germany Wiegel et al. (2004) 
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Table 4-3 (continued) 
Compound Sample matrix 
Concentration 
(ng/L) 
Location Reference 
Ciprofloxacin 
Down-stream 
Up-stream 
< LOD (24)-25 
< LOD (24) 
Finland Vieno et al. (2007) 
 Down-stream 135 ± 2 France Tuc Dinh et al. (2011) 
 Various 28.2a Serbia Petrovic et al. 2014 
 Down-stream 9-280 USA Batt et al. (2006) 
 
Down-stream 
Up-stream 
130a 
ND 
Spain Gros et al. (2006) 
 Various surface water 4.7 -54.2 USA Conley et al. (2008b) 
 Down-stream < 4.5 USA Conley et al. (2008) 
 Various surface water 26.2a Italy Castiglioni et al. (2004) 
 Down-stream <6-224 Spain Valcarcel et al. (2011) 
 Various surface water 9660a France Feitosa-Felizzola et al. (2009) 
 Down-stream 1300a Australia Watkinson et al. (2009) 
 Down-stream 1.32 – 26.89 Italy Zuccato et al. (2010) 
Clarithromycin 
Down-stream 
Up-stream 
4.6 – 9.0 
1.4 
USA Spongberg et al. (2008) 
 Down-stream 36.9a Spain Silva et al. (2011) 
 Various surface water 2330a France Feitosa-Felizzola et al. (2009) 
 Various surface water 20.3a Italy Castiglioni et al. (2004) 
 Down-stream 75 Switzerland McArdell et al. (2003) 
 Various surface water 616a Serbia Petrovic et al. (2014) 
 Down-stream 130-1727 Spain Valcarcel et al. (2011) 
 
Down-stream 
Up-stream 
250a 
60a 
Spain Gros et al. (2006) 
 Down-stream 0.89-36.0 Italy Zuccato et al. (2010) 
 Down-stream < 30 - 40 Germany Wiegel et al. (2004) 
Amoxicillin Down-stream 200a Australia Watkinson et al. (2009) 
 Down-stream 68c France Tuc Dinh et al. (2011) 
 Down-stream 622ac Wales Kasprzyk-Hordern et al. (2008b) 
 Various surface water ND Italy Castiglioni et al. (2004) 
 Down-stream 3.57 – 9.91c Italy Zuccato et al. (2010) 
Vancomycin Down-stream 0.44 – 5.17 Italy Zuccato et al. (2010) 
 Down-stream 90 France Tuc Dinh et al. (2011) 
ND = not detected, a maximum detected, b Mean value detected, c Semi quantitative method used 
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Ciprofloxacin is a broad spectrum antibiotic used to treat bacterial infections. The structure 
of ciprofloxacin contains a carboxylic acid functional group which can be deprotonated and 
an amino group in the heterocyclic ring (piperazinyl) which can be protonated. Therefore 
the compound is amphoteric in nature and may exist in cationic, zwitterionic, or anionic 
forms depending on the pH conditions. Following ingestion, ciprofloxacin is partially 
metabolised in the liver but renal excretion is the primary route and approximately 50 % can 
be excreted as the original compound. Ciprofloxacin has been detected in environmental 
waters (see Tables 4-2 and 4-3) which is a concern as it’s  low biodegradability and toxic 
effects towards environmental bacteria have been well documented (Kümmerer et al., 
2000, Hartmann et al., 1998). In addition, environmental risk assessments conducted by 
Halling-Sorensen et al. (2000) and Martins et al. (2012) identified ciprofloxacin as a potential 
risk to aquatic organisms. 
Clarithromycin is a semi synthetic macrolide antibiotic derived from erythromycin and 
possesses hydrophobic properties. The structure of clarithromycin consists of a macro-cyclic 
14-membered lactone ring attached to two sugar moieties (cladinose and desoamine). 
Clarithromycin is eliminated by urinary and biliary excretion and approximately 20 % can be 
excreted as the parent compound. There are reports of the detection of clarithromycin in 
environmental waters (see Tables 4-2 and 4-3). To assess the acute toxicity of clarithromycin 
towards aquatic organisms, toxicity tests were performed on bacteria, algae, rotifers, 
microcrustaceans and fish by Isidori et al. (2005). It was found that adverse effects did not 
occur due to clarithromycin at concentrations typically observed in the environment (ng/L). 
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Results from chronic toxicity tests indicated that clarithromycin is toxic to algae (EC50 range 
between 2.0 – 12000 µg/L depending on the species). 
Both amoxicillin and cefpodoxime are classed as β lactam antibiotics due to the β lactam 
ring within their molecular structure which is responsible for their antibacterial activity. 
They differ in their spectrum of activity due to variations in the side chains within their 
molecular structure and belong to different antibiotic subgroups; penicillins and 
cephalosporins respectively. Amoxicillin is a widely used antibiotic  (Andreozzi et al., 2004). 
The prescription levels in England are high (~ 163 Tonnes a-1 in 2012) and most of the 
ingested active ingredient is excreted unchanged (DrugBank, 2005). However, the 
prescription quantities of cefpodoxime are very low (0.002 Tonnes a-1 in England in 2012). 
Pharmacokinetic studies have demonstrated that over 80 % of a cefpodoxime dose is 
excreted unchanged in the urine (Tremblay et al., 1990) but a study of 200 surface and 
wastewater samples failed to detect a variety of β lactams (including penicillins and 
cephalosporins) (Cha et al., 2006). However, there are some studies that report the 
prevalence of β lactam antibiotics in sewage influents, settled sewage and surface waters 
(see Tables 4-2 and 4-3). Nevertheless, despite the high usage of β lactams, the number of 
reports is less frequent than for other antibiotics (Tables 4-2 and 4-3).  
The rare detection of β lactams in environmental waters is possibly due to their low stability 
in aqueous solution. The β lactam ring is rapidly hydrolysed in aqueous solution, with 
maximum stability at pH 6.0-7.2. In addition, transition metals (e.g. mercury, zinc and 
copper) catalyse their degradation (Ternes et al., 2008). Due to the low prescription 
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quantities for cefpodoxime in England, this compound was not included for the work in this 
study. Toxicity tests have demonstrated that amoxicillin, present at concentrations between 
50 ng/L and 50 mg/L is not toxic to algae species. However, hazard quotients estimated by 
Park et al. (2008) and acute toxicity tests reported by Wang et al. (2012) demonstrate that 
environmentally relevant concentrations of penicillins and cephalosporins pose a potential 
ecological risk.  
Vancomycin is a glycopeptide antibiotic widely used in the US but in Europe it is reserved for 
the treatment of bacterial infections where other antibiotics have proven ineffective 
(Kümmerer, 2009). Following ingestion, more than 80 % of a dose of vancomycin is excreted 
in the original active form (Matzke et al., 1986). Despite the low consumption levels of 
vancomycin in Europe, its presence in wastewater and surface water has been reported in 
France  and Italy  at low concentrations (ng/l), although these reports are rare compared to 
the more frequent reports of other antibiotics (Table 4-2 and Table 4-3). The prescription 
quantities in England are very low (0.025 Tonnes a-1 in 2012) and hence this antibiotic was 
not selected for the analytical methodology work described in this chapter. Ecotoxicity data 
for vancomycin is limited, although high concentrations (1 – 6 mg/l) which are well above 
those detected in environmental waters, have been found to inhibit anaerobic sludge micro-
organisms (Wexler Philip, 2009).  
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4.2 Materials and methods for the analysis of pharmaceuticals in 
environmental waters 
4.2.1 Chemicals and reagents 
Methanol, acetonitrile, formic acid, ammonium hydroxide, acetic acid and ammonium 
acetate were purchased from Fisher Scientific UK Ltd (Leicestershire, UK) and were either 
HPLC or LCMS grade. Reagent grade sulphuric acid and nitric acid were also purchased from 
Fisher Scientific UK Ltd. Ciprofloxacin (> 98 % HPLC), carbamazepine (>98 % HPLC, 
bezafibrate (> 98% HPLC) and clarithromycin (> 98 % HPLC) were purchased from Sigma-
Aldrich Company Ltd (Dorset, UK) 
4.2.2 Description of study area 
The studied wastewater treatment plant (WWTP) is a large urban treatment plant in 
London, UK and is shown in Figure 4-1. It is the ninth largest WWTP in England and receives 
approximately 244,000 m3 of wastewater per day from a 399 km2 urban catchment serving a 
total population of approximately 870,000. The treatment plant applies primary 
sedimentation and secondary activated sludge treatment and has  a hydraulic retention 
time of approximately 13 h (Ellis, 2006).  
Sewage entering the plant is first screened for rags and grit. The screened sewage is then 
treated in one of sixteen primary settling tanks where solids are settled out and pumped to 
the sludge treatment plant for anaerobic digestion. The settled sewage is pumped to 
aerated activated sludge basins (twelve basins in total) followed by final settlement tanks 
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(thirty two tanks) in order to remove organic pollutants (Thames Water, 2012). A more 
detailed description of the WWTP process is given in Chapter 2, Section 2.2.1.2.  
 
Figure 4-1: Arial view of the WWTP from which samples were collected. Arrows identify the locations for grit 
removal, the primary settling tanks, the activated sludge basins (AS) and the final settlement tanks.  
The treated effluent from the final settlement tanks is discharged through the final effluent 
channel into Pymmes Brook via Salmons Brook, both of which are tributaries of the River 
Lee. In addition, partially treated sewage maybe discharged to the Salmons Brook during 
periods of high rainfall. The River Lee is a large lowland river extending over 85 km from its 
source near Luton to its confluence (Bow creek) with the Thames. The river is divided into 
two catchments referred to as the upper and lower Lee. Agriculture is more dominant in the 
Final tanks Grit removal 
Sludge plant 
Primary tanks 
AS basin 
Image source: AECOM (2014) 
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upper Lee catchment compared to the lower Lee where  the watercourse flows through 
predominantly urban areas (Snook et al., 2004).  
The lower Lee river system has been heavily modified over the last century to cope with 
increasing urbanisation and to reduce the risk of flooding in the catchment. There are 
sections of the river in which the flow is split in to two or more parallel channels including a 
canalised channel (River Lee navigation) and the Flood Relief Channel (River Lee Diversion) 
(Davies, 2011). In addition, there are a number of tributaries including Nazeing Brook, 
Turnford Brook, Salmons Brook, Ching Brook and Pymmes Brook. The river system within 
the lower Lee catchment feeds a number of reservoirs collectively known as the Chingford 
reservoirs. Water abstracted from the River Lee accounts for approximately one-sixth of 
London’s water supply (Snook et al.,2004) 
The lower Lee has historically suffered from poor water quality. A substantial  contribution 
to the pollution of the River Lee is due to discharges from  sewage treatment works and in 
dry weather, the base flow down-stream of Pymmes Brook, is mainly treated effluent (The 
Environment Agency, 2013). In addition, widespread pollution within the River Lee has been 
attributed to sewer misconnections and combined sewer overflow discharges of sewage to 
surface water (Thames Water, 2014;  The Environment Agency, 2013). 
4.2.3 Sample collection 
Wastewater samples were collected at three points representing different stages of the 
treatment process (see Figure 4-2).  
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Figure 4-2: Schematic of the WWTP sampled in this study. Red arrows indicate the positions of sampling 
points. 
In this study, screened sewage refers to sewage following gross solid and grit removal. 
Settled sewage refers to sewage that has passed through primary settlement tanks (the 
primary sedimentation treatment stage). Final treated effluent refers to sewage that has 
been treated by activated sludge followed by final sedimentation (in final settlement tanks). 
Whilst the plant remained operational, at the time of sampling the WWTP was undergoing 
an engineering upgrade to replace ageing infrastructure and to increase capacity in line with 
predicted population expansion.  
Surface water samples were collected from the River Lee (Lee navigation channel) from 
positions both up- and down-stream of the Pymmes Brook confluence with the River Lee 
and therefore up- and down-stream of the WWTP treated effluent discharge point (Figure 
Influent Discharge 
Screen Grit 
chamber 
Primary 
sedimentation 
Aerobic  
Basin 
Secondary 
sedimentation 
Screened sewage Settled sewage Final treated effluent 
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4-3). Figure 4-4 shows in more detail the confluence of the Pymmes Brook with the River 
Lee and the location of the sampling point down-stream of the confluence point.
 
Figure 4-3: Map of the lower Lee catchment showing the locations of the surface water sampling points 
relative to the WWTP.  
For each surface water sampling point a total of 20 L was collected and fully mixed on return 
to the laboratory. At each of the wastewater treatment process sampling points, a total of 
7.5 L was collected. Samples were filtered on the day of collection. Acidified samples (to pH 
2.5 using sulphuric acid) were stored at 4°C until extraction (within 4 days). Settled sewage, 
final treated effluent and surface water were collected on six occasions between February 
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Up-stream 
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Chingford 
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Map source: OpenStreetMap - Creative Commons-Share Alike License [CC-BY-SA] 
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2011 and February 2012. Additionally screened sewage was collected on three occasions 
between February 2011 and February 2012.  
 
Figure 4-4: Map showing in more detail the location of the sampling point located down-stream of the WWTP 
effluent discharge. 
4.2.4 Water quality parameter analysis 
pH and total suspended solids (TSS) were measured for each sample. TSS was determined 
according to the procedure given in the standard methods for the examination of water and 
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wastewater (American Public Health Association (APHA), 1992). Filter papers (Whatman 90 
mm GF/C) were heated in an oven (105 °C) until dry then placed in a desiccator until cool. 
The filter papers were then weighed. Fully mixed samples were passed through the filter 
papers under vacuum. The filter papers were placed in the oven overnight at 105 °C and re-
weighed to constant weight after cooling in a desiccator. Each sample was analysed in 
triplicate. The suspended solids concentration was calculated using Equation 4-1. 
Equation 4-1:  
𝑇𝑆𝑆 (𝑚𝑔/ 𝐿) =  
𝐹2 − 𝐹1
𝑉
 𝑥 1000 
Where: 
F2 = the weight of dried filter paper after filtration (mg) 
F1 = the weight of dried filter paper before filtration (mg) 
V = volume of the sample filtered (mL)  
4.2.5 Analytical method to determine target pharmaceutical concentrations 
4.2.5.1 Extraction of water samples 
Solid phase extraction (SPE) was performed using Strata™ X cartridges which were first 
conditioned with 6 mL methanol (LC-MS grade), equilibrated with 6 mL LC-MS water and 
then 6 mL LC-MS water with the pH adjusted to 2.5 (sulphuric acid). Samples were 
percolated (100 mL, 200 mL, 200 mL and 1000 mL for screened sewage, settled sewage, 
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final treated effluent and surface waters respectively) through the conditioned cartridges at 
an approximate flow rate of 2 mL/min using a vacuum extraction manifold (Phenomenex, 
UK). Larger volumes of surface water were extracted to provide the concentration required 
to be able to detect the lower levels of pharmaceuticals expected in these samples. To 
release the pharmaceuticals, the sorbent was washed with 6 mL water and then with 6 mL 5 
% (v/v) methanol in water containing 2 % acetic acid and dried under vacuum for at least 10 
minutes prior to elution with 2 % ammonium hydroxide in methanol (3 x 3 mL). The 
resulting combined extract was evaporated under a gentle nitrogen stream using a 
TurboVap® (Biotage, Sweden) at 30°C and reconstituted with 1.0 mL 5% (v/v) 
methanol/ultrapure water, before transferring to 0.2 µm nylon Mini-UniPrep® filter vials 
(Whatman Ltd, UK) for subsequent analysis. 
4.2.5.2 Instrumental analysis 
Analysis of the extracts was performed using reverse phase high performance liquid 
chromatography mass spectrometry (LC-MS) with electrospray ionization in positive (+ve) 
selective ionization mode (SIM) using a Shimadzu LC2010 instrument. The selected 
pharmaceuticals were separated using an Ascentis® Express 2.1 mm x 50 mm C18 column 
(Sigma Aldrich, UK). Amoxicillin, bezafibrate, carbamazepine, ciprofloxacin and 
clarithromycin were separated using mobile phases of LC-MS water acidified with 0.1% 
formic acid (mobile phase A) and acetonitrile acidified with 0.1 % formic acid (mobile phase 
B). The solvent gradient started at 5% B and reached 67% B in 20 minutes before increasing 
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to 95% B for 5 minutes and then returning to 5% B for 10 minutes. The column was 
maintained at 30 °C with a flow rate of 0.2 mL/min and an injection volume of 10 µL. 
The developed analytical method was not applied to vancomycin and cefpodoxime. Initially, 
these antibiotics were not selected for this study because they are prescribed in very low 
quantities and therefore not expected to be present in environmental waters at detectable 
levels. Furthermore, reports on the presence of these compounds in environmental studies 
are rare (see Section 4.1.1). However whilst conducting the work for Chapter 5, it was 
decided it was important to look at the susceptibility of faecal bacteria to vancomycin and 
cefpodoxime as these are critically important for human medicine (see Chapter 5, Section 
5.1.2). 
4.2.6 Validation of the analytical method to determine target pharmaceuticals in 
environmental waters 
The target compounds were monitored using their parent ion ([M-H]+) in positive selective 
ion monitoring (SIM) mode. Quantification of the compounds of interest was performed 
using the standard addition method in which different concentrations were spiked into 
separate aliquots of each sample. The analyte concentration was then determined by linear 
regression. At least four concentration points were used to check the linear range of the 
method. To assess the overall impact of sample preparation and matrix effects on the 
measurement of the target compounds, spiking experiments were performed and the 
recovery of the spiked amount calculated. Screened sewage, settled sewage, final treated 
effluent and surface water were spiked with 3000, 1500, 1000 and 240 ng/L of each target 
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compound respectively. The concentration of targets used for the spiking experiments were 
selected based on those reported in literature (see Table 4-2 and Table 4-3). To evaluate the 
method repeatability (precision) for the individual compounds, the separate extractions and 
analyses of wastewater and surface water were carried out in triplicate.  
The instrumental detection limit (IDL) was determined using external standards (HPLC grade 
pharmaceutical compounds dissolved in 5 % v/v methanol/LC-MS water). The IDL is defined 
as the analyte concentration that gives a signal to noise ratio of > 3 and refers to the limit of 
detection determined using clean solutions (external standards). The method limit of 
detection (MLOD) was estimated using real samples (processed through the entire analytical 
method) and is defined as the minimum concentration of analyte that gives a signal to noise 
ratio of > 3 in a given matrix. It was difficult to determine the method limit of detection 
(MLOD) for effluent and surface waters, as the samples already contained the compounds of 
interest. 
4.2.7 Prediction of pharmaceutical consumption 
The Health and Social Care Information Centre - Prescribing and Primary Care Services 
(2012) maintains a database based on NHS prescription services in England. The database, 
which is produced annually, only includes the quantities of pharmaceuticals dispensed in the 
community (community pharmacists, appliance contractors, dispensing doctors, and items 
personally administered by doctors). The consumption of the selected pharmaceuticals for 
this study in England and in the catchment area of the WWTP under investigation was 
calculated based on the information available in this database. 
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4.3 Wastewater and surface water analysis 
4.3.1 Water quality parameters 
The pH and total suspended solids (TSS) determined for screened sewage, settled sewage, 
final treated effluent and the receiving surface waters are presented in Table 4-4. 
Measurements were made in triplicate on each of the six sampling occasions. 
Table 4-4: Water quality parameters (mean ± standard deviation) measured for each sampling point for each 
sampling occasion. 
Sample pH TSS (mg/L) 
Screened sewage 6.8 ± 0.2 433.6 ±147.9 
Settled sewage 6.9 ± 0.4 316.2 ± 102.4 
Final treated effluent 7.1 ± 0.5 50.2 ± 21.9 
Down-stream 7.8 ± 0.4 124.8 ± 52.5 
Up-stream 7.6 ± 0.5 81.1 ± 33.9 
Up- and down-stream refer to surface water collected up- and down-stream relative to the WWTP final 
effluent discharge point. Values are a mean of triplicate measurements made on 6 sampling occasions (18 
measurements in total). 
On average, a high proportion of suspended solids were removed during the full wastewater 
treatment process (> 85 %). Higher TSS values were observed in the surface water down-
stream of the wastewater treatment plant (WWTP) treated effluent discharge point 
compared to up-stream. In addition, TSS values were higher in surface water than in the 
final treated effluent. The surface water pH values measured are within the range ( ≥ 6.0 – ≤ 
9.0) expected in rivers in the UK for the support of biota (UK Technical Advisory Group on 
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the Water Framework Directive  (UKTAG), 2008). Biological treatment of wastewater occurs 
generally at neutral pH (Bitton, 1944) and in this study the wastewater pH values were 
within the range 6.8  to 7.1. 
4.3.2 Detection of pharmaceuticals in environmental waters with LC-MSn 
The instrumental detection limits (IDL) determined using the method given in Chapter 4, 
Section 4.2.6 for each of the target pharmaceuticals are given in Table 4-5.  
Table 4-5: Physicochemical properties of target pharmaceuticals and instrumental detection 
limits (IDL). 
Pharmaceutical pKa Log Kow Solubility (mg/L) IDL (µg/L) 
Amoxicillin 2.4, 7.4, 9.6a 0.87c 3740c 12 
Bezafibrate 3.6a 4.25a 1.5c 0.3 
Carbamazepine 13.9a 2.45a 18.0b 0.2 
Ciprofloxacin 6.09, 8.74b 0.28b 30,000b 0.8 
Clarithromycin 8.99a 3.16a 0.3c 0.2 
Vancomycin 2.6, 7.2, 8.6c 1.1c 225.0c ND 
Cefpodoxime 3.22c 0.05c 185.0c ND 
pKa = acid dissociation constant, Log Kow = Octanol water coefficient, a Ternes et al. (2008), b 
Wexler Philip (2001), c Wishart et al. (2008). ND – not determined in this study 
The IDLs were not sensitive enough to enable the direct detection of the target compounds 
in environmental waters as they are typically present at ng/L concentrations (see Table 4-2 
and Table 4-3. In addition, environmental waters are complex matrices that contain 
components that may interfere with the analytical measurement by matrix effects. 
Therefore, the concentration/purification step provided by solid phase extraction was 
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included to improve method sensitivity. The definition of instrumental detection limit (IDL) 
and method limit of detection are given in Chapter 4, section 4.2.6, page 78. 
In LC-MSn analysis, the chromatographic retention time may shift significantly due to matrix 
effects. Additional matrix components may mask the signal from the analytes of interest by 
raising the chromatographic baseline and with electrospray ionisation, matrix components 
may suppress or enhance ionisation by competing for charged sites on electrospray droplets 
(Gracia-Lor et al., 2010). Matrix effects can also cause false positive identification due to 
other sample components having similar mass to charge ratios (m/z). The most direct means 
of obtaining the appropriate method sensitivity and method selectivity for the detection of 
pharmaceuticals in environmental waters is through the reduction of matrix components 
prior to LC-MSn analysis by applying a selective extraction and improved sample clean-up 
(Fatta et al., 2007).  In this work, solid phase extraction (SPE) was selected to concentrate 
the analytes of interest and reduce matrix interferences in order to improve method 
sensitivity and selectivity.  However, the different physicochemical properties of amoxicillin, 
bezafibrate, carbamazepine, ciprofloxacin and clarithromycin (Table 4-5) presented a 
challenge when selecting the SPE parameters required to achieve an efficient extraction of 
all selected compounds from the different environmental water matrices.  
Amoxicillin is relatively unstable in aqueous solutions and its degradation is catalysed by 
both acids and bases which are commonly used to optimise solid phase extraction 
recoveries. Castiglioni et al. (2005) and Watkinson et al. (2009) have reported low 
amoxicillin recoveries (36 and 29 % respectively), making it difficult to accurately and 
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reproducibly detect this compound in wastewaters. In this study, amoxicillin could not be 
detected following the solid phase extraction of collected water samples.  Bezafibrate is an 
acidic drug that is the most hydrophobic of the selected pharmaceuticals as demonstrated 
by the chromatographic retention time (given in Table 4-8) and octanol water coefficient 
(Table 4-5). Ciprofloxacin is zwitterionic and hydrophilic, clarithromycin is a basic 
hydrophobic compound and carbamazepine (a neutral drug) is moderately hydrophobic 
compared to bezafibrate. A polymeric sorbent (Strata™ X) was therefore chosen for the 
extraction process as it retains acidic, basic and neutral compounds. The neutral polar 
functionalised styrene reversed phase polymer exhibits hydrophobic, hydrogen-bonding, 
and aromatic retention mechanisms and has been successfully employed in previous studies 
focused on the extraction of pharmaceuticals from environmental waters (Babić et al., 2010;  
Lacey et al., 2008).  
The sample pH and elution solvent characteristics were the two SPE parameters that were 
manipulated to ensure the maximum recovery of target compounds using the polymeric 
sorbent, whilst minimising other matrix components that may interact with the sorbent 
reducing the interaction sites for the target analytes and subsequently reducing detection. 
Generally in other studies, the pH of the samples have been adjusted to favour either the 
dissociated or the non-dissociated forms to ensure optimal retention of the compounds of 
interest to the sorbent without retention of other matrix components. The compounds of 
interest are then eluted with a solvent that is efficient at reducing the interaction between 
the sorbent and the target analytes.  
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For macrolides and fluoroquinolones, Senta et al., (2008) achieved recoveries (> 60 %) with 
a low sample pH using either Strata™ X or Oasis® HLB polymeric sorbents and a basic 
methanol elution solvent. Renew et al., (2004) achieved relative extraction recoveries (the 
peak area of target compound compared to the peak area of an internal standard) of 90-
129% for fluoroquinolones from final wastewater treatment effluents utilising two different 
sorbents in tandem (anionic followed by polymeric), a sample pH of 2.5 and elution with a 
buffered (H3PO4) methanol solution.   
Babić et al. (2010) used Strata™ X cartridges for the extraction of fluoroquinolones and 
macrolides achieving extraction recoveries of > 50 % when samples were adjusted to pH 4 
and target analytes were eluted with methanol. For the extraction of macrolides from 
wastewater effluents, Oasis® HLB polymeric sorbents were used by Pedrouzo et al. (2008). 
Samples were adjusted to pH 7 with sodium hydroxide and eluted with a basic methanol 
solution. However, extraction recoveries for macrolides were < 50%.  McArdell et al., (2003) 
achieved relative extraction recoveries (compared to an internal standard) of 81% ± 9 for 
clarithromycin from wastewater effluents using Lichrolute reversed phase and copolymer 
sorbents, a sample pH adjusted to 7 and elution with methanol. Oasis® HLB polymeric 
sorbent and a sample pH adjusted to 10 have been utilised by Vieno et al. (2006) to extract a 
range of pharmaceuticals with different physicochemical properties including 
carbamazepine and ciprofloxacin. This approach resulted in extraction recoveries of 64% for 
ciprofloxacin and 94% for carbamazepine from wastewater influent. Bezafibrate was 
extracted using a mixed mode cationic polymeric sorbent (Oasis® MCX) and a sample pH of 
2 by Lindqvist et al., (2005). The water extracts were eluted with acetone and absolute 
85 
 
 
 
recoveries (area of analyte of interest compared to external standards) of 64% were 
achieved. 
In this work, the sample pH was adjusted to pH 2.5 in order to suppress the dissociation of 
the carboxylic functional groups present in bezafibrate and ciprofloxacin and therefore to 
favour the hydrophobic interactions of these analytes with the polymeric sorbent (Senta et 
al., 2008). For acidic moieties, reducing the sample pH below the pKa will favour the non-
dissociated form making them less soluble. According to other studies, carbamazepine is not 
affected by adjusting sample pH as it is a neutral compound (Vieno et al., 2006) and a better 
extraction of clarithromycin is achieved at a lower sample pH (Senta et al., 2008;  Göbel et 
al., 2007). Increasing the retention of the analytes to the sorbent allowed for a more 
aggressive clean-up of the matrix components with an acidified methanol and water 
solution prior to elution. A 2% ammonium hydroxide in methanol solution was used to 
disrupt the hydrophobic interactions for elution and desorb the target analytes. The 
percentage recovery of the target compounds from each water matrix was assessed using 
spiking studies. Triplicate aliquots of each sample matrix were spiked with a known amount 
of each target analyte and the % recovery calculated according to Equation 4-2. The 
percentage recoveries identify the losses resulting from SPE extraction. 
The spiked amounts were chosen to be relevant to each sample matrix and to ensure the 
concentrations were within the method linear range. The recoveries of target analytes 
calculated for screened sewage (spiked at 3000 ng/L), settled sewage (spiked at 1500 ng/L), 
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final treated effluent (spiked at 1000 ng/L) and surface waters up- and down-stream of the 
treated effluent discharge point (spiked at 240 ng/L) are shown in Table 4-6.  
Recoveries exceeded 60% for the target compounds in the five matrices and the precision 
(% RSD) of triplicate extractions were typically < 15%. Higher recoveries were obtained for 
carbamazepine (75–98%) and bezafibrate (75-98%) compared to ciprofloxacin (61–87%) and 
clarithromycin (60-96%). Generally, higher recoveries resulted from treated effluent (87-
98%) and up-stream surface waters (75–93%) for all compounds compared to screened 
sewage (60-87%), settled sewage (60-80%) and surface water down-stream of the effluent 
discharges (60-95%). These results are consistent with the treated effluents and up-stream 
waters generally containing less organic matter. Spiking experiments showed a more 
efficient extraction of bezafibrate was achieved from down-stream surface water (95 %) 
compared to up-stream (75 %). This is surprising as the surface water down-stream from the 
effluent discharge point contains elevated suspended solids (Table 4-4) which will hinder the 
extraction efficiency. However, this could be due to the elevated concentrations of 
bezafibrate already present in the down-stream surface water matrix compared to up-
stream which were not accounted for in Equation 4-2. Amoxicillin could not be reliably 
detected following sample extraction and is therefore not included in Table 4-6. 
Equation 4-2: 
% 𝑟𝑒𝑐𝑜𝑣𝑒𝑟𝑦 = (
𝑃𝑟𝑒 𝑆𝑝𝑖𝑘𝑒
𝑃𝑜𝑠𝑡 𝑆𝑝𝑖𝑘𝑒
) 100 
Where: 
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𝑃𝑟𝑒 𝑠𝑝𝑖𝑘𝑒  = The amount of the target compound measured in an aliquot of sample 
spiked with a known amount of the target prior to sample preparation 
𝑃𝑜𝑠𝑡 𝑠𝑝𝑖𝑘𝑒  = The amount of the target compound measured in an aliquot of the same 
sample spiked with a known amount of the target just before LC-MSn injection 
Table 4-6: SPE recoveries and extraction precision (% RSD) determined for target 
pharmaceuticals in the different environmental water matrices investigated in this study. 
 % Recovery (% RSD) 
 Screened 
sewage 
Settled 
sewage 
Final treated 
effluent 
Up-stream Down-
stream 
Bezafibrate 87 (10) 80 (10) 91 (9) 75 (6) 95 (13) 
Carbamazepine 84 (10) 75 (1) 98 (6) 93 (6) 73 (3) 
Ciprofloxacin 61 (4) 66 (15) 87 (10) 83 (11) 67 (6) 
Clarithromycin 60 (8) 60 (4) 96 (6) 82 (11) 60 (3) 
% Recovery and relative standard deviation (% RSD) are mean values calculated from 3 replicate extractions. 
Variations in the recoveries of the target compounds can affect the accuracy of 
quantification and to reduce this there are a number of compensatory approaches that can 
be used. These include  calibration with matrix matched external standards, dilution of the 
extract from the complex matrix, the application of internal standards, improvement of 
chromatographic separation and the use of the standard addition technique. It is difficult to 
match the matrix of an environmental water sample due to the complex array of unknown 
constituents and therefore this approach was not used in this work. Dilution of the samples 
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was not used either as it would decrease the sensitivity of the method as shown in a study 
of fluoroquinolones in settled sewage and final treated effluent (Lee et al., 2007).  
The use of internal standards is a common method employed to compensate for extraction 
recoveries and for the quantification of pharmaceuticals in environmental waters (Göbel et 
al., 2007;  McArdell et al., 2003). An internal standard should not be naturally present in the 
environmental waters and should have similar physicochemical properties to the 
compounds of interest and therefore similar chromatographic retention times, to 
adequately compensate for matrix effects. Generally, isotope labelled compounds are used 
(surrogate standard) and spiked into the sample before SPE to compensate for sample 
preparation losses as well as matrix effects. For the analysis of pharmaceuticals with 
different physicochemical properties, a representative internal standard would be required 
for each class or group of pharmaceutical for accurate quantification (Hernández et al., 
2007). The cost implications ruled this method out as a quantification technique in this 
study.  
Standard addition was utilised to quantify target analytes and compensate for sample 
extraction losses.  A disadvantage of this method is that it is an extrapolation method and is 
less precise than interpolation methods. Therefore the analyte concentration (the 
extrapolated value) can have an elevated standard deviation. The standard deviation of the 
extrapolated value (𝑠𝑋𝐸) can be calculated using Equation 4-3 employing the standard 
deviation of the 𝑦 residuals (𝑠𝑦/𝑥) which is calculated using Equation 4-4.  
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Equation 4-3: 
𝑠𝑋𝐸 =
𝑠𝑦/𝑥
𝑏
{
1
𝑛
+
?̅?2
𝑏2 ∑ (𝑥𝑖− ?̅?)𝑖 
2   }
1
2
 
Where: 
𝑏   = gradient of regression line 
𝑛   = sample size 
 ?̅?  = arithmetic mean of 𝑦 residuals 
?̅? = arithmetic mean of 𝑥 values 
𝑥𝑖   = Individual 𝑥 value 
Equation 4-4: 
𝑠𝑦/𝑥 = {
∑ (𝑦𝑖− ?̂?𝑖)𝑖
2
𝑛 − 2
}
1
2
 
Where: 
?̂?𝑖  = values calculated from the regression line corresponding to the individual 𝑥 values 
𝑦 = Individual 𝑦 measurement 
Examples of the standard deviations of the extrapolated derived analyte concentrations are 
given in Table 4-7. 
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Table 4-7: Examples of the target pharmaceutical concentrations in environmental waters quantified by 
standard addition and the standard deviation of the extrapolated value (±) 
 
Screened 
sewage 
Settled 
sewage 
Final treated 
effluent 
Down -stream Up -stream 
Carbamazepine 
(ng/L) 
1214.2 
± 152.2 
1501.9 
± 407.9 
1010.0 
± 254.6 
251.4 
± 46.2 
128.8 
± 30.5 
Bezafibrate 
(ng/L) 
1693.8 
± 362.2 
1341.8 
± 259.6 
246.9 
± 25.32 
103.6 
± 34.6 
30.79 
± 21.5 
Ciprofloxacin 
(ng/L) 
2539.9 
± 161.1 
3479.8 
± 594.2 
490.0 
± 143.1 
149.8 
± 38.4 
<MLOD 
Clarithromycin 
(ng/L) 
<MLOD 
783.5 
± 478.1 
460.9 
± 232.2 
28.6 
± 8.2 
< MLOD 
< MLOD not detected in these samples at concentrations above the method limit of detection. Down-stream 
and up-stream = relative to the treated effluent discharge point. 
Peak resolution is important to aid the identification of the analytes and to prevent false 
positive identification of other analytes with similar m/z values. In this study the adequate 
separation of the target analytes was achieved using a combination of aqueous and 
acetonitrile mobile phases acidified with formic acid.  An example of the chromatographic 
separation of the target analytes is shown in Figure 4-5. Formic acid was added to the 
mobile phases to suppress interaction of the basic amino moiety of ciprofloxacin with the 
column silanol groups that can cause peak tailing, effecting peak asymmetry and reducing 
sensitivity. Acidic additives are known to promote protonation of basic functionalities and as 
a result can enhance the signal in the electrospray ionisation source by operating in positive 
mode (Lee et al., 2007). 
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Figure 4-5: Mass spectrometer chromatogram showing positive selective ion monitoring of 
target pharmaceuticals in settled sewage.  
In addition, formic acid (0.1 %) was also used as it is volatile and easily removed during 
electrospray ionisation. Trifluoroacetic acid was trialled as a mobile phase additive but this 
suppressed ionisation of the analytes and using ammonium acetate resulted in poor peak 
asymmetry for ciprofloxacin and therefore its use was discontinued. Some pharmaceuticals 
with basic and acidic functional groups can either be protonated or depronated for 
detection in positive or negative electrospray ionisation modes. Bezafibrate is an example 
that is sensitive in both modes (Gros et al., 2006). However, in this study positive selective 
ionisation mode (SIM) was the most sensitive for all compounds. The positive ions 
monitored in addition to retention times, for identification and quantification, are shown in 
Table 4-8. 
Retetion time 
Si
gn
al
 in
te
n
si
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Table 4-8: Retention times and parent ion [M-H]+ for the target pharmaceuticals. 
Compound LC-MS retention time (minutes) [M+H]+ 
Bezafibrate 11.9 362 
Carbamazepine 10.1 237 
Ciprofloxacin 7.6 332 
Clarithromycin 10.6 748 
 
The performance of the method developed for the determination of bezafibrate, 
carbamazepine, ciprofloxacin and clarithromycin in different environmental water matrices 
is summarised in Table 4-9. At least four point calibrations were used for the standard 
addition quantification of target analytes (in the ranges 500 – 6000 ng/L, 250 - 4000 ng/L, 
250 – 4000 ng/L and 40 - 500 ng/L for screened sewage, settled sewage, final treated 
effluent and surface waters respectively). Overall, good linearity was obtained for target 
compounds in the different matrices, with correlation coefficients (r2) generally > 0.94 for 
the concentration ranges expected in each matrix. Although the method developed in this 
work was not as sensitive as methods reported in other studies for individual compounds, it 
was suitable to detect the selected compounds in all the matrices. The method limit of 
detection (MLODs) ranged between 5 ng/L for bezafibrate in surface waters to 500 ng/L for 
ciprofloxacin in screened sewage (see Table 4-9).  
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Table 4-9: Linearity of calibration method and method limit of detection (MLOD) determined for the selected 
pharmaceuticals in different environmental water matrices.  
 
 
Linearity (r2) 
MLOD (ng/L) 
Pharmaceutical Screened 
sewage 
Settled 
sewage 
Final treated 
effluent 
Up-
stream 
Down-
stream 
Bezafibrate 0.9901 
~ 80 
0.9859 
~ 40 
0.9941 
~ 20 
0.9677 
~ 5 
0.9805 
~ 10 
Carbamazepine 0.9929 
~ 60 
0.9686 
~ 60 
0.9790 
~ 20 
0.9915 
~ 5 
0.9406 
~ 10 
Ciprofloxacin 0.9934a 
~ 450 
0.9760a 
~ 150 
0.9590b 
~ 30 
0.9901b 
~ 25 
0.9700a 
~ 40 
Clarithromycin 0.9867 
~ 500 
0.9450b 
~ 150 
0.9943 
~ 40 
0.9730 
~ 10 
0.9851 
~ 10 
MLOD was estimated for each sample matrix at a signal to noise ratio 3. 6 point calibration except where 
indicated. a4 point calibration. b5 point calibration. 
4.3.3 Occurrence of pharmaceuticals in wastewaters and surface waters 
The developed analytical method for the detection of bezafibrate, carbamazepine, 
ciprofloxacin and clarithromycin was applied to the analysis of wastewaters sampled at 
three different treatment points in a large urban wastewater treatment plant and in the 
surface waters both up- and down-stream realtive of the treated effluent discharge point. 
The ranges of the target pharmaceutical concentrations observed at each sampling point are 
presented in Table 4-10.  
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Table 4-10: Pharmaceuticals detected in wastewater sampled at different points throughout the treatment 
process and receiving waters between February 2011 and February 2012. 
Compound Screened 
sewage 
(n = 3) 
Settled 
sewage 
(n = 6) 
Treated 
effluent 
(n = 6) 
Up-
stream 
(n = 5) 
Down-
stream 
(n = 5) 
Bezafibrate Range (ng/L) 
Freq (%) 
628-2147 
100 % 
121-1342 
83 % 
39-411 
100 % 
22-40 
60 % 
44-88 
100 % 
Carbamazepine Range (ng/L) 
Freq (%) 
369-1460 
100 % 
206-1502 
100 % 
47-1010 
100 % 
39-251 
80 % 
156-585 
100 % 
Ciprofloxacin Range (ng/L) 
Freq (%) 
731-2696 
67 % 
297-3478 
67 % 
44-229 
83 % 
Nd 
0 % 
65–150 
40 % 
Clarithromycin Range (ng/L) 
Freq (%) 
Nd 
0 % 
a783 
17 % 
57-598 
83 % 
Nd 
0 % 
19-34 
60 % 
Freq (%) = frequency of detection. n = number of sampling occasions. Nd = not detected on any sampling 
occasion. Up- and Down- = in surface water from the discharge point. aOnly detected on one occasion and 
therefore no range given. 
Not all target compounds were detected in all samples as indicated by the frequencies of 
detection identified in Table 4-10. Figure 4-6  displays the mean concentrations (± standard 
deviation) of each compound at each sampling point. Where the relevant monitoring data is 
available, the general trend observed is a decrease in target pharmaceutical concentrations 
throughout the wastewater treatment process (Figure 4-6). The levels of the target 
pharmaceuticals were highly variable at each sampling point, particularly for ciprofloxacin in 
the screened and settled sewage. However, the levels (mean ± standard deviation) of 
bezafibrate (1356.8 ± 689.6 ng/L) and ciprofloxacin (1713.4 ± 1389.4 ng/L) observed in the 
screened sewage were higher compared to carbamazepine (871.7 ± 547.4 ng/L).  
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Figure 4-6: Mean concentrations of target pharmaceuticals detected in different samples 
In the settled sewage, the concentrations of target pharmaceuticals were within the range 
of 680.7 ± 494.4 (carbamazepine) to 1248.2 ± 1505.1 (ciprofloxacin) ng/L, indicating that 
small reductions occurred during the primary sedimentation process. Clarithromycin could 
only be detected in one settled sewage sample (783.5 ng/L) and was not detected in the 
screened sewage. 
Noticeably reduced bezafibrate (202.6 ± 156.5 ng/L) and ciprofloxacin (133.3 ± 252.8ng/L) 
levels were observed in the final treated effluent samples. Conversely, carbamazepine was 
detected at only modestly reduced concentrations in the final treated effluents (559.9 ± 
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66.4 ng/L) compared to the screened and settled sewage. The frequency of clarithromycin 
detection was greater for the final treated effluent samples (83 %) compared to other 
sampling points (≤ 17 %) in the wastewater treatment process. 
Bezafibrate, carbamazepine, ciprofloxacin and clarithromycin were all detected in the 
surface water down-stream of the WWTP effluent discharge point but whereas bezafibrate 
and carbamazepine were consistently detected ciprofloxacin and clarithromycin were found 
intermittently. Bezafibrate and carbamazepine were also detected in the surface water up-
stream of the wastewater treatment plant effluent discharge point. However, ciprofloxacin 
and clarithromycin were not detected at this location (Table 4-10). 
4.3.4 Reduction of pharmaceuticals through wastewater treatment processes. 
The reduction of target compounds following primary sedimentation, following activated 
sludge treatment and the overall reduction efficiency of the wastewater treatment process 
were calculated for each sampling occasion using Equation 4-5, Equation 4-6 and Equation 
4-7, respectively. The calculated percentage reductions are presented in Table 4-11. The use 
of pharmaceutical concentrations in these calculations assumes that the flows remain 
unchanged as the compounds pass through the sewage treatment plant.  
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Equation 4-5: 
Reduction following primary sedimentation (%) =  
screened sewage-settled sewage
screened sewage
 x 100 
Equation 4-6: 
Reduction following activated sludge treatment (%) = 
Settled sewage-final treated effluent
settled sewage
x 100 
Equation 4-7: 
Overall WWTP reduction (%) = 
screened sewage-final treated effluent
screened sewage
 x 100 
Where: 
Screened sewage = measured concentration in screened sewage (ng/L) 
Settled sewage = measured concentration in settled sewage (ng/L) 
Final treated effluent = measured concentration in final treated effluent (ng/L) 
Low and variable mean percentage reductions (< 22 %) were observed for bezafibrate, 
carbamazepine and ciprofloxacin during primary sedimentation. In addition, Figure 4-7 
shows some negative reductions were obtained on some sampling occasions due to the 
detection of higher concentrations in the settled sewage compared to the screened sewage. 
Clarithromycin could not be detected in the screened sewage and hence the reduction of 
clarithromycin following primary sedimentation could not be calculated. Following activated 
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sludge treatment, the individual percentage reductions were high for bezafibrate (within the 
range: 40.7 – 90.8 %) and ciprofloxacin (within the range: 40.9 – 95.8 %). Conversely, lower 
and highly variable reductions were obtained for carbamazepine (within the range: -96.3 – 
46.3 %) with negative reductions observed on two sampling occasions (Figure 4-7).  
Table 4-11: Mean (n = 6) percentage reductions (mean ± standard deviation) of pharmaceuticals at different 
treatment stages of the WWTP. 
Pharmaceutical Primary sedimentation 
% reduction (n = 3) 
Activated sludge  
% reduction  (n = 6) 
Overall 
% reduction  (n = 3) 
Bezafibrate 21.9 ± 43.3 73.5 ± 20.6 89.7 ± 5.7 
Carbamazepine 20.0 ± 29.7 -4.7 ± 52.9 22.5 ± 11.9 
Ciprofloxacin 15.1 ± 62.4 77.1 ± 24.6  94.3 ± 0.5 
Clarithromycin nc a59.5 nc 
nc = not calculated. a Only detected on one occasion 
A reduction of 59.5 % was obtained for clarithromycin following activated sludge treatment 
but this was based on the detection of clarithromycin in one settled sewage sample. Overall, 
the target pharmaceuticals were not completely removed from the wastewater treatment 
process (Table 4-11). High overall reductions (mean ± standard deviation) were observed for 
bezafibrate (89.7 ± 5.7 %) and ciprofloxacin (94.3 ± 0.5 %). Whereas, the overall reduction 
for carbamazepine was much lower (22.5 ± 11.9 %). 
99 
 
 
 
  
Figure 4-7: The percentage reduction of bezafibrate, carbamazepine and ciprofloxacin 
calculated for each sampling occasion; following primary sedimentation (n = 3), activated 
sludge treatment (n = 6) and the overall reduction (n = 3). Percentage reductions have not 
been reported where compounds could not be detected in wastewater samples at levels 
above the MLOD (signal to noise > 3). 
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4.3.5 Comparison of predicted and measured influent concentrations 
Prescription cost analysis (PCA) data collated by The Health and Social Care Information 
Centre - Prescribing and Primary Care Services (2012) was used to estimate the quantities of 
selected pharmaceuticals (bezafibrate, carbamazepine, ciprofloxacin and clarithromycin) 
prescribed in England per annum and are given in Table 4-12.   
Table 4-12: Prescription quantities (England, 2011) for selected pharmaceuticals and predicted wastewater 
influent concentrations 
Pharmaceutical Tonnes a-1 (2011) PEC influent (ng/L) 
Bezafibrate 7.0 ~ 1,400 
Carbamazepine 43.0 ~ 8,000 
Ciprofloxacin 7.2 ~ 1,400 
Clarithromycin 12.0 ~ 2,000 
Tonnes a-1 = tonnes prescribed per annum, PECinfluent = Predicted environment concentration for the WWTP 
catchment influent ignoring any transformation or metabolic processes. 
The quantities prescribed in 2011 varied between 7.0 (bezafibrate) and 43.0 
(carbamazepine) tonnes and highlight that there are considerable differences in the types 
and quantities prescribed each year which will influence the levels of these compounds 
finding their way to urban wastewaters. The pharmaceuticals selected for this study are only 
available on prescription in England and therefore the prescription data provided by the 
NHS is a good indicator of the quantities used. The low prescribed levels of vancomycin and 
cefpodoxime meant that these compounds were not included when selecting 
pharmaceuticals for monitoring in the environmental waters in this work. These low 
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prescription levels are consistent with these compounds being rarely reported in 
environmental waters compared to compounds such as bezafibrate and carbamazepine. 
By scaling down the estimated pharmaceutical prescription quantities for England to those 
expected for the population within the catchment of the studied WWTP (population 
870,000), predicted influent concentrations (𝑃𝐸𝐶𝑖𝑛𝑓𝑙𝑢𝑒𝑛𝑡) entering the WWTP have been 
estimated using Equation 4-8 and are given in Table 4-12. 
Equation 4-8: 
(
𝑃𝑜𝑝𝑐𝑎𝑡𝑐ℎ𝑚𝑒𝑛𝑡
𝑃𝑜𝑝𝐸𝑛𝑔𝑙𝑎𝑛𝑑
) × 𝑄
(𝐷𝑊𝐹 × 365)
 =  𝑃𝐸𝐶𝑖𝑛𝑓𝑙𝑢𝑒𝑛𝑡 
Where: 
𝑃𝑜𝑝𝑐𝑎𝑡𝑐ℎ𝑚𝑒𝑛𝑡  =  Population of catchment (~ 870,000) 
𝑃𝑜𝑝𝐸𝑛𝑔𝑙𝑎𝑛𝑑  = Population of England (~ 52 million) 
𝑄 = Quantity estimated from PCA data (tonnes a-1) 
DWF = Dry weather flow (typical 244,000 m3 day-1) 
𝑃𝐸𝐶𝑖𝑛𝑓𝑙𝑢𝑒𝑛𝑡 = Predicted environment concentration for the catchment wastewater influent 
without taking into account metabolism or transformation 
The predicted influent concentrations (PEC influent) for carbamazepine and clarithromycin are 
higher than the concentrations typically reported in the literature (see Table 4-2). Whilst the 
predicted bezafibrate and ciprofloxacin influent concentrations fall within the range of 
concentrations reported in literature (Table 4-2). However, the pharmaceuticals selected for 
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this study are typically administered orally or by injection and therefore will undergo 
metabolic processes within the body before excretion.  Consequently, not all the 
pharmaceuticals will be excreted in the unchanged form.  
Therefore, for a more realistic indication of the pharmaceutical load into urban wastewater 
treatment plants, the percentage of the pharmaceutical excreted as the unchanged 
compound needs to be considered. Taking into account the typical percentage of each of 
the selected pharmaceuticals excreted in the unchanged form, predicted environmental 
concentrations of the excreted unchanged pharmaceuticals have been calculated using 
Equation 4-9 for the influent to the WWTP under study (PECinfluent-unchanged).  
Equation 4-9 
𝑃𝐸𝐶𝑖𝑛𝑓𝑙𝑢𝑒𝑛𝑡-unchanged =  𝑃𝐸𝐶𝑖𝑛𝑓𝑙𝑢𝑒𝑛𝑡 𝑥 % 𝑒𝑥𝑐𝑟𝑒𝑡𝑒𝑑 𝑢𝑛𝑐ℎ𝑎𝑛𝑔𝑒𝑑 
The proportions of carbamazepine (< 10 %) and clarithromycin (20 %) excreted in the 
unchanged form are lower than for bezafibrate (50 %) and clarithromycin (50 %). When the 
proportions of bezafibrate, carbamazepine and ciprofloxacin excreted in the unchanged 
form are taken into account, the predicted influent concentrations (PECinfluent-unchanged) are 
consistent with their measured ranges in the screened sewage (Table 4-13). On the basis 
that only 20 % of clarithromycin is typically excreted in the original form, the estimated 
influent concentration for clarithromycin in the unchanged form (500 ng/L) explains why 
clarithromycin could not be detected above the analytical method quantification limit (500 
ng/L) in the screened sewage.  
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132Table 4-13: Predicted influent concentrations (using typical excretion data) compared to those measured in 
screened sewage. 
Pharmaceutical 
Excreted unchanged 
(%) a 
PECinfluent-unchanged 
(ng/L) 
MECscreened sewage 
(ng/L) 
Bezafibrate ~ 50  ~700 628-2147 
Carbamazepine ~ 10  ~800 369-1460 
Ciprofloxacin ~ 50 ~700 731-2696 
Clarithromycin ~ 20 ~500 (< 500) 
MEC = Measured (range) environmental concentrations in screened sewage of WWTP studied for this work. 
PECinfluent-unchanged = Predicted influent concentration of the unchanged pharmaceutical. Method limit of 
quantification given in parenthesis where targets were below detection limits. ND – Not detected using 
described method. a Wishart et al. (2008). Excreted unchanged values will vary depending on age and sex of 
patient. 
4.3.6 Comparison of pharmaceutical levels in surface waters up- and down-stream of the 
WWTP treated effluent discharge point 
The incomplete removal of pharmaceuticals in wastewater treatment processes poses 
problems for receiving waters as evidenced by the consistently increasing down-stream 
levels. The incomplete removal of bezafibrate, carbamazepine, ciprofloxacin and 
clarithromycin resulted in down-stream (mean ± standard deviation) concentrations of 67.5 
± 19.5, 305.5 ± 172.9,  107.4 ± 60.0 and 27.0 ± 10.0 ng/L respectively compared to 31.0 ± 
9.4, 116.6 ± 98.5 ng/L for bezafibrate and carbamazepine up-stream (Figure 4-6). 
Ciprofloxacin and clarithromycin could not be detected in the surface water up-stream of 
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the effluent discharge point at concentrations greater than the method limit of detection 
given in Table 4-9 (25 and 10 ng/L for ciprofloxacin and clarithromycin respectively). 
Figure 4-8 graphically presents the individual concentrations of bezafibrate, carbamazepine, 
ciprofloxacin and clarithromycin detected in all surface water samples collected during this 
study and also displays the action limit recommended by the European Medicines Agency 
(2006).   
 
Figure 4-8: Interval plot presenting the individual concentrations of target pharmaceuticals in the surface 
waters both up- and down-stream of the treated effluent discharge point of the WWTP investigated in this 
study. The red dashed line indicates the action limit recommended by the European Medicines Agency (2006). 
The presence of the target pharmaceuticals up-stream of the final treated effluent discharge 
point of the WWTP studied demonstrated the presence of additional sources of 
clarithromycinciprofloxacincarbamazepineBezafibrate
600
500
400
300
200
100
0
co
n
ce
n
tr
at
io
n
 (
n
g/
L)
action Limit (10 ng/L)
up-stream
down-stream
105 
 
 
 
pharmaceuticals higher up in the catchment. Interestingly, where the pharmaceuticals have 
been detected in the surface water samples, the concentrations exceed the action limit 
(10ng/L). Therefore if these pharmaceutical compounds were new to the market they would 
require experimental testing to evaluate their environmental fate and effects (see Section 
2.5.4) prior to approval from drug regulatory agencies such as the European Medicines 
Agency (EMA, 2012). 
4.4 Discussion 
4.4.1.1 Detection of target pharmaceuticals in wastewater and surface waters 
In this study a liquid chromatography mass spectrometry method has been employed to 
detect bezafibrate, carbamazepine, ciprofloxacin and clarithromycin in environmental 
waters. Initially an attempt to extract amoxicillin from environmental waters was made. 
However, amoxicillin is unstable in aqueous solutions and its hydrolysis is catalyzed in the 
acidic conditions which were used for sample extraction. Unfortunately, due to the different 
physico-chemical properties of pharmaceutical compounds, it is difficult to find method 
parameters that are suitable for the extraction and analysis of all selected analytes. 
However, analyte recoveries (Table 4-6), method limits of detection and linearity (Table 4-9) 
were considered adequate to detect bezafibrate, carbamazepine, ciprofloxacin and 
clarithromycin in wastewater and surface water samples.  
106 
 
 
 
4.4.1.2 Occurrence of target pharmaceuticals in wastewaters 
The concentrations of the target pharmaceuticals detected in the screened sewage, settled 
sewage and final treated effluent samples collected in this study (Table 4-10) are consistent 
with those found in the literature of which a comprehensive selection is presented in Table 
4-2. Bezafibrate and carbamazepine were more frequently detected in both the screened 
and settled sewage and treated effluent than the other compounds which is consistent with 
the findings reported by Jelic et al. (2011). This was not surprising considering the high 
annual prescription levels identified in Table 4-12 and considering the numerous reports 
from other studies such as those collated in Table 4-2. In addition, bezafibrate and 
carbamazepine are typically prescribed for long term usage to treat chronic conditions 
compared to those which are typically prescribed for short term treatment of bacterial 
infections (e.g. enterococci and E.coli). Therefore, it is expected that bezafibrate and 
carbamazepine will be more prevalent than antibiotics in wastewaters than antibiotics.  
Despite high reported prescription quantities (12 tonnes a-1), clarithromycin could not be 
detected in the screened sewage, and was detected only once in settled sewage. 
Ciprofloxacin was detected in the wastewater but less frequently than bezafibrate and 
carbamazepine. Although higher concentrations of ciprofloxacin compared to the other 
compounds were observed in the screened and settled sewage this was not the case in the 
treated effluent (Table 4-10).  
In a long term study of wastewater influents and effluents by Gros et al. (2010b), 
bezafibrate and carbamazepine were detected more frequently than ciprofloxacin which is 
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consistent with the findings in this work. However in the same study, clarithromycin was 
detected in 100 % of wastewater samples which contradicts the findings given in Table 4-10. 
This is possibly due to the limitations of the analytical method used in this study. The 
method limit of detection determined for clarithromycin in wastewaters (see Table 4-9) is 
greater than the typical wastewater concentrations reported by Gros et al. (2010b). 
4.4.1.3 Comparison of predicted and measured influent concentrations of target 
pharmaceuticals 
There are many factors that can influence the concentrations of pharmaceuticals present in 
wastewaters. These include population characteristics, wastewater treatment plant age and 
design, wastewater treatment process employed and seasonal changes (higher 
pharmaceutical loads have been encountered in winter compared to summer) (Loraine et 
al., 2005, Gros et al., 2010). Pharmaceutical consumption is considered to be a critical 
influencing parameter. In this study, prescription data was used to indicate the levels of the 
selected pharmaceuticals in sewage entering the monitored WWTP. Based on the 
prescription data, the highest predicted concentration for the wastewater influent 
(PECinfluent) was carbamazepine (~ 7900 ng/L) followed by clarithromycin (~ 2300 ng/L), 
bezafibrate (~ 1400 ng/L) and ciprofloxacin (~ 1300 ng/L).  
Although prescribed in the largest quantities, carbamazepine was found in the screened 
sewage at levels much lower (369 – 1460 ng/L) than those predicted (~ 7900 ng/L). In 
addition, carbamazepine was present at lower concentrations than bezafibrate and 
ciprofloxacin in the screened and settled sewage (Figure 4-6). This is consistent with reports 
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by Collado et al. (2014) who found elevated levels of bezafibrate and ciprofloxacin 
compared to carbamazepine in wastewater influent (see Table 4-2). In addition, Gros et al. 
(2010b) found elevated levels of fluoroquinolones (including ciprofloxacin) and bezafibrate 
compared to carbamazepine, although the actual concentrations detected were not 
reported.  
The lower than expected levels of carbamazepine detected in the screened sewage is 
probably due to the low proportion of carbamazepine excreted as the original compound. 
Following ingestion, pharmaceutical compounds will be excreted either as the original 
compound or as free or conjugated metabolites (Garcia-Ac et al., 2009). Not all 
pharmaceuticals are metabolised to the same extent and the proportion excreted as the 
original compound depends on the pharmacokinetics of the drug. Carbamazepine 
undergoes extensive metabolism in the human body and less than 10 % is excreted as the 
original compound. More than 30 human metabolites have been identified (Maggs et al., 
1997) and consequently some have been identified in wastewaters including 10, 11 –
dihydro- 10, 11 epoxycarbamazepine,  10, 11 –dihydro- 10, 11 dihydroxycarbamazepine, 2-
hydroxycarbamazepine, 3 hydroxycarbamazepine, acridone and acridine (Leclercq et al., 
2009). Furthermore, 10, 11 –dihydro- 10, 11 –dihydroxycarbamazepine has been identified 
in wastewaters at levels greater than the parent compound (Bahlmann et al., 2014;  Miao et 
al., 2003;  Leclercq et al., 2009).  
Taking into account the proportion of the drug excreted in the original form (excretion 
factor), the predicted level (PEC influent unchanged) for carbamazepine was more consistent with 
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those measured in the screened sewage (see Table 4-13). Compared to carbamazepine, a 
larger proportion of bezafibrate and ciprofloxacin are excreted in the unchanged form and 
therefore, the predicted influent levels excreted unchanged (PEC influent unchanged) were within 
the range of concentrations detected in the screened sewage. There were no reports found 
on the occurrence of bezafibrate and ciprofloxacin human metabolites in wastewaters 
during the literature search for this study. The predicted level for clarithromycin was at a 
similar level to the corresponding method limit of detection (MLOD) and therefore it was 
not surprising that this compound was not detected in the screened sewage.  
The concentrations of the target pharmaceuticals in the screened sewage varied between 
individual samples and  will have been influenced by  catchment characteristics including 
diurnal (general habits of individuals) and daily variations (e.g. working days vs weekends) 
(Ternes et al., 2008). Researchers have reported seasonal (Birosova et al., 2014;  Li et al., 
2011;  McArdell et al., 2003) and temporal (Musolff et al., 2009) differences in 
pharmaceutical WWTP influent levels. Plosz et al. (2010) found concentrations of antibiotics 
in WWTP influent reduce throughout the day with maximum levels identified in the 
morning. The fluctuations in concentrations due to catchment characteristic will not have 
been captured using the grab sampling technique employed in this study. To evaluate 
pharmaceutical loads or mass fluxes in WWTPs, composite sampling techniques have been 
recommended (Ort et al., 2010). Analytical errors may have also contributed to the 
variations of pharmaceutical concentrations in the screened sewage and in the other 
samples. In this study, the standard addition technique was used as a method of 
quantification and to compensate for sample losses due to sample extraction. This 
110 
 
 
 
procedure is considered an accurate method for quantifying compounds in complex 
matrices (Ternes et al., 2008). However, the estimated errors (standard deviations) 
associated with quantifying the target compounds by extrapolation in  wastewater and 
surface water samples were, as expected,  sometimes quite large (Table 4-7).  
4.4.1.4 Removal of target pharmaceuticals during the wastewater treatment processes 
The removal of pharmaceuticals throughout the wastewater treatment process is complex 
but two important mechanisms are sorption and biodegradation (as presented in Section 
2.2.1.2). The removal efficiencies of pharmaceuticals will vary depending on their tendency 
to sorb to sludge material or to the extent of biodegradation by micro-organisms. 
In this study, high overall removal rates from wastewater were observed for ciprofloxacin 
(94.3 ± 0.5 %) whilst low removal rates were found for carbamazepine (22.1 ± 11.9 %). Since 
neither of these compounds is readily  biodegraded (Zhang et al., 2008;  Kümmerer et al., 
2000;  Al-Ahmad et al., 1999), sorption will be the predominant  removal mechanism. In 
part, their different physico-chemical properties influence their sorption to wastewater 
solids together with the ambient pH. At neutral pH, ciprofloxacin mainly exists as a 
zwitterion carrying a positive charge from the protonation of a secondary amine of the 
piperazinyl moiety (see Section 4.1.1). Compounds that exhibit a positive charge are likely to 
interact with the negatively charged surface of microorganisms of activated sludge material 
(Ternes et al., 2004). The high activated sludge solid-water distribution coefficient (Kd) value 
determined for ciprofloxacin (2600 L/kg) confirms the affinity of this compound for 
activated sludge (Golet et al., 2003).  
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Looking at the wastewater treatment process more closely, it was observed that a high 
proportion of ciprofloxacin was removed (77.1 ± 24.6 %) during activated sludge treatment 
(see Table 4-11) which is consistent with the activated sludge Kd value determined by Golet 
et al., (2003) and with the activated sludge removal rates observed by Zorita et al., (2009). 
However, for compounds containing functional groups that can be protonated or 
deprotonated, the ambient pH is an important parameter influencing the level of sorption 
(Polesel et al., 2014). The pH values determined for the wastewater samples in this study 
were within the 6.8 – 7.1 range and may account for the different proportions of 
ciprofloxacin removed during activated sludge treatment (40.9 – 95.8 % as shown in Figure 
4-7). As the ambient pH changes, the proportion of ciprofloxacin that exists in the 
zwitterionic form will change and consequently the capacity to sorb. The maximum sorption 
capacity for ciprofloxacin has been  observed at its isoelectric point (pH 7.4) in sorption 
experiments carried out by Polesel et al., (2014). 
A lower proportion of ciprofloxacin was removed during primary sedimentation (15.1 ± 62.4 
%). This is expected as the proportion of microorganisms is lower in primary sludge 
compared to activated sludge and the expected impact is consistent with the lower Kd value 
determined for primary sludge (260 L/kg) by (Golet et al., 2003). The removal by sorption 
processes in wastewater treatment plants is considered negligible for compounds with 
solid-water distribution coefficients < 300 L/Kg (see Chapter 2, Section 2.2.1.3) 
Carbamazepine is a neutral molecule at neutral pH and therefore sorption to wastewater 
solids will be mainly through hydrophobic interactions. However, the octanol-water 
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coefficient for carbamazepine is low (pKow= 2.45, see Table 4-5) and uncharged chemicals 
with log Kow < 2.5 are predicted to show a low sorption potential (Golet et al., 2003).  This is 
agreeable with both the sludge-water adsorption coefficient (Kd) determined for primary 
sludge material (20 L/kg) and for activated sludge material (1.2 L/Kg) suggesting a low level 
of sorption to wastewater particulate matter (Ternes et al., 2004). Therefore, the low overall 
removal of carbamazepine through the wastewater treatment process is explained by its 
physicochemical properties and is consistent with observations found by Jelic et al. (2011).  
A closer inspection of the removal of carbamazepine at different stages within  the 
wastewater treatment process revealed that primary sedimentation processes provided the 
main contribution to the removal of carbamazepine (20.0 ± 29.7 %) with an average  
negative removal (-4.7 ± 52.9 %) being observed for activated sludge treatment (see Table 
4-11). Similar results were reported by  Vieno et al. (2006);  Clara et al. (2004) and Gros et al. 
(2010) and attributed to the desorption of carbamazepine from wastewater solids. 
Carbamazepine absorbs to wastewater solids through hydrophobic interactions. However, 
hydrophobic components of wastewater solids are degraded during biological treatment 
thus releasing the compound back to the aqueous phase (Ternes et al., 2008). Furthermore, 
it has been reported that carbamazepine levels may increase due to the deconjugation of 
carbamazepine metabolites in the activated sludge tank, thus releasing the parent 
compound (Vieno et al., 2007). The metabolites and transformation products of the target 
pharmaceuticals were not investigated in this study.  
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In the removal of bezafibrate, the activated sludge treatment process substantially 
contributed to the high overall removal rate (89.7%) and this is consistent with removal 
values reported elsewhere (Radjenovic et al., 2009;  Castiglioni et al., 2004). Sorption during 
the activated sludge treatment process is not considered to be an important removal 
mechanism for bezafibrate. This is because at neutral pH it is in the anionic form and will 
therefore not interact with the negatively charged surfaces of microorganisms present in 
activated sludge. However, Quintana et al. (2005) and Ternes (1998) reported that 
biodegradation is an important removal mechanism for bezafibrate during the activated 
sludge process.  
The removal of clarithromycin during the primary sedimentation process could not be 
assessed as this compound was not detected in the screened sewage above the method 
limits of quantification. However, it has been reported by Göbel et al. (2007) that primary 
sedimentation does not significantly reduce the levels of clarithromycin. Joss et al. (2006)  
demonstrated that biodegradation is not an important removal mechanism for 
clarithromycin in the activated sludge processes. Therefore the removal of 59.5 % of 
clarithromycin following activated sludge treatment suggests sorption is an important 
removal mechanism. In addition, clarithromycin was expected to sorb onto the negatively 
charged surface of activated sludge because it carries a positive charge (through the 
protonation of the tertiary amino group) at neutral pH. However, the moderate monitored 
removal of clarithromycin contradicts a report by Göbel et al. (2005) in which < 5% was 
removed during activated sludge treatment. In addition, the solid-water distribution 
coefficient (260 L/Kg) determined by Golet et al. (2003) for clarithromycin suggests 
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negligible sorption onto activated sludge material. However, the sorption of compounds can 
vary due to variations in the sewage composition (Ternes et al., 2004). In addition, the 
removal of clarithromycin (59.5 %) during the activated sludge process is only based on one 
settled sludge measurement and therefore further measurements would be required for a 
better assessment of the fate of clarithromycin during wastewater treatment processes. The 
overall reduction of clarithromycin could not be calculated, as clarithromycin was not 
detected in the screened sewage.  
The removal of the target pharmaceuticals (in particular carbamazepine) was found to be 
variable in this study with both negative and positive removal efficiencies observed (Figure 
4-7). Differences in the wastewater treatment plant operating conditions (e.g. the hydraulic 
retention time (HRT) and sludge age (SRT)) may account for some of the variability (Verlicchi 
et al., 2014b). Clara et al., (2005) found that bezafibrate removal was more efficient with a 
sludge age > 10 days presumably because this equates to a larger microbial diversity and 
consequently to more varied potential biodegradation pathways. However, Gros et al., 
(2010) found changes in HRT did not affect the removal of carbamazepine and Vieno et al. 
(2007) reported no obvious correlation between the proportion of carbamazepine and 
ciprofloxacin removed and SRT.  
The variability in the observed removal efficiencies could be due to the limitations of the 
grab sampling technique used in this study. Grab samples only provide an instantaneous 
measurement of the target pharmaceutical concentration. Therefore this technique will not 
compensate for the short and long term fluctuations that may occur in wastewater 
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treatment plants due to  changes in hydraulic retention time and sludge retention time 
(Ternes et al., 2008). Some studies have used composite sampling techniques over 24 hrs 
(Golet et al., 2002) to account for such variations. However, despite using composite 
sampling techniques, Gros et al. (2010b) also reported both positive and negative removal 
efficiencies for bezafibrate, carbamazepine and ciprofloxacin consistent with  those found in 
this study. 
4.4.1.5 Occurrence of target pharmaceuticals in surface water 
Although at lower concentrations than those observed for sewage and treated effluent 
samples, bezafibrate, carbamazepine, ciprofloxacin and clarithromycin were detected in the 
surface water down-stream of the treated effluent discharge point of the WWTP. In the 
treated effluent, carbamazepine was present in higher concentrations compared to the 
other selected pharmaceuticals and correspondingly it was also present at higher 
concentrations in the surface water (Figure 4-6). This perhaps reflects the resistance of 
carbamazepine to biodegradation and sorption processes. These findings are consistent 
with those reported by Fernandez et al. (2010), Daneshvar et al. (2010) and Petrovic et al. 
(2014) who also found elevated levels of carbamazepine compared to other pharmaceutical 
compounds in surface waters. 
Both bezafibrate and carbamazepine were detected in the surface water up-stream relative 
to the treated effluent discharge point. The occurrence of pharmaceuticals in the surface 
water up-stream of the WWTP samples indicates there are alternative sources of 
pharmaceuticals further up-stream. This is probably due to a number of misconnections of 
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the ageing sewer infrastructure and discharges of sewage from combined sewerage 
overflows to the surface water within this area (Thames Water, 2014). 
Where detected, the pharmaceutical levels were typically higher downstream compared to 
upstream of the WWTP treated effluent discharge point (Figure 4-8). This demonstrates that 
pharmaceutical compounds are incompletely removed during the wastewater treatment 
process and that surface waters are vulnerable to pharmaceutical contamination from point 
sources. Ciprofloxacin and clarithromycin were only detected down-stream of the WWTP 
discharge point. This perhaps indicates that bezafibrate and carbamazepine are more 
ubiquitous and persistent than ciprofloxacin and clarithromycin in surface water. 
Furthermore, it suggests the constant release of pharmaceutical contamination to surface 
waters within WWTP treated effluent discharges. It is possible that ciprofloxacin and 
clarithromycin were present in upstream samples at levels below the method detection 
limits (25 and 10 ng/L respectively) and therefore not detected. In addition, the 
concentrations of the selected pharmaceuticals in surface water samples may have been 
underestimated as a consequence of filtration prior to extraction, removing any suspended 
solid bound pharmaceuticals. Silva et al., (2011) observed bezafibrate, carbamazepine and 
clarithromycin in the suspended solid samples of various river water samples but not always 
in the corresponding aqueous phase. Furthermore, 30 % of the 43 pharmaceuticals 
investigated were found to be predominantly associated with suspended solids compared to 
the aqueous phase.  
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The measured target pharmaceuticals (Table 4-10) in the surface water are consistent with 
those reported by other researchers (Table 4-3) for river waters receiving treated effluent 
discharges. The data in Table 4-3 show that although present in variable concentrations 
bezafibrate, carbamazepine, ciprofloxacin and clarithromycin, if detected in surface waters 
are generally present at ng/L concentrations. Surprisingly, there are reports that these 
compounds have been detected at concentrations in excess of 1 µg/L (Valcarcel et al., 2011;  
Watkinson et al., 2009;  Feitosa-Felizzola et al., 2009). 
Pharmaceutical consumption levels and WWTP pharmaceutical removal efficiencies will 
initially influence the levels of these compounds discharged to receiving waters but 
subsequently  further sorption, and photodegradation processes may take place in the 
surface water (Batt et al., 2006).  Photodegradation may be an important removal process 
for some pharmaceuticals in surface waters. However, Cardoza et al., (2005) found the 
presence of particulate organic carbon dramatically reduced the photodegradation of 
ciprofloxacin. Similarly, the presence of humic acids reduced the photodegradation of 
carbamazepine in studies conducted by Andreozzi et al., (2002) and photodegradation was 
found to have a limited impact on clarithromycin in surface water  (Vione et al., 2009). In 
the current study, high levels of suspended solids were measured in the surface water (see 
Table 4-4) and therefore may have limited UV light penetrating the surface limiting removal 
by photodegradation. 
Pharmaceutical compounds with higher soil/water organic carbon sorption coefficients (Koc) 
may sorb to surface water particulates and therefore be removed from the surface water. 
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14C-ciprofloxacin studies by Cardoza et al. (2005) confirmed ciprofloxacin to be significantly 
adsorbed onto aquatic particulate organic carbon (Koc values of 13,900 to 20,500 L/kg at 
neutral pH). It may be that sorption processes partially explain why ciprofloxacin was 
infrequently detected in the surface water samples in this study (see Table 4-10). When 
detected, high levels of ciprofloxacin may have been released from the WWTP in a non-
sorbed state or perhaps desorption from particles and solids occurred in the surface water. 
Desorption may occur due to changes in the ambient pH. pH values can greatly affect the 
behaviour of ionisable compounds (Verlicchi et al., 2014b). For example, Polesel et al. (2014) 
found that ciprofloxacin had reduced sorption capacity at a pH value of 6.3 (Kd = 366 L/kg) 
and a pH value of 8 (Kd =371 L/Kg) compared to a pH value of 7.4 (Kd = 1225 L/Kg). The pH 
values determined for the surface water down-stream of the WWTP treated effluent 
discharge point ranged between 7.2 and 8.3 (mean ± standard deviation = 7.8 ± 0.4) and 
therefore corresponded to levels at which the sorption capacity of ciprofloxacin could have 
been expected to decrease. In contrast to ciprofloxacin, carbamazepine is expected to sorb 
much less to surface water particulates based on the experimentally derived Koc value of 
521 L/Kg (Drillia et al., 2005) and its low octanol-water coefficient (282) enabling it to be 
detected in the majority of surface samples analysed in this study (Table 4-10).   
Where detected, the target pharmaceuticals have been detected in surface waters up- and 
down-stream of the WWTP discharge point at levels greater than the action limit (10 ng/L) 
given by regulatory guidelines for the environmental risk assessment of new 
pharmaceuticals to market (European Medicines Agency 2006). An array of tests including 
the algal growth inhibition test (OECD 201) and Daphnia sp. reproduction test (OECD 211) 
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have been recommended for pharmaceutical compounds with predicted surface water 
concentrations that exceed this action limit (Chapter 2, Section 2.5.4). However, the tests 
are performed on a small selection of organisms and therefore the effects on specific 
organisms may be missed. In addition, there is no recommendation for tailored tests to 
investigate the effects that may be specific to certain groups of pharmaceuticals. The effects 
of antibiotics in aquatic ecosystems and the potential to select for antibiotic resistant 
bacteria is an example.  Most importantly, bezafibrate, carbamazepine, ciprofloxacin and 
clarithromycin are exempt from environmental risk assessment as the current legislation 
(European Commission, 2001) only applies to new medicines to the market (Section 2.5.4) 
and therefore information on the fate and effects of these compounds is not 
comprehensive. This is of concern as there are reports indicating the potential risk of these 
selected compounds in aquatic ecosystems (Martins et al., 2012;  Isidori et al., 2005;  
Halling-Sorensen et al., 2000).   
4.5 Summary 
Using solid phase extraction combined with LC-MS, bezafibrate, carbamazepine, 
ciprofloxacin and clarithromycin have been detected in the wastewaters of a large urban 
wastewater treatment plant and in the surface waters receiving the WWTP discharged 
treated effluent. Method detection limits ranged between 5 and 500 ng/L for surface waters 
and screened sewage respectively. The analysis of prescription data has indicated the high 
quantities of four pharmaceuticals (bezafibrate, carbamazepine, ciprofloxacin and 
clarithromycin) prescribed per year that could ultimately arrive at wastewater treatment 
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plants following ingestion and excretion. The analysis of wastewaters and samples collected 
both up- and down-stream of the discharged effluent from a large wastewater treatment 
plant show that these compounds are incompletely eliminated. Although the percentage 
removed during wastewater treatment depends on a number of factors including the type 
of treatment and the population characteristics, sorption is shown to be an important 
removal process particularly for ciprofloxacin. A comparison of pharmaceutical 
concentrations up- and down-stream of the discharged effluent suggests receiving waters 
are vulnerable to pharmaceutical contamination from point sources.  
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5 Antibiotic resistance patterns of Escherichia coli and enterococci 
in an urban environment 
5.1 Introduction  
Antibiotic resistant bacteria and antibiotic residues are present in wastewater and it is a 
concern that wastewater treatment plants provide a hotspot for the dissemination of 
antibiotic resistance which could ultimately impact surface waters receiving treated 
wastewater effluent discharges.  
Few studies have investigated antibiotic resistance amongst bacteria in environmental 
waters such as wastewater treatment plants and surface waters and typically in these 
studies bacteria are assessed using qualitative antibiotic susceptibility tests (e.g. disc 
diffusion) that define bacteria as being either resistant or susceptible according to clinical 
breakpoint values (Servais et al., 2009;  Faria et al., 2009). However, clinical breakpoint 
values (CBPs) may differ between different antibiotic susceptibility testing methods, can 
vary internationally and may be set at different antibiotic levels in animals and humans 
(Kahlmeter et al., 2003). This lack of internationally accepted harmonised breakpoints 
makes it difficult to interpret and compare the resistance levels reported by different 
studies. In addition, clinical breakpoint values are primarily established for guidance on 
therapy and distinguish between treatable and non-treatable bacteria influenced by 
pharmacodynamic and pharmakinetics data. They are not always appropriate for subtly 
detecting emerging phenotypic resistance. Quantitative antibiotic susceptibility methods 
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result in an antibiotic concentration that can inhibit visible growth of micro-organisms 
(minimum inhibitory concentration) and can be interpreted using epidemiological cut off 
values (ECOffs) or clinical breakpoint values if required. Epidemiological cut off values 
(ECOffs) have been established by The European Committee for Antimicrobial Susceptibility 
Testing (EUCAST, 2010) and are used for the detection of bacteria with acquired resistance 
mechanisms and for the sensitive detection of emerging resistance. The cut off value will 
remain the same despite changes in antibiotic therapy in humans and animals (Kahlmeter et 
al., 2003). Antibiotic susceptibility testing and interpretative breakpoints and 
epidemiological cut off values have been described in more detail in Chapter 3, Section 3.4. 
In this chapter, the presence of bacteria indicative of human faecal contamination and their 
respective antibiotic resistant sub populations in environmental waters (settled sewage, 
final treated effluent and surface water) are investigated. Water samples are collected from 
the settled sewage and final treated effluent associated with a large urban wastewater 
treatment plant and in surface waters both up- and down-stream of the discharge point of 
the final effluent, in which antibiotics have previously been detected (presented in Chapter 
4). Quantitative antibiotic susceptibility tests are interpreted using harmonised clinical 
breakpoint values and epidemiological cut off values defined by EUCAST (2012). It was 
decided to use both harmonised clinical breakpoint and epidemiological cut off values as 
currently there are no accepted standardised procedures to assess the transfer of antibiotic 
resistance in environmental waters. In addition, harmonised clinical breakpoint values are 
considered when epidemiological cut off values for certain bacteria/antibiotic combinations 
have yet to be determined. 
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5.1.1 Selection of bacteria 
Coliform bacteria, enterococci, staphylococci and Pseudomonas aeruginosa are all 
potentially pathogenic bacteria and are common causes of clinical infections (Health 
Protection Agency. 2007). They are all associated with the gastrointestinal tract of humans 
and animals and consequently are detected in sewage. Their use as microbial indicators of 
water quality is presented in Chapter 3, Section 3.1. Whilst in the host, coliforms, 
enterococci, staphylococci and Pseudomonas aeruginosa are exposed to a variety of medical 
and veterinary antibiotic treatments and consequently can become resistant to the 
antibiotics used against them (Section 3.4). Therefore coliform, enterococci, staphylococci 
and Pseudomonas aeruginosa bacteria were selected for consideration as representative 
bacterial groups to study the transfer of antibiotic resistance from wastewater to receiving 
surface waters. In addition, it was decided to perform a heterotrophic count on all water 
samples as an indication of the levels of culturable bacteria. However, preliminary studies 
revealed that the detection and identification (to species level) of staphylococci (including 
Staphylococcus aureus) and pseudomonas (including Pseudomonas aeruginosa) from 
environmental waters was difficult and therefore subsequent antibiotic susceptibility tests 
were not performed on these organisms (Sections 5.3.3 and 5.3.4). 
Antibiotic resistance can vary between species of a bacterial group (e.g. coliforms) or genera 
(e.g. enterococci). For example, within the coliform group there are different genera 
including Citrobacter, Enterobacter, Escherichia, Hafnia, Klebsiella, Serratia and Yersinia and 
antibiotic resistance in some maybe more predominant than in others. Whilst within the 
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Enterococci genera, Enterococcus faecium are considerably more resistant to penicillins than 
Enterococcus faecalis bacteria. In addition, Enterococcus casseliflavus and Enterococcus 
gallinarum inherently display a low level resistance to vancomycin whereas other species of 
the group do not (Eliopoulos, 2007). Therefore, it was decided that identification to species 
level was necessary to help understand the antibiotic resistance patterns observed in the 
collected wastewater and surface water samples. The final selection of bacterial species for 
study was based on the efficiency of bacteriological analysis methods and the frequency 
with which individual species were detected in the collected water samples (Section 5.3.2). 
The bacterial species selected were Escherichia coli and Enterococcus faecium.  
5.1.2 Selection of antibiotics for susceptibility testing  
Amoxicillin and ciprofloxacin are important for the treatment of both Gram negative and 
gram positive bacterial infections and correspondingly are prescribed in large quantities in 
England (~ 228 and 7 tonnes for amoxicillin and ciprofloxacin respectively per year). 
Approximately 80 % and 50 % of a dose of amoxicillin and ciprofloxacin respectively are 
excreted in the original form and potentially transferred to wastewater treatment plants. 
Ciprofloxacin has been detected in wastewater and receiving surface waters in this study 
(presented in Chapter 4). 
The surveillance of penicillin resistance (including amoxicillin) in E.faecium and E.coli in 
clinical settings within the UK has indicated high rates of resistance. Surveillance has shown 
that penicillin resistance in E.faecium has increased from 77.6 % to 93.1 % between 2005 
and 2012 (European Centre for Disease Prevention and Control - Antimicrobial resistance 
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interactive database (EARS-net), 2014). Whilst, the levels of penicillin resistance in E.coli was 
reported to be 62.7 % (European Centre for Disease Prevention and Control - Antimicrobial 
resistance interactive database (EARS-net), 2013b).  
There is no mandatory surveillance of fluoroquinolone resistance in E.faecium in the UK, but 
there are studies that report resistance to fluoroquinolones is widespread in the enterococci 
genus (Eliopoulos, 2007). Surveillance of E.coli has demonstrated that fluoroquinolone 
resistance levels reached 16.6 % in the UK in 2012 (European Centre for Disease Prevention 
and Control - Antimicrobial resistance interactive database (EARS-net), 2013c). In addition, 
ciprofloxacin has been classified by the World Health Organization (2011) as a critically 
important antibiotic. The classification describes antibiotics that are the sole treatment for 
serious human infections and for antibiotics that are used to treat infections caused by 
bacteria from non-human sources (World Health Organization, 2011). Due to their 
importance in human medicine and the potential impact on environmental waters, both 
amoxicillin and ciprofloxacin were chosen for this work.  
Clarithromycin is a macrolide antibiotic prescribed in high quantities each year (~ 17 tonnes  
a.i in England) and a substantial proportion (~ 25 %) is excreted in the active form (Ternes et 
al., 2008). Furthermore, clarithromycin has been detected in wastewaters and receiving 
surface waters (discussed in Chapter 4) and therefore was selected for further investigation.  
Macrolide antibiotics (including clarithromycin) constitute an important alternative therapy 
for the treatment of insidious enterococci infections (Portillo et al., 2000). However, Gram 
negative bacteria are intrinsically resistant to macrolides due to their outer membrane 
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(Chapter 3, Section 3.3.5.3). Therefore clarithromycin susceptibility studies were only 
carried out on E.faecium and not on E.coli. 
The surveillance of vancomycin resistance in enterococci species is mandatory in clinical 
settings due to the importance of vancomycin therapy for enterococci infections. Clinical 
surveillance of vancomycin resistance in E.faecium have shown that resistance rates have 
reduced from 33.0 % (2005) to 13.3 % (2012) in the UK (European Centre for Disease 
Prevention and Control - Antimicrobial resistance interactive database (EARS-net), 2014b). 
In addition, the prescription quantities of vancomycin are very low (0.03 tonnes a.i, in 
England) and there are very few reports of the detection of vancomycin in environmental 
waters (Chapter 4, Section 4.1.1). Vancomycin was selected for this work as a contrast to 
amoxicillin, ciprofloxacin and clarithromycin which are prescribed in high quantities in 
England and because of its importance in the treatment of methicillin resistant 
Staphylococcus aureus (Kos et al., 2012). Vancomycin resistance levels in E.coli were not 
investigated because of their intrinsic resistance to this antibiotic. 
Cefpodoxime is considered a critically important antibiotic  because it is one of a small 
number of Cephalosporins (3rd and 4th generation) that can be used to treat bacterial 
meningitis and diseases due to Salmonella in children (World Health Organization, 2011). 
enterococci species are intrinsically resistant to cephalosporins (e.g. cefpodoxime), 
(European Antimicrobial Resistance Surveillance Network, 2011). However, clinical 
surveillance has shown that resistance to 3rd generation cephalosporins (including 
cefpodoxime) in E.coli  has increased (2001 – 2012) from 1.2 – 13.1 % in the UK  (European 
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Centre for Disease Prevention and Control - Antimicrobial resistance interactive database 
(EARS-net), 2013a). This is despite the low quantities of cefpodoxime prescribed each year 
(0.002 tonnes a.i, in England). Although cephalosporins are rarely detected in environmental 
waters (see Chapter 4, Section 4.1.1), cefpodoxime was selected for susceptibility testing in 
E.coli as a contrast to amoxicillin and ciprofloxacin. 
5.2 Materials and methods for bacterial analysis 
5.2.1 Method overview 
In this chapter, the detection and enumeration of coliform bacteria, Escherichia coli, 
enterococci, staphylococci and pseudomonas in wastewater and surface water samples are 
described (presented in Section 5.2.5). A membrane filtration method was selected as it is a 
recognised bacteriological method for water quality monitoring (see Chapter 3, Section 3.2). 
Non-target bacteria can grow on the specific growth media used in membrane filtration and 
therefore the bacteria detected on the membrane filters were considered presumptive. A 
variety of confirmation tests (presented in Section 5.2.5.4) recommended by the 
Environment Agency (2000) were carried out on a proportion of the presumptive bacteria to 
confirm that they belonged to the target group (e.g. coliforms) or genera (e.g. enterococci). 
In addition, the effectiveness of a chromogenic agar to differentiate between E.faecium 
from other presumptive enterococci bacteria was assessed as a confirmation test. 
Further testing was required to identify the detected bacteria to species level. Initially the 
identification of coliform bacteria, E.coli, enterococci, staphylococci and pseudomonas were 
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performed using commercial biochemical kits. However during the study an opportunity to 
use matrix assisted laser desorption-time of flight- mass spectrometry (MALDI-TOF-MS) for 
the identification (to species level) of isolated bacteria became available.  
From the coliform and enterococci group, E.coli and E.faecium were selected for subsequent 
antibiotic susceptibility testing because they were frequently and easily detected (see 
Sections 5.3.2.1 and 5.3.2.5). E.coli (n = 229) and E.faecium (n = 129) detected in wastewater 
and surface water samples were isolated and processed for identification to species levels 
using MALDI-TOF-MS analysis and antibiotic susceptibility testing using antibiotic gradient 
strips. The principles and background for the methods used in this chapter are outlined in 
Chapter 3. 
5.2.2 Study area 
Full details of the study site have been given in Chapter 4, Section 4.2.2 
5.2.3 Sample collection 
Samples of settled sewage and final treated effluent were collected on five occasions, 
between July 2011 and February 2012, from an urban wastewater treatment plant 
employing activated sludge. Samples were also taken from surface waters up- and down-
stream of the effluent discharge point (see Chapter 4, Section 4.2.2). Samples were 
collected simultaneously to the collection of samples for chemical analysis described in 
Chapter 4. Duplicate samples were collected in 500 mL sterile (Gamma radiated) bottles 
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(Sterilin, Ltd, UK) and stored in a cool box (with frozen ice packs) during transport to the 
laboratory. All samples were processed within 4 h of collection. 
5.2.4 Media and reagents 
Brilliance E.coli /coliform selective agar (BO1014M), Slanetz and Bartley agar (CM0377), Bile 
aesculin agar (CM0888), R2A agar (CM0906), Mannitol salt agar (CM0085), Pseudomonas 
base agar (CM0559) and Pseudomonas aeruginosa selective supplement (SR0102) which 
contains nalidixic acid and cetrimide and Mueller Hinton agar (CM0337),  tryptone water 
(CM0087), Gram staining set (R40080 - contains crystal violet, iodine and safranin) and 
Microbat oxidase detection strips (MB0266) were purchased from Oxoid Ltd. Sodium azide 
(99 % SpeciFied) and 6 % hydrogen peroxide solution (CertiFied) were purchased from 
Fisher Scientific (UK). All media were prepared according to the instructions outlined by the 
manufacturer. API 20E (for Enterobacteriaceae), API 20 Strep (for the identification of 
enterococci), API Staph (to identify staphylococci) and API NE (for the identification of non-
enteric Gram negative rods) identification kits and reagents (catalogue references: 20100, 
20600, 20500 and 70050 respectively) and Etest® antibiotic gradient strips for ciprofloxacin 
(0.002-32 µg/mL), amoxicillin (0.016-256 µg/mL), clarithromycin (0.016-256 µg/mL), 
vancomycin (0.016-256 µg/mL) and cefpodoxime (0.016-256 µg/mL) were purchased from 
Biomerieux Ltd, UK (catalogue references 508618, 500918, 508618,  525518 and 505818 
respectively).   
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5.2.5 Detection and enumeration methods 
5.2.5.1 Membrane filtration method 
The detection and enumeration of bacteria in the collected samples were carried out using 
the membrane filtration method. Samples were subjected to 10-fold serial dilutions with 
sterile water. 100 mL aliquots of the diluted samples were filtered (in duplicate) using 47 
mm cellulose nitrate membrane filters (0.45 µm) and incubated on different culture media 
(as summarised in Table 5-1).  
Table 5-1: Culture media used for the specific detection of target indicator bacteria 
Target bacteria Media Incubation a Results 
E.coli/ 
coliforms 
E.coli/coliform 
chromogenic agar 
37 °C for 24 h 
coliforms = purple colonies 
E.coli = pink colonies 
Enterococci 
Slanetz and Bartley 
agar 
37 °C for  4 h & 
44 °C for 40 h 
Enterococci  = maroon colonies 
Staphylococci -
including 
Staphylococcus 
aureus 
Mannitol salt agar 
with 0.005 % sodium 
azide 
30 °C for 24 h 
Staphylococci = pink colonies 
Staphylococcus aureus = cream 
colonies 
Pseudomonas 
-including 
Pseudomonas 
aeruginosa 
Pseudomonas base 
agar with naladixic 
acid and cetrimide 
35°C for 24 
and 48 h 
Pseudomonas = cream colonies 
Pseudomonas aeruginosa 
blue/green or red/brown 
colonies 
a results are considered presumptive. Selective, differential and indicative properties of the 
growth media are given in Chapter 3, Section 3.2. 
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Blank (negative) controls of 100 mL sterile water were processed in the same manner as the 
samples. The enumeration of target bacteria were only carried out for plates displaying 
approximately 10 – 100 colonies.  
5.2.5.2 Spread plate method 
Heterotrophic bacteria counts were performed on the samples using the spread plate 
method following guidelines produced by the Environment Agency (2007). 0.1 mL aliquots 
of diluted samples (diluted by a 10-fold serial dilution with sterile water) were spread on 
R2A agar (low nutrient agar) in 90 mm petri dishes using sterile plastic bent rods in 
duplicate. For each sample one plate was incubated at 30 ± 5 °C for three days and the other 
at room temperature (21 ± 5 °C) for 7 days. A blank control was also processed (0.1 mL 
sterile water) to check for no growth.  
5.2.5.3 Isolation and storage of isolates 
Presumptive bacteria of interest were purified by sub culturing using nutrient agar. Working 
stocks of each isolate were stored on nutrient agar slants at 4° C and preserved in nutrient 
broth with 20 % glycerol (stored at -80 ° C) until further analysis. 
5.2.5.4 Methods to confirm presumptive isolates 
From each specific growth medium, a proportion of the presumptive colonies were isolated 
from plates, displaying growth of approximately 10-100 colonies for subsequent 
confirmation tests. The tests used are summarised in (Table 5-2). The enumeration of target 
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bacteria were adjusted for the proportion of isolates that were confirmed as belonging to 
the target group as identified by the Environment Agency (2000).   
Table 5-2: Confirmation tests used for presumptive bacteria  
Target  Test Test details Expected results 
E.coli 
coliforms 
indole test Tryptone water was inoculated 
with colonies and incubated at 44 
°C for 24 h. Two drops of Kovac’s 
reagent was then added 
E.coli = red colouration 
with Kovac’s reagent 
Coliforms = no change 
E.coli 
Coliforms 
Pseudomonas 
Oxidase 
test 
Colonies were applied on to 
oxidase detection strips 
impregnated with NNN’N’ 
tetramethyl -p- phenylene-
diamine dihydrochloride 
E.coli = no change 
Coliforms = no change  
Pseudomonas = purple 
coloured formed in 5 s 
Enterococci aesculin 
hydrolysis 
Colonies were streaked on to bile 
aesculin agar and incubated at 44 
°C for 24 h 
Enterococci = blackening 
of the agar 
Enterococci growth in 
6.5 % 
sodium 
chloride 
(NaCl) 
Colonies were inoculated into 
nutrient broth containing 6.5 % 
(weight/volume) NaCl and 
incubated at 44 °C for 24 h 
Enterococci = If the broth 
is turbid following 
incubation 
Staphylococci 
 
Gram stain Colonies were applied to a 
microscope slide. Crystal violet 
dye is added, left for 1 min and 
then washed off. Gram's Iodine 
solution is added and washed off 
after 1 min. 95 % alcohol was 
added and washed off after 10 s. 
Safranin was added washed off 
after 30, ready for microscope 
analysis 
Staphylococci = Gram 
Positive 
 
Staphylococci catalase 3 % hydrogen peroxide is added to 
colonies applied to microscope 
slides 
Staphylococci = bubbles 
formed 
More details on the confirmation tests are given in Chapter 3, Section 3.2.1.1.  
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5.2.5.5 Evaluation of growth media efficiency 
Presumptive E.coli (50 isolates), coliform bacteria (30 isolates), enterococci (61 isolates) 
staphylococci (62 isolates) and pseudomonas (86 isolates) taken from wastewater and 
surface water samples and reference control strains (see Section 5.2.8) were identified to 
species level (by either phenotypic identification or a combination of phenotypic 
identification and MALDI-TOF-MS analysis). This was to evaluate the efficiency of the growth 
media used to detect the target bacteria and inhibit non-target bacteria. The growth media 
constituents used for the selective and differential detection of target bacteria are given in 
Chapter 3, Section 3.2.  
5.2.5.6 Evaluation of a chromogenic agar to differentiate E.faecium from other 
Enterococci species 
While enterococci are quite easily cultivated on Slanetz and Bartley media, the isolation and 
differentiation of a specific species such as Enterococcus faecium from mixed enterococci 
populations can be problematic. This is because different species of enterococci produce 
colonies of similar appearance on Slanetz and Bartley media. Therefore, the effectiveness of 
a chromogenic media (cephalextin arabinose agar) to differentiate between E.faecium and 
presumptive enterococci isolates was evaluated. The intention was to use the agar as a 
confirmation test to specifically detect E.faecium from a mixed enterococci population. The 
red coloured chromogenic media utilises a chromogenic substrate to specifically detect the 
presence of the enzyme β-glucosidase which is characteristic of enterococci. Cleaving the 
substrate produces blue presumptive enterococci colonies. E.faecium can be differentiated 
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from other enterococci species due to the presence of arabinose in the agar. Species such as 
E.faecalis does not ferment arabinose and therefore retains the blue colour. Conversely, 
E.faecium does ferment arabinose producing green coloured colonies. A yellow colouration 
to the medium is also produced upon fermentation of arabinose as the media also contains 
phenol red pH indicator. The agar is supplemented with aztreonam and cephalextin to 
inhibit Gram negative bacteria and Gram positive bacteria other than enterococci. 
Presumptive enterococci isolates (n = 262) taken from surface and wastewaters and control 
reference strains (see Section 5.2.8 were sub-cultured onto the chromogenic media. 
Following incubation 153 green (presumptive E.faecium) and 109 blue (presumptive other 
Enterococci species) colonies were observed and identified using matrix assisted laser 
desorption- time of flight (MALDI-TOF-MS) analysis.  
5.2.6 Identification methods 
5.2.6.1 Phenotypic identification methods 
Phenotypic identification to species level was performed using commercial biochemical 
standardised systems (API®, Biomerieux). There are different systems for 
Enterobacteriaceae, staphylococci, streptococci and Gram negative rods. Each API® system 
comprises of a strip holding a series of different diagnostic media contained in microtubes 
used to detect certain metabolic reactions specific to the group of bacteria in each system 
(Figure 5-1).  
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Figure 5-1: API 20 Strep strips used for the identification of presumed enterococci isolates 
For isolates to be identified, suspensions were made from single well isolated young 
colonies suspended in 5 mL 0.85 % NaCl sterile solution. Bacterial suspensions were used to 
inoculate the dehydrated media on the relevant API strip and then incubated. The 
diagnostic media used in each system are shown in Appendices 1 to 4. The resulting changes 
to the media are used to create a biochemical profile of the tested isolate.  For identification 
purposes the biochemical profile is compared to the profile of 600 species of bacteria in a 
database (apiweb™ software (v 1.2.1). 
The proposed identification is supported by the calculation of two indices; the identification 
percentage (the frequency of the unknown biochemical profile occurring for the proposed 
species) and the T index (comparison of the unknown biochemical profile to the most typical 
profile for the proposed species). The level of identification produced by the software is 
categorised as either excellent (≥ 99.9 % id and ≥ 0.75 T index), very good (≥ 94.9 % id and ≥ 
0.5 T index) or good (≥ 90.0 % id and ≥ 0.25 T index). Only isolate identifications categorised 
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as good, very good or excellent were used in this study. If the level of identification was < 90 
%, the bacteria under test was considered to be unidentified by this approach.  
5.2.6.2 MALDI-TOF-MS identification method 
Initially, MALDI-TOF-MS analysis was not available for this study. Therefore, the 
identification of presumptive coliform bacteria, E.coli (see Section 5.3.2.1), staphylococci 
(see Section 5.3.2.2), pseudomonas (see Section 5.3.2.3) and enterococci (see Section 
5.3.2.4) to species level was performed using phenotypic biochemical kits. When MALDI-
TOF-MS became available, presumptive enterococci isolates were identified to species level 
using this technique. In addition, all isolates (presumptive E.coli and E.faecium) selected for 
subsequent antibiotic susceptibility testing were identified to species level using this 
technique to confirm species identity. 
MALDI-TOF-MS identification of isolates was performed on fresh overnight cultures (Mueller 
Hinton agar) using a MALDI Biotyper (Bruker Daltonics, Billerica, MA) at the Department for 
Bioanalysis and Horizon Technologies, Public Health England (PHE). Samples for analysis 
were prepared using the ethanol/formic acid extraction method. A loop full of a fresh 
culture was homogenised in 300 µL deionised water in an Eppendorf tube. The mixture was 
vortexed and then 900 µL of ethanol was added. The mixture was mixed again and then 
centrifuged at 18,000 r.p.m for 2 min. The supernatant was decanted and the remaining 
pellet centrifuged again. The residual ethanol/deionised water was removed with a pipette 
and the pellet left to air dry for a further 2 min. Acetonitrile (50 µL) and 70 % formic acid (50 
µL) were added to the pellet and centrifuged for 2 min. 1 µL of the supernatant was 
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transferred to a spot on a MALDI target (96 spot, polished steel plate). Once the spots had 
dried, 2 µL of a saturated solution of α-cyano-4-hydroxycinnamic acid (HCCA; Bruker 
Daltonics) matrix was applied on top of each spot and left to dry prior to MALDI-TOF-MS 
analysis.  
Analytical methods were validated, optimised and calibrated by PHE staff scientists. Routine 
protein calibrations were performed using a bacterial test solution containing an extract of 
the strain E.coli DH5 alpha spiked with additional proteins to cover a mass range between 2 
and 20 kDa. Protein calibrations were performed to optimise the laser intensity and to 
ensure the mass errors for the measured masses of the test solution proteins were within 
300 parts per million (mass error/exact mass x 106) of the reference masses. 
The MALDI Biotyper consists of a MicroFlex bench top MALDI mass spectrometer with a 
nitrogen laser (337 nm) operated in positive linear mode (voltage 20 Kv; mass range 2 – 20 
kDa) controlled by FlexControl version 3.3. A mass spectrum of mainly ribosomal intrinsic 
proteins from each sample was obtained by averaging 40 pulsed shots acquired in 
automatic mode. 
Identification of the microorganisms from the acquired mass spectra was achieved using 
MALDI Biotyper Realtime Classification software (version 3.1) which compares the acquired 
spectra to all entries in a database containing more than 3700 spectra entries representing 
approximately 319 genera and 2000 species. Unknown samples are given a score which is 
based on a matching algorithm to reference samples and reflects the level of identification 
obtained.  
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The score value defined by three components, the percentage of matches of peaks in the 
unknown spectrum compared to the total peaks in the reference spectrum (%), the 
percentage matches of the peaks in the reference spectra to the total peaks in the unknown 
spectrum (%) and the correlation of the intensities of the matched peaks (between 0 to 1). 
An example of how mass spectra are compared and interpreted is shown in Figure 5-2. 
Figure 5-2: Example of the comparison of MALDI-TOF-MS analysis acquired spectrum of an 
unknown bacterial sample to a reference spectrum in manufacturer’s bacteria database for 
the calculation of identification scores. 
Unknown spectra: 15 peaks 
Reference spectra: 10 peaks 
5 peaks in unknown 
spectra match 
reference spectra 
% matches of the 
reference spectrum 
5=/10 = 0.5 
% matches of the 
unknown spectrum 
=5/15 = 0.3 
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An overall score in the range from 0 (no match) to 1000 (perfect match) is derived which is transformed to a 
log score between 0 and 3.  According to the manufacturer’s guidelines, a score > 2.3 is a highly probable 
identification to species level, a score > 2.0 is a probable identification to species level and a score between 1.7 
and 1.999 is a highly probable identification to genus level. A microorganism cannot be identified if a score < 
1.7 is achieved. In this study only scores > 2.3 were accepted for identification. All samples were spotted in 
duplicate on MALDI targets and each MALDI target contained control strains also spotted in duplicate. 
5.2.7 Antibiotic susceptibility testing method 
Amoxicillin and ciprofloxacin minimum inhibitory concentration values (MICs) for 229 E.coli 
isolates and 129 E.faecium isolates were assessed using antibiotic gradient strips (Etest®, 
Biomerieux) according to manufacturer instructions. In addition, cefpodoxime MIC values 
for 187 E.coli isolates, clarithromycin MIC values for 129 E.faecium isolates and vancomycin 
MIC values for 109 E.faecium isolates were also assessed. There are different antibiotic 
susceptibility methods available (see Chapter 3, Section 3.4). However, gradient strips 
produce minimum inhibitory concentration values (the lowest concentrations of an 
antibiotic that will inhibit visible growth of a microorganism) and are easy to interpret.  
Each gradient strip holds a predefined stable gradient of 15 two-fold (log2) antibiotic 
concentrations. The concentration gradients for amoxicillin, cefpodoxime, clarithromycin 
and vancomycin spanned the range, 0.016 – 256 mg/L. The ciprofloxacin concentration 
gradient was between 0.002 and 32 mg/L.  For each isolate under investigation, a bacterial 
suspension was made from colonies taken from a fresh overnight culture emulsified in 0.85 
% NaCl sterile solution to achieve inocula turbidity comparable to a 0.5 McFarland standard 
solution (0.05 mL of 1.175% barium chloride dihydrate and 9.95 mL of 1% sulphuric acid). 
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The inoculums were applied to 140 mm Mueller Hinton agar petri dishes (50 mL of Mueller 
Hinton agar in each plate to give a depth of 4 mm) with a sterile swab, covering the entire 
surface to ensure a continuous bacterial growth with no discrete colonies (confluent 
growth). The plates were allowed to dry for approximately 15 min before the antibiotic 
gradient strips were aseptically applied with tweezers and the plates incubated at 37 °C for 
16-20 h. After the required incubation period, the MIC values for bactericidal (amoxicillin, 
ciprofloxacin, cefpodoxime and vancomycin) antibiotics were read directly from the point 
where the edge of the inhibition ellipse intersected the side of the antibiotic gradient strips 
(shown by the red arrow in Figure 5-3). 
 
Figure 5-3: The measurement of amoxicillin and ciprofloxacin MIC values using antibiotic 
Amoxicillin 
MIC valve 
Ciprofloxacin 
MIC valve 
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gradient strips. The MIC value is observed where the edge of the ellipse of inhibition 
intersects the antibiotic gradient strip as shown by the red arrow. 
5.2.7.1 Interpretation of minimum inhibitory concentration values (MIC) 
In this study, the antibiotic concentrations used to distinguish between resistant and 
sensitive bacterial strains used for treatment purposes in clinical settings will be referred to 
as resistant and sensitive clinical breakpoint values (CBPs) respectively. The antibiotic 
concentrations that are used to distinguish between wild type (WT) bacteria that do not 
harbour acquired or mutational resistance and non-wild type (NWT) bacteria that have 
acquired resistance will be referred to as epidemiological cut off values (ECOffs). 
The CBP and ECOff values used to interpret the MIC values obtained for E.coli isolates are 
given in Table 5-3 and were taken from EUCAST (2012).   
Table 5-3: E.coli CBP and ECOff values for selected antibiotics 
 Clinical breakpoint values (mg/L) Epidemiological cut off values (mg/L) 
 Resistant Sensitive Wild type 
Amoxicillin > 8 ≤ 8 ≤ 8 
Ciprofloxacin > 1 ≤ 0.5 ≤ 0.064 
Cefpodoxime > 1 ≤ 1 ≤ 2 
Values taken from EUCAST (2012) 
The CBP and ECOff values used to interpret the MIC values obtained for E.faecium isolates 
are given in Table 5-4 and were also taken from EUCAST (2012).  
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Table 5-4: E.faecium CBP and ECOff values for selected antibiotics 
 Clinical breakpoint values (mg/L) Epidemiological cut off values (mg/L) 
 Resistant Sensitive Wild type 
Amoxicillin > 8 mg/L ≤ 4 mg/L ND 
Ciprofloxacin > 4 mg/L ≤ 4 mg/L WT ≤ 4 mg/L 
Clarithromycin ND ND WT ≤ 4 mg/L 
Vancomycin > 4 mg/L ≤ 4 mg/L WT ≤ 4 mg/L 
All values taken from EUCAST (2012). ND – not determined. 
5.2.8 Reference control strains  
The reference control strains used were obtained in ampules from the National Collection of 
Type Cultures (NCTC), Public Health England, UK and from the National Collection of 
Industrial Food and Marine Bacteria (NCIMB) and in the form of Culti-loops® (Remel, 
Thermo Scientific, UK). The reference control strains used are outlined in Table 5-5 and were 
analysed in parallel with the isolated samples. The control strains recommended by the 
British Antimicrobial Susceptibility Committee (BSAC, 2011) for antibiotic susceptibility 
testing were used. For the performance of the antibiotic tests to be acceptable the 
minimum inhibitory concentration values (MICs) for control strains should be within one 
two-fold dilution (log2 ) of the expected MIC values (BSAC, 2011). 
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Table 5-5: Reference bacteria control strains used in the methods for detection, identification of bacteria and 
for antibiotic susceptibility testing. 
 
Reference 
strain 
Microorganism Test details 
Growth 
media 
reference 
strains 
NCTC 10416 Escherichia coli 
To ensure if  E.coli/coliform chromogenic agar 
facilitated the growth of E.coli 
To assess if pseudomonas agar and Slanetz and 
Bartley inhibited non-target bacteria (e.g. E.coli) 
NCTC 10662 
Pseudomonas 
aeruginosa 
To ensure pseudomonas agar facilitated the 
growth of Pseudomonas aeruginosa  
To assess if E.coli/coliform chromogenic agar 
inhibited non-target bacteria (e.g. Pseudomonas 
aeruginosa) 
NCTC 775 
Enterococcus 
faecalis 
To ensure Slanetz and Bartley selective growth 
media facilitated the growth of E.faecalis 
NCTC 6571 
Staphylococcus 
aureus 
To ensure mannitol salt agar facilitated the 
growth of Staphylococcus aureus 
NCTC 10416 Escherichia coli 
To assess if mannitol salt agar inhibited non-
target bacteria (e.g. E.coli) 
MALDI-TOF 
identification 
reference 
strains 
NCIMB 8023 
Leuconostoc 
mesenteroides 
To monitor the performance of using MALDI-TOF-
MS for the identification of enterococci species 
(and phenotypically similar bacteria) and E.coli 
NCIMB 700814 
Pediococcus 
pentosaeceus 
NCTC 35667 
Enterococcus 
faecium 
NCTC 775 
Enterococcus 
faecalis 
NCTC 12361 
Enterococcus 
casseliflavus 
NCTC 12368 
Enterococcus 
Hirae 
NCTC 12359 
Enterococcus 
gallinarum 
 NCTC 10416 Escherichia coli  
Antibiotic 
susceptibility 
testing 
NCTC 10416 Escherichia coli 
Amoxicillin, cefpodoxime and ciprofloxacin 
minimum inhibitory concentrations values (MICs) 
expected are 2.0, 0.25 and 0.015 mg/L 
respectively  
NCTC 6571 
Staphylococcus 
aureus 
Amoxicillin, ciprofloxacin and clarithromycin MICs 
expected are all 0.12 mg/L. The MIC expected for 
vancomycin is 0.5 mg/L (sensitive) 
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5.2.9 Repeated sub-culture of resistant isolates 
E.coli and E.faecium isolated from settled sewage, final treated effluent and surface waters 
both up- and down-stream of the final effluent discharge point identified as resistant (using 
methods given in section 5.2.7) were sub-cultured repeatedly and retested for antibiotic 
susceptibility to the same antibiotics. A selection of fresh overnight cultures from preserved 
stocks of resistant isolates (nutrient broth with 20 % glycerol and stored at -80 ° C) were 
sub-cultured onto nutrient agar on ten separate daily occasions (incubated overnight at 30 
°C). From the tenth sub-culture, colonies were selected for antibiotic susceptibility testing 
using the methods given in section 5.2.7. Isolates were considered to have maintained 
resistance if the MIC values determined following repeated sub-culture were within one 
two-fold dilution of the originally defined MIC. 
5.2.10 One and two proportions statistical analysis 
Using the clinical breakpoints and epidemiological cut off values, the proportions (%) of 
E.coli and E.faecium isolates at each sampling point (settled sewage, final treated effluent, 
up- and down-stream surface water from the treated effluent discharge point) resistant to 
selected antibiotics were estimated. The 1-proportion test was used to calculate the 95.0 % 
confidence interval for the estimated proportions of resistance.  The 2-proportions test 
(Fishers exact test) was used to compare the difference of the proportions of resistance 
between sampling points.  All statistical analysis was performed using Minitab software v. 
16. 
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5.3 Wastewater and surface water bacterial analysis 
5.3.1 Enumeration of indicator bacteria in wastewater and surface waters 
Microbiological analysis of the settled sewage samples indicated that the levels of 
heterotrophic bacteria were in the range 8.8 – 9.7 log10 CFU/100 mL compared to total 
coliforms, E.coli and enterococci which were present in the ranges 7.0 -7.2 log10 CFU/100 
mL, 6.7 -7.0 log10 CFU/100 mL and 5.9 – 6.7 log10 CFU/100 mL, respectively (Table 5-6). 
Typically E.coli are present in municipal sewage at concentrations 10 to 100 times higher 
than enterococci  (Sinton et al., 1993) as human faeces contain greater concentrations of 
E.coli (up to 109 per gram of faeces) compared to enterococci (up  to 106 per gram of faeces) 
(Environment Agency, 2002) and therefore the higher E.coli concentrations present in the 
settled sewage were expected.  
Staphylococci and pseudomonas were found to be in lower concentrations at approximately 
4 - 5 log10 CFU/100 mL. Heterotrophic bacteria, total coliforms, E.coli, enterococci, 
staphylococci and pseudomonads were present at lower concentrations in the final treated 
effluent. Activated sludge treatment had reduced the enumerated organisms by > 97 % 
corresponding to decreases in the enumerated organism concentrations in the range 1.8 – 
3.2 log10 CFU/mL (Table 5-7).  
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Table 5-6: a Enumeration of bacteria in wastewater effluents and surface waters. 
 Settled sewage Final effluent Up-stream Down-stream 
 Mean ± standard deviation Log10  CFU/100 mL 
Heterotrophic 
bacteria 
9.4 ± 0.4 
(8.8 – 9.7) 
7.5± 0.7 
(6.8 – 8.1) 
6.5 ± 0.6 
(6.2 – 6.8) 
7.4 ± 0.20 
(7.1 – 7.3) 
Total coliforms 7.1 ± 0.1 
(7.0 – 7.2) 
4.8 ± 0.7 
(4.6 – 4.9) 
3.8 ± 0.1 
(3.6 – 4.00) 
5.0 ± 0.5 
(4.3 -5.2) 
E.coli 
 
6.8 ± 0.2 
(6.7 – 7.0) 
4.4 ± 0.4 
(4.4 – 4.9) 
2.9 ± 0.2 
(2.7 – 3.1) 
4.4 ± 0.6 
( 3.6 – 5.1) 
enterococci 
 
6.2 ± 0.2 
(5.9 – 6.7) 
3.0 ± 0.2 
(2.9 – 3.1) 
1.9 ± 0.1 
(1.8 – 2.0) 
2.9 ± 0.2 
(2.5 – 3.2) 
staphylococci 4.7± 0.2 
(4.5 – 4.9) 
2.6 ± 0.1 
(2.5 – 2.6) 
1.7 ± 0.3 
(1.3 – 1.7) 
2.5 ± 0.5 
(1.4 -2.9) 
pseudomonas 4.8± 0.3 
(3.9 – 5.0) 
2.5 ± 0.3 
(1.8 – 2.7) 
1.4 ± 0.2 
(< lod -1.6) 
2.1 ± 0.6 
(1.0 -2.3) 
a enumerations corrected using confirmation test results. Mean value of five sampling occasions. The 
concentration range is given in the parenthesis. 
Typically, of the order of one log10 unit higher concentrations of total heterotrophic 
bacteria, total coliforms, E.coli, enterococci, staphylococci and pseudomonas were detected 
in the surface waters down-stream of the wastewater treatment plant discharge point 
compared to the up-stream point. The concentration of the enumerated bacteria in the final 
treated effluent was similar (2-Sampled T test; P > 0.05) to those detected in the surface 
waters down-stream of the treated effluent discharge point.  
Table 5-7: Reduction of indicator bacteria during activated sludge treatment  
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Mean % reduction ±  
standard deviation 
Mean Log10 reduction ± 
standard deviation 
Total heterotrophic bacteria 97.8 ± 1.5 1.8 ± 0.4 
Total coliforms 99.4 ± 0.2 2.3 ± 0.2 
E.coli 99.5 ± 0.2 2.4 ± 0.3 
enterococci 99.9 ± 0.1 3.2 ± 0.3 
staphylococcus 99.2 ± 0.4 2.1 ± 0.2 
Pseudomonas 99.4 ± 0.2 2.2 ± 0.2 
Mean reduction calculated from the mean bacterial concentrations observed in settled sewage and final 
treated effluent from five sampling occasions. % reduction = [settled sewage] – [final treated effluent] / 
[settled sewage] x 100. 
5.3.2 Evaluation of detection and enumeration growth media to detect indicator 
bacteria in wastewater and surface water 
5.3.2.1 Escherichia coli and total coliforms  
The importance of coliform bacteria and E.coli as indicators of water quality is described in 
Chapter 3, Section 3.1.1. To assess the effectiveness of using chromogenic agar, based on β-
galactosidase and β- glucuronidase enzymatic activity, for the selective and differential 
detection of coliforms and E.coli in wastewater and surface water, fifty purple colonies 
(presumptive E.coli) and thirty pink colonies (presumptive coliforms other than E.coli) were 
isolated and identified using a commercial biochemical identification kit (API 20E) in 
addition to the biochemical confirmation tests (indole and oxidase). The results are given in 
Table 5-8. MALDI-TOF-MS analysis was not available for this part of the study. 
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Table 5-8: a Phenotypic identification (Biochemical kits) to species level of presumptive E.coli and coliform 
bacteria isolated from wastewaters and surface waters grown on E.coli/coliform chromogenic agar. 
Species 
No. of presumptive E.coli 
(% of total presumptive 
E.coli) 
No. of presumptive coliforms 
(% of total presumptive 
coliforms) 
 IND+ IND- OX- OX+ 
     
Escherichia coli 44 (88.0)  d 2 (6.7)  
Serratia odorifera   3 (10.0)  
Enterobacter cloacae   5 (16.7)  
Klebsiella pneumoniae   3 (10.0)  
Klebsiella oxytoca   2 (6.7)  
Citrobacter freundii  1 (2.0) 2 (6.7)  
Raoultella orninthinolytica 1 (2.0)    
Pantoea spp 1 (2.0)    
Aeromonas spp    7 (23.3) 
Unidentified 2 (4.0) 1 (2.0) 2 (6.7) 4 (13.3) 
     
Total 48 (96.0) 2 (4.0) 19 (63.3) 11 (36.7) 
Total b 50  c30 
a MALDI-TOF-MS was not available at this point of the study to identify presumptive bacteria, b total 
presumptive E.coli, c total presumptive coliforms, d Indole positive 
Forty eight presumptive E.coli isolates (96.0% of total) produced indole from tryptophan at 
44 °C (IND+) which is characteristic of E.coli. Three presumptive E.coli isolates could not be 
identified to species or even genus level using the commercial biochemical kit. Two (4.0%) 
of the unidentified isolates produced indole from tryptophan at 44 °C (IND+) and one isolate 
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(2.0%) did not (IND-). Three presumptive E.coli isolates were identified as Enterobacteria 
(including Citrobacter freundii) other than E.coli. E.coli false positive results caused by 
Citrobacter species were also found in a similar study by Alonso et al. (1996). From a total of 
forty eight presumptive E.coli colonies that produced indole from tryptophan at 44 °C 
(IND+), forty four isolates were successfully identified as E.coli. Therefore an E.coli 
confirmation rate of 91.6% was achieved when using this chromogenic agar in combination 
with testing for indole production at 44 °C. Thus, the use of the chromogenic agar in 
combination with indole confirmation was considered suitable to detect and enumerate 
E.coli from environmental waters.  
From the thirty presumptive coliform isolates tested, nineteen were oxidase negative (do 
not produce cytochrome oxidases) and eleven pink isolates produced a positive oxidase 
reaction (OX+) not characteristic of the coliform group. Seventeen oxidase negative (OX-) 
isolates were identified as Serratia odorifera (10.0%), Enterobacter cloacae (16.7%), 
Citrobacter freundii (6.7%), Klebsiella oxytoca (6.7%) and Klebsiella pneumoniae (10.0%) and 
two isolates were identified as Escherichia coli giving a E.coli false negative rate of 6.7%. 
Olson et al. (1991) reported that E.coli false negatives can occur due to cell injury, cell 
impermeability or inability of the cell to metabolise the chromogenic substrate and lack of 
gene expression. However, these two E.coli isolates did produce indole at 44 °C (IND+). 
Therefore, from a total of seventeen OX-, IND- negative isolates, fifteen could be successfully 
identified as bacteria belonging to the coliform group giving a coliform confirmation rate of 
88.2%.  
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To be able to study the impact of wastewater on receiving surface waters, bacteria of faecal 
origin were desirable. E.coli bacteria are predominantly of faecal origin (Environment 
Agency, 2000) and were easily detected (91.6 % confirmed) using this chromogenic agar. In 
addition, the concentrations of E.coli detected in the settled sewage, treated effluent and 
surface waters (See Section Table 5-6) were high enough to investigate the proportions of 
antibiotic resistance within this species. Therefore, E.coli bacteria were selected for 
subsequent antibiotic susceptibility testing. Conversely, coliform bacteria were not selected 
for subsequent antibiotic resistance testing despite the high concentrations detected in the 
water samples. This is because of the diversity of bacterial species within the coliform group 
taken from the water samples in which some species are not necessarily of faecal origin (e.g. 
Citrobacter freundii). In addition, antibiotic resistance may be more predominant in some 
species of the coliform group than others. Therefore coliforms as a group were not selected 
to investigate the transfer of resistance from wastewaters to surface waters. 
5.3.2.2 Staphylococcus  
To evaluate the use of mannitol salt agar to detect Staphylococcus including Staphylococcus 
aureus isolated from environmental waters, eighty eight colonies were sub-cultured for 
confirmation tests (Gram staining and catalase) and identified using a commercial 
biochemical kit (API Staph®). It was difficult to differentiate between presumptive cream 
coloured Staphylococcus aureus colonies and staphylococci pink coloured colonies 
particularly with higher bacterial counts. This was due to the fermentation of the mannitol 
masking the colour of the pink colonies and therefore this media could not be used for the 
151 
 
 
 
differentiation of Staphylococcus aureus from other staphylococci species in environmental 
waters.  
All eighty eight colonies confirmed as Gram positive, however 26 presumptive staphylococci 
isolates confirmed as catalase negative and therefore are not characteristic of the 
staphylococci. These isolates were not tested any further. A total of 16 (25.8 %) of the 
confirmed (Gram stain and catalase) staphylococci isolates could not be identified using the 
commercial biochemical kit and 22 isolates (35.5 %) could only be identified to genus levels 
(all staphylococci), leaving 24 isolates (38.7 %) that could be identified to species level (Table 
5-9).  
The different staphylococci species identified are given in Table 5-9. The diversity of the 
species was expected as they are ubiquitous bacteria reported as part of the normal 
microbiota  associated with air, soil, water, humans and other animals (Faria et al., 2009;  
Zadoks et al., 2009;  Resch et al., 2011). However, due to the difficulty in differentiating 
Staphylococcus aureus using mannitol salt agar membrane filtration and the difficulty in 
identifying staphylococci species from environmental waters using API Staph®, monitoring 
the antibiotic resistance profiles of staphylococci species was not carried out. 
Table 5-9: Identification of presumptive staphylococci species isolated from environmental waters using API 
Staph®. 
Identification 
Gram and catalase positive 
cream colonies 
Gram positive and catalase 
negative 
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Staphylococcus cohnii 2 (3.2 %)  
Staphylococcus sciuri 16 (25.8 %)  
Staphylococcus 
saprophyticus 
2 (3.2 %)  
Staphylococcus aureus 2 (3.2 %)  
Staphylococcus xylosus 2 (3.2 %)  
Identified to genus only 22 (35.5 %)  
Unidentified 16 (25.8 %) 26 
Total a62 b26 
The % of total Gram and catalase positive presumptive Staphylococcus aureus colonies are given in the 
parenthesis. a of the total 88 colonies, 62 confirmed as staphylococci. b 28 colonies not characteristic of 
staphylococci genera. 
5.3.2.3 Pseudomonas   
In total eighty six presumptive pseudomonas isolates (twenty nine red/brown, thirty four 
blue/green and twenty three cream coloured colonies) were sub-cultured for further 
confirmation (oxidase) and phenotypic identification tests (API NE®). From surface waters 
up-stream of the treated effluent discharge point, typically only cream coloured colonies 
grew on the membrane filters regardless of the range of sample dilutions. Five cream 
coloured colonies (5.8 % of total isolated) were not oxidase positive and therefore were not 
further identified. It has been reported that pseudomonas agar base can support the growth 
of Acinetobacter species which are typically found in the environment and are oxidase 
negative (Casanovas-Massana, 2006). All red/brown and blue/green colonies were oxidase 
positive and therefore tested using the commercial biochemical kit (Table 5-10).  
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Table 5-10: Identification of presumptive pseudomonas isolated from environmental waters using API 20 NE® 
 
Red/brown 
colonies 
Cream coloured 
colonies 
Blue/green 
colonies 
Pseudomonas 
aeruginosa 
  15 (17.4) 
a pseudomonas 11  (12.8) 13 (15.1) 9 (10.4) 
Unidentified 18 (20.9) 5 (5.8) 10 (11.6) 
Oxidase –ve (not identified)  5 (5.8)  
Total 86 
a identified to genus level only. All oxidase positive unless stated. -ve = negative. The % of total isolates is given 
in the parenthesis.  
Only 15 (17.4 %) of the isolates (all from blue/green coloured colonies) could be identified 
to species level and all were identified as Pseudomonas aeruginosa.  Thirty three isolates 
could be identified to genus levels, all belonging to the pseudomonas genera. However, 
thirty three isolates could not be identified using the commercial biochemical identification 
system. The difficulty in identifying the presumptive pseudomonas isolates to species level, 
emphasises that phenotypic identification is challenging and thus in this study it also makes 
it difficult to assess the use of pseudomonas agar (with supplement) for the selective 
isolation of Pseudomonas aeruginosa from environmental waters. Therefore antibiotic 
resistance profiles of Pseudomonas aeruginosa in environmental waters were not 
monitored further in this work. 
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5.3.2.4 Enterococci  
Enterococci include a number of different species that occur in the faeces of humans and 
warm-blooded animals and can therefore provide an indication of such pollution. In 
addition, high numbers of enterococci were detected in the collected water samples (see 
Section 5.3.1) and therefore enterococci were considered as ideal representative organisms 
to study the transfer of antibiotic resistant bacteria from wastewater to surface waters.  
Although enterococci are easily isolated on Slanetz and Bartley media, the distinction 
between the different species is difficult as they produce colonies of similar appearance. 
Therefore additional tests were required to identify presumptive enterococci to species 
level. There are different methods available to identify bacteria to species level including 
biochemical methods and mass spectrometry (Chapter 3, section 3.2.3). In this study the API 
20 Strep biochemical profile system was initially used to identify presumptive enterococci 
isolates (n = 61) from waste and surface waters to species levels (Table 5-11). The same 
isolates were then identified using matrix assisted laser desorption ionisation time of flight 
mass spectrometry analysis (MALDI-TOF-MS) when the instrument became available. 
Only 30 presumptive enterococci isolates (49.2 %) could be identified to species level using 
the commercial kit, whilst the identification to species level of all 61 isolates was achieved 
using MALDI-TOF-MS analysis.  When comparing the results from phenotypic identification 
to MALDI-TOF-MS identification, five discordant identifications occurred. However, atypical 
enterococci strains can be misidentified as Lactococcus species using biochemical systems 
(Facklam et al., 1989) and  species such as E.hirae are difficult to identify phenotypically due 
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to the variation of sugar fermentation profiles observed within the species (Arias et al., 
2006). 
Table 5-11: Identification of presumptive enterococci isolates using API 20 Strep biochemical system and 
MALDI-TOF-MS analysis 
 a No. of presumptive enterococci isolates 
Enterococci spp Identified with 
MALDI-TOF 
Identification 
with API 20 
Strep 
Discordant 
identification 
Not 
identified 
with API 20 
Strep 
Enterococcus faecium 40 (65.6 %) 22 b5 13 
Enterococcus faecalis 4 4 0 0 
Enterococcus duran 3 1 0 2 
Enterococcus  hirae 5 0 c2 3 
Enterococcus mundtii 1 0 0 1 
Aerococcus virridan 3 3 0 0 
Escherichia coli 5 0 0 5 (8.2 %) 
Total 61 30 (49.2) 7 (11.5) 24 (39.3) 
a Maroon colonies isolated from Slanetz and Bartley media using the membrane filtration method given in 
Section 5.2.4. Using the biochemical system, isolates identified but not consistent with MALDI-TOF 
identification were b Lactococcus lactis and c Enterococcus faecium. The % of total isolates is given in the 
parentheses.  
The biochemical tests included in the phenotypic system do not include tests to identify 
Gram negative bacteria and this therefore explains why five isolates (8.2 %) could not be 
identified using this test kit. It was decided that identification of presumptive enterococci 
isolates using the commercial systems was not sufficiently reliable for this study. 
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Conversely, for routine isolates, MALDI-TOF-MS analysis has shown overall correct 
identification levels often greater than 99 % (Bizzini et al., 2011;  Eigner et al., 2009;  
Cherkaoui et al., 2010) when compared to 16S rRNA Gene Sequencing for Identification 
(considered as the ‘gold standard’ method for identification) and therefore selected for this 
work. 
A total of 262 presumptive enterococci isolates taken from wastewater and surface water 
were sub-cultured onto E.faecium chromogenic agar to assess if the media could 
differentiate E.faecium from the other species of enterococci. 112 of presumptive E.faecium 
isolates producing green colonies were identified as E.faecium (73.2 %). However, 41 (26.8 
%) of the isolates producing green colonies were identified as enterococci species other 
than E.faecium giving a false positive rate of 26.8 % (Table 5-12).  
30 of the isolates producing blue colonies (presumptive other enterococci species) were 
identified as E.faecium giving a false negative rate of 27.5 %. Ford et al. (1994) reported that 
E. mundtii, E.gallinarum and E.casseliflavus can ferment arabinose and therefore can be 
misidentified as E.faecium using cephalextin arabinose agar. Due to the high false positive 
and negative rate using this media that may lead to misidentification of presumptive 
enterococci species to species level, this chromogenic agar was not used as a confirmation 
test for subsequent work in this study. Therefore, for subsequent work in this chapter, the 
identification of presumptive enterococci (grown on Slanetz and Bartley media) to species 
level was performed using MALDI-TOF-MS analysis. 
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Table 5-12: Assessment of a chromogenic media to differentiate Enterococcus faecium from other enterococci 
species.  
 a No. of isolates 
d Identification 
Green colonies 
(presumptive E.faecium) 
Blue colonies 
(presumptive enterococci) 
Enterococcus faecium 112 (73.2) 30 (27.5) 
Enterococcus faecalis 11 (7.2) 36 (33.0) 
Enterococcus casseliflavus 2 (1.3) 1 (0.9) 
Enterococcus gallinarum 2 (1.3) 0 
Enterococcus hirae 4 (2.6) 29 (26.6) 
Enterococcus mundtii 1 (0.7) 1 (0.9) 
Enterococcus durans 1 (0.7) 1 (0.9) 
Enterococcus avium 0 1 (0.9) 
Escherichia coli 20 (13.1) 5 (4.6) 
Aerococcus virrdan 0 3 (2.8) 
Streptococcus equinus 0 1 (0.9) 
Total b153 c109 
Total false positives 41 (26.8)  
Total false negatives  30 (27.5) 
a originally detected on Slanetz and Bartley media using membrane filtration. b Total number of green colonies. 
c Total number of blue colonies. d identification carried out with MALDI-TOF-MS. The % of total isolates given in 
parentheses.  
5.3.2.5 Distribution of enterococci species in wastewater and surface waters 
The distribution of the enterococci species identified in the environmental waters sampled 
for this study are shown in Figure 5-4.  By far the most abundant species identified in the 
settled sewage, final treated effluent and surface water down-stream of the treated effluent 
discharge point was E.faecium, followed by E.faecalis and then E.hirae. Therefore E.faecium 
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was selected as a representative species to study the transfer of antibiotic resistance from 
wastewater to surface water. 
 
Figure 5-4: The distribution (%) of enterococci species in settled sewage (Settled), final treated effluent (Final), 
surface water up-stream (Up) and down-stream (Down) of the wastewater treatment plant discharge point. 
The number of isolates in each species group is given above each bar. 
The other species detected included, E. durans, E. avium, E. muntdii, E.gallinarum and 
E.casseliflavus. Significantly lower proportions (2-proportions test; P < 0.001) of E.faecium 
were identified in the surface water up-stream of the treated effluent discharge point 
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compared to the other sampling points (Table 5-13). Elevated levels (2-proportions test; P < 
0.001) of E.hirae were detected in the surface water up-stream of the final effluent 
discharge point compared to the levels at other sampling points. 
Table 5-13: The proportion (%) of the most prevalent of enterococci species identified in the 
environmental waters sampled for this study.  
 E.faecium (%) E.faecalis (%) E.hirae (%) 
Settled sewage 73.1 (60.9 – 83.2) 17.9 (9.6 – 29.2) 6.0 (1.7 – 14.6) 
Final effluent 74.6 (61.6 – 85.0) 20.3 (11.0 – 32.8) 5.1 (1.1 – 14.1) 
Down-stream 78.6 (64.7 – 88.7) 11.8 (4.4 – 23.9) 7.8 (2.2 -18.9) 
Up-stream a38.5 (28.4 – 49.2) 22.0 (14.0 – 31.9) b31.8 (22.5 - 42.5) 
1-proportion 95 % confidence intervals are given in the parenthesis. a 2-proportions test of the proportion of 
E.faecium between samples; p < 0.001. b 2-proportions test between E.hirae proportions; P < 0.001). 
5.3.3 Antibiotic resistance in Escherichia coli from environmental waters 
5.3.3.1 Escherichia coli MIC determination 
Amoxicillin and ciprofloxacin minimum inhibitory concentrations for 229 E.coli isolates 
recovered from the settled sewage (n = 60), final treated effluent (n = 56) and surface 
waters both up-(n = 59) and down-stream (n = 54) relative to the treated effluent discharge 
point were measured and are presented in Table 5-14. In addition, cefpodoxime minimum 
inhibitory concentrations were measured for a total of 187 E.coli isolates, which were 
similarly distributed between the four sampling sites, and are also presented in Table 5-14.  
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Table 5-14: Amoxicillin, cefpodoxime and ciprofloxacin minimum inhibitory concentration values (mg/L) for 
E.coli isolated from wastewaters and surface waters 
Antibiotic Sample point MIC range (mg/L) MIC50 (mg/L) MIC90 (mg/L) 
Amoxicillin 
Settled sewage (n = 60) 2-256 4 256 
Final effluent (n = 56) 2-256 4 256 
Up-stream (n = 59) 1-256 4 8 
Down-stream (n = 54) 1-256 4 256 
Ciprofloxacin 
Settled sewage (n = 60) 0.002-32 0.012 0.190 
Final effluent (n = 56) 0.002-32 0.008 0.125 
Up-stream (n = 59) 0.002- 0.03 0.008 0.016 
Down-stream (n = 54) 0.002-4 0.008 0.064 
Cefpodoxime 
Settled sewage (n = 60) 0.19–24 0.5 0.75 
Final effluent (n = 56) 0.19- 256 0.5 1 
Up-stream (n = 59) 0.006-1 0.5 1 
Down-stream (n = 54) 0.125-2 0.38 1 
MIC50 is equivalent to the concentration of antibiotic that inhibits 50% of E.coli; MIC90 is equivalent to the 
concentration of antibiotic that inhibits 90% of E.coli.  
The MIC values measured span the concentrations that define sensitive (according to clinical 
breakpoints) and wild type strains (according to epidemiological cut off values) up to 
concentrations greater than those used to define resistant and non-wild type strains. The 
concentrations of amoxicillin (4 mg/L), ciprofloxacin (0.008 – 0.012 mg/L) and cefpodoxime 
(0.38 – 0.50 mg/L) that inhibited 50 % of the E.coli isolates (MIC50) were similar and within 
one two-fold dilution for all sampling points.  
The concentrations of cefpodoxime that inhibited 90 % of the E.coli isolates in the settled 
sewage, final treated effluent and surface waters both up- and down-stream from the 
effluent discharge point were similar (0.75 – 1 mg/L) and within one two-fold dilution for all 
sampling points. However, the concentrations of amoxicillin and ciprofloxacin that inhibited 
90 % of E.coli (MIC90) were lower for isolates taken from the surface water up-stream of the 
treated effluent discharge point compared to down-stream.  This is possibly indicating an 
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impact of the discharged wastewater treated effluent on the prevalence of amoxicillin and 
ciprofloxacin resistant E.coli within surface waters down-stream from the discharge point. 
No significant differences in amoxicillin, ciprofloxacin or cefpodoxime MIC values amongst 
sampling points were found by applying a Mann-Whitney analysis (P > 0.05). 
5.3.3.2 Distribution of antibiotic minimum inhibitory concentration values determined for 
E.coli taken from wastewater and receiving surface water 
The distributions of the amoxicillin MIC values measured for E.coli isolates taken from 
settled sewage, final treated effluent and surface waters both up- and down-stream of the 
final effluent discharge point are presented in Figure 5-5 and show that amoxicillin resistant 
E.coli, according to both the resistant CBP value (R > 8 mg/L) and ECOff value (WT ≤ 8 mg/L) 
(Table 5-3) were present at each sampling point. 
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Figure 5-5: Distributions of the amoxicillin MIC values measured for E.coli isolated from settled sewage, final 
effluent and surface waters up- and down-stream of the effluent discharge point. The red dashed line 
represents the clinical resistance breakpoint value (R > 8 mg/L) and the green arrow represents the 
epidemiological cut-off value (WT ≤ 8 mg/L). The blue bars represent wild type E.coli (wild type) and the red 
bars represent non-wild type E.coli (acquired resistance). 
The distributions of ciprofloxacin MIC values measured for E.coli isolated from all sampling 
points are presented in Figure 5-6. E.coli with acquired ciprofloxacin resistance (wild type ≤ 
0.064 mg/L) and considered resistant according to CBP values (R > 1 mg/L) were identified in 
the settled sewage, final treated effluent and surface water down-stream from the final 
effluent discharge point. No ciprofloxacin resistant or non-wild type E.coli isolates were 
detected in surface waters up-stream of the final treated effluent discharge point.  
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Figure 5-6: Distributions of ciprofloxacin MIC values measured for E.coli isolated from settled sewage, final 
effluent and surface waters up- and down-stream of the effluent discharge point. The red dashed line 
represents the clinical resistance breakpoint value (R > 1 mg/L) and the green arrow represents the 
epidemiological cut-off value (WT ≤ 0.064 mg/L). The blue bars represent wild type E.coli (wild type) and the 
red bars represent non-wild type E.coli (acquired resistance). 
The distributions cefpodoxime MIC values measured for the E.coli strains isolated from all 
sampling points are shown in Figure 5-7.  Cefpodoxime resistant strains (according to the 
CBP value; R > 1 mg/L) were present in settled sewage, final treated effluent and surface 
waters down-stream of the urban wastewater treatment plant discharge point. E.coli 
isolates with cefpodoxime acquired resistance (WT ≤ 2 mg/L) were only detected in the 
settled sewage and final treated effluent. Only cefpodoxime sensitive E.coli strains without 
acquired or mutational resistance were isolated from the surface water up-stream of the 
treated effluent discharge point. 
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Figure 5-7: Distributions of cefpodoxime MIC values measured for E.coli isolated from settled sewage, final 
effluent and surface waters up- and down-stream of the effluent discharge point. The red dashed line 
represents the clinical resistance breakpoint value (R > 1 mg/L) and the green arrow represents the 
epidemiological cut-off value (WT ≤ 2 mg/L). The blue bars represent wild type E.coli (wild type) and the red 
bars represent non-wild type E.coli (acquired resistance). 
5.3.3.3 The proportion of E.coli resistant to antibiotics in wastewaters and receiving 
surface water 
Overall, a high prevalence of E.coli taken from waste and surface waters, which were 
resistant to amoxicillin (20.1 %), was found (Table 5-15).  Only 1.8 % of the all the E.coli 
isolated were identified as ciprofloxacin resistant (according to CBP values). However, when 
interpreting the ciprofloxacin minimum inhibitory concentrations according to the ECOff 
value, 9.2 % of the total E.coli isolates were identified as non-wild type strains with acquired 
ciprofloxacin resistance. Conversely, 4.3 % of E.coli taken from all samples was found to be 
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resistant to cefpodoxime (according to CBP values) however, only 1.6 % of E.coli was 
identified as non-wild type according to the cefpodoxime ECOffs value (Table 5-15). 
Table 5-15: The proportion (%) of E.coli isolates from four different water samples which were resistant 
(according to ECOffs and CBP values) to amoxicillin, ciprofloxacin and cefpodoxime. 
 % E.coli 
 
d Settled  
sewage  
d Final treated 
effluent 
d Down- 
stream 
d Up- 
stream 
b % of total 
isolates 
a Amoxicillin 
ECOff 
25.0 
(14.7 – 37.9) 
23.2 
( 13.0 – 36.4) 
29.6 
(18.0 – 43.6) 
3.4 
(0.4 -11.7) 
20.1 
(15.1 - 25.9) 
CBP 
25.0 
(14.7 – 37.9) 
23.2 
( 13.0 – 36.4) 
29.6 
(18.0 – 43.6) 
3.4 
(0.4 – 11.7) 
20.1 
(15.1 - 25.9) 
Ciprofloxacin 
ECOff 
16.7 
(8.3 – 28.5) 
10.7 
(4.0 – 21.9) 
9.3 
(3.1 – 20.3) 
ND 
9.2 
(5.8 -13.7) 
CBP 
3.3 
(0.4 – 11.5) 
1.8 
(0.04 – 9.5) 
1.9 
(0.1 – 9.9) 
ND 
1.8 
(0.5 – 4.4) 
Cefpodoxime 
ECOff 
1.9 
(0.1 – 10.0) 
5.4 
(0.6 – 18.2) 
ND ND 
1.6 
(0.3 – 4.6) 
CBP 
3.7 
(0.5 – 12.8) 
8.1 
(1.7 – 21.9) 
6.7 
(1.4 – 18.3) 
ND 
4.3 
(1.9 – 8.3) 
c Multi antibiotics 
ECOff 
10.0 
 (3.8 – 20.5) 
5.4 
(1.1 – 14.9) 
5.6 
(1.2 – 15.4) 
None 5.2 
(2.7 – 9.0) 
CBP 
3.3 
(0.4 – 11.5) 
3.6 
(0.4 – 12.3) 
5.6 
(1.2 – 15.4) 
None 3.1 
(1.2 – 6.2) 
1 - proportion 95 % confidence intervals (Fisher’s exact test) are given in the parentheses. ND = none detected. 
a significantly different proportions (2-proportions test; P < 0.05) amongst sampling points. b % of total isolates 
from all sample points (i.e settled sewage, treated effluent, and surface water up- and down-stream of treated 
effluent discharge point). In total from all sample points, 229 isolates were tested for amoxicillin and 
ciprofloxacin susceptibility. A total of 187 isolates from settled sewage, treated effluent and surface water 
were tested for susceptibility to cefpodoxime. c Multi antibiotics = % isolates with acquired resistance 
(according to ECOff values) or resistant (according to CBP values) to more than one of the antibiotics tested.  d 
The number of isolates tested for amoxicillin and ciprofloxacin susceptibility in settled sewage, treated effluent 
and surface water both up- and down-stream was 60, 56, 54 and 59 respectively. However for cefpodoxime 
the number of isolates tested were 54, 37, 51 and 45 respectively. 
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Overall, the levels of resistance to amoxicillin, ciprofloxacin and clarithromycin (according to 
ECOff values) were similar (2-proportions test; P > 0.05) in the settled sewage, final treated 
effluent and surface water down-stream from the effluent discharge point. However, in the 
surface water up-stream from the effluent discharge point, lower levels of resistant E.coli 
were found (Table 5-15). When interpreting the measured cefpodoxime MIC values for 
E.coli according to clinical breakpoint values the levels of resistance were similar in the 
settled sewage, final treated effluent and surface water down-stream from the effluent 
discharge point. However, when using the cefpodoxime ECOff value, E.coli with acquired 
resistance to cefpodoxime were only detected in the settled sewage and final treated 
effluent. Only cefpodoxime wild type and sensitive E.coli strains were detected in the 
surface water up-stream from the effluent discharge point. 
The proportion of E.coli isolates with acquired resistance (using ECOff values) or resistance 
(using CBP values) to more than one of the antibiotics tested were similar (2-proportions 
test; P > 0.05) in the settled sewage, final treated effluent and surface water down-stream 
from the effluent discharge point. However, lower proportions were observed when using 
the clinical breakpoint values compared to the epidemiological cut off values. No E.coli 
isolates with multi resistance (using ECOffs or CBP values) were identified in the surface 
water up-stream from the WWTP effluent discharge point.  
5.3.3.4 Maintenance of resistance in E.coli 
The proportion of E.coli isolates resistant to amoxicillin, ciprofloxacin and cefpodoxime 
(according to ECOff and CBP values) that maintained their resistance following ten repeated 
sub-cultures on antibiotic free nutrient agar are presented in Table 5-16.  
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Table 5-16: Proportion of resistant E.coli isolates (according to ECOff values and CBP values) maintaining 
resistance, following repeated sub-culture. 
 % maintained resistance 
Resistance to Settled sewage Final treated effluent Down-stream Up-stream 
a Amoxicillin  93.3 (15) 85.7 (14) 83.3 (12) 100.0 (2) 
Ciprofloxacin 
(using ECOffs) 
83.3 (6) 83.3 (6) 57.1 (7) ND 
 (using CBPs) 100.0 (2) 100.0 (1) 100.0 (1) ND 
Cefpodoxime 
(using ECOffs) 
100.0 (1) 100.0 (1) ND 
ND 
 (using CBPs) 100.0 (2) 100.0 (3) 100.0 (3) ND 
a ECOff and resistant CBP values are identical for amoxicillin (8 mg/L). Total number of isolates tested after five 
passages are given in the parentheses. ND – not resistant isolates initially detected.  
A high proportion (83.3 -100.0 %) of E.coli isolated from settled sewage, final treated 
effluent and surface waters both up- and down-stream from the final effluent discharge 
point, initially identified as resistant to amoxicillin (according to both ECOff and CBP values) 
maintained their resistance. Similarly, all four E.coli isolates (100.0 %) identified as resistant 
to ciprofloxacin using resistant CBP values (R > 1 mg/L) retained their resistance. 
A higher proportion (83.3 %) of E.coli isolated from settled sewage and final treated effluent 
classified with acquired ciprofloxacin resistance (using ECOff values) maintained their 
resistance compared with the proportion of E.coli isolated from surface water down-stream 
of the discharge point that maintained their resistance (57.1 %). However, there is not 
enough evidence (2-proportion test; P > 0.05) to suggest that the proportion of E.coli 
isolates that have maintained their resistance are statistically different. All E.coli isolates 
initially identified as resistant to cefpodoxime (using CBP and ECOff values) maintained their 
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resistance level. In the surface water sample collected up-stream of the effluent discharge 
point, no ciprofloxacin or cefpodoxime resistant strains were detected and hence no sub-
culture experiments performed. 
5.3.4 Antibiotic resistance in E.faecium from environmental waters 
5.3.4.1 E.faecium MIC determination 
The amoxicillin, ciprofloxacin and clarithromycin minimum inhibitory concentrations (MICs) 
measured for E.faecium isolated from settled sewage (n = 32), final treated effluent (n =38) 
and surface waters both up- (n = 35) and down-stream (n = 23) of the final effluent 
discharge point are presented in Table 5-17. Additionally, vancomycin MIC values were 
measured for 32 (settled sewage), 34 (final effluent), 19 (up-stream) and 25 (down-stream) 
isolates of E.faecium from the same samples.  
The amoxicillin, ciprofloxacin and clarithromycin MIC values measured span the 
concentrations that define sensitive (according to clinical breakpoint values) and wild type 
strains (according to epidemiological cut of values) up to concentrations greater than those 
used to define resistant and non-wild type strains. The vancomycin MIC values measured for 
E.faecium indicate all isolates tested in this study were vancomycin sensitive and wild type.   
The concentrations of amoxicillin (0.38 - 0.5 mg/L), ciprofloxacin (2 - 4 mg/L), clarithromycin 
(2 - 6) and vancomycin (1 - 2 mg/L) that inhibited 50 % of the E.faecium isolates (MIC50) 
tested were similar (within a two-fold dilution) for all sampling points (Table 5-18). 
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Table 5-17: Amoxicillin, ciprofloxacin, clarithromycin and vancomycin minimum inhibitory concentrations 
(mg/L) for E.faecium isolated from wastewaters and surface waters 
Antibiotic Sample point MIC range (mg/L) 
MIC50 
(mg/L) 
MIC90 
(mg/L) 
Amoxicillin 
Settled sewage (n = 32) 0.064-256 0.38 64 
Final effluent (n = 38) 0.032-256 0.5 12 
Up-stream (n = 23) 0.094-4 0.38 0.75 
Down-stream (n = 35) 0.064-32 0.38 1.0 
Ciprofloxacin Settled sewage (n = 32) 0.19-32 2 8 
 Final effluent (n = 39) 0.25-32 2 32 
 Up-stream (n = 23) 0.38-32 4 32 
 Down-stream (n = 35) 0.25-32 2 8 
Clarithromycin Settled sewage (n = 32) 0.19-64 6 12 
 Final effluent (n = 39) 0.25-256 4 256 
 Up-stream (n = 23) 0.25-256 2 12 
 Down-stream (n = 35) 0.25-24 6 12 
Vancomycin Settled sewage (n = 32) 0.38-4 2 3 
 Final effluent (n = 34) 0.19-4 1 2 
 Up-stream (n = 19) 0.5-4 1 2 
 Down-stream (n = 25) 0.38-4 1 3 
MIC50 is equivalent to the concentration of antibiotic that inhibits 50% of E.faecium; MIC90 is equivalent to the 
concentration of antibiotic that inhibits 90% of E.faecium.  
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The concentration of amoxicillin (0.75 – 1 mg/L) that inhibited 90 % of the E .faecium tested 
(MIC90) was lower for surface waters up- and down-stream of the treated effluent discharge 
point compared to the settled sewage (64 mg/L) and final treated effluent (12 mg/L) 
although statistically not significantly different (Mann-Whitney; P > 0.05). The 
concentrations of ciprofloxacin (8 - 32 mg/L), clarithromycin (12 – 256 mg/L) and 
vancomycin that inhibited 90 % of E.faecium isolates were above the clinical breakpoint 
values given in Table 5-4, for all sample points. 
5.3.4.2 Distribution of the antibiotic minimum inhibitory concentration values 
determined for E.faecium taken from wastewater and receiving surface water 
The distribution of amoxicillin MIC values measured for E.faecium isolates in settled sewage, 
final treated effluent and surface waters both up- and down-stream of the final effluent 
discharge point are presented in Figure 5-8. It can be seen that E.faecium resistant to 
amoxicillin according to the clinical breakpoint value (R > 8 mg/L) were present at each 
sampling point apart from the surface waters up-stream of the effluent discharge point.  
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Figure 5-8: Distribution of amoxicillin MIC values measured for E.faecium isolated from 
settled sewage, final effluent and surface waters up- and down-stream of the effluent 
discharge point. The red dashed line represents the clinical resistance breakpoint (R > 8 
mg/L). There is no epidemiological cut off value reported for E.faecium/ amoxicillin. 
The distribution of ciprofloxacin MIC values measured for E.faecium isolated from all 
sampling points is presented in Figure 5-9.  E.faecium resistant to ciprofloxacin (according to 
both epidemiological cut off values and clinical breakpoints, which are identical at 4 mg/L, 
were identified at all sampling points (settled sewage, final treated effluent and surface 
water both up- and down-stream relative to the effluent discharge point).  
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Figure 5-9: Distribution of ciprofloxacin MIC values measured for E.faecium isolated from settled sewage, final 
effluent and surface waters up- and down-stream of the effluent discharge point. The green arrow represents 
the epidemiological cut-off value (WT ≤ 4.0 mg/L). The blue bars represent wild type E.faecium (wild type) and 
the red bars represent non-wild type E.faecium (acquired resistance). The red dashed line represents the 
clinical breakpoint value (R > 4.0 mg/L) 
The distributions of clarithromycin MIC values measured for the E.faecium strains isolated 
from all sampling points are presented in Figure 5-10 and demonstrate that E.faecium with 
acquired clarithromycin resistance are present at each sampling point. The changes in 
clarithromycin resistance rates in E.faecium were assessed only against the epidemiological 
cut of value as there are no clinical breakpoints reported by EUCAST (2012). 
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Figure 5-10: Distribution of clarithromycin MIC values measured for E.faecium isolated from settled sewage, 
final effluent and surface waters up- and down-stream of the effluent discharge point. The green arrow 
represents the epidemiological cut-off value (wild type ≤ 4 mg/L). The blue bars represent wild type E.faecium 
(wild type) and the red bars represent non-wild type E.faecium (acquired resistance). There are currently no 
clinical breakpoints for E.faecium/ clarithromycin reported by EUCAST.  
Only vancomycin sensitive E.faecium strains were detected in the settled sewage, final 
treated effluent and receiving surface water both up- and down-stream from the final 
effluent discharge point as shown in Figure 5-11. 
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Figure 5-11: Distribution of vancomycin MIC values measured for E.faecium isolated from settled sewage, final 
effluent and surface waters up- and down-stream of the effluent discharge point. The green arrow represents 
the epidemiological cut-off value (WT ≤ 4 mg/L). The red dashed line represents the clinical resistance 
breakpoint (R > 4 mg/L). 
5.3.4.3 Proportion of E.faecium resistant to antibiotics in wastewaters and surface water 
Overall from a total 129 E.faecium isolates obtained from all sampling points, resistance to 
clarithromycin (51.9 %) was more prevalent in E.faecium than was the case for ciprofloxacin 
(25.6 %) or amoxicillin (8.5 %). No vancomycin resistant sensitive or non-wild type strains of 
E.faecium strains were detected in any of the monitored water samples (Table 5-18). 
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Table 5-18: The proportion (%) of E.faecium isolates resistant (according to ECOFF and CBP values) to 
amoxicillin, ciprofloxacin, clarithromycin and vancomycin. 
 % E.faecium 
 
Settled 
Sewage 
(n = 32) 
Final 
effluent 
(n = 39) 
Down-
stream 
(n = 35) 
Up- 
stream 
(n 23) 
b % of total 
isolates 
(n =129) 
Amoxicillin  
ECOff 
No ECOff No ECOff No ECOff No ECOff No ECOff 
a CBP 
15.6 
(5.3 -32.8) 
13.2 
(4.4 – 28.1) 
2.9 
(0.1 – 28.1) 
ND 
8.5 
(4.3 – 14.7) 
Ciprofloxacin 
ECOff 
25.0 
(11.5– 43.4) 
20.5 
(9.3 – 36.5) 
22.9 
(10.4 – 40.1) 
39.1 
(19.7 – 61.5) 
25.6 
(18.3 -34.0) 
CBP 
25.0 
(11.5– 43.4) 
20.5 
(9.3 – 36.5) 
22.9 
(10.4 – 40.1) 
39.1 
(19.7 – 61.5) 
25.6 
(18.3 -34.0) 
Clarithromycin 
ECOff 
56.3 
(37.7 – 73.6) 
51.3 
(34.8 – 67.6) 
51.3 
(34.8 – 67.6) 
47.8 
(26.8 – 69.4) 
51.9 
(43.0 – 60.8) 
CBP No CBP No CBP No CBP No CBP No CBP 
Vancomycin 
ECOff 
ND ND ND ND ND 
CBP ND ND ND ND ND 
c  Multi 
antibiotics 
ECOff 
6.3 
(0.8 -20.8) 
12.8 
4.3 - 27.4) 
14.3 
(4.8–30.3) 
13.0 
(2.8 -33.6) 
11.6 
(6.7 -18.5) 
CBP 
12.5 
(3.5 – 28.9) 
10.3 
(2.9 – 24.2) 
2.9 
(0.1 – 15.0) 
None 
7.0 
(3.2 -12.8) 
1-proportion 95 % confidence intervals are given in the parentheses. ND = none detected. No CBP or No ECOff 
= No clinical breakpoint or epidemiological cut off value. a significantly different proportions (2-proportions 
test; P < 0.05) amongst sampling points. b overall % of total isolates from all sampling points (n = 129). c Multi 
antibiotics = % of total isolates with acquired resistance (according to ECOff values – not including amoxicillin) 
or resistant (according to CBP values – not including clarithromycin) to more than one of the antibiotics tested.  
None – no isolates identified with resistance to multiple antibiotics. 
Elevated levels of E.faecium resistant to amoxicillin were observed in the settled sewage 
(15.6 %) and final treated effluent (13.2 %) compared to the surface waters (2 proportions 
test; P < 0.01). However, the proportion of E.faecium resistant to clarithromycin and 
ciprofloxacin was more consistent in all collected water samples (Table 5-18).  According to 
the epidemiological cut off values for clarithromycin, ciprofloxacin and vancomycin, 11.6 % 
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(n = 15) of the total E.faecium isolated (n = 129) from the water samples demonstrated 
acquired resistance to more than of one the tested antibiotics (excluding amoxicillin as 
there is no ECOff value currently determined). In addition, It was observed that the 
proportion of E.faecium with acquired resistance to more than one of the tested antibiotics 
were similar (2-proportions test; P > 0.05) between all sampling points (Table 5-18). When 
using the clinical breakpoint values, a lower percentage of E.faecium (n =1; 2.9%) with 
resistance to more than one antibiotic (excluding clarithromycin due to no CBP value) was 
observed in surface water down-stream from the WWTP treated effluent discharge point 
compared to the settled sewage (n =4; 12.5%) and final treated effluent (n = 4; 10.3%). No 
isolates with multi resistance to more than of the tested antibiotics (according to CBP 
values) were observed up-stream. 
5.3.4.4 Maintenance of resistance in E.faecium 
The proportion of E.faecium resistant to amoxicillin, ciprofloxacin and clarithromycin 
(according to ECOff and CBP values) that maintained their resistance following the repeated 
(10 times) sub-culture on antibiotic free nutrient agar are presented in Table 5-19. 
Interestingly, following repeated sub-culturing, all the E.faecium isolates originally identified 
as resistant maintained their resistance. 
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Table 5-19: Proportion (%) of resistant E.faecium isolates maintaining resistance, following repeated sub-
culture 
 % maintained resistance 
Resistance to 
Settled 
sewage 
Final treated effluent Down-stream Up-stream 
a Amoxicillin  100.0 (5) 100.0 (5) 100.0 (1) ND 
b Ciprofloxacin 100.0 (7) 100.0 (8) 100.0 (8) 100.0 (6) 
c Clarithromycin 100.0 (18.0) 100.0 (15) 100.0 (18) 100.0 (10) 
b vancomycin ND ND ND ND 
a according to CBP values (R > 8 mg/L), b to CBP and ECOff values (both 4 mg/L), c to the ECOff value (WT ≤ 4 
mg/L). Total number of isolates tested after five passages are given in the parentheses. ND – not resistant 
isolates initially detected. 
5.4 Discussion 
5.4.1 Indicator bacteria in wastewater and surface water 
Total heterotrophic bacteria represent a pool of cultivable and viable bacteria that could 
acquire antibiotic resistance or spread antibiotic resistance. In this study, the concentrations 
of heterotrophic bacteria in settled sewage and final treated effluent (Table 5-6) are in 
agreement (~ 9.0 log10 and 8.0 log10 CFU/100 mL heterotrophic bacteria in raw and treated 
wastewater respectively) with those previously reported for urban wastewaters (Ferreira Da 
Silva et al., 2006). In addition, the concentrations of total coliforms, E.coli and enterococci 
detected in the settled sewage and final treated effluent (Table 5-6) are similar to reports 
for raw wastewaters (~ 7.0, 6.0 and 6.0 log10 CFU/100 mL for total coliforms, E.coli and 
enterococci respectively) and treated wastewaters (~ 6.0, 4.0 and 3.0 log10 CFU/100 mL for 
total coliforms, E.coli and enterococci respectively) taken from urban wastewater treatment 
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plants elsewhere in Europe (Blanch et al., 2003;  Silva et al., 2006;  Silva et al., 2007;  Servais 
et al., 2009). Although the wastewater treatment process significantly reduced the 
concentration of indicator bacteria (> 97 %), high numbers were still prevalent in the final 
treated effluents. This is a concern as the abundant levels of nutrients and oxygenated 
conditions combined with high concentrations of bacteria and low concentrations of 
antibiotics in activated sludge treatment tanks have the potential  to stimulate bacteria in 
the dissemination of resistance genes on mobile genetic elements (Kummerer, 2004).  
In this study, the bacterial concentrations measured in the receiving surface water (down-
stream) were similar (within 0.1 – 0.4 logs) to the concentrations observed in the final 
treated effluent (Table 5-6). This was expected as there is a long history of water quality 
issues with the river water sampled (e.g. high sediment accumulation and water 
abstraction). The concentrations of indicator bacteria within the surface water up-stream 
from treated effluent discharges were typically one order of magnitude less than those 
observed in the final effluent. Heterotrophic bacteria and faecal indicators can often be 
present at levels two or three orders of magnitude greater in surface waters down-stream 
of wastewater effluent discharge points compared to up-stream (Maier et al., 2009) 
supported by the presence of elevated amounts of organic matter and nutrients in treated 
effluent discharges. Studies by Goni-Urriza et al. (2000) have reported significant increases 
of coliforms and E.coli in surface waters receiving treated effluent (E.coli concentration ~ 6.0 
log10 CFU/100 mL) compared to surface water up-stream (E.coli concentration ~ 3.0 log10 
CFU/100 mL) from treated effluent discharge points, whilst a wide range of enterococci 
concentrations (1.5 – 3.2 log10 CFU/100 mL ) in a variety of surface waters down-stream 
from different treated effluent discharge points were observed by Blanch et al. (2003). 
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5.4.1.1 Distribution of E.faecium in wastewater and surface water 
E.faecium was the most prevalent of the enterococci species in the settled sewage, final 
treated effluent and receiving surface water (down-stream) (Figure 5-4). Wastewater 
treatment processes, did not influence the proportion of E.faecium and therefore the 
proportions of E.faecium in the settled sewage (73.1 %) and final treated effluent (74.6 %) 
were similar. This is in contrast to the results reported by Ferreira Da Silva et al. (2006), who 
identified E.hirae as the most abundant species in urban wastewaters and observed an 
increase in the proportion of E.faecium following activated sludge treatment. Some studies 
have found a higher prevalence of E.hirae in environmental waters associated with pigs and 
cattle (Kuhn et al., 2003). Interestingly Blanch et al. (2003) reported that E.faecium was the 
most prevalent species in the wastewaters and receiving surface waters in Spain and the UK 
whilst contrastingly in Sweden, E.faecalis was the most prevalent species. The different 
proportions of E.faecium, E.faecalis and E.hirae in wastewaters, reported in other studies, 
could be due to differences in the catchment area diet, seasonal differences or the type of 
wastewater treatment employed (Layton et al., 2009 and Blanch et al., 2003).  
The similar proportions of E.faecium in the final treated effluent and receiving surface 
waters demonstrate that the treated wastewater effluent discharges impact the receiving 
surface water. This is because E.faecalis and E.faecium are typically the most prevalent of 
species in human faeces and thus the most common species in urban wastewater (Layton et 
al., 2009). A higher predominance of E.faecium within wastewaters (91.0 – 96.0 %) and 
receiving surface waters (89.0 %) compared to other enterococci species was also found by 
Leclercq et al. (2007). Species such as E.casseliflavus are more associated with plants 
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(Layton et al., 2009) and E. durans and E.hirae are considered to be mainly of animal origin 
(Klein, 2003). Therefore, the lower prevalence of E.faecium (38.5 %) and the greater 
diversity in species of the enterococci genera observed in surface waters up-stream from 
the effluent discharge point compared to the other monitored samples was expected. Due 
to the higher predominance of E.faecium in the collected water samples indicating human 
activity, this species was selected as an ideal candidate for monitoring the transfer of 
antibiotic resistance from wastewater to surface waters.   
5.4.2 Interpretive criteria for assessing antibiotic susceptibility in environmental bacteria 
Currently, there are two different types of interpretive criteria that are available for 
interpreting in vitro antibiotic susceptibility tests. These are clinical breakpoint values (CBP 
values) and epidemiological cut-off values (ECOff values) as introduced in Chapter 3, section 
3.4.1. Clinical breakpoints are useful to determine if a bacterium responds to therapy. 
Whereas, epidemiological cut off values help define bacteria that possess any kind of 
resistance mechanisms or resistance genes (Walsh, 2013). Although CBP and ECOff values 
are determined by different approaches they can be identical for some bacteria/drug 
combinations. For example the CBP and ECOff values are identical for the combination 
E.faecium/ vancomycin. However, there are exceptions when the ECOff value is either lower 
(E.coli/ ciprofloxacin) or greater (E.coli/ cefpodoxime) than the CBP value and hence 
different conclusions can be drawn depending on the interpretive criteria used.   
In this study, E.coli resistance levels to ciprofloxacin were underestimated when the 
resistant clinical breakpoint value was used (1.8 %) compared to the epidemiological cut off 
value (9.2 %). Conversely, cefpodoxime resistance levels in E.coli taken from environmental 
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waters (4.3 %) were overestimated using the current cefpodoxime resistant clinical 
breakpoint value compared to the epidemiological cut off value (1.6 %) as presented in 
Table 5-15. Furthermore, when using clinical breakpoint values, no E.faecium isolates (taken 
from all samples) were identified with resistance to multiple antibiotics (from those tested). 
However, when using the epidemiological cut off value, 13 % of the E.faecium isolates were 
identified to have acquired resistance to multiple antibiotics (Table 5-18). The comparison of 
the MIC valves with both harmonised clinical breakpoint and epidemiological cut off values 
from the European Committee for Antimicrobial Susceptibility Testing (EUCAST, 2000) has 
demonstrated that there is an urgent need for the standardisation of the interpretive 
criteria used for assessing antibiotic susceptibility data. In addition, this data demonstrates 
that the monitoring of antibiotic minimum inhibitory concentration values within a species 
and the use of epidemiological cut of values for interpretation is the most appropriate 
method for detecting subtle changes in resistance. 
Schwarz et al. (2010) have suggested that antibiotic susceptibility surveillance publications 
should include the distribution of minimum inhibitory concentration values for each 
bacterial species/drug combination, so that readers may use the reported data in the right 
context. This is also important for bacterial species/antibiotic combinations that have no 
defined ECOff or CBP values. For example, there is no ECOff value for amoxicillin 
susceptibility in E.faecium and no CBP value for clarithromycin susceptibility in E.faecium 
Problems associated with surveillance programmes using different antibiotic susceptibility 
interpretative criteria were illustrated in a report by Silley et al. (2011). When applying the 
clinical breakpoint value (> 2 mg/L) to the surveillance of ciprofloxacin susceptibility in 
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salmonella taken from animals (in the Netherlands in 2004), 0.3 % were found to be 
resistant. The surveillance carried out the following year showed elevated resistance levels 
in salmonella (10.1 %). However the rise is misleading as the ECOff value (> 0.06 mg/L) was 
used in this case. This demonstrates that the term resistance although frequently used is not 
clearly understood and emphasises that the standardisation and harmonisation of values 
used to define resistance are imperative for effective surveillance of antibiotic resistance 
development. In addition, a single standardised approach to assessing antibiotic 
susceptibility is crucial for effective risk assessment and when the comparison of resistance 
from different sources (e.g. food, environment and humans) is required.  
5.4.3 The antibiotic susceptibility of E.faecium and E.coli in environmental waters 
The results obtained show that E.coli resistant (according to ECOff and CBP values) to 
amoxicillin, and to ciprofloxacin and cefpodoxime and E.faecium resistant to amoxicillin, 
ciprofloxacin and clarithromycin were present in environmental waters (settled sewage, 
treated effluent and surface waters). In addition, isolates with resistance to more than one 
antibiotic were also present. 
The prescription levels estimated for England in 2011 (Chapter 4) for amoxicillin (168 tonnes 
a.i), ciprofloxacin (7 tonnes a.i) and cefpodoxime (0.002 tonnes a.i) correlate with the levels 
of resistance (according to ECOff values) to amoxicillin (20.1 %), ciprofloxacin (9.2 %) and 
cefpodoxime (1.6 %) observed in E.coli. By comparing the levels of resistance in E.coli to 
prescription levels it can be hypothesised that clinical use of these substances has 
influenced the positive selection of resistant strains. Similarly, the high prescription 
quantities of clarithromycin (12 tonnes a.i) and ciprofloxacin (7 tonnes a.i) and their 
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presence in the active form in environmental waters (although at sub inhibitory 
concentrations) may account for the high proportion of E.faecium resistant to 
clarithromycin (51.9 %) and ciprofloxacin (25.6 %) in the wastewater and surface water 
samples. In contrast, a low prevalence of E.faecium resistance to amoxicillin was observed 
(8.5 %). despite the elevated use of amoxicillin in medicine and the high prevalence of 
penicillin (including amoxicillin) resistance observed in E.faecium through clinical 
surveillance (93.1 % in 2012) in England (European Centre for Disease Prevention and 
Control - Antimicrobial resistance interactive database (EARS-net), 2014a). However, a lower 
prevalence of resistance in environmental samples compared to clinical samples would be 
expected. The absence of E.faecium strains resistant to vancomycin was also expected 
(Figure 5-11) and may reflect the low prescription levels in England each year (0.03 tonnes 
a.i) and the decrease in the prevalence of vancomycin resistant E.faecium observed through 
clinical surveillance (33.0 -13.3 %) between 2005 -2012 (European Centre for Disease 
Prevention and Control - Antimicrobial resistance interactive database (EARS-net), 2014b). 
This is also consistent with the report from Martins da Costa et al. (2007) who found very 
low proportions of enterococci in wastewaters resistant to vancomycin (0.6 %).  
5.4.3.1 The antibiotic susceptibility of E.coli and E.faecium in wastewater 
Whether resistance develops throughout the wastewater treatment process is still currently 
under discussion. Wastewater treatment plants are a reservoir of antibiotics (Watkinson et 
al., 2007), antibiotic resistant bacteria (Faria et al., 2009) and antibiotic resistance genes 
(Munir et al., 2011;  Szczepanowski et al., 2009). Therefore, in combination with the 
presence of high nutrient and oxygen levels, it is believed that WWTPs provide desirable 
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conditions for the dissemination of antibiotic resistance (Novo et al., 2010;  Luczkiewicz et 
al., 2010).  
There are studies that have reported increases in the proportion of resistant bacteria 
throughout the wastewater treatment process. Silva et al. (2007) found comparatively 
higher levels of amoxicillin (28.0 and 34.8 % before and after activated sludge treatment) 
and ciprofloxacin (2.5 and 9.7 % before and after activated sludge treatment) resistant E.coli 
following activated sludge treatment and Silva et al. (2006) reported that wastewater 
treatment increased enterococci resistance levels to ciprofloxacin from 9 to 25 %.  
Conversely, Guardabassi et al. (2002) found that the wastewater treatment process  
significantly reduced (P < 0.05) the levels of antibiotic resistant bacteria (Acinetobacter). In 
addition, a reduction in the levels of antibiotic resistant bacteria and antibiotic resistant 
genes with wastewater treatment was observed by Munir et al. (2011).  
Interestingly, the results from this study demonstrate that wastewater treatment did not 
positively or negatively select for antibiotic resistant E.coli and E.faecium. Therefore this 
data does not support the hypothesis that wastewater treatment processes serve as 
potential hotspots for the dissemination of resistance genes or elements (Guardabassi et al., 
2002). However, despite the large reduction of the faecal bacteria with activated sludge 
treatment (Table 5-7), the wastewater treatment did not reduce the proportion E.coli 
resistant to amoxicillin, ciprofloxacin and cefpodoxime or the proportion of E.faecium 
resistant to amoxicillin, ciprofloxacin and clarithromycin. This suggests that the presence of 
low concentrations of antibiotics detected in wastewater (presented in Chapter 4) may serve as 
a selective pressure to maintain the proportion of resistance among faecal bacteria. This is also 
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in agreement with the work reported by Galvin et al. (2010) and Koczura et al. (2012), who 
found that the levels of antibiotic resistant E.coli were not eliminated by wastewater 
treatment. Similarly, Leclercq et al. (2007) observed the level of resistance within 
enterococci  were  not affected by the treatment process.  
There are a number of factors that may influence the fate of antibiotic resistant bacteria in 
WWTPs including the type of wastewater treatment and treatment plant operation (Bouki 
et al., 2013). Activated sludge treatment processes with enhanced sludge retention times 
may correspond to an enhancement in the levels of antibiotic resistant bacteria (Luczkiewicz 
et al., 2010). Longer hydraulic retention times or sludge retention times may give rise to a 
more diverse biomass that may favour horizontal gene transfer processes and therefore the 
dissemination of resistance (Novo et al., 2010;  Luczkiewicz et al., 2010). Whilst differences 
in the initial composition of sewage may account for the varying levels of antibiotic resistant 
bacteria (Guardabassi et al., 2002). Munir et al. (2011) found the level of the reduction of 
antibiotic resistant bacteria levels varied between different types of treatment facilities.  
Significantly higher reductions of antibiotic resistant bacteria and antibiotic resistant genes 
were observed in a membrane biological reactor facility compared to treatment facilities 
employing activated sludge treatment. However, no significant differences in the levels of 
antibiotic resistant bacteria were found between pre- and post-disinfected wastewaters. 
Seasonal differences and climate differences may also impact on the dissemination of 
antibiotic resistance in wastewater treatment facilities. Novo et al. (2013) reported that the 
levels of antibiotic resistant bacteria in wastewaters differed depending on the season. It 
was found that the wastewater treatment process significantly increased the levels of 
amoxicillin and ciprofloxacin resistance in autumn but not in the spring. 
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Although reports do vary, collectively they indicate that wastewater treatment plants do not 
completely eliminate antibiotic resistant faecal bacteria from wastewater. Consequently, 
treated effluents may be a constant source of antibiotic resistant faecal bacteria to receiving 
water thus contributing to the spread of resistant bacteria in environmental waters.  
5.4.3.2 The antibiotic susceptibility of E.faecium and E.coli in surface waters 
In order to study the impact of the final treated effluent on the antibiotic resistance of a 
receiving surface water, the resistance levels of E.coli and E.faecium up- and down-stream 
of the WWTP final effluent discharge point were also determined.  
High proportions of E.coli and E.faecium with acquired antibiotic resistance were identified 
in the wastewater treated effluent demonstrating WWTPs do not completely eliminate 
antibiotic resistant bacteria (Table 5-15 and Table 5-18). Consequently they are discharged 
to the environment. It was expected that the levels of faecal bacteria in the final treated 
effluent discharges would be diluted when discharged to the river water. However, the 
levels in the final treated effluent and surface water down-stream from the WWTP treated 
effluent discharge point were similar (Table 5-6). Correspondingly, the levels of E.coli with 
acquired resistance to amoxicillin and ciprofloxacin (Table 5-15) and the levels E.faecium 
(Table 5-18) with acquired resistance to ciprofloxacin and clarithromycin were similar (2-
proportions test; P > 0.05) between the final treated effluent and surface water down-
stream of the discharge point.  
Significant increases in the proportion of E.coli resistant to antibiotics in surface waters 
down-stream of treated effluent discharges were observed compared to up-stream by 
Koczura et al. (2012). Similarly,  Zhang et al. (2009) found higher numbers of resistant 
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bacteria in river water samples taken down-stream from treated effluent discharges than in 
up-stream river water samples. Therefore, it was hypothesised that the proportion of 
acquired resistance in E.coli, taken from surface waters down-stream of the treated effluent 
discharge point, would be elevated compared to up-stream. 
In this study, the proportion of E.coli with acquired resistance to amoxicillin and 
ciprofloxacin was more elevated in the surface water down-stream compared to up-stream 
relative to the WWTP treated effluent discharge point.  This indicates that the discharges of 
treated effluent influence the proportion of resistance in E.coli in the receiving surface 
water compared to surface water up-stream from effluent discharges.  The lower 
prevalence of resistance observed up-stream probably correspond to problems with 
leakages from sewer misconnections which may act as a source of antibiotic resistant 
bacteria further up-stream.  
The presence of E.coli and E.faecium with acquired resistance to antibiotics in surface 
waters indicates that the bacterial strains with acquired resistance are not at any significant 
survival disadvantage in environmental waters. Studies by (Flint, 1987;  Caldwell et al., 1989) 
support this conclusion as they have shown resistance plasmids are stable within E.coli 
whilst under survival conditions in river water. This is supported further by reports from 
Korezeniewska (2013), who identified large proportions (8 – 32 %) of E.coli with resistance 
to antibiotics  (e.g. penicillins) in surface waters receiving urban wastewater treated effluent 
discharges and by Zurfluh (2013) who identified a high proportion (36 %) of E.coli taken 
from a variety of river water samples carrying plasmid mediated resistance mechanisms to β 
lactam antibiotics. In addition, these findings are consistent with the enterococci 
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fluoroquinolone resistant levels observed in surface waters by Junco et al. (2001) and the 
macrolide resistance levels identified in Sweden and Spain by Blanch et al. (2003). 
Additionally, these data indicate that the presence of low levels of antibiotics present in the 
treated effluents and receiving surface waters may select for resistance within the faecal 
bacteria population. However, studies such as those reported by Muela et al. (1994) found 
horizontal gene transfer processes within the E.coli population were inhibited in surface 
water conditions (e.g. low nutrient levels). 
Previous reports have demonstrated ciprofloxacin and clarithromycin resistance is 
widespread in enterococci from humans as well as other sources. Studies carried out by 
Barry et al. (1984) found that shortly after the introduction of ciprofloxacin (1983), 
approximately 50 % of clinical E.faecium isolates were resistant. Similarly, Kuhn et al. (2000) 
found macrolide resistance was widespread in enterococci from humans, pigs and broilers 
and Eliopoulos (2007) identified that macrolide resistance was very common among clinical 
isolates of E.faecium. Therefore it was expected that resistant E. faecium isolates would be 
identified at all sampling points including the surface water up-stream of the treated 
effluent discharge point. The proportions of E.faecium with acquired resistance to 
ciprofloxacin and clarithromycin were similar between the surface waters collected up- and 
down-stream of the treated effluent discharge point and also similar to the wastewater 
samples (presented in Table 5-18), highlighting that treated wastewater effluent is not the 
only source of resistant E. faecium isolates to surface waters. 
Conversely, a decrease in the proportion of amoxicillin resistant E.faecium was observed in 
the receiving surface water compared to the wastewater samples. In the surface water 
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down-stream from the WWTP treated effluent discharge point, only 2.9 % of E.faecium 
isolates were identified as amoxicillin resistant. Whereas, no amoxicillin resistant E.faecium 
resistant isolates were identified in the water samples collected from up-stream (Figure 
5-8). This may be related to the poor survival of amoxicillin resistant strains in surface water 
or more likely due to the dilution of the resistant strains with more sensitive enterococci 
counterparts (Leclercq et al., 2007). It has been reported that enterococci penicillin 
(including amoxicillin) resistance is widespread in human clinical isolates but not in animals, 
poultry and food (Mannu et al., 2003, Martins da Costa et al., 2007). Considering that the 
enterococci present in surface waters will be from a variety of sources (animals and plants) 
in addition to the treated effluent discharges, it was not surprising that the proportion of 
E.faecium resistant to amoxicillin was lower in the surface water compared to wastewater. 
Overall, the elevated proportion of resistant E.faecium and E.coli in surface waters is of 
concern. Appropriate measures need to be taken in order to monitor and assess the 
anthropogenic contribution of antibiotic resistance to the environment. New strategies for 
the treatment of wastewater or more stringent treatments need to be assessed to reduce 
the proportion of resistant bacteria present in surface waters. 
5.5 Summary 
E.coli and E.faecium were isolated from settled sewage, treated effluent and surface water 
both up- and down-stream of an effluent discharge point using culturable methods for 
subsequent quantitative antibiotic susceptibility testing. 
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 Due to the difficulty of selectively detecting Staphylococcus aureus and 
Pseudomonas aeruginosa in wastewater and surface water samples in high 
proportions using recommended culturable methods it was decided not to 
investigate the antibiotic resistance profiles of these bacterial species in 
environmental waters. In addition, as they are not exclusively of faecal origin 
(Environment Agency, 2000) but are commonly found in soil and on plants they are  
not necessarily  ideal indicator organisms to use to assess the impact of urban 
treated effluent on receiving surface waters. 
 E.coli was easily selected and differentiated from other enterobacteriaceae using β- 
galactosidase/β glucuronidase chromogenic media with a high E.coli confirmation 
rate (91.6 %) that is comparable to reports from other studies (Alonso et al., 1996;  
Wohlsen, 2011). The identification of the presumptive coliform colonies (Table 5-8) 
indicated a diverse range of species from the coliform group which are all of faecal 
origin (Citrobacter, Klebsiella and Enterobacter) and therefore antibiotic 
susceptibility tests were carried out only for E.coli and not other coliform bacteria.   
 The use of Slanetz and Bartley media for the detection and enumeration of 
enterococci can facilitate the growth of other bacteria physiologically similar to 
enterococci (e.g. Lactococcus spp, Leuconostoc spp and Aerococcus spp) and does 
not enable the distinction between different Enterococci species (Swenson et al., 
1990). However, with additional identification using MALDI-TOF-MS analysis it was 
demonstrated that E.faecium were present in high enough proportions in the 
wastewater and surface water to study antibiotic resistance profiles.  
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 The proportion of E.coli from environmental waters resistant to ciprofloxacin was 
underestimated when minimum inhibitory concentrations were interpreted using 
clinical breakpoints. Contrastingly, the levels of cefpodoxime resistance in E.coli were 
overestimated when using the resistant clinical breakpoint. 
 Different antibiotic resistance patterns were observed between E.coli and E.faecium 
from settled sewage, treated effluent and surface water. Overall it was found that 
antibiotic resistance is more prevalent in E.faecium than E.coli. However, elevated 
levels of E.coli were more resistant to amoxicillin compared to E.faecium. 
 Wastewater treatment did not significantly change the proportion of E.coli resistant 
to amoxicillin, ciprofloxacin and cefpodoxime or the proportion of E.faecium 
resistance to amoxicillin, ciprofloxacin and clarithromycin. Only vancomycin sensitive 
E.faecium strains were detected in the wastewater. 
 According to epidemiological cut off values, elevated levels of E.coli resistant to 
amoxicillin and ciprofloxacin and E.faecium resistant to amoxicillin were observed in 
the surface water down-stream of the treated effluent discharge point compared to 
the surface water up-stream, indicating treated effluent discharges influence the 
levels of antibiotic resistant bacteria in receiving surface water. However, similar 
clarithromycin and ciprofloxacin resistance levels for E.faecium were observed at all 
sampling points. 
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6 The prevalence of E.coli with resistance to ciprofloxacin within 
constructed microcosms.  
6.1 Introduction 
There are now increasing reports of the presence of antibiotic residues and antibiotic 
resistant bacteria  in wastewaters and river waters (Moore et al., 2010;  Lacey et al., 2008;  
Senta et al., 2008;  Guardabassi et al., 1998). However, very few studies have examined the 
impact that antibiotic residues have on the development of resistance in these 
environments and particularly in surface waters. Studies by Zhang et al., (2009) and 
Engemann et al. (2008) are two examples. There is increasing evidence that sub-therapeutic 
levels of antibiotics can promote the dissemination of antibiotic resistance in bacteria in 
clinical (Gullberg et al., 2011) and animal husbandry environments (Gellin et al., 1989). 
Therefore it is possible that the antibiotics episodically released into river waters within 
treated effluent discharges, although at sub-therapeutic levels, may exert the necessary 
pressure to support the development and spread of resistant bacteria. 
In Chapter 5, it was observed that a greater proportion of ciprofloxacin resistant Escherichia 
coli (according to epidemiological cut off values) were present in the surface water down-
stream from the wastewater treated effluent discharge point compared to up-stream 
(Section 5.3.4.3). However, it is unclear if the sub-therapeutic concentrations (65 – 149 ng/L) 
of ciprofloxacin detected in the surface water (see Chapter 4, Section 4.3.3) select for 
ciprofloxacin resistant E.coli.  
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In this chapter the overall objective is to provide a better understanding of the effect 
ciprofloxacin discharged within treated wastewater effluent will have on the total E.coli 
population within receiving surface waters. In addition, the effect ciprofloxacin has on the 
prevalence of ciprofloxacin resistant E.coli will be investigated. Due to the complex variables 
within the environment that can influence the levels of resistance in surface waters, the use 
of microcosms was selected for this work. The relevance of E.coli as representative 
organisms to study the transfer of antibiotic resistance from wastewater to receiving 
surface waters and the importance of studying ciprofloxacin resistant profiles of E.coli in 
environmental waters has been discussed in Chapter 5, Section 5.1. The use of clinical 
breakpoints to interpret antibiotic susceptibility results from the environment may 
underestimate subtle changes in resistance (as discussed in Chapter 5, Section 5.4.2). 
Therefore, the E.coli/ciprofloxacin epidemiological cut off value (WT ≤ 64 µg/L) is used in 
this chapter. Epidemiological cut off values were introduced in Chapter 3, Section 3.4.1. 
6.1.1.1 Small scale aquatic studies to monitor resistance in environmental waters 
There are a number of laboratory aquatic studies to investigate the environmental fate and 
effects of medicinal products that have been recommended by The European Medicines 
Agency (2006) to assess and predict their potential risk to the environment (see Chapter 2, 
Section 2.5.4). However, within these guidelines there are no recommendations for more 
tailored studies to investigate the effects of antibiotics in aquatic ecosystems and the 
potential to exert a selective pressure for antibiotic resistant bacteria. 
A number of researchers have carried out surveillance of the antibiotic resistance profiles of 
bacteria in surface waters to assess the impact of antibiotic contamination from sources 
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such as wastewater treatment plants (Moore et al., 2010;  Servais et al., 2009;  Leclercq et 
al., 2007;  Goni-Urriza et al., 2000). Although this information is important for performing 
environmental risk assessments, collecting the data can be time consuming and the results 
can be influenced by environmental variability (e.g. climate and the catchment area 
characteristics). In addition, information on the association between antibiotic residues and 
the level of resistance cannot be obtained. 
Laboratory microcosm studies use a compartment of the natural environment (soil or 
water) circumscribed under controlled conditions corresponding to natural ones (e.g. 
temperature, light and dissolved oxygen) for the assessment of the effects of a test 
substance on natural ecosystems (Barra Caracciolo et al., 2013). Laboratory microcosm 
studies and other small scale controllable systems (e.g. mesocosms) have been widely used 
as simple models of natural ecosystems to study the effects of pharmaceuticals and other 
organic pollutants (Rico et al., 2014;  Shibata et al., 2014;  Gonzalez-Pleiter et al., 2013;  
Boonstra et al., 2011;  Pathak et al., 1994). The effects of antibiotics on the proliferation of 
antibiotic resistance in small scale aquatic systems have also been reported. Helt et al. 
(2012) monitored the prevalence of antibiotic resistant faecal bacteria in a constructed 
wetland system using qualitative phenotypic antibiotic susceptibility tests (disc diffusion). 
Whilst Munoz-Aguayo et al. (2007), assessed the proliferation of culturable antibiotic 
resistant bacteria in simulated river water systems exposed to chlortetracycline. In addition, 
some studies have set up systems to represent waters receiving agricultural waste such as 
swine and cattle waste and to monitor the presence of antibiotic resistant genes (Knapp et 
al., 2010;  Zhang et al., 2009;  Engemann et al., 2008).  
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6.1.1.2 Survival of E.coli in environmental waters 
Previous studies have demonstrated that antibiotic-resistant E.coli may be found in different 
aquatic ecosystems including rivers (Sidrach-Cardona et al., 2014;  Watkinson et al., 2007), 
streams (Akiyama et al., 2010), lakes (Jones et al., 1986) in addition to wastewaters (Silva et 
al., 2007). However, E.coli is a commensal bacterium from the gastrointestinal tracts of 
humans and vertebrate animals and the survival in secondary habitats such as river waters 
requires the ability to overcome environmental stresses. These include nutrient deprivation 
(Barcina et al., 1997), low temperature (Flint, 1987), salinity (Sinton et al., 2002), exposure 
to solar radiation (Sinton et al., 2002;  McCambridge et al., 1981), competition with 
autochthonous microbial communities, and protozoan grazing (van Elsas et al., 2011;  
Barcina et al., 1997). 
In addition, it has been assumed that antibiotic resistance confers a metabolic burden for 
bacteria. Therefore, antibiotic resistant bacteria will be out-competed by their sensitive 
(wild type) counterparts in the absence of selective pressures (Martinez, 2009). However, 
the fate of antibiotic resistant bacteria in the environment varies with the bacterial strain, 
the resistance elements (e.g. plasmid) and the habitat. Studies have demonstrated that the 
acquisition of resistance elements do not always affect the survival of the microorganism.  
For example, Enne et al. (2005) found that the fitness impact imposed on E.coli strain 345-2 
RifC through the acquisition of antibiotic resistance elements was generally low or non-
existent and indicated that once resistance was established it may be difficult to eliminate 
through reduction in antibiotic pressure. Flint (1987) demonstrated that the acquisition of 
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resistance plasmids R144-3 and R1drd-19 was not factor in the survival of E.coli in river 
water.  
6.1.1.3 Ciprofloxacin resistance in natural waters 
Fluoroquinolone resistance in E.coli has been discussed in Chapter 3, Section 3.3.5.2. 
Plasmid mediated ciprofloxacin resistance can occur through the acquisition of Qnr genes 
and the resulting minimum inhibitory concentrations values (MIC values) can increase 
between 8 and 64 fold following acquisition. Although the resulting MIC values may be 
lower than clinical breakpoint values, plasmids can facilitate higher quinolone resistance 
through the presence of more than one Qnr resistance gene (Robicsek et al., 2006). Their 
occurrence has been described in municipal biosolids and raw sewage (Kaplan et al, 2013) 
and in water borne Aeromonas, Acinetobacter and Enterobacteria species isolated from 
environmental waters (Marti et al., 2013;  Figueira et al., 2011;  Cattoir et al, 2008;  Picao et 
al, 2008). Their prevalence in environmental waters indicates that the dissemination of 
plasmid mediated quinolone resistant genes do occur in environmental waters. The 
mechanisms of antibiotic resistance and the dissemination of antibiotic resistance are 
introduced in Sections 3.3.2 and 3.3.3, respectively of Chapter 3. 
6.2 Material and methods 
6.2.1 Method overview 
In the present study, microcosms were constructed to simulate surface river water receiving 
wastewater treated effluent in order to monitor the ciprofloxacin resistance profiles of E.coli 
over 14 days. The microcosms were prepared from final treated wastewater effluent diluted 
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with surface river water (1:5 ratio) to simulate the dilution of wastewater effluent typically 
observed in receiving surface waters. In Europe, surface waters that receive wastewater 
treated effluent can have a dilution ratio within the range 1:1 to 1:5 (O'Brien et al., 2004). In 
addition, the microcosms were seeded with settled sewage to ensure the concentration of 
E.coli within the constructed microcosms were sufficient for the enumeration of total 
culturable E.coli and the associated ciprofloxacin resistant sub populations over the course 
of the experiment (14 days). The construction of the microcosms to assess the proliferation 
of ciprofloxacin resistant E.coli is described in Section 6.2.9. 
Preliminary experiments were carried out to assess the effect of protozoa inhibitor 
compounds (cycloheximide and colchicine) on the survival of E.coli in surface water 
microcosms (see Section 6.2.8).  The concentration of E.coli will decrease in surface waters 
due to predation by protozoa (McCambridge et al., 1981) and therefore the use of protozoa 
inhibitor compounds was important to ensure that the  E.coli concentrations remained high 
enough for enumeration. 
Assessing the impact of antibiotics on the proliferation of antibiotic resistant bacteria in 
surface waters is challenging as the natural background of resistance in surface waters (the 
proportion of resistance in environmental bacteria without anthropogenic impact), is 
unknown. Therefore in this study, environmentally relevant ciprofloxacin concentrations 
(already present and in the surface water/wastewaters collected for the microcosm studies 
and quantified by liquid chromatography-mass spectrometry) were investigated and 
compared to microcosms which were exposed to additional levels of ciprofloxacin (5, 10, 50 
and 100 µg/L). The selected exposure concentrations (although sub-therapeutic) are greater 
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than those typically measured in surface waters receiving wastewater treated effluent 
discharges (see Chapter 4, Section 4.1.1) despite  concentrations as high as 9.6 µg/L having 
been detected in surface waters by Feitosa-Felizzola et al. (2009). In addition, the selected 
exposure concentrations span the epidemiological cut off value (wild type without acquired 
ciprofloxacin resistance  ≤ 64 µg/L) established by the European Committee of Antimicrobial 
Susceptibility Testing (EUCAST, 2012) which is used to distinguish between E.coli with and 
without acquired ciprofloxacin resistance. The working hypothesis was that within 
microcosms exposed to ciprofloxacin levels greater than the epidemiological cut off value, a 
more pronounced effect on the proportion of E.coli with acquired resistance would be 
observed. 
Frequently in studies investigating the antibiotic resistance profiles of bacteria in 
environmental waters, the target bacteria are processed for isolation, identification and 
resistance to antibiotics (Ferreira da Silva et al., 2007;  Goni-Urriza et al., 2000). This can be a 
time consuming and costly process when used for broad spatial or temporal assessments of 
antibiotic resistance patterns in environmental waters. Novo et al. (2013) and Watkinson et 
al. (2008) both reported that using the membrane filtration method incorporating  a 
chromogenic media specific for the detection of E.coli supplemented with antibiotics can be 
reliably used for the enumeration of antibiotic resistant populations of E.coli in 
environmental waters. This method was employed for this work using tryptone bile x 
glucuronide (TBX) supplemented to final nominal ciprofloxacin concentrations of 16, 32, 64, 
125 and 2000 µg/L. TBX media was selected for the work in this chapter as it has been 
reported that it is a highly specific medium for E.coli (Hansen et al., 1984). The antibiotic 
concentrations were selected to determine the level of resistance to various concentrations 
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of ciprofloxacin (both above and below inhibitory concentrations) and to estimate the 
ciprofloxacin minimum inhibitory concentrations among the total culturable E.coli 
population. In addition, the concentrations of ciprofloxacin were chosen to determine the 
proportion of total culturable E.coli with acquired ciprofloxacin resistance (according to the 
epidemiological cut off value) and to identify if any E.coli strains exhibited minimum 
inhibitory concentration values  greater than the ciprofloxacin clinical breakpoint value 
(resistant > 1000 µg/L).  
Typically, culture techniques including the agar dilution method used to determine 
antibiotic minimum inhibitory concentration values are carried out using a reference media 
(e.g. Mueller Hinton) (Andrews 2001). The techniques available to determine bacterial 
resistance to antibiotics were introduced in Chapter 3, Section 3.4. Medium supplements 
used to support the growth of specific bacteria or to inhibit the growth of non-target 
bacteria may influence the minimum inhibitory concentration value determined. Therefore, 
the use of TBX supplemented with ciprofloxacin for the determination of ciprofloxacin 
resistant levels of E.coli was evaluated. A total of fifty E.coli strains taken from wastewater 
and surface water samples with known ciprofloxacin minimum inhibitory concentration 
values (achieved using antibiotic gradient strips as described in Chapter 5) were re-tested 
using TBX supplemented with different concentrations of ciprofloxacin (see Section 6.2.6).  
TBX has been reported as a highly specific chromogenic medium for the detection of E.coli. 
The media employs a chromogenic substrate which detects glucuronide activity which has 
been reported to be 94 – 96 % of E.coli (Manafi, 2000). However, glucuronide activity may 
be present in other bacterial species (see Chapter 5, Section 5.3.2) including Citrobacter 
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Freundii which are present in surface waters (Alonso et al. 1996). In addition, 
supplementation with ciprofloxacin may affect the performance of TBX to detect E.coli 
within surface waters whilst inhibiting non-target species. Therefore, a trial was conducted 
using surface water samples to assess the performance of TBX to selectively detect E.coli 
resistance to different levels of ciprofloxacin. In addition, the levels of ciprofloxacin 
resistance determined using this method were verified. 
6.2.2 Media and reagents 
Tryptone bile X-glucuronide (TBX) media (CM0945) and Mueller Hinton (MH) agar (CM0337) 
were purchased from Oxoid Ltd. Ciprofloxacin (≥ 98 % HPLC) was purchased from Sigma-
Aldrich Company Ltd, UK. Colchicine (97%), sodium hydroxide (98 % CertiFied AR) and 
cycloheximide (95%) were purchased from Fisher Scientific UK Ltd and ciprofloxacin Etest® 
strips (0.002-32 µg/mL) were purchased from Biomerieux Ltd, UK.  
6.2.2.1 Preparation of ciprofloxacin stock solutions 
A 10 g/L stock solution of ciprofloxacin was prepared by dissolving 10g in sterile deionised 
water. Whilst the solution was stirred, a 0.1 M sodium hydroxide solution (prepared with 
sterile water) was added drop by drop until the antibiotic dissolved. Sterile water was then 
used to make up to 1 L, inverted to fully mix and filtered (Millipore, Millex sterile, syringe 
filter 0.2 µm). The stock solution was stored in 100 mL aliquots at -30 °C until required. 
Working stock solutions for microcosm or media preparation were prepared by diluting the 
10 g/L stock with sterile deionised water on the day of use. 
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6.2.2.2 Preparation of TBX media supplemented with ciprofloxacin 
Batches of Tryptone bile X-glucuronide (TBX) media were prepared by dissolving 36.6 g of 
TBX in 1 L sterile water followed by autoclaving at 121 °C.  Different concentrations of 
ciprofloxacin in the molten agar were prepared according to the dilution details given in 
Table 6-1.  
Table 6-1: Preparation of ciprofloxacin solutions used to prepare TBX supplemented with 16, 32, 64, 125 and 
2000 µg/L ciprofloxacin. 
Ciprofloxacin 
stock used 
(mg/L) 
Volume 
of stock 
(mL) 
Diluted with 
sterile water 
(mL) 
Ciprofloxacin  
concentration 
obtained (mg/L) 
Final nominal concentration in 
TBX after addition to 950 mL of 
agar (µg/L) 
10,000 0.1 9.9 100 - 
100 1.0 9.0 10 - 
10 1.6 48.4 0.32 16 
10 3.2 46.8 0.64 32 
10 6.4 43.6 1.28 64 
10 12.5 37.5 2.50 125 
100 20 30 40 2000 
 
The molten agar supplemented with ciprofloxacin (8 mL) was then dispensed into 50 mm 
petri dishes for membrane filtration testing (see Section 6.2.5). In addition, 50 mL of each 
ciprofloxacin concentration was dispensed into 120 mm square petri dishes for the 
evaluation of tryptone bile X-glucuronide media for E.coli ciprofloxacin susceptibility testing. 
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6.2.3 Microcosm preparation 
Microcosms were established in 4L conical flasks to simulate surface water receiving treated 
wastewater effluent. Flasks were closed with a silicone stopper (Bugstopper™, Whatman, 
UK) to prevent the evaporation of water and to prevent organisms entering the flasks whilst 
allowing a free passage of air to vent the flasks. The flasks were gently agitated using 
magnetic stirrers to facilitate oxygen transfer to the water from the flask headspace, so that 
aerobic conditions were adequately maintained. To prevent UV- light inactivation of E.coli, 
the microcosms were wrapped in aluminium foil. The microcosms were located in a 
laboratory with a controlled temperature of 21 °C.  
The surface water and wastewaters used in the microcosms were collected on the same day 
that the microcosms were to be established. 50 L of surface water was collected up-stream 
of the final treated effluent discharge point of a large urban wastewater plant. 5 L of settled 
sewage and 10 L of final treated effluent were collected from sampling points prior to and 
after the activated sludge treatment system (described in Chapter 4 Section 4.2.2). The 
surface water, effluent and settled sewage were collected in 10 L jerricans (Fisher scientific, 
UK) previously sterilised by irradiation and stored in ice during return to the laboratory. The 
surface water (37.5 L), final treated effluent (7.5 L) and settled sewage (2.25 L) were mixed 
thoroughly in sterile containers before distributed to each of the 4 L conical flasks.  
More details on the construction of the surface water microcosms to assess the use of 
protozoa inhibitor compounds on the survival of E.coli are given in Section 6.2.8. The 
microcosm experiment set up to monitor the proliferation of ciprofloxacin resistant E.coli is 
described in Section 6.2.9. 
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6.2.4 Enumeration of total culturable E.coli  
The concentrations of total culturable E.coli present within each microcosm were 
enumerated using the membrane filtration technique (previously described in Chapter 5, 
Section 5.2.4.1). However, tryptone bile x-glucuronide (TBX) media was employed as it is 
specific for the detection of E.coli. Water samples from each microcosm were serially 
diluted (ten-fold) and 100 mL aliquots were filtered through 0.45 µm, 47 mm, cellulose 
nitrate membrane filters. The membrane filters were then placed on to TBX (in 50 mm petri 
dishes) and incubated for 4 h at 30°C, followed by 18 - 24 h at 44°C. E.coli produce 
blue/green colonies on TBX and therefore all blue/green colonies were enumerated.  
6.2.5 Enumeration of E.coli resistant to 32, 64, 125 and 2000 µg/L ciprofloxacin  
The counts of E.coli resistant to different concentrations of ciprofloxacin were enumerated 
by the membrane filtration technique (previously described in Chapter 5, Section 5.2.4.1) 
using TBX media supplemented with ciprofloxacin (to final nominal concentrations 16, 32, 
64, 125, and 2000 µg/L). The ciprofloxacin concentrations were selected as they span the 
concentrations that define sensitive and wild type strains up to concentrations greater than 
those used to define resistant and non-wild type strains. The E.coli/ciprofloxacin clinical 
breakpoint and the epidemiological cut off values defined by the European Committee of 
Antimicrobial Susceptibility Testing and used for interpretation in this study are given in 
Chapter 5, Section 5.2.7.1. 
From the diluted samples used to enumerate the total culturable E.coli (described in Section 
6.2.4), five additional 100 mL aliquots were filtered through 0.45 µm, 47 mm, cellulose 
nitrate membrane filters and placed on to TBX with the final nominal ciprofloxacin 
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concentrations of 16, 32, 64, 125 and 2000 µg/L). Following incubation for 4 h at 30°C, 
followed by 18 - 24 h at 44°C, blue/green colonies on each filter were enumerated. 
6.2.5.1  Interpretation of E.coli counts enumerated on TBX supplemented with 
ciprofloxacin 
The proportion (%) of total culturable E.coli resistant to 16, 32, 64, 125 and 2000 µg/L 
ciprofloxacin within each microcosm was estimated by comparing the E.coli counts 
(CFU/100 mL) on TBX supplemented with the appropriate level of ciprofloxacin with the 
corresponding counts of total culturable E.coli on TBX without ciprofloxacin using Equation 
6-1.  
Equation 6-1 
% resistance to x µg/L ciprofloxacin= 
[E.coli] on  TBX supplemented with x µg/L ciprofloxacin
[E.coli]  on TBX
 
Where: 
[E.coli]    =  concentration of E.coli (CFU/100 mL) 
x   =  final nominal ciprofloxacin concentration of TBX media 
The concentration (CFU/100 mL) of E.coli enumerated on each TBX plate supplemented with 
ciprofloxacin and the corresponding proportion (%) of the total culturable E.coli population 
were interpreted as follows: 
MIC50: The TBX ciprofloxacin concentration that inhibits ~ 50 % of the total culturable E.coli 
population within each microcosm 
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MIC90: The TBX ciprofloxacin concentration that inhibits ~ 90 % of the total culturable E.coli 
population within each microcosm 
% acquired resistance: The proportion (%) of total culturable E.coli determined on TBX 
supplemented with a final nominal concentration of 125 µg/L ciprofloxacin.  According to 
the epidemiological cut off value, E.coli strains with ciprofloxacin minimum inhibitory 
concentration value > 64 µg/L are non-wild type with acquired resistance. Therefore TBX 
supplemented with 125 µg/L ciprofloxacin was selected to determine the proportion of the 
total E.coli population with acquired ciprofloxacin resistance. 
6.2.6 Evaluation of TBX supplemented with ciprofloxacin to determine ciprofloxacin MIC 
values. 
To evaluate TBX supplemented with ciprofloxacin for the determination of E.coli 
ciprofloxacin minimum inhibitory concentration (MIC) values, a selection of E.coli strains 
with known ciprofloxacin MICs (determined using ETEST®) were selected. The ciprofloxacin 
MICs determined using TBX were then compared to those obtained by the ETEST method® 
To obtain ciprofloxacin MIC values using TBX, the agar dilution method reported by EUCAST 
(2000) was used. A suspension (comparable to a 0.5 McFarland turbidity standard) of each 
isolate (fresh culture) was prepared in a 0.85 % sodium chloride solution and applied onto 
TBX media supplemented with twofold concentrations of ciprofloxacin (within the range 16 
– 2000 µg/L). TBX without ciprofloxacin was used as a positive control for E.coli growth. The 
media was incubated for 4 h at 30°C, followed by 18 - 24 h at 44°C.  Following incubation, 
the MIC value was determined from TBX with a final ciprofloxacin concentration that visibly 
inhibited the growth of the isolate.  
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The MIC values determined by both methods were analysed using the Mann Whitney test 
(data did not have a normal distribution with or without data transformation). In addition, 
the MIC values determined using both methods were analysed for essential agreement. 
Essential agreement describes the proportion (%) of MIC values obtained for the fifty 
isolates by the two antibiotic susceptibility testing methods that are within ± one two-fold 
concentration (Canton et al., 2000). 
6.2.7 Application of TBX supplemented with ciprofloxacin to detect E.coli within surface 
waters 
The membrane filtration technique employing TBX supplemented with ciprofloxacin was 
trialled to detect E.coli resistant to different concentrations of ciprofloxacin within surface 
water. Surface water samples were collected (in duplicate) down-stream relative to a 
treated effluent discharge point of a large urban wastewater treatment plant (the 
description and map of the sampling site are given in Chapter 5, Section 5.2.2). E.coli with 
and without acquired ciprofloxacin resistance were previously detected at this sampling 
location (see Chapter 5, Section 5.3.4.3) and therefore the sampling site was selected for 
this trial.  
A selection of blue/green colonies (n = 131) were taken from membrane filters incubated on 
TBX supplemented with final nominal concentrations of ciprofloxacin (16, 32, 64, 125 and 
2000 µg/L). The identity of each colony was confirmed using MALDI-TOF-MS analysis 
(according to the method given in Chapter 5, Section 5.2.6.2). In addition, the identity of a 
selection of blue/green colonies (n = 30) from membrane filters incubated on TBX without 
ciprofloxacin were verified using MADI-TOF-MS analysis. 
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All 131 colonies taken from TBX supplemented with ciprofloxacin to a final ciprofloxacin 
concentration of x µg/L were presumed to produce ciprofloxacin minimum inhibitory 
concentration (MIC) values > x µg/L. To verify the level of ciprofloxacin resistance 
determined using TBX supplemented with ciprofloxacin, the ciprofloxacin MIC values for 
each isolate were determined using ETEST® (according to the method given in Chapter 5, 
Section 5.2.7). If the ciprofloxacin MIC value exceeded the TBX supplemented concentration 
the isolate was taken from, the level of ciprofloxacin resistance was considered as verified. 
6.2.8 Evaluation of protozoa inhibitor compounds on the survival of E.coli in microcosms 
The effect of different protozoa inhibitor treatments on the survival of E.coli in surface 
water microcosms was assessed using twelve flasks set up as described in Section 6.2.3.  
Three different protozoa inhibitor treatments and a control (no protozoa inhibitors used) 
were assessed in triplicate. The protozoa inhibitors used, the quantity used and when the 
inhibitors were administered to the microcosms are described in Table 6-2. Water samples 
for the enumeration of E.coli (using the method outlined in Section 6.2.4) were taken on the 
day the microcosms were set up (day 0), and then on days 3, 7, 10 and 14. The enumeration 
of E.coli within each microcosm was performed in triplicate. 
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Table 6-2: Protozoa inhibitors used to increase the survival of E.coli in surface water microcosms. 
Protozoa 
inhibitor 
Quantity added to 
microcosm (mg) 
Final volume 
of microcosm 
(L) 
Final concentration 
of inhibitor in 
microcosm (mg/L) 
Administered 
(day) 
Control - 2 - - 
Cycloheximide 1000 2 500 a 0 
Periodic addition 
of cycloheximide  
1000 per addition 2 1000 
a 0 and 3, 7 
and 10 
Cycloheximide 
and colchicine 
400 (cycloheximide) 
200 (colchicine) 
2 
200 (cycloheximide) 
100 (colchicine) 
a0 
-No protozoa added. a Protozoa inhibitor added at the commencement of the microcosms 
6.2.9 Microcosm experiment to assess the proliferation of ciprofloxacin resistant E.coli 
For this experiment, fifteen flasks each containing 3L of a surface water/wastewater mix 
were set up as described in Section 6.2.3. To inhibit protozoa, colchicine (300 mg) and 
cycloheximide (600 mg) were added to each flask to give final concentrations of 200 and 
100 mg/L. The decision to use colchicine and cycloheximide to inhibit protozoa was based 
on the results presented in Section 6.3.1. Five groups of triplicate microcosms (see Table 
6-3) were used to investigate the ciprofloxacin resistance profiles of E.coli exposed to five 
different levels of additional ciprofloxacin (0, 5, 10, 50 and 100 µg/L).  Appropriate volumes 
of a ciprofloxacin stock solution were added to the microcosms to reach nominal 
ciprofloxacin exposure concentrations as outlined in Table 6-3. The exposure concentration 
defines the concentration added to the microcosm which is additional to the concentration 
already present in the surface water/wastewater sample within each microcosm. The 
concentration already present in the surface water/ wastewater sample was determined by 
liquid chromatography mass spectrometry as outlined in Section 6.2.9.1. 
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Table 6-3: Administration of ciprofloxacin to constructed microcosms.  
a Exposure level of 
additional ciprofloxacin 
(µg/L) 
Spiking volume of 100 mg/L 
ciprofloxacin stock solution 
(mL) 
Volume of homogenised 
sample in flask (L) 
0 0 3 
5 0.15 3 
10 0.3 3 
50 1.5 3 
100 3.0 3 
 a nominal concentration that is additional to the concentration already present in the sample.  
The microcosm experiment was initially carried out in November 2012 and repeated in July 
2013. Samples from each microcosm for bacteriological analysis (enumeration of total 
culturable E.coli and E.coli resistant to ciprofloxacin) were taken on day 0 (the day the 
microcosms were established, before additional ciprofloxacin exposure). Additional samples 
were taken on days 1, 7, 10 and 14 (post ciprofloxacin exposure). During the experiment 
carried out in July 2013, additional samples for bacteriological analysis were also taken on 
day 3 (post additional ciprofloxacin exposure). 
6.2.9.1 Chemical analysis 
Aliquots of the surface water/wastewater mixed sample used for the microcosms were 
taken for quantification by liquid chromatography mass spectrometry (see the method 
description in Chapter 4, Section 4.2.5) to determine the ciprofloxacin levels already present 
in the microcosm surface water/wastewater mix. Water quality parameters (pH, total 
suspended solids (TSS) and dissolved oxygen (DO)) were measured for each microcosm at 
the commencement of the experiment. Dissolved oxygen (DO) was subsequently measured 
at daily intervals to ensure aerobic conditions were maintained (> 65 % saturation).  TSS was 
determined by the method described in Chapter 4, Section 4.2.4. 
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Kruskal-Wallis one-way analysis of variance was used to ascertain if the water quality 
parameters differed significantly. This non-parametric test was used as the acquired data 
was not normally distributed. 
6.2.9.2 Bacteriological analysis 
Duplicate samples (60 mL) for the determination of E.coli ciprofloxacin resistance profiles 
were extracted using a sterile pipette and stored in  100 mL sterile polypropylene containers 
at 4 °C until analysis (within 4 h) on the day the experiment commenced (i.e. before 
exposure to additional ciprofloxacin) and then on days 1, 7, 10 and 14. In the second 
microcosm experiment carried out in July 2013, samples for bacterial analysis were also 
extracted on day 3. 
6.2.9.3 Statistical analysis 
Analysis of difference of the proportion of total culturable E.coli with acquired ciprofloxacin 
resistance among microcosms exposed to different levels of ciprofloxacin was carried out 
using one-way ANOVA with post hoc Tukey analysis. Additionally, the proportion of 
ciprofloxacin acquired resistance within the constructed microcosms over time was 
performed using one-way ANOVA with post hoc Tukey analysis.  
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6.3 Microcosm bacteriological analysis 
6.3.1 The effect of protozoa inhibitors on the survival of E.coli in surface water 
microcosms 
Protozoa can impair the survival of E.coli in natural waters through grazing (Enzinger et al., 
1976). The effect of three different protozoa inhibitor treatments (cycloheximide, periodic 
addition of cycloheximide and a combination of cycloheximide and colchicine) on the 
survival of E.coli within surface water microcosms (mixed with wastewater) were assessed 
in triplicate over 14 days. In addition, triplicate surface water microcosms without the 
addition of a protozoa inhibitor compound were monitored as a control. 
At the commencement of the experiment (day 0), the concentrations of E.coli were similar 
(one-way ANOVA - p > 0.05) in all microcosms (within the range 5.0 – 5.4 log10 CFU/100 mL) 
followed by a progressive decrease over 14 days (Figure 6-1). A larger decrease in the 
concentration of E.coli was observed in the control microcosms (no protozoa inhibitor 
compounds added) compared to the other microcosms. Thus indicating protozoa do impact 
the survival of E.coli in natural waters. 
However, the addition of a both cycloheximide and colchicine into the surface water 
microcosms at day 0 resulted in significantly higher concentrations (average ± standard 
deviation = 3.6 ± 0.1 log10 CFU/100 mL) of E.coli on day 14 compared to all other 
microcosms (one-way ANOVA – p < 0.05). Therefore, cycloheximide and colchicine were 
used to inhibit protozoa in subsequent microcosm experiments. 
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Figure 6-1: Changes in the total culturable E.coli concentrations within microcosms exposed to different 
protozoa inhibitor treatments 
6.3.2 Evaluation of TBX supplemented with ciprofloxacin to determine ciprofloxacin 
minimum inhibitory concentration values of E.coli. 
The ciprofloxacin minimum inhibitory concentration (MIC) values of fifty E.coli isolates were 
determined by two methods: the agar dilution method employing TBX supplemented with 
ciprofloxacin and with ETEST® antibiotic gradient strips. A summary of the MIC values 
obtained by both methods is given in Table 6-4.  
Mann Whitney analysis of the determined MIC values did not find any significant difference 
between the two methods (Table 6-4). The proportion of MIC values determined using TBX 
that were in essential agreement with the ETEST® method (98.0 %) was high. Furthermore, 
the proportion of isolates that were identified as non-wild type (with acquired ciprofloxacin 
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resistance according to the epidemiological cut off value) by the two methods differed by 
only 2 %. Therefore the use of TBX for the determination of E.coli ciprofloxacin MIC values 
was considered appropriate for use in this study. 
Table 6-4: Comparison of the ciprofloxacin MIC values determined for fifty E.coli isolates by TBX supplemented 
with ciprofloxacin and the ETEST®. 
 TBX ETEST® 
MIC range (µg/L) 16 - 2000 16 - 2000 
Median (µg/L) 64 64 
% ≤ ECOff 54.0  56.0 
% > ECOff 46.0 44.0 
Identical MIC values (%) 80.0 
a % Essential agreement 98.0 
Mann Whitney  p = 0.876 
a Essential agreement – the proportion of MIC values by the two methods that are within ± one two fold 
concentration 
6.3.3 Application of TBX supplemented with ciprofloxacin to detect E.coli resistant to 
different concentrations of ciprofloxacin. 
Surface water samples were processed using the membrane filtration technique employing 
TBX supplemented with different concentrations of ciprofloxacin (0, 16, 32, 64, 125 and 
2000 µg/L). A selection of blue/green colonies (presumptive E.coli) was isolated in order to 
verify their identity using MALDI-TOF-MS analysis. In addition, for each isolate taken from 
TBX supplemented with ciprofloxacin, the ciprofloxacin MIC values were determined. The 
proportion of isolates that confirmed as E.coli is given in Table 6-5. The proportion of 
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isolates with ciprofloxacin MIC values exceeding the TBX supplemented concentration is 
also presented in Table 6-5. 
Table 6-5: The proportion (%) of isolates taken from surface water using TBX, verified as E.coli and the 
proportion of isolates that produced ciprofloxacin MIC values exceeding the TBX supplemented concentration. 
 % of total presumptive E.coli 
a TBX ciprofloxacin 
concentration (µg/L) 
Number of 
isolates tested 
b identity verified as 
E.coli 
  Ciprofloxacin MIC 
value > TBX 
ciprofloxacin 
concentration 
0 30 96.7 ND 
16 20 100.0 100.0 
32 40  90.0  100.0 
64 20 100.0 100.0 
125 31 93.5 100.0 
2000 20 100.0 100.0 
a TBX media was supplemented with the stated final nominal concentrations. b Isolates not verified as E.coli 
were identified as C. freundii. ND – not done 
A high proportion (> 90.0 %) of presumptive E.coli isolates taken from TBX supplemented 
with different concentrations of ciprofloxacin was verified as E.coli. In addition, all isolates 
taken from TBX supplemented with ciprofloxacin produced ciprofloxacin MIC values 
exceeding the TBX supplemented concentration. The isolates that were not verified as E.coli 
were identified as Citrobacter Freundii. Similar false positive identifications using 
chromogenic media specifically for the detection of E.coli and coliforms have been reported 
by Alonso et al. (1996).  
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The results show that TBX supplemented with ciprofloxacin is highly specific for the 
detection of E.coli within surface water and is suitable for the detection of E.coli resistant to 
different levels of ciprofloxacin. 
6.3.4 Microcosm experiments to assess the proliferation of ciprofloxacin resistant E.coli 
Microcosm experiments to assess the proliferation of ciprofloxacin resistant E.coli in surface 
waters were carried out in November 2012 and repeated in July 2013. The counts of total 
culturable E.coli and of E.coli resistant to different levels of ciprofloxacin were enumerated 
within all microcosms over the course of 14 days. Appropriate physicochemical parameters 
were also monitored during each microcosm experiment. 
6.3.4.1 Microcosm physicochemical parameters 
Table 6-6 summarises the water quality parameters observed in the microcosm experiments 
conducted in November 2012 and in July 2013. The dissolved oxygen levels were maintained 
throughout the duration of the experiments (7.9 – 8.1 mg/L) and ensured the preservation 
of aerobic conditions (Kruskal-Wallis; p = > 0.05) amongst all microcosms. The pH values 
measured in the all of the constructed microcosms were comparable (7.4 – 7.6) (Kruskal-
Wallis; p = > 0.05) and within the range ( ≥ 6.0 – ≤ 9.0) expected in rivers in the UK for the 
support of biota (UK Technical Advisory Group on the Water Framework Directive  (UKTAG), 
2008). The total suspended solid (TSS) concentrations were consistent for the different 
series of experiments (Kruskal-Wallis; p = > 0.05) performed in November 2012 and July 
2013. However elevated TSS concentrations (150.0 – 155.0 mg/L) were observed for the July 
experiment compared to those observed in November 2012 (90.6 – 96.3 mg/L).  
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Table 6-6: Water quality parameters measured within microcosms exposed to different 
additional concentrations of ciprofloxacin (0, 5, 10, 50 and 100 μg/L), in the experiments 
carried out in November 2012 and July 2013 
 Water quality parameters (mean ±standard deviation) 
Exposure level of additional 
ciprofloxacin (µg/L) 
TSS (mg/) pH DO (mg/L) 
a Ciprofloxacin 
(ng/L) 
November 2012 experiment 
0 96.3 ± 3.1 7.4 ±0.1 8.1 ± 0.1 
257 ± 16 
5 93.3 ± 2.5 7.5 ± 0.1 8.0 ± 0.1 
10 92.0 ± 1.1 7.5 ± 0.2 8.0 ± 0.1 
50 95.2 ± 0.6 7.5 ± 0.1 8.0 ± 0.1 
100 90.6 ± 2.1 7.4 ± 0.1 7.9 ± 0.1 
July 2013 experiment 
0 154.0 ±5.6 7.6 ± 0.0 7.9 ± 0.1 
161 ± 81 
5 155.0  ±4.7 7.6 ± 0.1 7.9 ± 0.1 
10 150.0 ± 2.7 7.6 ± 0.0 7.9 ± 0.1 
50 154.0 ± 2.0 7.6 ± 0.1 7.9 ± 0.1 
100 152.1 ± 2.9 7.5 ± 0.0 7.9 ± 0.1 
a Levels of ciprofloxacin detected in the mixed surface water/sewage sample prior to exposure to additional 
levels of ciprofloxacin. TSS represents the mean total suspended solids concentration of triplicate microcosms 
measured on day 0 when the experiment was commenced. pH is the mean value of triplicate microcosms 
measured on day 0. DO represents the mean (n = 42) dissolved oxygen level measured over the course of the 
experiment (days 0, 1, 7, 10 and 14).   
The concentrations of ciprofloxacin measured in the surface water/wastewater mixed 
samples used for the microcosm experiments were 257 ± 16 ng/L (November 2012) and 161 
± 81 ng/L (July 2013). These values are comparable to those previously detected in surface 
waters down-stream from the WWTP treated effluent discharge point (Chapter 4, Section 
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4.3.3) and are comparable to concentrations reported in surface waters in other studies 
(Tuc Dinh et al., 2011 and Watkinson et al., 2009).  
6.3.4.2 Enumeration of total culturable E.coli in surface water microcosms exposed to 
different levels of ciprofloxacin 
The concentrations of total culturable E.coli enumerated within all microcosms over the 
course of the 14 day experiments  carried out in November 2012 and in July 2013 are shown 
in Figure 6-2 A and B. For both experiments, total culturable E.coli were present in similar 
concentrations for all microcosms on the first sampling date (Day 0 – before exposure to 
additional ciprofloxacin). However, the initial concentration of total culturable E.coli were 
slightly higher (in the order of 5.9 log10 CFU/100 mL) among microcosms analysed in July 
2013 compared to November 2012 (in the order of 4.8 log10 CFU/100 mL). This could, in 
part, be explained by the higher concentration of suspended solids that were present in 
microcosms analysed in July 2013 (see Table 6-6). 
The counts of total culturable E.coli decreased over the course of both experiments.  For the 
experiment carried out in July 2013, the concentration decreased to non-detectable limits in 
microcosms exposed to 100 µg/L additional ciprofloxacin on day 10. Additionally, total 
culturable E.coli could not be detected within microcosms exposed to 5 and 50 µg/L 
ciprofloxacin by day 14. During the experiment in November 2012, total culturable E.coli 
could not be enumerated in microcosms exposed to 100 µg/L additional ciprofloxacin on 
day 14. 
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Figure 6-2: The enumeration of total culturable E.coli (average ± standard deviation) within the constructed 
microcosms exposed to different levels of additional ciprofloxacin on five sampling dates in November 2012 
(A) and six sampling dates in July 2013 (B). 
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A closer look at the concentrations of total culturable E.coli for both experiments 
(November 2012 and July 2013) revealed that the reduction (%) in concentration between 
sampling day 0 (before additional ciprofloxacin exposure) and sampling day 1 (after 
ciprofloxacin exposure) was significantly greater (p < 0.05) within microcosms exposed to 50 
and 100 µg/L ciprofloxacin compared to the other microcosms (as shown in Table 6-7). Thus 
demonstrating an impact of exposure to additional ciprofloxacin at concentrations greater 
than 50 µg/L on the total culturable E.coli population. The percentage reduction of E.coli 
was calculated using Equation 6-2. 
Table 6-7: Reduction of E.coli (%) in constructed microcosms after 1 day following exposure to either, 0, 5, 10, 
50 or 100 µg/L additional ciprofloxacin. 
 a Mean % reduction ±  standard deviation  
Exposure level of additional 
ciprofloxacin (µg/l) 
November 2012 July 2013 
0 6.5 ± 9.4 1.4 ± 5.6 
5 11.3 ± 14.6 5.7 ± 12.4 
10 20.1 ± 6.5 32.0 ± 6.2 
50 *51.3 ± 17.2 *65.8 ± 3.9 
100 *70.9 ± 9.9 *70.0 ± 20.2 
a Calculated from Equation 6-2.* Statistical difference (p < 0.05) between microcosm groups (One-way ANOVA 
with Tukey post hoc analysis). 
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Equation 6-2: 
 Reduction following ciprofloxacin exposure (%) =  
day 0 - day 1
day 0
 x 100 
Where: 
day 0 = total culturable E.coli (CFU/100 mL) measured on day 0 (before exposure to 
ciprofloxacin) 
day 1 = total culturable E.coli (CFU/100 mL) measured on day 1 (after exposure to 
ciprofloxacin). 
During the experiment carried out in November 2012, the reduction in total culturable E.coli 
between the subsequent sampling days was similar (within the range 92.0 – 99.2 %) among 
all microcosms (data not shown). Similarly, the reduction in total culturable E.coli between 
subsequent sampling days (78.3 – 98.4 %) was similar among microcosms monitored in July 
2013. 
6.3.4.3 Minimum inhibitory concentration determination 
The ciprofloxacin MIC50 and MIC90 values determined for the total E.coli population within all 
microcosms over the course of the experiments commenced in November 2012 and in July 
2013 are summarised in Tables 6-8 and  6-9. In addition, the range of TBX supplemented 
ciprofloxacin concentrations for which E.coli could be detected is given. Not determined 
(ND) is recorded where E.coli counts on TBX supplemented with ciprofloxacin were below 
detectable limits.     
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Table 6-8: Ciprofloxacin minimum inhibitory concentration (MIC) values for the E.coli population within 
microcosms before (day 0) and after (days 1, 7, 10 and 14) exposure to different levels of additional 
ciprofloxacin during the experiment commenced November 2012.  
Exposure level of 
additional ciprofloxacin 
(µg/L) 
Sample day Range (µg/L) MIC50 (µg/L) MIC90 (µg/L) 
0 µg/L  
0 16 - 2000 16 125 
1 16 - 2000 16 125 
7 16 -2000 16 125 
10 16 - 64 16 ND 
14 ND ND ND 
 
5 µg/L  
0 16 - 2000 16 125 
1 16 - 2000 16 125 
7 16 - 2000 16 2000 
10 16 - 64 16 ND 
14 ND ND ND 
 
10 µg/L  
0 16 - 2000 16 125 
1 16 - 2000 16 2000 
7 16 - 2000 16 2000 
10 16 - 64 16 ND 
14 ND ND ND 
 
50 µg/L  
0 16 - 2000 16 125 
1 16 - 2000 125 >2000 
7 16 - 2000 125 >2000 
10 16 - 64 ND ND 
14 ND ND ND 
100 µg/L 
0 16 - 2000 16 125 
1 16 - 2000 125 >2000 
7 16 - 2000 125 >2000 
10 ND ND ND 
 14 ND ND ND 
MIC50 is an estimate of the concentration of antibiotic that inhibits 50% of the population of total E.coli. MIC90 
is an estimate of the concentration of antibiotic that inhibits 90% of the population of total E.coli. ND – could 
not be determined from the counts on TBX supplemented with ciprofloxacin.  
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Table 6-9: Ciprofloxacin minimum inhibitory concentration (MIC) values for the E.coli population within 
microcosms before (day 0) and after (days 1, 3, 7, 10 and 14) exposure to different levels of additional 
ciprofloxacin during the experiment commenced in July 2013. 
Exposure level 
of additional 
ciprofloxacin 
(µg/L) 
Sample 
day 
Range (µg/L) MIC50 (µg/L) MIC90 (µg/L) 
0 µg/L  
0 16 - 2000 16 125 
1 16 - 2000 16 125 
3 16 - 2000 16 125 
7 16 - 2000 16 125 
10 16 - 125 16 ND 
14 ND ND ND 
5 µg/L  
0 16 - 2000 16 125 
1 16 - 2000 16 125 
3 16 - 2000 16 2000 
7 16 - 2000 16 2000 
10 16 - 125 16 ND 
14 ND ND ND 
10 µg/L  
0 16 - 2000 16 125 
1 16 - 2000 16 2000 
3 16 - 2000 16 2000 
7 16 - 2000 16 2000 
10 ND ND ND 
14 ND ND ND 
50 µg/L  
0 16 - 2000 16 125 
1 16 - 2000 64 >2000 
3 16 - 2000 125 >2000 
7 16 - 2000 125 >2000 
10 16 - 2000 125 ND 
14 ND ND ND 
100 µg/L  
0 16 - 2000 16 125 
1 16 - 2000 125 >2000 
3 16 - 2000 125 >2000 
7 16 - 2000 125 >2000 
10 ND ND ND 
 14 ND ND ND 
MIC50 is an estimate of the concentration of antibiotic that inhibits 50% of the population of total E.coli. MIC90 
is an estimate of the concentration of antibiotic that inhibits 90% of the population of total E.coli. ND – could 
not be determined from the counts on TBX supplemented with ciprofloxacin. 
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During the experiment in November 2012, within all microcosms before and after exposure 
to additional ciprofloxacin up until sampling day 7, E.coli could be detected on TBX 
supplemented with ciprofloxacin at levels between 16 and 2000 µg/L. This demonstrates 
that E.coli with and without ciprofloxacin acquired resistance (according to the 
epidemiological cut off value – non-wild type > 64 µg/L) in addition to resistant E.coli 
(according to clinical breakpoints - resistant > 1000 µg/L) were present in all microcosms 
over 7 days. E.coli could not be detected on TBX supplemented with ciprofloxacin at 
concentrations > 64 µg/L by day 10. However, the low number of total culturable E.coli 
found in the microcosms on sampling day 10 (see Figure 6-2) may have contributed to an 
apparent decrease in resistance by lowering the probability of detecting the resistant 
bacteria.  Similar results were observed during the experiment commenced in July 2013, 
confirming that E.coli with acquired ciprofloxacin resistance mechanisms can survive in 
surface water microcosms for at least 7 days.   
For both experiments, an increase in the estimated ciprofloxacin MIC50 value (from 16 to 
125 µg/L) occurred following exposure to additional ciprofloxacin within microcosms 
exposed to 50 and 100 µg/L additional ciprofloxacin. No changes in the ciprofloxacin MIC50 
occurred in all the other microcosms as shown in Tables 6-8 and  6-9. The estimated 
ciprofloxacin MIC90 values from all microcosms except those without exposure to additional 
ciprofloxacin, also demonstrated an increase following exposure to additional ciprofloxacin 
(from 125 to 2000 µg/L). Where detected, the elevated MIC50 and MIC90 values remained 
constant within microcosms until the counts of E.coli became too low to detect ciprofloxacin 
resistant E.coli.  
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6.3.4.4 The prevalence of ciprofloxacin resistance among E.coli within microcosms 
exposed to different levels of ciprofloxacin  
The proportions (%) of total E.coli with acquired ciprofloxacin resistance measured in 
microcosms exposed to different levels of additional ciprofloxacin during the experiments 
commenced in November 2012 and in July 2013 are presented in Tables 6-10 and  6-11. 
Overall the trends observed from the microcosm experiments commenced in November 
2012 were similar to those observed for the experiment carried out in July 2013.  
Table 6-10: The proportion (%) of total E.coli with acquired ciprofloxacin resistance within microcosms exposed 
to different additional levels of ciprofloxacin over the course of the experiment in November 2012. 
 a % acquired resistance 
Exposure to 
additional 
ciprofloxacin 
(µg/L) 
b Day 0  
 
Day 1  
 
Day 7  
 
Day 10 
 
Day 14  
 
0  12.1 ±4.4 15.0 ± 5.6 11.9 ± 0.9 ND ND 
5 9.6 ± 0.8 11.7 ± 2.7 20.5 ± 3.7 ND ND 
10  12.2 ± 20 18.6 ± 1.8 20.8 ± 3.7 ND ND 
50 12.1 ± 4.1 46.6 ± 12.7* 47.3 ± 5.2* ND ND 
100  13.6 ± 0.1 54.4 ± 6.2* 51.7 ± 1.5* ND ND 
c One-way 
ANOVA 
P = 0.657 P < 0.001 P < 0.001 ND ND 
a average % ± standard deviation of triplicate microcosms. b Before exposure to additional ciprofloxacin. 
*Significantly different. c One way ANOVA with post hoc Tukey analysis. ND - could not be determined as E.coli 
counts on TBX supplemented with ciprofloxacin levels > 64 µg/L were below detection limits.  
The proportion of total E.coli with acquired ciprofloxacin resistance was similar (p > 0.05) 
among all microcosms prior to exposure with additional ciprofloxacin. However, significantly 
elevated levels of acquired ciprofloxacin resistance (p < 0.05) occurred within microcosms 
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exposed to 50 and 100 µg/L additional ciprofloxacin compared to the other microcosms 
following exposure (see Tables 6-10 and  6-11).  
Table 6-11: The proportion (%) of total E.coli with acquired ciprofloxacin resistance within microcosms exposed 
to different additional levels of ciprofloxacin over the course of the experiment in July 2013. 
 a% acquired resistance  
Exposure to 
additional 
ciprofloxacin 
(µg/L) 
b  Day 0  
 
 Day 1  
 
Day 3  
 
Day 7  
 
Day 10 
 
Day 14  
 
0  9.9 ±1.4 12.5 ± 3.0 15.5 ± 3.7 15.3 ± 6.1 ND ND 
5 10.7 ± 2.0 10.8 ± 0.7 30.4 ± 6.1 24.8 ± 5.0 ND ND 
10  10.5 ± 0.3 12.8 ± 11.3 29.2 ± 11.2 23.6 ± 8.6 ND ND 
50 9.7 ± 2.8 41.2 ± 13.5* 66.1 ± 5.6* 63.5 ± 9.8* 66.7 ± 1.8 ND 
100  14.7 ± 0.5 60.9 ± 19.6* 75.5 ± 8.4* 50 ± 0.0* ND ND 
c One-way 
ANOVA 
P = 0.09 P = 0.04 P < 0.001 P = 0.001 ND ND 
a average % ± standard deviation of triplicate microcosms. b Before exposure to additional ciprofloxacin. 
*Significantly different. c One way ANOVA with post hoc Tukey analysis. ND - could not be determined as E.coli 
counts on TBX supplemented with ciprofloxacin levels > 64 µg/L were below detection limits.  
This demonstrates a more pronounced effect of the influent antibiotic at concentrations 
close to the epidemiological cut off value (64 µg/L) on the prevalence of acquired resistance. 
The proportion of resistance within microcosms exposed to 50 and 100 µg/L additional 
ciprofloxacin remained high until the levels of E.coli became too low to evaluate the levels 
of acquired ciprofloxacin resistance (day 10). 
6.3.4.5 The changes in proportion of total E.coli with acquired ciprofloxacin resistance 
with time 
The proportion of E.coli with acquired ciprofloxacin resistance over the course of the 
experiments carried out in November 2012 and July 2013 are presented in Figure 6-3 A and 
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B. An overall comparison of the replicate experiments conducted in November 2012 and 
July 2013, reveals a trend in the prevalence of acquired ciprofloxacin resistance among 
microcosms. For both experiments the resistance levels, except for those without exposure 
to additional ciprofloxacin, demonstrated an increase. However, the level of acquired 
resistance remained constant (P < 0.05) within microcosms without additional ciprofloxacin 
exposure. In microcosms exposed to 50 and 100 µg/L additional ciprofloxacin, statistically 
elevated levels (p < 0.05) of acquired ciprofloxacin resistance were observed on sampling 
day 1 (after exposure). This was not surprising given that the total culturable E.coli 
population was significantly reduced within microcosms following exposure to 50 and 100 
µg/L additional ciprofloxacin (as shown in Table 6-7).  
Within all the constructed microcosms exposed to additional ciprofloxacin, the levels of 
acquired ciprofloxacin resistance peaked on sampling day 7 for the experiments carried out 
in November 2012 and day 3 for the experiments carried out in July 2013. Typically, the 
increase in the levels of resistance was found to be significant (one-way ANOVA with Tukey 
post hoc analysis – p < 0.05) as shown in Figure 6-3 A and B. Due to the low numbers of 
E.coli present within the microcosms on sampling days 10 and 14, the proportion of 
acquired ciprofloxacin resistance could not be measured and are therefore not presented in 
Figure 6-3.  
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Figure 6-3: The proportion (%) of E.coli with acquired ciprofloxacin resistance within microcosms exposed to 
different levels of ciprofloxacin over time. 
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6.4 Discussion 
6.4.1 Microcosm studies 
There are a wide range of environmental variables (e.g. rainfall, background resistance, 
competitive bacteria and temperature) that may influence the prevalence of antibiotic 
resistance in surface waters  making it a complex and challenging problem to monitor 
(Ashelford et al., 1997). Therefore, microcosm studies were used in this work as a simplified 
approach to study the prevalence of ciprofloxacin resistance among E.coli exposed to 
surface water receiving antibiotic residues within discharge treated wastewater effluent.  
To exert the required experimental control over the microcosms, the experiments were 
carried out without light and at a constant dissolved oxygen concentration. In addition, the 
presence of protozoa were minimised within the constructed microcosms to delay the 
decline of total culturable E.coli over the course of the experiment (see Section 6.3.1) and 
thereby provide sufficiently high numbers of E.coli to enumerate through culturable 
techniques. However, it is important to take into account that predation by eukaryotic 
organisms may impact the level of E.coli resistance that occurs within natural waters 
(Bellanger et al., 2014). 
6.4.2 Total culturable E.coli 
At the beginning of the microcosm experiments, the concentrations of total culturable E.coli 
bacteria were similar in all microcosms. However, the concentration declined over the 
course of the experiment despite the use of protozoa inhibitor compounds. This was 
expected as E.coli bacteria are not indigenous to surface waters and therefore their survival 
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requires the ability to overcome an array of environmental stresses such as competitive 
bacteria and nutrient depletion (Pathak et al., 1994;  Flint 1987). 
The epidemiological cut off value defines an antibiotic inhibitory concentration value that 
distinguishes between wild type strains without acquired resistance mechanisms and non-
wild type strains with acquired resistance  (Kahlmeter et al., 2003). Exposure to antibiotic 
levels close to the epidemiological cut off value will eliminate wild type strains from the 
population.  Therefore, it was expected that the impact of ciprofloxacin on the total 
culturable E.coli population would be more significant within microcosms exposed to 
ciprofloxacin levels close to the epidemiological cut off value (64 µg/L). The data from both 
microcosm experiments (commenced in November 2012 and July 2013) confirmed this 
hypothesis. The reduction in total culturable E.coli was significantly greater within 
microcosms exposed to 50 and 100 µg/L additional ciprofloxacin compared to microcosms 
exposed to lower levels of ciprofloxacin. This is similar to findings reported by Engemann et 
al. (2006) who observed that the size of the total bacterial community within simulated 
aquatic systems was significantly increased at greater levels of oxytetracycline (250 µg/L) 
compared to lower levels (25 µg/L).  
During both experiments, E.coli could not be detected on sampling day 10 within 
microcosms exposed to 100 µg/L additional ciprofloxacin and this probably corresponds to 
the large reduction (~ 70.0 %) in E.coli observed following exposure to additional 
ciprofloxacin on sampling day 1. 
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6.4.3 Ciprofloxacin MIC determination 
In both experiments, the range of ciprofloxacin minimum inhibitory concentration (MIC) 
values was the same for all microcosms until sampling day 10 when a smaller range of MIC 
values was observed. Although it appears there is a reduction of resistant E.coli on sampling 
day 10, the smaller MIC value range probably corresponds to the lower number of total 
E.coli and therefore a lower probability of detecting E.coli with higher ciprofloxacin MIC 
values. Despite the levels of ciprofloxacin, the range of MIC values were the same for all 
microcosms and spanned the concentrations that define wild and non-wild type E.coli and 
E.coli with MIC values that exceed the resistant breakpoint (1000 µg/L). This demonstrates 
resistant E.coli (according to both the epidemiological value and the clinical resistant 
breakpoint) are able to survive within the surface water microcosms irrespective of the level 
of ciprofloxacin exposure. 
Increases in the estimated ciprofloxacin MIC90 (the concentration that can inhibit the growth 
of 90 % of the total E.coli population) values were observed within all microcosms exposed 
to additional ciprofloxacin indicating that the resistance can become more pronounced 
following the selective pressure of added ciprofloxacin levels of 5 µg/L or greater. Conversely, 
no change in the estimated ciprofloxacin MIC values was observed within microcosms 
without additional exposure. Similar trends were reported by Helt et al. (2011) who found 
the average ciprofloxacin minimum inhibitory concentration value for the culturable 
heterotrophic population within a simulated aquatic system increased (from 2000 – 4000 
µg/L) following exposure to ciprofloxacin. Whereas, the MIC value of the heterotrophic 
231 
 
 
community in the simulated aquatic systems without ciprofloxacin exposure did not 
increase. 
The apparent absence of a change in MIC values within microcosms without additional 
ciprofloxacin exposure confirms that the trace level antibiotic concentrations typically 
present in surface waters (ng/L) are sufficient to maintain the levels of ciprofloxacin 
resistance. It also indicates there may not be an associated fitness cost with the acquisition 
of ciprofloxacin resistance mechanisms even though the survival of E.coli is impaired in 
surface water due to competitive bacteria and decreasing nutrients.  
6.4.4 Proportion of total E.coli with acquired ciprofloxacin resistance  
Bacterial resistance to antibiotics is common where antibiotics are heavily used (e.g. clinical 
environments) (Andersson et al., 2012). However, it has been established that long-term 
exposure to low concentrations of antibiotics over time is likely to contribute to the 
selection of resistant bacteria (Andersson et al., 2014;  Andersson et al., 2012;  Gullberg et 
al., 2011). In addition, there are now increasing numbers of studies that report the presence 
of antibiotic resistant bacteria in wastewater contaminated surface waters, sediments and 
increasingly in surface water environments where the concentrations of antibiotics are 
present at sub-inhibitory concentrations (Faria et al., 2009;  Pei et al., 2006;  Ash et al., 2002;  
Guardabassi et al., 1998;  Jones et al., 1986). Interestingly in this study, the introduction of 
ciprofloxacin at sub-inhibitory levels into surface water microcosms was found to have a 
considerable effect on the level of resistance (as presented in Figure 6-3).  
The results from two experiments (commenced in November 2012 and July 2013) show the 
proportion of acquired ciprofloxacin resistance significantly increased within all microcosms 
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under the selective pressure of additional ciprofloxacin exposure concentrations at levels of 
5 µg/L or above.  This is concerning because although the antibiotic concentrations in 
surface water are typically lower than this exposure level, there are reports of ciprofloxacin 
concentrations as high as 9.6  µg/L in surface waters (Feitosa-Felizzola et al. 2009). The 
increase in the prevalence of acquired ciprofloxacin resistance could be due to two 
mechanisms. Either the exposure permitted the development of resistant strains though the 
dissemination of resistance elements or eliminated wild type strains allowing for the 
proliferation of non-wild type E.coli until resistance becomes dominant.  
The increase in levels of E.coli with acquired ciprofloxacin resistance was more pronounced 
(one-way ANOVA – p < 0.05) with higher exposure concentrations (50 and 100 µg/L 
additional ciprofloxacin) and corresponds to a large reduction in the concentration of total 
culturable E.coli previously discussed in Section 6.4.2. The increased prevalence is therefore 
probably a consequence of non-wild type strains (with acquired ciprofloxacin resistance) out 
surviving their wild type (without acquired ciprofloxacin resistance) counterparts.  
Simulated freshwater studies by Yu et al. (2009) found similar trends in the prevalence of 
resistant bacteria (Enterococcus faecalis) with exposure to antibiotics (ciprofloxacin and 
oxytetracycline were investigated). In addition, Helt et al. (2011) observed increases in the 
levels of ciprofloxacin resistant E.coli within constructed wetland mesocosm studies soon 
after exposure to 2 mg/L ciprofloxacin. However, the results from replicate mesocosms 
studies did vary. Contrasting levels of resistance within a simulated river water system due to 
an influent antibiotic were reported by Munoz-Aguayo et al. (2007). The levels of resistant 
bacteria did not increase following exposure to low concentrations (8 µg/L) of chlortetracycline. 
In addition,  results from a study by Atoyan et al. (2007) demonstrated the proportion of 
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resistant bacteria within aerated and unaerated leachfield mesocosms did not increase upon the 
episodic exposure (every day for ten days) to 5 mg/L tetracycline. It was concluded that influent 
antibiotic concentrations are likely to have minimal consequences on E.coli bacteria within 
wastewater treatment processes. According to Helt et al. (2011) the contrasting results to this 
study may be a consequence of the different type of simulated system observed, the system 
conditions or a difference in the antibiotic resistance mechanisms being monitored. 
Additionally, the concentration of tetracycline used to define tetracycline resistance in E.coli by 
Atoyan et al. 2007 (10.0 mg/L) exceeds the epidemiological cut off value (8.0 mg/L) established 
by EUCAST (2012b). Therefore the level of resistance observed may have been underestimated. 
This provides another example of where a more consistent standardised approach to 
interpreting antibiotic resistance in environmental matrices is required. The interpretation of 
resistance surveillance has been discussed in more detail in Chapter 5, Section 5.4.2. 
The proportion of total E.coli with acquired ciprofloxacin resistance within microcosms 
without additional ciprofloxacin exposure did not alter over the course of both experiments. 
This suggests that at ciprofloxacin concentrations typically detected in surface waters (ng/L), 
the dissemination of ciprofloxacin resistance elements does not occur within the E.coli 
population. This is not surprising given that studies such as those reported by Muela et al. 
(1994) found horizontal gene transfer processes within the E.coli population were inhibited 
in surface water conditions (e.g. low nutrient levels). However, it has been identified that 
the investigation of horizontal gene transfer processes within environmental matrices is 
challenging and there are a complex array of parameters that can affect plasmid transfer in 
the environment. These include the burden the transferred element may have on the 
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bacterial cell survival, predation, physiological conditions in addition to selective pressure 
(Bellanger et al., 2014). 
Although the proportion of E.coli with acquired ciprofloxacin resistance did not increase 
within microcosms without additional ciprofloxacin exposure, the level was maintained. In 
addition to the ciprofloxacin MIC values discussed in Section 6.4.3 these findings suggest 
that E.coli bacteria with acquired ciprofloxacin resistance are not at any survival 
disadvantage compared to their wild type counterparts (strains without acquired 
resistance). Studies by (Caldwell et al., 1989;  Flint, 1987) support this conclusion as they 
have shown resistance plasmids are stable within E.coli whilst under survival conditions in 
river water. In addition, studies  by Enne et al. (2005) found that the burden of acquired 
resistance elements was small or non-existent to the survival of the certain strains of E.coli 
and suggested that once established, resistance may be difficult to eliminate through 
reduction in selective pressure. However, the fitness cost associated with acquired antibiotic 
resistance elements will depend on a number of factors such as the resistance element in 
question and the bacteria host and donor (Bellanger et al., 2014). It is also important to 
consider that genes encoding for antibiotic resistance are commonly found on the same 
plasmid as genes encoding for resistance to metals and disinfectants (Stepanauskas et al., 
2006). In addition, plasmids containing multiple antibiotic genes have been identified 
(Szczepanowski et al., 2009) Therefore, the level of resistance may be maintained through 
coselection. 
Although, an increase in the proportion of E.coli with acquired ciprofloxacin resistance was 
observed in microcosms following exposure to additional ciprofloxacin, the levels of 
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acquired ciprofloxacin resistance did not reach a maximum until sampling day three (during 
the experiment conducted in July 2013) and on sampling day seven (during the experiment 
conducted in November 2012). This is similar to the findings of  Yu et al. (2009), who found 
maximum levels of antibiotic resistance within freshwater mesocosms three days after 
antibiotic (ciprofloxacin and oxytetracycline) exposure. The time lag in reaching the 
maximum proportion of acquired ciprofloxacin resistance could be due to the time required 
for the bacterial population to adapt to the microcosm source water ecology and 
ciprofloxacin concentration (Helt et al. 2011). In addition, plasmid mediated acquired 
ciprofloxacin resistance occurs through a step wise acquisition of QNr genes (Kaplan et al, 
2013 and Cattoir et al, 2008) and the rate of this stepwise acquisition may account for the 
lag time observed. The observed rate at which the proportion of acquired ciprofloxacin 
resistance reached a maximum obviously differed between the experiments conducted in 
November 2012 and July 2013 due to the fewer sampling dates carried out in November 
2012. 
In the present study the prevalence of acquired resistance could not be interpreted beyond 
sampling day 7. However, Yu et al. (2009) and Helt et al. (2011) both found that following a 
single  exposure to an influent antibiotic, resistance levels within a bacterial population 
eventually decrease over time, indicating antibiotic resistance can be eliminated. In 
addition, Sorensen et al. (2005) reported that resistant traits can decline within a bacterial 
population with time when the selective pressure is removed. However, this maybe a 
gradual process if the traits do not pose a metabolic burden to the bacterial strain. Further 
studies investigating the episodic release of antibiotic residues within treated wastewater 
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effluent discharges to receiving waters on the maintenance of resistance within a bacterial 
population would need to be performed to investigate this further. 
Overall, the results from this work demonstrate that discharges of antibiotic residues have 
the potential to maintain or even increase the prevalence of acquired resistance in surface 
waters. This is of great concern especially for countries such as China and India where 
substantial quantities of antibiotics are manufactured and the reported concentrations of 
antibiotics (e.g. ciprofloxacin) in environmental waters can be a 1000 fold greater than those 
typically reported for Europe (Diwan et al., 2010 and Wei et al., 2012). In one monitoring 
study in India, ciprofloxacin concentrations as high as 2,500 µg/L were reported in river 
water down-stream of a waste water treatment plant which are greatly elevated compared 
to those used in this microcosm study (5 – 100 µg/L) (Soderstorm et al, 2009). It is therefore 
clearly evident that the maintenance of antibiotic resistance and the potential to 
disseminate resistance should be considered in environmental risk assessments as this is 
ultimately a concern to public health worldwide. The efficiencies of  wastewater treatment 
processes with regard to the removal of antibiotic residues need to be improved to 
contribute to the reduction in the potential of resistant bacteria to proliferate in surface 
waters that receive wastewater treated effluent discharges.  
6.5 Summary 
The results from two individual microcosm experiments simulating surface water receiving 
treated wastewater effluent indicate the potential of sub-inhibitory ciprofloxacin levels to 
influence the prevalence of acquired ciprofloxacin resistance among E.coli. This study 
supports the findings by Helt et al. (2011) and Yu et al. (2011) which  suggest that 
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ciprofloxacin can promote the prevalence of antibiotic resistant E.coli within surface waters. 
The results demonstrate that at ciprofloxacin levels typically detected in surface waters the 
prevalence of acquired ciprofloxacin resistance among E.coli does not increase. However, 
the prevalence of resistance is maintained. Thereby indicating non-wild type strains are not 
at a survival disadvantage compared to their wild type counterparts. 
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7 Conclusion 
7.1 Occurrence of pharmaceuticals in environmental waters 
The presence of pharmaceutical compounds in the environment has become a global 
concern over recent years, due to their ubiquitous presence and their pseudo-persistency. It 
is imperative that we understand the fate and effects of these compounds in the environment, 
in order to lessen their impact. 
In this study, the analysis of prescription data has indicated the high quantities of four 
pharmaceuticals (bezafibrate, carbamazepine, ciprofloxacin and clarithromycin) prescribed 
per year that could ultimately arrive at wastewater treatment plants following ingestion and 
excretion. The analysis of sewage and final effluents confirmed these compounds are 
present within wastewater and demonstrated that wastewater treatment processes do not 
completely eliminate these compounds. Although the percentage pharmaceutical removal 
during wastewater treatment depends on a number of factors including the type of 
wastewater treatment and the catchment population characteristics, sorption during 
activated sludge treatment is shown to be an important removal process for ciprofloxacin. 
The treatment and disposal of activated sludge material in addition to the discharges of 
treated effluent to surface waters must therefore be considered as part of thorough 
environmental risk assessments. 
A comparison of pharmaceutical concentrations in surface waters up- and down-stream of  
the final effluent discharge point from a  wastewater treatment plant confirm these 
compounds are not completely removed during wastewater treatment. Therefore surface 
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waters are vulnerable to pharmaceutical contamination from point sources. This is a 
concern as the monitoring of these compounds in natural waters is not enforced. 
Current legislation pertaining to pharmaceutical compounds in the environment requires 
that an environmental risk assessment is conducted on all new medicinal products before 
market approval. However, the pharmaceutical compounds currently on the market are 
exempt. Therefore the information on the fate and effects of these pharmaceuticals 
(including bezafibrate, carbamazepine, clarithromycin and ciprofloxacin) is incomplete. This 
is of concern as there are reports indicating the potential risk of these selected compounds 
to aquatic ecosystems. In addition, there is currently no recommendation for tailored tests 
to investigate the effects that may be specific to certain groups of pharmaceuticals. The 
effects of antibiotics in aquatic ecosystems and the potential to select for antibiotic resistant 
bacteria is an example.   
7.2 Antibiotic resistance profiles of faecal indicators in environmental 
waters 
In this work, E.coli and E.faecium were isolated from settled sewage, treated effluent and 
receiving surface waters to investigate the prevalence of antibiotic resistance amongst these 
bacteria. E.coli was easily selected and differentiated from other enterobacteriaceae using 
β- galactosidase/β glucuronidase chromogenic media. The use of Slanetz and Bartley media 
for the detection and enumeration of enterococci can facilitate the growth of other bacteria 
physiologically similar to enterococci and therefore does not enable the distinction between 
different enterococci species. However, with additional identification using MALDI-TOF-MS 
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analysis it was demonstrated that E.faecium were present in high enough proportions in the 
wastewater and surface water to study antibiotic resistance profiles.  
The comparison of the MIC values determined for E.coli with both harmonised clinical 
breakpoint and epidemiological cut off values demonstrated there is an urgent need for the 
standardisation of the interpretive criteria used for assessing antibiotic susceptibility data. 
Different conclusions could have been reported if the prevalence of resistant E.coli in 
wastewater and surface waters were interpreted using clinical breakpoints. The 
standardisation and harmonisation of values used to define resistance are imperative for 
effective surveillance of antibiotic resistance development. A single standardised approach 
is crucial for effective risk assessment and a comparison of the derived resistance from 
different sources (e.g. food, environment and humans) is required. The use of quantitative 
minimum inhibitory concentration data and interpretation using epidemiological cut off 
values enables the distinction of subtle changes in resistance and is therefore 
recommended. In addition, quantitative data is perhaps more useful for researchers to 
compare their findings. 
Despite the large percentage of faecal indicators that were removed during the wastewater 
treatment process, it was found that wastewater treatment did not significantly change the 
proportion of E.coli or E.faecium resistance to antibiotics. This indicates the level of 
resistance is maintained throughout wastewater treatment processes but does not provide 
evidence that wastewater treatment plants are hotspots for the dissemination of resistance. 
However, it was demonstrated that the discharges of treated wastewater effluent 
influenced the levels of antibiotic resistant bacteria in receiving surface water. The 
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increased prevalence of resistant bacteria suggests either the exposure to antibiotic residues 
within treated effluent permitted the development of resistant strains through the 
dissemination of resistance elements, or through the elimination of wild type strains, allowing 
the proliferation of non-wild type bacteria until resistance becomes dominant. 
7.3 Ciprofloxacin resistant profiles of E.coli in surface water microcosms 
The effects of antibiotics in aquatic ecosystems and the potential to select for antibiotic 
resistant bacteria were investigated through microcosm studies. The results obtained for 
the level of antibiotic resistance among E.coli isolates within surface water microcosms 
supports the idea that the introduction of an antibiotic to an aquatic system can lead to an 
increase in resistance. A significant increase in the level of ciprofloxacin resistance amongst 
E.coli was observed in microcosms exposed to antibiotic levels of 5 µg/L or greater during 
two replicate experiments. This is of concern given that antibiotic residue concentrations as 
high as this have been detected in surface waters receiving wastewater treated effluent 
discharges.  
Interestingly, at antibiotic residue levels typically detected in surface waters receiving 
treated wastewater effluent (~ < 5 ng/L - 200 ng/L), the levels of resistance amongst E.coli 
did not significantly alter. This demonstrates that the survival of non-wild type E.coli with 
acquired resistance mechanisms is not impaired compared to wild type E.coli. The findings 
presented in this work highlight that wastewater treatment processes to remove antibiotic 
residues need to be developed. This will reduce the potential of the proliferation of resistant 
bacteria in surface waters that receive wastewater treated effluent discharges.  
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7.4 Thesis recommendations and future work 
This research clearly shows that pharmaceutical compounds (including antibiotics) are not 
efficiently removed during wastewater treatment processes and consequently elevated 
concentrations are found in receiving surface waters. However, it is still unclear what the 
full impact of these compounds maybe on aquatic ecosystems. The assessment of the 
environmental risk that these compounds may pose for aquatic ecosystems should be more 
comprehensive and include tests that target specific effects such as the dissemination of 
antibiotic resistance. Furthermore, additional wastewater treatment processes should be 
developed and introduced if environmental risk assessments do indicate complete removal of 
these residues is required. 
The findings presented in this work demonstrate wastewater treatment processes maintain the 
levels of antibiotic resistance among faecal indicators. Additionally, results indicate that the 
discharge of treated effluents affect the levels of resistant faecal indicators within surface 
waters receiving treated effluent discharges. The dissemination of antibiotic resistance is of 
great concern and will impact both human and animal medicine as the threat to antibiotic 
therapy increases. Therefore the surveillance of antibiotic resistance in the environment, in 
addition to the surveillance already carried out in clinical environments, is imperative. In 
addition, epidemiological studies within wastewater treatment plants employing advanced 
treatment options should be considered. Bacteria in addition to those typically found in human 
gut flora should also be studied. A focus on bacteria indigenous to our surface waters such as 
Aeromonas species should be considered. However, it is necessary to standardise the 
interpretation of resistance in the environment and to consider interpretative criteria such as 
epidemiological cut off values to avoid underestimating subtle changes in antibiotic resistance. 
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In addition, a closer look into the cause of the increase of antibiotic resistance proportions 
would provide useful data. Is it the antibiotic residues or the excretion of antibiotic resistant 
bacteria the cause of elevated resistance proportions in surface waters down-stream from 
wastewater treated effluent discharge points. 
Simple microcosm studies have demonstrated that antibiotic concentrations at levels typically 
present in surface waters receiving discharges of wastewater treated effluents are sufficient to 
maintain the proportion of antibiotic resistance among faecal bacteria. In addition, it has been 
demonstrated that sub-inhibitory levels of antibiotics can significantly increase the prevalence 
of resistance. Additional microcosm studies to investigate the selective effects of antibiotic 
residues on the prevalence of resistance among a variety of waterborne bacteria will be useful 
to gain a more comprehensive representation of surface waters. It would also be an advantage 
to look at bacteria that are indigenous to surface waters in addition to faeceal bacteria. 
Microcosm studies that investigate the proportion of resistant bacteria in source water without 
antibiotic contamination would be useful as would an investigation into the spread of co-
resistance through the presence of other pollutants such as metal contamination. In addition, 
studies that look at the effects of protozoa and UV light on the spread of resistance would 
provide more information. Furthermore, a variety of antibiotics and their influence on the 
prevalence of multiple resistances needs to be considered. In addition, molecular studies 
although challenging would be useful to investigate the mechanisms of the dissemination of 
resistance in surface waters and to establish how stable and transferable resistance elements 
are once they have entered surface waters. For example, antibiotic resistance gene abundances 
could be monitored in a similar microcosm study set ups and the rate of plasmid mediated 
resistance acquisition could also be studied. Investigating antibiotic resistance in bacteria that 
cannot be cultured through techniques such as functional metagenomics would be invaluable to 
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this area of work. The use of simple microcosm’s studies could be improved to include biofilms, 
and enable the investigation of antibiotic resistance in water circulating microcosm studies to 
better simulate the river flow conditions and the water/ sediment mixing conditions found in 
surface waters.  
 
 
 
 
  
 
  
245 
 
 
8 References 
AECOM, AECOM is top of the league. Available from: 
<http://www.aecom.com/Where+We+Are/Europe/_carousel/AECOM+is+top+of+th
e+league>. [May 2014]. 
Akiyama T and Savin M C (2010), Populations of antibiotic-resistant coliform bacteria change 
rapidly in a wastewater effluent dominated stream, Science of The Total 
Environment. 408: 6192-6201. 
Al-Ahmad A, Daschner F D and Kümmerer K (1999), Biodegradability of Cefotiam, 
Ciprofloxacin, Meropenem, Penicillin G, and Sulfamethoxazole and Inhibition of 
Waste Water Bacteria, Archives of Environmental Contamination and Toxicology. 37: 
158-163. 
Al Aukidy M, Verlicchi P, Jelic A, Petrovic M and Barcelo D (2012), Monitoring release of 
pharmaceutical compounds: Occurrence and environmental risk assessment of two 
WWTP effluents and their receiving bodies in the Po Valley, Italy, Science of The Total 
Environment. 438: 15-25. 
Alexy R, Kümpel T and Kümmerer K (2004), Assessment of degradation of 18 antibiotics in 
the Closed Bottle Test, Chemosphere. 57: 505-512. 
Alonso J L, Amoros I, Chong S and Garelick H (1996), Quantitative determination of 
Escherichia coli in water using CHROMagar® E. coli, Journal of Microbiological 
Methods. 25: 309-315. 
American Public Health Association (APHA) (ed.) 1992, Standard methods for the 
examination of water and wastewater, 18th edn, Washington, DC. 
Amos G C A, Hawkey P M, Gaze W H and Wellington E M (2014), Waste water effluent 
contributes to the dissemination of CTX-M-15 in the natural environment, Journal of 
Antimicrobial Chemotherapy. 
Anderson S A, Turner S J and Lewis G D (1997), Enterococci in the New Zealand environment: 
Implications for water quality monitoring, Water Science and Technology. 35: 325-
331. 
Andersson D I and Hughes D (2012), Evolution of antibiotic resistance at non-lethal drug 
concentrations, Drug Resistance Updates. 15: 162-172. 
Andersson D I and Hughes D (2014), Microbiological effects of sublethal levels of antibiotics, 
Nat Rev Micro. 12: 465-478. 
Andreozzi R, Caprio V, Ciniglia C, de Champdore M, Lo Giudice R, Marotta R and Zuccato E 
(2004), Antibiotics in the Environment: Occurrence in Italian STPs, Fate, and 
Preliminary Assessment on Algal Toxicity of Amoxicillin, Environmental Science & 
Technology. 38: 6832-6838. 
Andreozzi R, Caprio V, Marotta R and Radovnikovic A (2003a), Ozonation and H2O2/UV 
treatment of clofibric acid in water: a kinetic investigation, Journal of Hazardous 
Materials. 103: 233-246. 
Andreozzi R, Marotta R, Pinto G and Pollio A (2002), Carbamazepine in water: persistence in 
the environment, ozonation treatment and preliminary assessment on algal toxicity, 
Water Research. 36: 2869-2877. 
Andreozzi R, Raffaele M and Nicklas P (2003b), Pharmaceuticals in STP effluents and their 
solar photodegradation in aquatic environment, Chemosphere. 50: 1319-1330. 
246 
 
 
Andrews J M (2001), Determination of minimum inhibitory concentrations, Journal of 
Antimicrobial Chemotherapy. 48: 5-16. 
Arias C A, Robredo B, Singh K V, Torres C, Panesso D and Murray B E (2006), Rapid 
Identification of Enterococcus hirae and Enterococcus durans by PCR and Detection of 
a Homologue of the E. hirae mur-2 Gene in E. durans, Journal of Clinical 
Microbiology. 44: 1567-1570. 
Ash R J, Mauck B and Morgan M (2002), Antibiotic resistance of Gram-negative bacteria in 
rivers, United States, Emerging Infectious Diseases. 8: 713-716. 
Ashelford K E, Fry J C, Day M J, Hill K E, Learner M A, Marchesi J R, Perkins C D and 
Weightman A J (1997), Using microcosms to study gene transfer in aquatic habitats, 
FEMS Microbiology Ecology. 23: 81-94. 
Atoyan J A, Patenaude E L, Potts D A and Amador J A (2007), Effects of tetracycline on 
antibiotic resistance and removal of fecal indicator bacteria in aerated and 
unaerated leachfield mesocosms, Journal of Environmental Science and Health, Part 
A. 42: 1571-1578. 
Babić S, Pavlović D M, Ašperger D, Perisa M, Zrnčić M, Horvat A J M and Kaštelan-Macan M 
(2010), Determination of multi-class pharmaceuticals in wastewater by liquid 
chromatography–tandem mass spectrometry (LC–MS–MS), Analytical and 
Bioanalytical Chemistry. 398: 1185-1194. 
Bahlmann A, Brack W, Schneider R J and Krauss M (2014), Carbamazepine and its 
metabolites in wastewater: Analytical pitfalls and occurrence in Germany and 
Portugal, Water Research. 57: 104-114. 
Baquero F, Martínez J-L and Cantón R (2008), Antibiotics and antibiotic resistance in water 
environments, Current Opinion in Biotechnology. 19: 260-265. 
Barcina I, Lebaron P and Vives-Rego J (1997), Survival of allochthonous bacteria in aquatic 
systems: a biological approach, FEMS Microbiology Ecology. 23: 1-9. 
Barra Caracciolo A, Bottoni P and Grenni P (2013), Microcosm studies to evaluate microbial 
potential to degrade pollutants in soil and water ecosystems, Microchemical Journal. 
107: 126-130. 
Barry A L, Jones R N, Thornsberry C, Ayers L W, Gerlach E H and Sommers H M (1984), 
Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and 
nalidixic acid, Antimicrobial Agents and Chemotherapy. 25: 633-637. 
Batt A L, Bruce I B and Aga D S (2006), Evaluating the vulnerability of surface waters to 
antibiotic contamination from varying wastewater treatment plant discharges, 
Environmental Pollution. 142: 295-302. 
Bellanger X, Guilloteau H, Bonot S and Merlin C (2014), Demonstrating plasmid-based 
horizontal gene transfer in complex environmental matrices: A practical approach for 
a critical review, Science of The Total Environment. 493: 872-882. 
Benito-Peña E, Partal-Rodera A I, León-González M E and Moreno-Bondi M C (2006), 
Evaluation of mixed mode solid phase extraction cartridges for the preconcentration 
of beta-lactam antibiotics in wastewater using liquid chromatography with UV-DAD 
detection, Analytica Chimica Acta. 556: 415-422. 
Biomerieux 2005, Package insert for the Identification system for Enterobacteriaceae and 
other non-fastidious Gram-negative rods (product number 2010), document number 
07854J. 
247 
 
 
Birosova L, Mackulak T, Bodak I, Ryba J, Skuback J and Grabic R (2014), Pilot study of 
seasonal occurrence and distribution of antibiotics and drug resistant bacteria in 
wastewater treatment plants in Slovakia, Science of The Total Environment. 490: 
440-444. 
Bitton G (1994), Wastwater Microbiology, Wiley-Liss, New York. 
Bizzini A, Jaton K, Romo D, Bille J, Prod'hom G and Greub G (2011), Matrix-Assisted Laser 
Desorption Ionization - Time of Flight Mass Spectrometry as an Alternative to 16S 
rRNA Gene Sequencing for Identification of Difficult-To-Identify Bacterial Strains, 
Journal of Clinical Microbiology. 49: 693-696. 
Black J (1996), General properties of antimicrobial agents, in Microbiology principles and 
applications, 3rd edn, ed. D Brake, Prentice-Hall, New Jersey, pp. 356-389. 
Blanch A R, Caplin J L, Iversen A, Kühn I, Manero A, Taylor H D and Vilanova X (2003), 
Comparison of enterococcal populations related to urban and hospital wastewater in 
various climatic and geographic European regions, Journal of Applied Microbiology. 
94: 994-1002. 
Boonstra H, Reichman E and van den Brink P (2011), Effects of the Veterinary 
Pharmaceutical Ivermectin in Indoor Aquatic Microcosms, Archives of Environmental 
Contamination and Toxicology. 60: 77-89. 
Bouki C, Venieri D and Diamadopoulos E (2013), Detection and fate of antibiotic resistant 
bacteria in wastewater treatment plants: A review, Ecotoxicology and Environmental 
Safety. 91: 1-9. 
Boxall A B A (2004), The environmental side effects of medication, EMBO reports. 5: 1110-
1116. 
Boxall A B A, Blackwell P, Cavallo R, Kay P and Tolls J (2002), The sorption and transport of a 
sulphonamide antibiotic in soil systems, Toxicology Letters. 131: 19-28. 
Brown D F J and Brown L (1991), Evaluation of the E test, a novel method of quantifying 
antimicrobial activity, Journal of Antimicrobial Chemotherapy. 27: 185-190. 
Brown K D, Kulis J, Thomson B, Chapman T H and Mawhinney D B (2006), Occurrence of 
antibiotics in hospital, residential, and dairy effluent, municipal wastewater, and the 
Rio Grande in New Mexico, Science of The Total Environment. 366: 772-783. 
BSAC, BSAC Methods for Antimicrobial Susceptibility Testing Version 10.2. Available from: 
<http://bsac.org.uk/susceptibility/guidelines-standardized-disc-susceptibility-testing-
method/>. [Jun 2011]. 
Bugg T D H, Braddick D, Dowson C G and Roper D I (2011), Bacterial cell wall assembly: still 
an attractive antibacterial target, Trends in Biotechnology. 29: 167-173. 
Caldwell B A, Ye C, Griffiths R P, Moyer C L and Morita R Y (1989), Plasmid expression and 
maintenance during long-term starvation-survival of bacteria in well water, Applied 
and Environmental Microbiology. 55: 1860-1864. 
Canton R, Perez-Vezquez M, Oliver A, Sanchez Del Saz B, Gutiirrez M O, Martinez-Ferrer M 
and Baquero F (2000), Evaluation of the Wider System, a New Computer-Assisted 
Image-Processing Device for Bacterial Identification and Susceptibility Testing, 
Journal of Clinical Microbiology. 38: 1339-1346. 
Carballa M, Fink G, Omil F, Lema J M and Ternes T (2008), Determination of the solid-water 
distribution coefficient (Kd) for pharmaceuticals, estrogens and musk fragrances in 
digested sludge, Water Research. 42: 287-295. 
248 
 
 
Carballa M, Omil F, Lema J M, Llompart M, García-Jares C, Rodríguez I, Gómez M and Ternes 
T (2004), Behavior of pharmaceuticals, cosmetics and hormones in a sewage 
treatment plant, Water Research. 38: 2918-2926. 
Carbonnelle E, Mesquita C, Bille E, Day N, Dauphin B, Beretti J-L, Ferroni A s, Gutmann L and 
Nassif X (2011), MALDI-TOF mass spectrometry tools for bacterial identification in 
clinical microbiology laboratory, Clinical Biochemistry. 44: 104-109. 
Cardoza L A, Knapp C W, Larive C K, Belden J B, Lydy M and Graham D W (2005), Factors 
Affecting the Fate of Ciprofloxacin in Aquatic Field Systems, Water, Air, and Soil 
Pollution. 161: 383-398. 
Casanovas-Massana A L, Francisco Blanch, Anicet R. (2006), Identification of Pseudomonas 
aeruginosa in water-bottling plants on the basis of procedures included in ISO 
16266:2006, Journal of Microbiological Methods. 81: 1-5. 
Castiglioni S, Bagnati R, Calamari D, Fanelli R and Zuccato E (2005), A multiresidue analytical 
method using solid-phase extraction and high-pressure liquid chromatography 
tandem mass spectrometry to measure pharmaceuticals of different therapeutic 
classes in urban wastewaters, Journal of Chromatography A. 1092: 206-215. 
Castiglioni S, Fanelli R, Calamari D, Bagnati R and Zuccato E (2004), Methodological 
approaches for studying pharmaceuticals in the environment by comparing predicted 
and measured concentrations in River Po, Italy, Regulatory Toxicology and 
Pharmacology. 39: 25-32. 
Castiglioni S, Pomati F, Miller K, Burns B P, Zuccato E, Calamari D and Neilan B A (2008), 
Novel homologs of the multiple resistance regulator marA in antibiotic-contaminated 
environments, Water Research. 42: 4271-4280. 
Cattoir. V, Poirel. L, Aubert. C, Soussy. C J and P N (2008), Unexpected Occurrence of 
Plasmid-Mediated Quinolone Resistance Determinants in Environmental Aeromonas 
spp, Emerging infectious diseases. 14: 231 - 237. 
Cha J M, Yang S and Carlson K H (2006), Trace determination of [beta]-lactam antibiotics in 
surface water and urban wastewater using liquid chromatography combined with 
electrospray tandem mass spectrometry, Journal of Chromatography A. 1115: 46-57. 
Chen H-C, Wang P-L and Ding W-H (2008), Using liquid chromatography-ion trap mass 
spectrometry to determine pharmaceutical residues in Taiwanese rivers and 
wastewaters, Chemosphere. 72: 863-869. 
Cherkaoui A, Hibbs J, Emonet S, Tangomo M, Girard M, Francois P and Schrenzel J (2010), 
Comparison of Two Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass 
Spectrometry Methods with Conventional Phenotypic Identification for Routine 
Identification of Bacteria to the Species Level, Journal of Clinical Microbiology. 48: 
1169-1175. 
Clara M, Strenn B, Gans O, Martinez E, Kreuzinger N and Kroiss H (2005), Removal of 
selected pharmaceuticals, fragrances and endocrine disrupting compounds in a 
membrane bioreactor and conventional wastewater treatment plants, Water 
Research. 39: 4797-4807. 
Clara M, Strenn B and Kreuzinger N (2004), Carbamazepine as a possible anthropogenic 
marker in the aquatic environment: investigations on the behaviour of 
Carbamazepine in wastewater treatment and during groundwater infiltration, Water 
Research. 38: 947-954. 
249 
 
 
CLSI, Antimicrobial Susceptibility Testing Available from: 
<http://www.clsi.org/source/orders/categories.cfm?section=Antimicrobial_Suscepti
bility_Testing&CAT=AST>. [July 2012]. 
Collado N, Rodriguez-Mozaz S, Gros M, Rubirola A, Barcelo D, Comas J, Rodriguez-Roda I and 
Buttiglieri G (2014), Pharmaceuticals occurrence in a WWTP with significant 
industrial contribution and its input into the river system, Environmental Pollution. 
185: 202-212. 
Conley J M, Symes S J, Kindelberger S A and Richards S M (2008a), Rapid liquid 
chromatography-tandem mass spectrometry method for the determination of a 
broad mixture of pharmaceuticals in surface water, Journal of Chromatography A. 
1185: 206-215. 
Conley J M, Symes S J, Schorr M S and Richards S M (2008b), Spatial and temporal analysis 
of pharmaceutical concentrations in the upper Tennessee River basin, Chemosphere. 
73: 1178-1187. 
Cunningham V L (2008), Special characteristics of pharmaceuticals related to environmental 
fate, in Pharmaceuticals in the environment: sources, fate, effects and risks, ed. K 
Kümmerer, Springer - Verlag, Berlin, pp. 23 - 34. 
Cunningham V L, Binks S P and Olson M J (2009), Human health risk assessment from the 
presence of human pharmaceuticals in the aquatic environment, Regulatory 
Toxicology and Pharmacology. 53: 39-45. 
Daneshvar A, Svanfelt J, Kronberg L, Prévost M and Weyhenmeyer G A (2010), Seasonal 
variations in the occurrence and fate of basic and neutral pharmaceuticals in a 
Swedish river-lake system, Chemosphere. 80. 
Davies G R (2011), A water quality analysis of the River Lee and major tributaries within the 
perimeter of the M25, from Waltham Abbey to Bow Locks., Thames21, London. 
Defra, Sewage Treatment in the UK-UK Implementation of the EC Urban Waste Water 
Treatment Directive. Available from: 
<http://www.defra.gov.uk/publications/2011/03/26/uk-sewage-treatment-
pb6655/>. [July 2012]. 
Defra, 05 October 2009, Water Framework Directive. Available from: 
<http://www.defra.gov.uk/environment/quality/water/wfd/daughter-dirs.htm>. [05 
January 2010]. 
Dingle T C and Butler-Wu S M, MALDI-TOF Mass Spectrometry for Microorganism 
Identification, Clinics in Laboratory Medicine. 33: 589-609. 
Drillia P, Stamatelatou K and Lyberatos G (2005), Fate and mobility of pharmaceuticals in 
solid matrices, Chemosphere. 60: 1034-1044. 
Droge M, Puhler A and Selbitschka W (1999), Horizontal gene transfer among bacteria in 
terrestrial and aquatic habitats as assessed by microcosm and field studies, Biology 
and Fertility of Soils. 29: 221-245. 
DrugBank 2005, Open data drug and drug target database: Amoxicllin. 
E. Kaplan, M. Ofek, E. Jurkevitch and E. Cytryn (2013), Characterization of fluoroquinolone 
resistance and qnr diversity in Enterobacteriaceae from municipal biosolids, Fronteirs 
in Microbiology: 1-7. 
Eigner U, Holfelder M, Oberdorfer K, Betz-Wild U, Bertsch D and Fahr A M (2009), 
Performance of a matrix-assisted laser desorption ionization-time-of-flight mass 
250 
 
 
spectrometry system for the identification of bacterial isolates in the clinical routine 
laboratory, Clin Lab. 2009;55(7-8):289-96. 
Eliopoulos G (2007), Antimicrobial Resistance in the Enterococcus, in Bacterial Resistance to 
Antimicrobials, Second Edition, CRC Press, pp. 255-289. 
Ellis J B (2006), Pharmaceutical and personal care products (PPCPs) in urban receiving 
waters, Environmental Pollution. 144: 184-189. 
EMA, Regulation of medicines. Available from: 
<http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/landing/regulati
on.jsp&mid=>. [02 July 2012]. 
Engemann C A, Adams L, Knapp C W and Graham D W (2006), Disappearance of 
oxytetracycline resistance genes in aquatic systems, FEMS Microbiology Letters. 263: 
176-182. 
Engemann C A, Keen P L, Knapp C W, Hall K J and Graham D W (2008), Fate of Tetracycline 
Resistance Genes in Aquatic Systems: Migration from the Water Column to 
Peripheral Biofilms, Environmental Science & Technology. 42: 5131-5136. 
Enne V I, Delsol A A, Davis G R, Hayward S L, Roe J M and Bennett P M (2005), Assessment of 
the fitness impacts on Escherichia coli of acquisition of antibiotic resistance genes 
encoded by different types of genetic element, Journal of Antimicrobial 
Chemotherapy. 56: 544-551. 
Environment Agency, The Microbiology of Recreational and Environmental Waters. 
Environment Agency (2002), The Microbiology of Drinking Water- Part 1 - Water Quality and 
Public Health. 
Environment Agency (ed.) 2007a, The Microbiology of Drinking Water (2007) - Part 7 – 
Methods for the enumeration of heterotrophic bacteria. 
Environment Agency (2007b), The Microbiology of Drinking Water Part 7 – Methods for the 
enumeration of heterotrophic bacteria. 
Environment Agency 2009, The Microbiology of Drinking Water (2009) - Part 4 - Methods for 
the isolation and enumeration of coliform bacteria and Escherichia coli (including E. 
coli O157:H7), Standing Committee of Analysts (SCA). [June 2012]. 
Environment Agency, The Microbiology of Drinking Water (2010) - Part 5 -The isolation and 
enumeration of enterococci by membrane filtration. 
Environment Agency, The Microbiology of Drinking Water (2010) - Part 8 - The isolation and 
enumeration of Aeromonas and Pseudomonas aeruginosa by membrane filtration  
Enzinger R M and Cooper R C (1976), Role of bacteria and protozoa in the removal of 
Escherichia coli from estuarine waters, Applied and Environmental Microbiology. 31: 
758-763. 
EPA, 18 November 2009, Clean Water Act (CWA). Available from: 
<http://www.epa.gov/oecaagct/lcwa.html#Summary>. [05 January 2010]. 
EUCAST (2000), Determination of minimum inhibitory concentrations (MICs) of antibacterial 
agents by agar dilution. 
EUCAST, Standard operating procedure: Harmonization of breakpoints for existing 
antimicrobial agents, EUCAST SOP 2.0. Available from: 
<http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/EUCAST_SOPs/EU
CAST_SOP_2_1_Setting_breakpoints_existing_agents_20130720f.pdf>. [July 2012]. 
EUCAST, Clinical breakpoints: definitions of clinical breakpoints and epidemiological cut off 
values. Available from: <http://www.eucast.org/clinical_breakpoints/>. [July 2012]. 
251 
 
 
EUCAST, MIC distributions. Available from: <http://www.eucast.org/mic_distributions/>. 
European Antimicrobial Resistance Surveillance Network (2011), European Centre for 
Disease Prevention and ControlAntimicrobial resistance surveillance in Europe 2010. 
Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-
Net), ECDC, Stockholm. 
European Centre for Disease Prevention and Control - Antimicrobial resistance interactive 
database (EARS-net) 2013a, Susceptibility of Escherichia coli Isolates to 3rd gen. 
cephalosporins in United Kingdom, 1998 - 2012. 
European Centre for Disease Prevention and Control - Antimicrobial resistance interactive 
database (EARS-net) 2013b, Susceptibility of Escherichia coli Isolates to 
Aminopenicillins in United Kingdom, 1998 - 2012. 
European Centre for Disease Prevention and Control - Antimicrobial resistance interactive 
database (EARS-net) 2013c, Susceptibility of Escherichia coli Isolates to 
Fluoroquinolones in United Kingdom, 1998 - 2012. 
European Centre for Disease Prevention and Control - Antimicrobial resistance interactive 
database (EARS-net) 2014a, Susceptibility of Enterococcus faecium Isolates to 
aminopenicillins in United Kingdom, 1998 - 2012, , vol. 11th February 2014. 
European Centre for Disease Prevention and Control - Antimicrobial resistance interactive 
database (EARS-net) 2014b, Susceptibility of Enterococcus faecium Isolates to 
vancomycin in United Kingdom, 1998 - 2012, . 
European Commission 2001, Directive 2001/83/EC of the European Parliament and of the 
Council of 6 November 2001 on the Community code relating to medicinal products 
for human use. Official Journal L 311, 28/11/2001 P.67. 
European Commission, Regulation (EC) No 1907/2006 of the European Parliament and of 
the Council of 18 December 2006 concerning the Registration, Evaluation, 
Authorisation and Restriction of Chemicals (REACH), establishing a European 
Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation 
(EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council 
Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC 
and 2000/21/EC. Official journal L 396, 30.12.2006, p. 1–849. 
European Commission (2008), Directive 2008/105/EC of the European Parliament and of the 
Council of 16 December 2008 on environmental quality standards in the field of 
water policy, amending and subsequently repealing Council Directives 82/176/EEC, 
83/513/EEC, 84/156/EEC, 84/491/EEC, 86/280/EEC and amending Directive 
2000/60/EC of the European Parliament and of the Council. Official journal L 348, 
24.12.2008, p. 84–97. 
European Medicines Agency, Guideline on the environmental risk assessment of medicinal 
products for human use. EMEA/CHMP/SWP/4447/00. The European Agency for the 
evaluation of medicinal products (2006). 
Facklam R R and Collins M D (1989), Identification of Enterococcus species isolated from 
human infections by a conventional test scheme, Journal of Clinical Microbiology. 27: 
731-734. 
Faria C, Vaz-Moreira I, Serapicos E, Nunes O C and Manaia C M (2009), Antibiotic resistance 
in coagulase negative staphylococci isolated from wastewater and drinking water, 
Science of The Total Environment. 407: 3876-3882. 
252 
 
 
Farré, Ferrer, Ginebreda A, Figueras M, Olivella L, Tirapu L, Vilanova M and Barceló D (2001), 
Determination of drugs in surface water and wastewater samples by liquid 
chromatography-mass spectrometry: methods and preliminary results including 
toxicity studies with Vibrio fischeri, Journal of Chromatography A. 938: 187-197. 
Farré M, Petrovic M and Barceló D (2007), Recently developed GC/MS and LC/MS methods 
for determining NSAIDs in water samples, Analytical and Bioanalytical Chemistry. 
387: 1203-1214. 
Fatta D, Achilleos A, Nikolaou A and Meriç S (2007), Analytical methods for tracing 
pharmaceutical residues in water and wastewater, TrAC Trends in Analytical 
Chemistry. 26: 515-533. 
Feitosa-Felizzola J and Chiron S (2009), Occurrence and distribution of selected antibiotics in 
a small Mediterranean stream (Arc River, Southern France), Journal of Hydrology. 
364: 50-57. 
Fernan¡ndez C, Gonzlez-Doncel M, Pro J, Carbonell G and Tarazona J V (2010), Occurrence of 
pharmaceutically active compounds in surface waters of the henares-jarama-tajo 
river system (madrid, spain) and a potential risk characterization, Science of The 
Total Environment. 408: 543-551. 
Fernandez-Astorga A, A Muela R C, J Iriberri and Barcina I (1992), Biotic and abiotic factors 
affecting plasmid transfer in Escherichia coli strains, Applied Environmental 
Microbiology. 58: 392-398. 
Fernandez C, Gonzlez-Doncel M, Pro J, Carbonell G and Tarazona J V (2010), Occurrence of 
pharmaceutically active compounds in surface waters of the henares-jarama-tajo 
river system (madrid, spain) and a potential risk characterization, Science of The 
Total Environment. 408: 543-551. 
Ferreira Da Silva M, Tiago I, Veríssimo A, Boaventura R A R, Nunes O C and Manaia C M 
(2006), Antibiotic resistance of enterococci and related bacteria in an urban 
wastewater treatment plant, FEMS Microbiology Ecology. 55: 322-329. 
Ferreira da Silva M, Vaz-Moreira I, Gonzalez-Pajuelo M, Nunes O C and Manaia C M (2007), 
Antimicrobial resistance patterns in Enterobacteriaceae isolated from an urban 
wastewater treatment plant, FEMS Microbiology Ecology. 60: 166-176. 
Figueira V, Vaz-Moreira I, Silva M and Manaia C M (2011), Diversity and antibiotic resistance 
of Aeromonas spp. in drinking and waste water treatment plants, Water Research. 
45: 5599-5611. 
Flint K P (1987), The long-term survival of Escherichia coli in river water, Journal of Applied 
Microbiology. 63: 261-270. 
Fluit A (2007), Genetic Methods for Detecting Bacterial Resistance Genes, in Bacterial 
Resistance to Antimicrobials, Second Edition, CRC Press, pp. 183-227. 
Ford M, Perry J D and Gould F K (1994), Use of cephalexin-aztreonam-arabinose agar for 
selective isolation of Enterococcus faecium, Journal of Clinical Microbiology. 32: 
2999-3001. 
Galvin S, Boyle F, Hickey P, Vellinga A, Morris D i and Cormican M (2010), Enumeration and 
Characterization of Antimicrobial-Resistant Escherichia coli Bacteria in Effluent from 
Municipal, Hospital, and Secondary Treatment Facility Sources, Applied and 
Environmental Microbiology. 76: 4772-4779. 
Garcia-Ac A, Segura P A, Gagnon C and Sauvé S (2009a), Determination of bezafibrate, 
methotrexate, cyclophosphamide, orlistat and enalapril in waste and surface waters 
253 
 
 
using on-line solid-phase extraction liquid chromatography coupled to polarity-
switching electrospray tandem mass spectrometry, Journal of Environmental 
Monitoring. 11: 830-838. 
Garcia-Ac A, Segura P A, Viglino L, Furtoss A, Gagnon C, Prevost M and Sauve S (2009b), On-
line solid-phase extraction of large-volume injections coupled to liquid 
chromatography-tandem mass spectrometry for the quantitation and confirmation 
of 14 selected trace organic contaminants in drinking and surface water, Journal of 
Chromatography A. 1216: 8518-8527. 
Geissler K, Manafi M, Amorós I and Alonso J L (2000), Quantitative determination of total 
coliforms and Escherichia coli in marine waters with chromogenic and fluorogenic 
media, Journal of Applied Microbiology. 88: 280-285. 
Gellin G, Langlois B E, Dawson K A and Aaron D K (1989), Antibiotic resistance of gram-
negative enteric bacteria from pigs in three herds with different histories of antibiotic 
exposure, Applied and Environmental Microbiology. 55: 2287-2292. 
Ginebreda A, Muñoz I, de Alda M L, Brix R, López-Doval J and Barceló D (2010), 
Environmental risk assessment of pharmaceuticals in rivers: Relationships between 
hazard indexes and aquatic macroinvertebrate diversity indexes in the Llobregat 
River (NE Spain), Environment International. 36: 153-162. 
Göbel A, McArdell C S, Joss A, Siegrist H and Giger W (2007), Fate of sulfonamides, 
macrolides, and trimethoprim in different wastewater treatment technologies, 
Science of The Total Environment. 372: 361-371. 
Göbel A, Thomsen A, McArdell C S, Alder A C, Giger W, Theiß N, Löffler D and Ternes T A 
(2005), Extraction and determination of sulfonamides, macrolides, and trimethoprim 
in sewage sludge, Journal of Chromatography A. 1085: 179-189. 
Golet E M, Alder A C and Giger W (2002), Environmental Exposure and Risk Assessment of 
Fluoroquinolone Antibacterial Agents in Wastewater and River Water of the Glatt 
Valley Watershed, Switzerland, Environmental Science & Technology. 36: 3645-3651. 
Golet E M, Alder A C, Hartmann A, Ternes T A and Giger W (2001), Trace Determination of 
Fluoroquinolone Antibacterial Agents in Urban Wastewater by Solid-Phase Extraction 
and Liquid Chromatography with Fluorescence Detection, Analytical Chemistry. 73: 
3632-3638. 
Golet E M, Xifra I, Siegrist H, Alder A C and Giger W (2003), Environmental Exposure 
Assessment of Fluoroquinolone Antibacterial Agents from Sewage to Soil, 
Environmental Science & Technology. 37: 3243-3249. 
Goni-Urriza M, Capdepuy M l, Arpin C, Raymond N, Caumette P and Quentin C (2000), 
Impact of an Urban Effluent on Antibiotic Resistance of Riverine Enterobacteriaceae 
andAeromonas spp, Applied and Environmental Microbiology. 66: 125-132. 
Gonzalez-Pleiter M, Gonzalo S, Rodea-Palomares I, Leganes F, Rosal R, Boltes K, Marco E and 
Fernandez-Pinas F (2013), Toxicity of five antibiotics and their mixtures towards 
photosynthetic aquatic organisms: Implications for environmental risk assessment, 
Water Research. 47: 2050-2064. 
Gracia-Lor E, Sancho J V and Hernández. F (2010), Simultaneous determination of acidic, 
neutral and basic pharmaceuticals in urban wastewater by ultra high-pressure liquid 
chromatography-tandem mass spectrometry, Journal of Chromatography A. 1217: 
622-632. 
254 
 
 
Gracia-Lor E, Sancho J V, Serrano R and Hernandez F (2012), Occurrence and removal of 
pharmaceuticals in wastewater treatment plants at the Spanish Mediterranean area 
of Valencia, Chemosphere. 87: 453-462. 
Gros M, Petrovic M and Barcelo D (2008), Tracing Pharmaceutical Residues of Different 
Therapeutic Classes in Environmental Waters by Using Liquid 
Chromatography/Quadrupole-Linear Ion Trap Mass Spectrometry and Automated 
Library Searching, Analytical Chemistry. 81: 898-912. 
Gros M, Petrovic M and Barceló D (2006), Development of a multi-residue analytical 
methodology based on liquid chromatography-tandem mass spectrometry (LC-
MS/MS) for screening and trace level determination of pharmaceuticals in surface 
and wastewaters, Talanta. 70: 678-690. 
Gros M, Petrović M and Barceló D (2007), Wastewater treatment plants as a pathway for 
aquatic contamination by pharmaceuticals in the Ebro river basin (Northeast Spain), 
Environmental Toxicology and Chemistry. 26: 1553-1562. 
Gros M, Petrovic M, Ginebreda A and Barcelo D (2010a), Removal of pharmaceuticals during 
wastewater treatment and environmental risk assessment using hazard indexes, 
Environment International. 36: 15-26. 
Gros M, Petrovic M, Ginebreda A and Barceló D (2010b), Removal of pharmaceuticals during 
wastewater treatment and environmental risk assessment using hazard indexes, 
Environment International. 36: 15-26. 
Guardabassi L, Lo Fo Wong D M A and Dalsgaard A (2002), The effects of tertiary wastewater 
treatment on the prevalence of antimicrobial resistant bacteria, Water Research. 36: 
1955-1964. 
Guardabassi L, Petersen A, Olsen J E and Dalsgaard A (1998), Antibiotic Resistance in 
Acinetobacter spp. Isolated from Sewers Receiving Waste Effluent from a Hospital 
and a Pharmaceutical Plant, Appl. Environ. Microbiol. 64: 3499-3502. 
Gullberg E, Cao S, Berg O G, Ilback C, Sandegren L, Hughes D and Andersson D I (2011), 
Selection of Resistant Bacteria at Very Low Antibiotic Concentrations, PLoS Pathog. 7: 
e1002158. 
Halling-Sorensen B, Lutzhoft H C H, Andersen H R and Ingerslev F (2000), Environmental risk 
assessment of antibiotics: comparison of mecillinam, trimethoprim and ciprofloxacin, 
Journal of Antimicrobial Chemotherapy. 46: 53-58. 
Handwerger S, Pucci M J, Volk K J, Liu J and Lee M S (1994), Vancomycin-resistant 
Leuconostoc mesenteroides and Lactobacillus casei synthesize cytoplasmic 
peptidoglycan precursors that terminate in lactate, Journal of Bacteriology. 176: 260-
264. 
Hansen W and Yourassowsky E (1984), Detection of beta-glucuronidase in lactose-
fermenting members of the family Enterobacteriaceae and its presence in bacterial 
urine cultures, Journal of Clinical Microbiology. 20: 1177-1179. 
Hao C, Zhao X and Yang P (2007), GC-MS and HPLC-MS analysis of bioactive pharmaceuticals 
and personal-care products in environmental matrices, TrAC Trends in Analytical 
Chemistry. 26: 569-580. 
Hartmann A, Alder A C, Koller T and Widmer R (1998), Identification of fluoroquinolone 
antibiotics as the main source of genotoxicity in native hospital wastewater, 
Environmental Toxicology and Chemistry. 17: 377-382. 
255 
 
 
Health and Social Care Information Centre - Prescribing and Primary Care Services, May 
2012, Prescription Cost Analysis for England 2011. Available from: 
<http://www.ic.nhs.uk/statistics-and-data-collections/primary-
care/prescriptions/prescription-cost-analysis-england--2011>. 
Health Protection Agency, Enumeration of Staphlylococcus by membrane filtration, National 
Standard Method W10, issue 3, Health Protection Agency. Available from: 
<http://www.hpa-standardmethods.org.uk/pdf_sops.asp.>. [3]. 
Health Protection Agency (2007), Surveillance of Healthcare Associated Infections Report 
2007. 
Health Protection Agency, 3rd July 2008, Klebsiella species. Available from: 
<http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/KlebsiellaSpecies/G
eneralInformation/kleb005KlebsiellaFAQ/>. [17th September 2011]. 
Helt C D, Weber K P, Legge R L and Slawson R M (2011), Antibiotic resistance profiles of 
representative wetland bacteria and faecal indicators following ciprofloxacin 
exposure in lab-scale constructed mesocosms, Ecological Engineering. 39: 113-122. 
Henriques I S, Fonseca F, Alves A, Saavedra M J and Correia A (2006), Occurrence and 
diversity of integrons and Beat-lactamase genes among ampicillin-resistant isolates 
from estuarine waters, Research in Microbiology. 157: 938-947. 
Hernández F, Sancho J V, Ibáñez M and Guerrero C (2007), Antibiotic residue determination 
in environmental waters by LC-MS, TrAC Trends in Analytical Chemistry. 26: 466-485. 
Hong T, Ndamukong J, Millett W, Kish A, Win K K and Choi Y J (1996), Direct application of 
Etest to Gram-positive cocci from blood cultures: Quick and reliable minimum 
inhibitory concentration data, Diagnostic Microbiology and Infectious Disease. 25: 
21-25. 
Hooper D C (2001), Mechanisms of Action of Antimicrobials: Focus on Fluoroquinolones, 
Clinical Infectious Diseases. 32: S9-S15. 
Hope R, Mushtaq S and Livermore D (2007), P1647 Evaluation of Etests for determining 
tigecycline MICs by BSAC methodology, International Journal of Antimicrobial Agents. 
29, Supplement 2: S465. 
Hua W, Bennett E R and Letcher R J (2006), Ozone treatment and the depletion of detectable 
pharmaceuticals and atrazine herbicide in drinking water sourced from the upper 
Detroit River, Ontario, Canada, Water Research. 40: 2259-2266. 
Huang J-J, Hu H-Y, Lu S-Q, Li Y, Tang F, Lu Y and Wei B, Monitoring and evaluation of 
antibiotic-resistant bacteria at a municipal wastewater treatment plant in China, 
Environment International. 
Intercontinental Marketing Services (IMS) - Health Market Prognosis, 2009 Global 
Prescription Sales Information. Available from: 
<http://www.imshealth.com/portal/site/ims/menuitem.d248e29c86589c9c30e81c0
33208c22a/?vgnextoid=8890ba440c900310VgnVCM10000071812ca2RCRD&vgnextf
mt=default>. [Jan 2011]. 
Isidori M, Lavorgna M, Nardelli A, Pascarella L and Parrella A (2005), Toxic and genotoxic 
evaluation of six antibiotics on non-target organisms, Science of The Total 
Environment. 346: 87-98. 
Isidori M, Nardelli A, Pascarella L, Rubino M and Parrella A (2007), Toxic and genotoxic 
impact of fibrates and their photoproducts on non-target organisms, Environment 
International. 33: 635-641. 
256 
 
 
Jamal W, Saleem R and Rotimi V O, Rapid identification of pathogens directly from blood 
culture bottles by Bruker matrix-assisted laser desorption laser ionization-time of 
flight mass spectrometry versus routine methods, Diagnostic Microbiology and 
Infectious Disease. 76: 404-408. 
Janda J M and Abbott S L (2007), 16S rRNA Gene Sequencing for Bacterial Identification in 
the Diagnostic Laboratory: Pluses, Perils, and Pitfalls, Journal of Clinical Microbiology. 
45: 2761-2764. 
Jelic A, Gros M, Ginebreda A, Cespedes-Sánchez R, Ventura F, Petrovic M and Barcelo D 
(2011), Occurrence, partition and removal of pharmaceuticals in sewage water and 
sludge during wastewater treatment, Water Research. In Press, Accepted 
Manuscript. 
Jobling S, Nolan M, Tyler C R, Brighty G and Sumpter J P (1998), Widespread Sexual 
Disruption in Wild Fish, Environmental Science & Technology. 32: 2498-2506. 
Jones J G, Gardener S, Simon B M and Pickup R W (1986), Antibiotic resistant bacteria in 
Windermere and two remote upland tarns in the English Lake District, Journal of 
Applied Microbiology. 60: 443-453. 
Joss A, Zabczynski S, Göbel A, Hoffmann B, Löffler D, McArdell C S, Ternes T A, Thomsen A 
and Siegrist H (2006), Biological degradation of pharmaceuticals in municipal 
wastewater treatment: Proposing a classification scheme, Water Research. 40: 1686-
1696. 
Junco T, Teresa M, Margarita G, Toledo P, Luisa M, Pablo L, Barrasa M and Luis J (2001), 
Identification and antibiotic resistance of faecal enterococci isolated from water 
samples, International Journal of Hygiene and Environmental Health. 203: 363-368. 
Kafka A P, Kleffmann T, Rades T and McDowell A (2011), The application of MALDI TOF MS in 
biopharmaceutical research, International Journal of Pharmaceutics. 417: 70-82. 
Kahlmeter G, Brown D, Goldstein F, MacGowan A, Mouton J, A.Österlund, Rodloff A, 
Steinbakk M, Urbaskova P and Vatopoulos A (2003a), European harmonization of 
MIC breakpoints for antimicrobial susceptibility testing of bacteria, Journal of 
Antimicrobial Chemotherapy: 145-148. 
Kahlmeter G, Brown D F J, Goldstein F W, MacGowan A P, Mouton J W, Ã–sterlund A, 
Rodloff A, Steinbakk M, Urbaskova P and Vatopoulos A (2003b), European 
harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria, 
Journal of Antimicrobial Chemotherapy. 52: 145-148. 
Kaplan E, Ofek M, Jurkevitch E and Cytryn E (2013), Characterization of fluoroquinolone 
resistance and qnr diversity in Enterobacteriaceae from municipal biosolids, Fronteirs 
in Microbiology: 1-7. 
Karthikeyan K G and Meyer M T (2006), Occurrence of antibiotics in wastewater treatment 
facilities in Wisconsin, USA, Science of The Total Environment. 361: 196-207. 
Kasprzyk-Hordern B, Dinsdale R and Guwy A (2008a), Multiresidue methods for the analysis 
of pharmaceuticals, personal care products and illicit drugs in surface water and 
wastewater by solid-phase extraction and ultra performance liquid chromatography 
electrospray tandem mass spectrometry, Analytical and Bioanalytical Chemistry. 391: 
1293-1308. 
Kasprzyk-Hordern B, Dinsdale R M and Guwy A J (2007), Multi-residue method for the 
determination of basic/neutral pharmaceuticals and illicit drugs in surface water by 
solid-phase extraction and ultra performance liquid chromatography-positive 
257 
 
 
electrospray ionisation tandem mass spectrometry, Journal of Chromatography A. 
1161: 132-145. 
Kasprzyk-Hordern B, Dinsdale R M and Guwy A J (2008b), The occurrence of 
pharmaceuticals, personal care products, endocrine disruptors and illicit drugs in 
surface water in South Wales, UK, Water Research. 42: 3498-3518. 
Kasprzyk-Hordern B, Dinsdale R M and Guwy A J (2009), Illicit drugs and pharmaceuticals in 
the environment - Forensic applications of environmental data. Part 1: Estimation of 
the usage of drugs in local communities, Environmental Pollution. 157: 1773-1777. 
Kasprzyk-Hordern B, Dinsdale R M and Guwy A J (2009), The removal of pharmaceuticals, 
personal care products, endocrine disruptors and illicit drugs during wastewater 
treatment and its impact on the quality of receiving waters, Water Research. 43: 363-
380. 
Klein G n (2003), Taxonomy, ecology and antibiotic resistance of enterococci from food and 
the gastro-intestinal tract, International Journal of Food Microbiology. 88: 123-131. 
Knapp C W, Zhang W, Sturm B S M and Graham D W, Differential fate of erythromycin and 
beta-lactam resistance genes from swine lagoon waste under different aquatic 
conditions, Environmental Pollution. 158: 1506-1512. 
Koczura R, Mokracka J, Jablonska L, Gozdecka E, Kubek M and Kaznowski A (2012), 
Antimicrobial resistance of integron-harboring Escherichia coli isolates from clinical 
samples, wastewater treatment plant and river water, Science of The Total 
Environment. 414: 680-685. 
Korezeniewska E (2013), Antibiotic resistant Escherichia coli in hospital and municipal 
sewage and their emmision to the environment, Ecotoxicology and Environmental 
Safety. 91: 96 -102. 
Kos V N, Desjardins C A, Griggs A, Cerqueira G, Van Tonder A, Holden M T G, Godfrey P, 
Palmer K L, Bodi K, Mongodin E F, Wortman J, Feldgarden M, Lawley T, Gill S R, Haas 
B J, Birren B and Gilmore M S (2012), Comparative Genomics of Vancomycin-
Resistant Staphylococcus aureus Strains and Their Positions within the Clade Most 
Commonly Associated with Methicillin-Resistant S. aureus Hospital-Acquired Infection 
in the United States, mBio. 3. 
Kosma C I, Lambropoulou D A and Albanis T A (2014), Occurrence and removal of PPCPs in 
municipal and hospital wastewaters in Greece, Journal of Hazardous Materials. 179: 
804-817. 
Kuhn I, Iversen A, Burman L G, Olsson-Liljequist B, Franklin A, Finn M, Aarestrup F, Seyfarth 
A M, Blanch A R, Taylor H, Caplin J, Moreno M A, Dominguez L and Mullby R (2000), 
Epidemiology and ecology of enterococci, with special reference to antibiotic 
resistant strains, in animals, humans and the environment: Example of an ongoing 
project within the European research programme, International Journal of 
Antimicrobial Agents. 14: 337-342. 
Kuhn I, Iversen A, Burman L G, Olsson-Liljequist B, Franklin A, Finn M, Aarestrup F, Seyfarth 
A M, Blanch A R, Vilanova X, Taylor H, Caplin J, Moreno M A, Dominguez L, Herrero I 
A and Malby R (2003), Comparison of enterococcal populations in animals, humans, 
and the environment - a European study, International Journal of Food Microbiology. 
88: 133-145. 
Kummerer K (2003), Significance of antibiotics in the environment, J. Antimicrob. Chemother. 
52: 5-7. 
258 
 
 
Kummerer K (2004), Resistance in the environment, J. Antimicrob. Chemother. 54: 311-320. 
Kümmerer K (2009a), Antibiotics in the aquatic environment - A review - Part I, 
Chemosphere. 75: 417-434. 
Kümmerer K (2009b), The presence of pharmaceuticals in the environment due to human 
use - present knowledge and future challenges, Journal of Environmental 
Management. 90: 2354-2366. 
Kümmerer K, Al-Ahmad A and Mersch-Sundermann V (2000), Biodegradability of some 
antibiotics, elimination of the genotoxicity and affection of wastewater bacteria in a 
simple test, Chemosphere. 40: 701-710. 
Lacey C, McMahon G, Bones J, Barron L, Morrissey A and Tobin J M (2008), An LCMS method 
for the determination of pharmaceutical compounds in wastewater treatment plant 
influent and effluent samples, Talanta. 75: 1089-1097. 
Layton B A, Walters S P, Lam L H and Boehm A B (2009), Enterococcus species distribution 
among human and animal hosts using multiplex PCR, Journal of Applied 
Microbiology. 109: 539-547. 
Leclercq M, Mathieu O, Gomez E, Casellas C, Fenet H l n and Hillaire-Buys D (2009), Presence 
and Fate of Carbamazepine, Oxcarbazepine, and Seven of Their Metabolites at 
Wastewater Treatment Plants, Archives of Environmental Contamination and 
Toxicology. 56: 408-415. 
Leclercq R, Oberle K, Galopin S, Cattoir V, Budzinski H and Petit F (2007), Changes in 
Enterococcal Populations and Related Antibiotic Resistance along a Medical Center-
Wastewater Treatment Plant-River Continuum, Applied and Environmental 
Microbiology. 79: 2428-2434. 
Lee H-B, Peart T E and Svoboda M L (2007), Determination of ofloxacin, norfloxacin, and 
ciprofloxacin in sewage by selective solid-phase extraction, liquid chromatography 
with fluorescence detection, and liquid chromatography-tandem mass spectrometry, 
Journal of Chromatography A. 1139: 45-52. 
Li B and Zhang T, Mass flows and removal of antibiotics in two municipal wastewater 
treatment plants, Chemosphere. 83: 1284-1289. 
Li Z-H, Zlabek V, Velisek J, Grabic R, Machova J, Kolarova J, Li P and Randak T (2011), Acute 
toxicity of carbamazepine to juvenile rainbow trout (Oncorhynchus mykiss): Effects 
on antioxidant responses, hematological parameters and hepatic EROD, 
Ecotoxicology and Environmental Safety. 74: 319-327. 
Lindqvist N, Tuhkanen T and Kronberg L (2005), Occurrence of acidic pharmaceuticals in raw 
and treated sewages and in receiving waters, Water Research. 39: 2219-2228. 
Loganathan B, Phillips M, Mowery H and Jones-Lepp T L (2009), Contamination profiles and 
mass loadings of macrolide antibiotics and illicit drugs from a small urban 
wastewater treatment plant, Chemosphere. 75: 70-77. 
Loraine G A and Pettigrove M E (2005), Seasonal Variations in Concentrations of 
Pharmaceuticals and Personal Care Products in Drinking Water and Reclaimed 
Wastewater in Southern California, Environmental Science & Technology. 40: 687-
695. 
Luczkiewicz A, Jankowska K, Fudala-Ksiazek S and Olanczuk-Neyman K (2010), Antimicrobial 
resistance of fecal indicators in municipal wastewater treatment plant, Water 
Research. 44: 5089-5097. 
259 
 
 
Maggs J L, Pirmohamed M, Kitteringham N R and Park B K (1997), Characterization of the 
Metabolites of Carbamazepine in Patient Urine by Liquid Chromatography/Mass 
Spectrometry, Drug Metabolism and Disposition. 25: 275-280. 
Maier R M, Pepper I L and Gerba C P (eds) 2009, Environmental Microbiology, 2nd edn, 
Elservier, Oxford. 
Mainardi J-L, Legrand R, Arthur M, Schoot B, van Heijenoort J and Gutmann L (2000), Novel 
Mechanism of beta-Lactam Resistance Due to Bypass of DD-Transpeptidation in 
Enterococcus faecium, Journal of Biological Chemistry. 275: 16490-16496. 
Manafi M (2000), New developments in chromogenic and fluorogenic culture media, 
International Journal of Food Microbiology. 60: 205-218. 
Mannu L, Paba A, Daga E, Comunian R, Zanetti S, DuprÃ¨ I and Sechi L A (2003), Comparison 
of the incidence of virulence determinants and antibiotic resistance between 
Enterococcus faecium strains of dairy, animal and clinical origin, International 
Journal of Food Microbiology. 88: 291-304. 
Marians K J and Hiasa H (1997), Mechanism of Quinolone Action, Journal of Biological 
Chemistry. 272: 9401-9409. 
Marti E and BalcÃ¡zar J L, Real-Time PCR Assays for Quantification of qnr Genes in 
Environmental Water Samples and Chicken Feces, Applied and Environmental 
Microbiology. 79: 1743-1745. 
Marti E, Huerta B, Rodriguez-Mozaz S, Barcelo D, Jofre J and Balcazar J L (2014a), 
Characterization of ciprofloxacin-resistant isolates from a wastewater treatment 
plant and its receiving river, Water Research. 61: 67-76. 
Marti E, Variatza E and Balcazar J L (2014b), The role of aquatic ecosystems as reservoirs of 
antibiotic resistance, Trends in Microbiology. 22: 36-41. 
Martinez J L (2009), Environmental pollution by antibiotics and by antibiotic resistance 
determinants, Environmental Pollution. 157: 2893-2902. 
Martins da Costa P, Oliveira M, Bica A, Vaz-Pires P and Bernardo F (2007), Antimicrobial 
resistance in Enterococcus spp. and Escherichia coli isolated from poultry feed and 
feed ingredients, Veterinary Microbiology. 120: 122-131. 
Martins N, Pereira R, Abrantes N, Pereira J, Gonçalves F and Marques C (2012), 
Ecotoxicological effects of ciprofloxacin on freshwater species: data integration and 
derivation of toxicity thresholds for risk assessment, Ecotoxicology. 21: 1167-1176. 
Matzke G R, Zhanel G G and Guay D R P (1986), Clinical Pharmacokinetics of Vancomycin, 
Clinical Pharmacokinetics. 11: 257-282. 
McArdell C S, Molnar E, Suter M J and Giger W (2003), Occurrence and fate of macrolide 
antibiotics in wastewater treatment plants and in the Glatt Valley watershed, 
Switzerland, Environ Sci Technol. 37: 5479-86. 
McCambridge J and McMeekin T A (1981), Effect of solar radiation and predacious 
microorganisms on survival of fecal and other bacteria, Applied and Environmental 
Microbiology. 41: 1083-1087. 
McDermott P J, Gowland P and Gowland P C (1993), Adaptation of Escherichia coli growth 
rates to the presence of pBR322, Letters in Applied Microbiology. 17: 139-143. 
Metcalfe C D, Miao X-S, Koenig B G and Struger J (2003), Distribution of acidic and neutral 
drugs in surface waters near sewage treatment plants in the lower Great Lakes, 
Canada, Environmental Toxicology and Chemistry. 22: 2881-2889. 
260 
 
 
Miao X-S, Bishay F, Chen M and Metcalfe C D (2004), Occurrence of Antimicrobials in the 
Final Effluents of Wastewater Treatment Plants in Canada, Environmental Science & 
Technology. 38: 3533-3541. 
Miao X-S, Koenig B G and Metcalfe C D (2002), Analysis of acidic drugs in the effluents of 
sewage treatment plants using liquid chromatography-electrospray ionization 
tandem mass spectrometry, Journal of Chromatography A. 952: 139-147. 
Miao X-S and Metcalfe C D (2003), Determination of Carbamazepine and Its Metabolites in 
Aqueous Samples Using Liquid Chromatography Electrospray Tandem Mass 
Spectrometry, Analytical Chemistry. 75: 3731-3738. 
Moldovan Z (2006), Occurrences of pharmaceutical and personal care products as 
micropollutants in rivers from Romania, Chemosphere. 64: 1808-1817. 
Moore J E, Moore P J A, Millar B C, Goldsmith C E, Loughrey A, Rooney P J and Rao J R 
(2010), The presence of antibiotic resistant bacteria along the River Lagan, 
Agricultural Water Management. 98: 217-221. 
Muela A, Pocino M, Arana I, Justo J I, Iriberri J and Barcina I (1994), Effect of growth phase 
and parental cell survival in river water on plasmid transfer between Escherichia coli 
strains, Applied and Environmental Microbiology. 60: 4273-4278. 
Munir M, Wong K and Xagoraraki I (2011), Release of antibiotic resistant bacteria and genes 
in the effluent and biosolids of five wastewater utilities in Michigan, Water Research. 
45: 681-693. 
Munoz-Aguayo J, Lang K S, LaPara T M, Gonzalez G and Singer R S (2007), Evaluating the 
Effects of Chlortetracycline on the Proliferation of Antibiotic-Resistant Bacteria in a 
Simulated River Water Ecosystem, Applied and Environmental Microbiology. 73: 
5421-5425. 
Musolff A, Leschik S, Möder M, Strauch G, Reinstorf F and Schirmer M (2009), Temporal and 
spatial patterns of micropollutants in urban receiving waters, Environmental 
Pollution. 157: 3069-3077. 
Nafsika G (2007), Antibiotic Resistance in Enterobacteria, in Bacterial Resistance to 
Antimicrobials, Second Edition, CRC Press, pp. 343-362. 
Novo A, Andre S, Viana P, Nunes O C and Manaia C M (2010), Antibiotic resistance, 
antimicrobial residues and bacterial community composition in urban wastewater, 
Water Research. 47: 1875-1887. 
Novo A, Andre S, Viana P, Nunes O C and Manaia C M (2013), Antibiotic resistance, 
antimicrobial residues and bacterial community in urban wastewater, Water 
Research. 47: 1875-1887. 
Nozal L, Arce L, Simonet B M, Ríos A and Valcárcel M (2004), Rapid determination of trace 
levels of tetracyclines in surface water using a continuous flow manifold coupled to a 
capillary electrophoresis system, Analytica Chimica Acta. 517: 89-94. 
O'Brien E and Dietrich D R (2004), Hindsight rather than foresight: reality versus the EU draft 
guideline on pharmaceuticals in the environment, Trends in Biotechnology. 22: 326-
330. 
Ohlsen K, T T, Werner G, Wallner U, Löffler D, W.Ziebuhr, W W W and Hacker J (2003), 
Impact of antibiotics on conjugational resistance gene transfer in Staphylococcus 
aureus in sewage  Environmental Microbiology. 5: 711-716. 
261 
 
 
Öllers S, Singer H P, Fässler P and Müller S R (2001), Simultaneous quantification of neutral 
and acidic pharmaceuticals and pesticides at the low-ng/l level in surface and waste 
water, Journal of Chromatography A. 911: 225-234. 
Olson B H, Clark D L, Milner B B, Stewart M H and Wolfe R L (1991), Total coliform detection 
in drinking water: comparison of membrane filtration with Colilert and Coliquik, 
Applied and Environmental Microbiology. 57: 1535-1539. 
Ort C, Lawrence M G, Reungoat J, Eaglesham G, Carter S and Keller J (2010), Determining the 
fraction of pharmaceutical residues in wastewater originating from a hospital, Water 
Research. 44: 605-615. 
Park S and Choi K (2008), Hazard assessment of commonly used agricultural antibiotics on 
aquatic ecosystems, Ecotoxicology. 17: 526-538. 
Paterson D L and Bonomo R A (2005), Extended-Spectrum beta-Lactamases: a Clinical 
Update, Clinical Microbiology Reviews. 18: 657-686. 
Pathak S P and Bhattacherjee J W (1994), Effect of pollutants on survival of Escherichia coli in 
microcosms of river water, Bulletin of Environmental Contamination and Toxicology. 
53: 198-203. 
Pathak S P, Bhattacherjee J W and Ray P K (1993), Seasonal varaitaion in survival and 
antibiotic resistance among various bacterial populations in a tropic river, The 
Journal of General and Applied Microbiology 39: 47-56. 
Payán M R, López M Á B, Fernández-Torres R, Mochón M C and Ariza J L G (2010), 
Application of hollow fiber-based liquid phase microextraction (HF-LPME) for the 
determination of acidic pharmaceuticals in wastewaters, Talanta. I. 
Pechere J (2001), Macrolide resistance mechanisms in Gram-positive cocci, International 
Journal of Antimicrobial Agents. 18, Supplement 1: 25-28. 
Pedrouzo M, Borrull F, Marcé R M and Pocurull E (2008), Simultaneous determination of 
macrolides, sulfonamides, and other pharmaceuticals in water samples by solid-
phase extraction and LC-(ESI) MS, Journal of Separation Science. 31: 2182-2188. 
Pedrouzo M, Borrull F, Pocurull E and Marce R (2011), Presence of Pharmaceuticals and 
Hormones in Waters from Sewage Treatment Plants, Water, Air, & Soil Pollution. 
217: 267-281. 
Pei R, Kim S-C, Carlson K H and Pruden A (2006), Effect of River Landscape on the sediment 
concentrations of antibiotics and corresponding antibiotic resistance genes (ARG), 
Water Research. 40: 2427-2435. 
Pérez S and Barceló D (2007), Application of advanced MS techniques to analysis and 
identification of human and microbial metabolites of pharmaceuticals in the aquatic 
environment, TrAC Trends in Analytical Chemistry. 26: 494-514. 
Petrovic M, Gonzalez S and Barceló D (2003), Analysis and removal of emerging 
contaminants in wastewater and drinking water, TrAC Trends in Analytical Chemistry. 
22: 685-696. 
Petrovic M, Skrbic B, zivancev•ev J, Ferrando-Climent L and Barcelo D (2014), Determination 
of 81 pharmaceutical drugs by high performance liquid chromatography coupled to 
mass spectrometry with hybrid triple quadrupole linear ion trap in different types of 
water in Serbia, Science of The Total Environment. 468: 415-428. 
Picao R C, Poirel L, Demarta A, Silva C S, Corvaglia A R, Petrini O and Nordmann P (2008), 
Plasmid-mediated quinolone resistance in Aeromonas allosaccharophila recovered 
from a Swiss lake, Journal of Antimicrobial Chemotherapy. 62: 948-950. 
262 
 
 
Plosz B G, Leknes H, Liltved H and Thomas K V, Diurnal variations in the occurrence and the 
fate of hormones and antibiotics in activated sludge wastewater treatment in Oslo, 
Norway, Science of The Total Environment. 408: 1915-1924. 
Polesel F, Lehnberg K, Dott W, Trapp S, Thomas K V and Ploz B G (2014), Factors influencing 
sorption of ciprofloxacin onto activated sludge: Experimental assessment and 
modelling implications, Chemosphere. 119: 105-111. 
Portillo A, Ruiz-Larrea F, Zarazaga M, Alonso A, Martinez J L and Torres C (2000), Macrolide 
Resistance Genes in Enterococcus spp, Antimicrobial Agents and Chemotherapy. 44: 
967-971. 
Quintana J B, Rodil R, López-Mahía P, Muniategui-Lorenzo S and Prada-Rodríguez D (2009), 
Investigating the chlorination of acidic pharmaceuticals and by-product formation 
aided by an experimental design methodology, Water Research. 44: 243-255. 
Quintana J B, Weiss S and Reemtsma T (2005), Pathways and metabolites of microbial 
degradation of selected acidic pharmaceutical and their occurrence in municipal 
wastewater treated by a membrane bioreactor, Water Research. 39: 2654-2664. 
R C. Picão L P, A. Demarta, C S. Silva, A R. Corvaglia, O. Petrini, P. Nordmann (2008), Plasmid-
mediated quinolone resistance in Aeromonas allosaccharophila recovered from a 
Swiss lake, Journal of Antimicrobial Chemotherapy. 62: 948-950. 
Radjenovic J, Petrovic M and Barceló D (2009), Fate and distribution of pharmaceuticals in 
wastewater and sewage sludge of the conventional activated sludge (CAS) and 
advanced membrane bioreactor (MBR) treatment, Water Research. 43: 831-841. 
Reinthaler F F, Feierl G, Galler H, Haas D, Leitner E, Mascher F, Melkes A, Posch J, Winter I, 
Zarfel G and Marth E, ESBL-producing E. coli in Austrian sewage sludge, Water 
Research. 44: 1981-1985. 
Renew J E and Huang C-H (2004), Simultaneous determination of fluoroquinolone, 
sulfonamide, and trimethoprim antibiotics in wastewater using tandem solid phase 
extraction and liquid chromatography-electrospray mass spectrometry, Journal of 
Chromatography A. 1042: 113-121. 
Rennie R P, Turnbull L, Brosnikoff C and Cloke J (2012), First Comprehensive Evaluation of 
the M.I.C. Evaluator Device Compared to Etest and CLSI Reference Dilution Methods 
for Antimicrobial Susceptibility Testing of Clinical Strains of Anaerobes and Other 
Fastidious Bacterial Species, Journal of Clinical Microbiology. 50: 1153-1157. 
Resch M S, Nerz C, Rosenstein R, Gaz F and Hertel C (2011), DNA microarray based detection 
of genes involved in safety and technologically relevant properties of food associated 
coagulase-negative staphylococci, International Journal of Food Microbiology. 145: 
449-458. 
Retsema J and Fu W (2001), Macrolides: structures and microbial targets, International 
Journal of Antimicrobial Agents. 18, Supplement 1: 3-10. 
Rico A, Dimitrov M R, Van Wijngaarden R P A, Satapornvanit K, Smidt H and Van den Brink P 
J (2014), Effects of the antibiotic enrofloxacin on the ecology of tropical eutrophic 
freshwater microcosms, Aquatic Toxicology. 147: 92-104. 
Roberts P H and Thomas K V (2006), The occurrence of selected pharmaceuticals in 
wastewater effluent and surface waters of the lower Tyne catchment, Science of The 
Total Environment. 356: 143-153. 
Robicsek A, Jacoby G A and Hooper D C (2006), The worldwide emergence of plasmid-
mediated quinolone resistance, The Lancet Infectious Diseases. 6: 629-640. 
263 
 
 
S. Mushtaq, M. Warner, J. Cloke, M. Afzal-Shah and M.Livermore D (2010), Performance of 
the Oxoid M.I.C.Evaluator™ Strips compared with the Etest® assay and BSAC agar 
dilution, Journal of Antimicrobial Chemotherapy. 65: 1702-1711. 
Sanchez-Prado L, Llompart M, Lores M, García-Jares C, Bayona J M and Cela R (2006), 
Monitoring the photochemical degradation of triclosan in wastewater by UV light 
and sunlight using solid-phase microextraction, Chemosphere. 65: 1338-1347. 
Schluter A, Szczepanowski R, Kurz N, Schneiker S, Krahn I and Puhler A (2007), Erythromycin 
resistance-conferring plasmid pRSB105, isolated from a sewage treatment plant, 
harbors a new macrolide resistance determinant, an integron-containing Tn402-like 
element, and a large region of unknown function, Applied and Environmental 
Microbiolgy  
Schwartz T, Kohnen W, Jansen B and Obst U (2003), Detection of antibiotic-resistant bacteria 
and their resistance genes in wastewater, surface water, and drinking water biofilms, 
FEMS Microbiology Ecology. 43: 325-335. 
Schwarz S, Silley P, Simjee S, Woodford N, van Duijkeren E, Johnson A P and Gaastra W 
(2010), Assessing the antimicrobial susceptibility of bacteria obtained from animals, 
Veterinary Microbiology. 141: 1-4. 
Seifrtová M, Nováková L, Lino C, Pena A and Solich P (2009), An overview of analytical 
methodologies for the determination of antibiotics in environmental waters, 
Analytica Chimica Acta. 649: 158-179. 
Senta I, Mato M, Jakopovi H K, Terzic S, Ä†urko J, MijatoviÄ I and Ahel M (2011), Removal of 
antimicrobials using advanced wastewater treatment, Journal of Hazardous 
Materials. 192: 319-328. 
Senta I, Terzia S and Ahel M (2008), Simultaneous Determination of Sulfonamides, 
Fluoroquinolones, Macrolides and Trimethoprim in Wastewater and River Water by 
LC-Tandem-MS, Chromatographia. 68: 747-758. 
Servais P and Passerat J (2009), Antimicrobial resistance of fecal bacteria in waters of the 
Seine river watershed (France), Science of The Total Environment. 408: 365-372. 
Sharma V K (2008), Oxidative transformations of environmental pharmaceuticals by Cl2, 
ClO2, O3, and Fe (VI): Kinetics assessment, Chemosphere. 73: 1379-1386. 
Shibata K, Amemiya T and Itoh K (2014), Effects of oxytetracycline on populations and 
community metabolism of an aquatic microcosm, Ecological Research. 29: 401-410. 
Sidrach-Cardona R, Hijosa-Valsero M, Marti E, Balcazar J L and Becares E (2014), Prevalence 
of antibiotic-resistant fecal bacteria in a river impacted by both an antibiotic 
production plant and urban treated discharges, Science of The Total Environment. 
488: 220-227. 
Silley P, de Jong A, Simjee S and Thomas V (2011), Harmonisation of resistance monitoring 
programmes in veterinary medicine: an urgent need in the EU?, International Journal 
of Antimicrobial Agents. 37: 504-512. 
Silva B F d, Jelic A, Lopez-Serna R, Mozeto A A, Petrovic M and Barcelo D (2011), Occurrence 
and distribution of pharmaceuticals in surface water, suspended solids and sediments 
of the Ebro river basin, Spain, Chemosphere. 85: 1331-1339. 
Silva F D, Tiago M, Veríssimo I, Boaventura A, Nunes O C and Manaia C M (2006), Antibiotic 
resistance of enterococci and related bacteria in an urban wastewater treatment 
plant, FEMS Microbiology Ecology. 55: 322-329. 
264 
 
 
Silva F d, Vaz-Moreira M, Gonzalez-Pajuelo I, Nunes M and Manaia C M (2007), 
Antimicrobial resistance patterns in Enterobacteriaceae isolated from an urban 
wastewater treatment plant, FEMS Microbiology Ecology. 60: 166-176. 
Sim W-J, Lee J-W, Lee E-S, Shin S-K, Hwang S-R and Oh J-E (2011), Occurrence and 
distribution of pharmaceuticals in wastewater from households, livestock farms, 
hospitals and pharmaceutical manufactures, Chemosphere. 82: 179-186. 
Sinton L W, Donnison A M and Hastie C M (1993), Faecal streptococci as faecal pollution 
indicators: A review. Part II: Sanitary significance, survival, and use, New Zealand 
Journal of Marine and Freshwater Research. 27: 117-137. 
Sinton L W, Hall C H, Lynch P A and Davies-Colley R J (2002), Sunlight Inactivation of Fecal 
Indicator Bacteria and Bacteriophages from Waste Stabilization Pond Effluent in 
Fresh and Saline Waters, Applied and Environmental Microbiology. 68: 1122-1131. 
Snook D L and Whitehead P G (2004), Water quality and ecology of the River Lee: mass 
balance and a review of temporal and spatial data, Hydrol. Earth Syst. Sci. 8: 636-
650. 
Sorensen S J, Bailey M, Hansen L H, Kroer N and Wuertz S (2005), Studying plasmid 
horizontal transfer in situ: a critical review, Nat Rev Micro. 3: 700-710. 
Spongberg A L and Witter J D (2008), Pharmaceutical compounds in the wastewater process 
stream in Northwest Ohio, Science of The Total Environment. 397: 148-157. 
Stackelberg P E, Furlong E T, Meyer M T, Zaugg S D, Henderson A K and Reissman D B (2004), 
Persistence of pharmaceutical compounds and other organic wastewater 
contaminants in a conventional drinking-water-treatment plant, Science of The Total 
Environment. 329: 99-113. 
Standard Methods Committee (SMC), Standard Methods for the Examination of Water and 
Wastewater Available from: <http://www.standardmethods.org/>. [July 2012]. 
Stepanauskas R, Glenn T C, Jagoe C H, Tuckfield R C, Lindell A H, King C J and McArthur J V 
(2006), Coselection for microbial resistance to metals and antibiotics in freshwater 
microcosms, Environmental Microbiology. 8: 1510-1514. 
Stülten D, Zühlke S, Lamshöft M and Spiteller M (2008), Occurrence of diclofenac and 
selected metabolites in sewage effluents, Science of The Total Environment. 405: 
310-316. 
Sturini M, Speltini A, Pretali L, Fasani E and Profumo A (2009), Solid-phase extraction and 
HPLC determination of fluoroquinolones in surface waters, Journal of Separation 
Science. 32: 3020-3028. 
Swenson J M, Facklam R R and Thornsberry C (1990), Antimicrobial susceptibility of 
vancomycin-resistant Leuconostoc, Pediococcus, and Lactobacillus species, 
Antimicrobial Agents and Chemotherapy. 34: 543-549. 
Szczepanowski R, Krahn I, Bohn N, Puhler A and Schluter A (2007), Novel macrolide 
resistance module carried by the IncP-1beta resistance plasmid pRSB111, isolated 
from a wastewater treatment plant, Antimicrob Agents Chemother. 2007 
Feb;51(2):673-8. Epub 2006 Nov 13. 
Szczepanowski R, Linke B, Krahn I, Gartemann K-H, GÃ¼tzkow T, Eichler W, PÃ¼hler A and 
SchlÃ¼ter A (2009), Detection of 140 clinically relevant antibiotic-resistance genes in 
the plasmid metagenome of wastewater treatment plant bacteria showing reduced 
susceptibility to selected antibiotics, Microbiology. 155: 2306-2319. 
265 
 
 
Tennstedt T, Szczepanowski R, Krahn I, Puhler A and Schluter A (2005), Sequence of the 
68,869 bp IncP-1alpha plasmid pTB11 from a waste-water treatment plant reveals a 
highly conserved backbone, a Tn402-like integron and other transposable elements, 
Plasmid. 2005 May;53(3):218-38. Epub 2004 Dec 9. 
Ternes and Joss (eds) 2008, Human Pharmaceuticals, Hormones and Fragrances, IWA 
Publishing, London. 
Ternes T A (1998), Occurrence of drugs in German sewage treatment plants and rivers, 
Water Research. 32: 3245-3260. 
Ternes T A, Herrmann N, Bonerz M, Knacker T, Siegrist H and Joss A (2004), A rapid method 
to measure the solid-water distribution coefficient (Kd) for pharmaceuticals and musk 
fragrances in sewage sludge, Water Research. 38: 4075-4084. 
Thames Water, A630 Deephams Sewage Works Upgrade, Treatment Options Assessment, 
Stage 2b Report, Public consultation version. Available from: 
<http://www.thameswater.co.uk/deephams/Treatment_options_assessment.pdf>. 
Thames Water, 15th May 2014, Lee Tunnel. Available from: 
<http://www.thameswater.co.uk/about-us/10113.htm>. [23rd May 2014]. 
The Environment Agency, 05 September 2013, Case study – Water quality in the Lower Lee 
catchment. Available from: <http://www.environment-
agency.gov.uk/research/library/publications/116038.aspx>. [12 January 2014]. 
The European Committee on Antimicrobial Susceptibility Testing - EUCAST, Antibiotic 
Suceptibility Testing. Available from: 
<http://www.eucast.org/antimicrobial_susceptibility_testing/>. [27th September 
2014]. 
The NHS Information Centre - Prescribing and Primary Care Services, Hospital Prescribing, 
England: 2010. Available from: <http://www.ic.nhs.uk/statistics-and-data-
collections/primary-care/prescriptions/hospital-prescribing-england-2010>. [January 
2012]. 
The Organisation for Economic Co-operation and Development 2013, OECD Guidelines for 
the Testing of Chemicals. 
Tong L, Li P, Wang Y and Zhu K (2009), Analysis of veterinary antibiotic residues in swine 
wastewater and environmental water samples using optimized SPE-LC/MS/MS, 
Chemosphere. 74: 1090-1097. 
Tremblay D, Dupront A, Ho C, Coussediere D and Lenfant B (1990), Pharmacokinetics of 
cefpodoxime in young and elderly volunteers after single doses, Journal of 
Antimicrobial Chemotherapy. 26: 21-28. 
Tuc Dinh Q, Alliot F, Moreau-Guigon E, Eurin J l, Chevreuil M and Labadie P (2011), 
Measurement of trace levels of antibiotics in river water using on-line enrichment 
and triple-quadrupole LC-MS/MS, Talanta. 85: 1238-1245. 
Turndge J (2005), Antimicrobial susceptibilty on solid media, in Antibiotics in laboratory 
medicine, 5th edn, ed. F Destefano, Lippiniott Williams and Wilkins, Philadelphia, p. 
889. 
Turnidge J, Kahlmeter G and Kronvall G (2006), Statistical characterisation of bacterial wild-
type MIC value distributions and the determination of epidemiological cut-off values, 
Clinical Microbiology and Infection. 12: 418-425. 
UK Technical Advisory Group on the Water Framework Directive  (UKTAG) (2008), UK 
ENVIRONMENTAL STANDARDS AND CONDITIONS. 
266 
 
 
US Food and Drug Administration, October 2010, Most Probable Number from Serial 
Dilutions. Available from: 
<http://www.fda.gov/Food/FoodScienceResearch/LaboratoryMethods/ucm109656.
htm>. [March 2014]. 
UWWTD (1991), Council Directive 91/271/EEC of 21 May 1991 concerning urban waste-
water treatment. Official journal L 135, 30.5.1991, p. 40–52. 
Valcarcel Y, Gonzalez Alonso S, Rodriguez-Gil J L, Gil A and Catala M (2011), Detection of 
pharmaceutically active compounds in the rivers and tap water of the Madrid Region 
(Spain) and potential ecotoxicological risk, Chemosphere. 84: 1336-1348. 
van Elsas J D, Semenov A V, Costa R and Trevors J T (2011), Survival of Escherichia coli in the 
environment: fundamental and public health aspects, ISME J. 5: 173-183. 
Vargha M r, TakÃ¡ts Z n, Konopka A and Nakatsu C H (2006), Optimization of MALDI-TOF MS 
for strain level differentiation of Arthrobacter isolates, Journal of Microbiological 
Methods. 66: 399-409. 
Verlicchi P, Al Aukidy M, Jelic A, Petrovic M and Barcelo D (2014a), Comparison of measured 
and predicted concentrations of selected pharmaceuticals in wastewater and surface 
water: A case study of a catchment area in the Po Valley (Italy), Science of The Total 
Environment. 470â€“471: 844-854. 
Verlicchi P, Al Aukidy M and Zambello E (2014b), Occurrence of pharmaceutical compounds 
in urban wastewater: Removal, mass load and environmental risk after a secondary 
treatmentâ€”A review, Science of The Total Environment. 429: 123-155. 
Vieno N, Tuhkanen T and Kronberg L (2007), Elimination of pharmaceuticals in sewage 
treatment plants in Finland, Water Research. 41: 1001-1012. 
Vieno N M, Tuhkane T and L K (2006), Analysis of neutral and basic pharmaceuticals in 
sewage treatment plants and in recipient rivers using solid phase extraction and 
liquid chromatography-tandem mass spectrometry detection, Journal of 
Chromatography A. 1134: 101-111. 
Vione D, Feitosa-Felizzola J, Minero C and Chiron S (2009), Phototransformation of selected 
human-used macrolides in surface water: Kinetics, model predictions and 
degradation pathways, Water Research. 43: 1959-1967. 
Volkmann H, Schwartz T, Bischoff P, Kirchen S and Obst U (2004), Detection of clinically 
relevant antibiotic-resistance genes in municipal wastewater using real-time PCR 
(TaqMan), Journal of Microbiological Methods. 56: 277-286. 
Vulliet E and Cren-Olive C (2011), Screening of pharmaceuticals and hormones at the 
regional scale, in surface and groundwaters intended to human consumption, 
Environmental Pollution. 159: 2929-2934. 
Walsh F (2013), Investigating antibiotic resistance in non-clinical environments, Frontiers in 
Microbiology. 4. 
Wang X-H and Lin A Y-C (2012), Phototransformation of cephalosporin antibiotics in an 
aqueous environment results in higher toxicity, Environmental Science & Technology. 
46: 12417-12426. 
Watanakunakorn C (1984), Mode of action and in-vitro activity of vancomycin, Journal of 
Antimicrobial Chemotherapy. 14: 7-18. 
Watkinson A J, Micalizzi G R, Bates J R and Costanzo S D (2007a), Novel method for rapid 
assessment of antibiotic resistance in Escherichia coli isolates from environmental 
267 
 
 
waters by use of a modified chromogenic agar, Appl. Environ. Microbiol. 73: 2224-
2229. 
Watkinson A J, Murby E J and Costanzo S D (2007b), Removal of antibiotics in conventional 
and advanced wastewater treatment: Implications for environmental discharge and 
wastewater recycling, Water Research. 41: 4164-4176. 
Watkinson A J, Murby E J, Kolpin D W and Costanzo S D (2009), The occurrence of antibiotics 
in an urban watershed: From wastewater to drinking water, Science of The Total 
Environment. 407: 2711-2723. 
Wellington E M H, Boxall A B A, Cross P, Feil E J, Gaze W H, Hawkey P M, Johnson-Rollings A 
S, Jones D L, Lee N M, Otten W, Thomas C M and Williams A P (2013), The role of the 
natural environment in the emergence of antibiotic resistance in Gram-negative 
bacteria, The Lancet Infectious Diseases. 13: 155-165. 
Wexler Philip (2001), TOXNET: An evolving web resource for toxicology and environmental 
health information, Toxicology. 157: 3-10. 
WFD (2000), Directive 2000/60/EC of the European Parliament and of the Council of 23 
October 2000 establishing a framework for Community action in the field of water 
policy. Official journal L 327, 22.12.2000, p. 1–73. 
Wiegel S, Aulinger A, Brockmeyer R, Harms H, Loffler J, Reincke H, Schmidt R, Stachel B, von 
Tumpling W and Wanke A (2004), Pharmaceuticals in the river Elbe and its 
tributaries, Chemosphere. 57: 107-126. 
Winston L G, Pang S, Haller B L, Wong M, Chambers Iii H F and Perdreau-Remington F 
(2004), API 20 strep identification system may incorrectly speciate enterococci with 
low level resistance to vancomycin, Diagnostic Microbiology and Infectious Disease. 
48: 287-288. 
Wishart D, Knox C, Guo A, Cheng D, Shrivastava S, Tzur D, Gautam B and Hassanali M (2008), 
DrugBank - a knowledgebase for drugs, drug actions and drug targets, Nucleic Acids 
Research. 36. 
Wohlsen T D (2011), Comparative evaluation of chromogenic agar CM1046 and mFC agar 
for detection of E. coli and thermotolerant coliform bacteria from water samples, 
Letters in Applied Microbiology. 53: 155-160. 
World Health Organization, Critically important antimicrobials for human medicine - 3rd 
revision [January 2013]. 
Xu W-h, Zhang G, Zou S-c, Li X-d and Liu Y-c (2007), Determination of selected antibiotics in 
the Victoria Harbour and the Pearl River, South China using high-performance liquid 
chromatography-electrospray ionization tandem mass spectrometry, Environmental 
Pollution. 145: 672-679. 
Yu D, Yi X, Ma Y, Yin B, Zhuo H, Li J and Huang Y (2009), Effects of administration mode of 
antibiotics on antibiotic resistance of Enterococcus faecalis in aquatic ecosystems, 
Chemosphere. 76: 915-920. 
Zadoks R N and Watts J L (2009), Species identification of coagulase-negative staphylococci: 
Genotyping is superior to phenotyping, Veterinary Microbiology. 134: 20-28. 
Zhang W, Sturm B S M, Knapp C W and Graham D W (2009), Accumulation of tetracycline 
resistance genes in aquatic biofilms due to periodic waste loadings from swine 
lagoons, Environmental Science & Technology. 43: 7643-7650. 
268 
 
 
Zhang W, Zhang M, Lin K, Sun W, Xiong B, Guo M, Cui X and Fu R (2012), Eco-toxicological 
effect of carbamazepine on Scenedesmus obliquus and Chlorella pyrenoidosa, 
Environmental Toxicology and Pharmacology. 33: 344-352. 
Zhang Y, GeiBen S-U and Gal C (2008), Carbamazepine and diclofenac: Removal in 
wastewater treatment plants and occurrence in water bodies, Chemosphere. 73: 
1151-1161. 
Zhang Y, Marrs C F, Simon C and Xi C (2009), Wastewater treatment contributes to selective 
increase of antibiotic resistance among Acinetobacter spp, Science of The Total 
Environment. 407: 3702-3706. 
Zorita S, Martensson L and Mathiasson L (2009), Occurrence and removal of 
pharmaceuticals in a municipal sewage treatment system in the south of Sweden, 
Science of The Total Environment. 407: 2760-2770. 
Zuccato E, Castiglioni S, Bagnati R, Melis M and Fanelli R (2010), Source, occurrence and fate 
of antibiotics in the Italian aquatic environment, Journal of Hazardous Materials. 
179: 1042-1048. 
Zurfluh K (2013), Characteristics of Extended - spectrum Beta-Lactamase- and 
carbapenemase- producing Enterobacteriaceae Isolates from Rivers and Lakes in 
Switzerland, Applied Environmental Microbiology. 79: 3021. 
 
 
  
269 
 
 
Appendix 1 
Biochemical tests included in the API 20E system (Biomerieux, 2005) 
Test Media substrate 
To detect the following 
Enzyme activity/ reaction 
Positive 
reaction 
Negative 
reaction 
ONPG 
2-nitrophenyl-ßD-
galactopyranoside 
ß-galactosidase Yellow No colour 
ADH L-arginine Arginine Dihydrolase Yellow red 
LDC L-Lysine Lysine decarboxylase Yellow red 
ODC L-ornithine Ornithine Decarboxylase Yellow red 
CIT trisodium citrate citritase Pale yellow Blue 
H2S sodium thiosulfate Production hydrogen sulfide Colourless Black 
URE Urea Urease Yellow Red 
TDA L-Tryptophan Tryptophane DeAminase Yellow Brown 
IND L-Tryptophan Tryptophane DeAminase Colourless Pink 
VP sodium pyruvate 
Acetyl-methyl-carbinol 
production 
Colourless Pink 
GEL Gelatin (bovine origin) Gelatinase No diffusion Diffusion 
GLU D-Glucose Fermentation-oxidation Blue Yellow 
MAN D-Mannitol Fermentation-oxidation Blue Yellow 
INO D-Insitol Fermentation-oxidation Blue Yellow 
SOR D-Sorbitol Fermentation-oxidation Blue Yellow 
RHA L-Rhamnose Fermentation-oxidation Blue Yellow 
SAC D-Saccharose Fermentation-oxidation Blue Yellow 
MEL D-Melibose Fermentation-oxidation Blue Yellow 
AMY Amydaline Fermentation-oxidation Blue Yellow 
ARA L-Arabinose Fermentation-oxidation Blue Yellow 
The oxidase test is included in the profile 
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Appendix 2 
Biochemical tests included in the API 20 Strep system 
Test Media substrate 
To detect the following 
Enzyme activity/ reaction 
Positive 
reaction 
Negative 
reaction 
VP sodium pyruvate 
Acetyl-methyl-carbinol 
production 
Colourless Pink 
HIP Hippuric acid Hydrolysis by Hippuricase Colourless Dark blue 
ESC Esculin ferric citrate 
Hydrolysis of esculin by Β-
Glucosidase 
Colourless Black 
PYRA 
Pyroglutamic acid β-
naphthylamide 
Pyrorolidonyl arylamidase 
activity 
Colourless Orange 
αGAL 
6-bromo – 2 –
naphthyl-αD-
galactopyranoside 
α Galactosidase activity Colourless Violet 
βGUR 
Naphthol ASBI-
glucuronic acid 
β Glucuronidase activity Colourless Blue 
βGAL 
2-naphthyl - β 
Galactopyranoside 
β Galactosidase activity Colourless Violet 
PAL 2-naphthyl phosphate Alkaline Phosphatase Colourless Violet 
LAP 
L-leucine-ß-
naphtylamide 
Leucine AminoPeptidase Colourless orange 
ADH L-arginine Arginine Dihydrolase Yellow red 
RIB D-ribose Acidification Red Yellow 
ARA L-Arabinose Fermentation-oxidation Blue Yellow 
MAN D-Mannitol Fermentation-oxidation Blue Yellow 
LAC D-lactose Acidification Red Yellow 
TRE D-trehalose Acidification Red Yellow 
INU Inulin Acidification Red Yellow 
RAF D-Raffinose Acidification Red Yellow 
AMD Starch Acidification Red Yellow 
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Appendix 3 
Biochemical tests included in the API 20 Staph system 
Test Media substrate 
To detect the following 
Enzyme activity/ reaction 
Positive 
reaction 
Negative 
reaction 
0 No substrate Negative control Red - 
GLU D-glucose Positive control Red Yellow 
FRU D-fructose Acidification Red Yellow 
MNE D-mannose Acidification Red Yellow 
MAL D-maltose Acidification Red Yellow 
LAC D-lactose Acidification Red Yellow 
TRE D-trehalose Acidification Red Yellow 
MAN D-mannitol Acidification Red Yellow 
XLT Xylitol Acidification Red Yellow 
MEL D-melibiose Acidification Red Yellow 
NIT potassium nitrate Reduction of nitrates to nitrites Colourless Red 
PAL ß-naphthyl phosphate alkaline Phosphatase Yellow Violet 
VP sodium pyruvate 
Acetyl-methyl-carbinol 
production 
Colourless Pink 
RAF  D-raffinose Acidification Red Yellow 
XYL D-xylose Acidification Red Yellow 
SAC  D-saccharose Acidification Red Yellow 
MDG  
methyl-
αDglucopyranoside  
Acidification Red Yellow 
NAG  N-acetyl-glucosamine Acidification Red Yellow 
ADH L-arginine Arginine dihydrolase Yellow Red 
URE  urea urease Yellow Red 
The acidification tests should be compared to the negative (0) and positive (GLU) controls. 
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Appendix 4 
Biochemical tests included in the API 20NE system 
Test Media substrate 
To detect the following 
Enzyme activity/ reaction 
Positive 
reaction 
Negative 
reaction 
NO3 Potassium nitrate 
Reduction nitrate to 
nitrites 
Colourless  Pink 
GLU D-Glucose Fermentation-oxidation Pink Colourless 
TRP L-tryptophane Indole production Colourless  Pink 
ADH L-arginine Arginine Dihydrolase Blue Yellow 
URE  urea urease Yellow Orange/red 
ESC Esculin ferric citrate 
Hydrolysis of esculin by Β-
Glucosidase 
Yellow Orange/red 
PNPG 
4-nitrophenyl-β D- 
galactopyranoside 
β-galactosidase (Para-
NitroPhenyl-ßD- 
Galactopyranosidase) 
 
Yellow Brown/black 
GEL Gelatin (bovine origin) Gelatinase No diffusion Diffusion 
GLU D-Glucose  Assimilation  Transparent opaque 
ARA L-Arabinose  Assimilation  Transparent opaque 
MNE D-mannose  Assimilation  Transparent opaque 
MAN D-mannitol  Assimilation  Transparent opaque 
NAG  N-acetyl-glucosamine  Assimilation  Transparent opaque 
MAL D-maltose  Assimilation  Transparent opaque 
CAP Capric acid  Assimilation  Transparent opaque 
ADI adipic acid  Assimilation  Transparent opaque 
MLT Malic acid  Assimilation  Transparent opaque 
CIT trisodium citrate  Assimilation  Transparent opaque 
PAC phenylacetic acid  Assimilation  Transparent opaque 
The oxidase test is included in the profile 
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